data_2ezb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ezb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 4.0700000000000003 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.5 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.8 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92000000000000004 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.5 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.3999999999999999 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 1.26 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.95 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.93999999999999995 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78000000000000003 109.475 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 1.29 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 1.1499999999999999 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.71999999999999997 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.5 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 2.3599999999999999 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 1.1599999999999999 111.188 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 1.3100000000000001 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 1.3100000000000001 110.588 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 2.3500000000000001 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.5800000000000001 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.1400000000000001 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.9299999999999999 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 1.28 109.394 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 1.3700000000000001 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 1.3300000000000001 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 3.1899999999999999 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.8100000000000001 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.8300000000000001 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 1.3400000000000001 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HG ' HE21 ' A' ' 35' ' ' GLN . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.3500000000000001 109.53 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.6100000000000001 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.4700000000000002 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.427 HE21 ' HG ' ' A' ' 32' ' ' SER . 7.2 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 2.0699999999999998 108.803 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 1.3300000000000001 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.9399999999999999 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 1.3300000000000001 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 3.1499999999999999 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.92000000000000004 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 1.4099999999999999 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 1.22 108.266 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.58999999999999997 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 3.3900000000000001 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 1.26 108.151 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.9900000000000002 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 1.1399999999999999 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.8400000000000001 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 1.22 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 2.0 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.99 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 1.24 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 1.21 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 1.53 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 1.24 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 64' ' ' THR . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 2.3199999999999998 107.934 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 1.1699999999999999 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.57999999999999996 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.3899999999999999 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 1.3600000000000001 110.089 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 1.1399999999999999 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.59999999999999998 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.5899999999999999 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2000000000000002 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 2.3599999999999999 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 1.24 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.24 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.80000000000000004 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.56000000000000005 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 2.0600000000000001 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 1.24 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 2.4500000000000002 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 1.21 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 1.1200000000000001 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.3100000000000001 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.1600000000000001 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 1.24 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.79 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 1.1399999999999999 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 1.3200000000000001 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 1.3999999999999999 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 1.23 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.5099999999999998 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.5900000000000001 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 2.3799999999999999 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.6200000000000001 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.8899999999999999 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 1.27 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 1.1599999999999999 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 1.25 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 1.0800000000000001 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 2.02 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.1799999999999999 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 1.1899999999999999 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2000000000000002 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.85999999999999999 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 2.0 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 1.3200000000000001 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.1400000000000001 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.3799999999999999 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.3500000000000001 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.71 108.555 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.8300000000000001 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.5800000000000001 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.7999999999999998 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.27 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.5800000000000001 109.184 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.9199999999999999 108.431 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2000000000000002 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.5299999999999998 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 1.45 107.97 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 1.5 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 1.23 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.73 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.3200000000000001 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 1.2 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.48999999999999999 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.513 ' HZ3' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 3.1099999999999999 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.9500000000000002 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.73 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 1.22 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.513 ' NH2' ' HZ3' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.7799999999999998 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 2.0299999999999998 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 1.2 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 1.28 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68999999999999995 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 1.3100000000000001 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.8799999999999999 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 146' ' ' ILE . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 1.3600000000000001 109.302 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.403 ' CD1' ' H ' ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.9299999999999999 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 1.3400000000000001 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.98 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 1.3799999999999999 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 153' ' ' GLN . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 1.3999999999999999 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.467 ' N ' ' CG2' ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.7400000000000002 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.4099999999999999 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 1.28 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 1.1499999999999999 107.464 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 1.2 109.588 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 1.1599999999999999 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 1.2 109.615 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 1.3200000000000001 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.3399999999999999 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 1.26 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 1.3600000000000001 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.63 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 1.0700000000000001 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 1.1799999999999999 109.561 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.71 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 1.22 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.5499999999999998 109.803 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.96 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 172' ' ' ASN . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 2.46 108.812 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 2.4199999999999999 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 1.1599999999999999 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.95 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.41999999999999998 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.52000000000000002 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 1.1599999999999999 107.462 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 1.22 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.2400000000000002 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.6499999999999999 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 2.1000000000000001 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.8400000000000001 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.7800000000000002 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 3.2400000000000002 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 2.1099999999999999 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 1.0600000000000001 109.522 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 2.0899999999999999 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.8799999999999999 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 2.0099999999999998 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 1.27 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 1.1799999999999999 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.5800000000000001 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 1.1399999999999999 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 1.28 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 1.28 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.69999999999999996 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 1.1899999999999999 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 1.25 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 1.29 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.92000000000000004 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 1.3100000000000001 108.361 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 1.0 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.9199999999999999 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 1.27 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 1.3400000000000001 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 2.0699999999999998 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.8599999999999999 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 1.3 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.6200000000000001 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.3999999999999999 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.54 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 1.25 110.426 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 1.26 107.429 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 1.1799999999999999 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.2200000000000002 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.557 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 1.2 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 1.48 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.8199999999999998 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 2.1099999999999999 109.301 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 2.6499999999999999 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 1.29 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 1.4199999999999999 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 1.26 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 2.1499999999999999 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.81999999999999995 111.495 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 2.1099999999999999 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 3.1699999999999999 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.0600000000000001 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.6499999999999999 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.47 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 3.0 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.6299999999999999 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 3.1600000000000001 109.204 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 4.0700000000000003 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.5 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.8 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92000000000000004 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.5 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 1.3999999999999999 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 1.26 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.95 108.805 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' N ' ' HG ' ' A' ' 8' ' ' SER . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.93999999999999995 113.847 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78000000000000003 109.628 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 1.29 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 1.1499999999999999 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.71999999999999997 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.5 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 2.3599999999999999 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.1599999999999999 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 1.24 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 1.3100000000000001 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 2.3500000000000001 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.5800000000000001 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.9299999999999999 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 1.28 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 1.3700000000000001 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 26' ' ' ILE . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 1.3300000000000001 108.882 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.3700000000000001 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 3.1899999999999999 108.422 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.8100000000000001 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.8300000000000001 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 1.3400000000000001 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.3500000000000001 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.6100000000000001 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.4700000000000002 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 2.0699999999999998 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 1.3300000000000001 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.9399999999999999 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 1.3300000000000001 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 3.1499999999999999 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.92000000000000004 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 1.22 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.58999999999999997 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 3.3900000000000001 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 1.26 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.9900000000000002 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.8400000000000001 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 1.22 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 2.0 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.99 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 1.24 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 1.21 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 1.53 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 1.24 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 2.3199999999999998 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 1.1699999999999999 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.57999999999999996 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.3899999999999999 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.3600000000000001 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 1.1399999999999999 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.59999999999999998 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.5899999999999999 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2000000000000002 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 2.3599999999999999 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 1.24 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 1.24 109.758 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.80000000000000004 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.56000000000000005 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 19.3 m170 -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 2.0600000000000001 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 1.24 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 2.4500000000000002 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 1.21 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 1.1200000000000001 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.3100000000000001 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 1.24 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.79 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 1.1399999999999999 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 1.3200000000000001 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 1.3700000000000001 110.093 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 1.3999999999999999 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.23 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.5099999999999998 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.5900000000000001 112.267 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 2.3799999999999999 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.8899999999999999 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 1.27 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.418 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 1.1599999999999999 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 1.25 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.1299999999999999 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 1.0800000000000001 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 2.02 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 1.1799999999999999 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.1899999999999999 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 106' ' ' GLU . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2000000000000002 110.312 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.85999999999999999 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 2.0 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 1.3200000000000001 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 2.1400000000000001 109.651 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.641 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.3799999999999999 110.079 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.3500000000000001 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.8300000000000001 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.7999999999999998 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.27 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.5800000000000001 110.077 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 127' ' ' ALA . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.9199999999999999 108.342 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2000000000000002 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.5299999999999998 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 1.45 107.626 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 1.5 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.3500000000000001 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 1.23 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.452 HH22 ' HZ3' ' A' ' 135' ' ' LYS . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.73 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.3200000000000001 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 1.2 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.48999999999999999 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HZ3' HH22 ' A' ' 131' ' ' ARG . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 3.1099999999999999 109.144 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.9500000000000002 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.73 109.13 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 1.22 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.7799999999999998 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.6 m120 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 2.0299999999999998 109.171 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 141' ' ' ILE . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 1.2 109.167 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 1.28 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68999999999999995 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 1.3100000000000001 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.406 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.8799999999999999 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 1.3600000000000001 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.9299999999999999 109.354 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 1.3400000000000001 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.98 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 1.3799999999999999 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.7400000000000002 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.4099999999999999 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 1.28 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 1.1499999999999999 108.297 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 1.2 109.489 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 1.1599999999999999 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 1.2 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 1.3200000000000001 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 1.26 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 1.3600000000000001 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.63 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 1.0700000000000001 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 1.1799999999999999 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 1.1399999999999999 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.71 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 1.22 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.5499999999999998 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.96 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 2.46 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 2.4199999999999999 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 1.1599999999999999 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.95 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.41999999999999998 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.52000000000000002 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 1.1599999999999999 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 1.22 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.2400000000000002 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.6499999999999999 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 2.1000000000000001 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.8400000000000001 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.7800000000000002 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 3.2400000000000002 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 2.1099999999999999 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 2.0899999999999999 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.8799999999999999 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 192' ' ' ILE . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 2.0099999999999998 109.746 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 1.27 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 1.1799999999999999 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.512 ' NE ' ' OG ' ' A' ' 191' ' ' SER . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.5800000000000001 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.1399999999999999 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.28 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 1.28 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.69999999999999996 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 1.1899999999999999 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 1.25 107.234 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 1.29 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.92000000000000004 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 203' ' ' VAL . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 1.3100000000000001 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 1.0 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.9199999999999999 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 1.27 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 2.0699999999999998 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.8599999999999999 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 1.3 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.469 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.48 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.6200000000000001 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.3999999999999999 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.54 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 1.25 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 1.26 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.2200000000000002 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 1.2 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 1.48 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 224' ' ' ASN . 2.2 t-20 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.8199999999999998 107.484 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 2.1099999999999999 109.193 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 2.6499999999999999 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 1.29 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 1.4199999999999999 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.26 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 230' ' ' ASN . 0.2 OUTLIER 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 2.1499999999999999 110.128 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.81999999999999995 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 3.1699999999999999 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.0600000000000001 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.6499999999999999 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.47 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 3.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.6299999999999999 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 3.1600000000000001 109.384 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 4.0700000000000003 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.5 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.8 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92000000000000004 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.5 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 1.3999999999999999 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 1.26 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.95 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.93999999999999995 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78000000000000003 109.091 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 1.29 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 1.1499999999999999 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.71999999999999997 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.5 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 2.3599999999999999 109.888 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 1.1599999999999999 110.801 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 1.24 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 1.3100000000000001 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 1.3100000000000001 110.191 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 2.3500000000000001 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.5800000000000001 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.1400000000000001 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.9299999999999999 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 1.28 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 1.3700000000000001 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 1.3300000000000001 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 3.1899999999999999 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.8100000000000001 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.8300000000000001 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 1.3400000000000001 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.3500000000000001 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.6100000000000001 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.4700000000000002 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 2.0699999999999998 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 1.3300000000000001 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.9399999999999999 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 1.3300000000000001 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 3.1499999999999999 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.92000000000000004 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 1.4099999999999999 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 1.22 107.995 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.58999999999999997 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 3.3900000000000001 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 1.26 107.787 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.9900000000000002 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 1.1399999999999999 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.8400000000000001 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 1.22 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.698 HE22 ' ND2' ' A' ' 140' ' ' ASN . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 2.0 109.477 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.99 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 1.24 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 1.21 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 1.53 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 1.24 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 2.3199999999999998 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 1.1699999999999999 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.57999999999999996 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.3899999999999999 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 1.3600000000000001 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 1.1399999999999999 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.59999999999999998 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LYS . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.5899999999999999 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.495 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2000000000000002 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 2.3599999999999999 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 1.24 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 1.24 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.80000000000000004 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.56000000000000005 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 2.0600000000000001 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 77' ' ' ILE . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 1.24 108.263 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 2.4500000000000002 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 1.21 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 1.1200000000000001 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.3500000000000001 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.1600000000000001 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 1.24 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.79 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 1.1399999999999999 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 1.3200000000000001 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 1.3700000000000001 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 1.3999999999999999 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 93' ' ' ILE . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 1.23 110.12 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.5099999999999998 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.5900000000000001 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 2.3799999999999999 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.6200000000000001 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.8899999999999999 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 1.27 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 1.1599999999999999 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 1.25 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 1.1299999999999999 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 1.0800000000000001 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 2.02 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 1.1799999999999999 110.02 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 1.1899999999999999 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2000000000000002 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.85999999999999999 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 2.0 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 1.3200000000000001 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 2.1400000000000001 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.3799999999999999 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.3500000000000001 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.71 108.534 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.8300000000000001 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.5800000000000001 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.27 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.5800000000000001 109.517 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.9199999999999999 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2000000000000002 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.472 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.5299999999999998 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 1.45 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 1.5 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.3500000000000001 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 1.23 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.73 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.3200000000000001 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 133' ' ' ILE . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 1.2 109.432 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.48999999999999999 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 3.1099999999999999 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.9500000000000002 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.73 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 1.22 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.7799999999999998 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.698 ' ND2' HE22 ' A' ' 53' ' ' GLN . 13.5 m120 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 2.0299999999999998 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 1.2 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 1.28 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68999999999999995 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 1.3100000000000001 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.515 ' CB ' ' ND2' ' A' ' 140' ' ' ASN . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.8799999999999999 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 1.3600000000000001 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.9299999999999999 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 1.3400000000000001 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.98 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 1.3799999999999999 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 1.3999999999999999 109.573 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.7400000000000002 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.4099999999999999 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 1.28 109.179 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 1.1499999999999999 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 1.2 109.983 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 1.1599999999999999 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 1.2 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 1.3200000000000001 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.3399999999999999 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 1.26 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 1.3600000000000001 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' A' ' 168' ' ' THR . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.63 113.158 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 1.0700000000000001 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.568 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 1.1799999999999999 109.367 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 1.1399999999999999 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.71 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 1.22 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.675 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.0 OUTLIER -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.5499999999999998 109.989 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.96 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 2.46 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 2.4199999999999999 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 1.1599999999999999 109.386 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.95 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.41999999999999998 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.52000000000000002 110.218 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 1.1599999999999999 107.383 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 1.22 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.2400000000000002 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.6499999999999999 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 2.1000000000000001 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.8400000000000001 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.7800000000000002 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 3.2400000000000002 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.568 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 1.0600000000000001 109.174 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.0899999999999999 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.8799999999999999 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 2.0099999999999998 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 1.27 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 1.1799999999999999 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.5800000000000001 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 1.1399999999999999 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 1.28 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 1.28 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.69999999999999996 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 1.1899999999999999 111.664 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 1.25 106.92 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 1.29 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.92000000000000004 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 203' ' ' VAL . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 1.3100000000000001 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.9199999999999999 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 1.27 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 1.3400000000000001 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 2.0699999999999998 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.8599999999999999 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 1.3 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.48 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 215' ' ' ASP . 0.4 OUTLIER -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.6200000000000001 109.69 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.682 ' H ' HD21 ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.3999999999999999 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.54 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 1.25 110.379 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 1.26 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 1.1799999999999999 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.2200000000000002 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 1.2 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 1.48 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.8199999999999998 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 223' ' ' VAL . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 2.1099999999999999 109.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 2.6499999999999999 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 1.29 109.096 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 1.4199999999999999 109.217 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 1.26 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 2.1499999999999999 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.81999999999999995 112.214 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 2.1099999999999999 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 3.1699999999999999 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.0600000000000001 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.6499999999999999 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.47 109.193 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 3.0 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.6299999999999999 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 3.1600000000000001 108.263 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 4.0700000000000003 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.5 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.8 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92000000000000004 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 6' ' ' LEU . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.5 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 1.3999999999999999 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 1.26 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.95 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.93999999999999995 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78000000000000003 109.218 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 11' ' ' ILE . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 1.29 109.301 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 1.1499999999999999 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.71999999999999997 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.5 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 2.3599999999999999 110.039 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 1.1599999999999999 111.229 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 1.24 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 1.3100000000000001 111.309 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 1.3100000000000001 109.531 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HZ2' ' ND2' ' A' ' 214' ' ' ASN . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 2.3500000000000001 109.271 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.5800000000000001 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.1400000000000001 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.9299999999999999 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 1.28 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 1.3700000000000001 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 1.3300000000000001 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 3.1899999999999999 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.8100000000000001 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.8300000000000001 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 1.3400000000000001 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.3500000000000001 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.6100000000000001 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.4700000000000002 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 2.0699999999999998 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 1.3300000000000001 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.9399999999999999 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 1.3300000000000001 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 3.1499999999999999 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.92000000000000004 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 1.4099999999999999 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 1.22 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.58999999999999997 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 3.3900000000000001 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 1.26 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.9900000000000002 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 109.371 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.8400000000000001 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 1.22 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 2.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.99 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 1.24 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 1.21 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 1.53 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 1.24 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 1.1699999999999999 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.57999999999999996 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.3899999999999999 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 1.3600000000000001 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 1.1399999999999999 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.59999999999999998 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.5899999999999999 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 2.3599999999999999 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 1.24 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 1.24 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.80000000000000004 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.56000000000000005 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 2.0600000000000001 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 1.24 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 2.4500000000000002 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 1.21 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 1.1200000000000001 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.3100000000000001 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 1.24 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.79 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 1.1399999999999999 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 1.3200000000000001 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 1.3700000000000001 110.449 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 1.3999999999999999 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 1.23 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.5099999999999998 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.5900000000000001 112.048 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 2.3799999999999999 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.6200000000000001 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.8899999999999999 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 1.27 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.1599999999999999 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 1.25 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 1.1299999999999999 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 1.0800000000000001 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 2.02 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 1.1799999999999999 109.978 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 1.1899999999999999 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2000000000000002 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.85999999999999999 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 2.0 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 1.3200000000000001 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 2.1400000000000001 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.3799999999999999 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.3500000000000001 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.71 108.386 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.8300000000000001 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.5800000000000001 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.7999999999999998 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.27 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.5800000000000001 109.82 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.9199999999999999 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2000000000000002 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.5299999999999998 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 1.45 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 1.5 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.3500000000000001 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 1.23 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.73 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.3200000000000001 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 1.2 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.48999999999999999 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 3.1099999999999999 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.9500000000000002 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.73 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 1.22 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.7799999999999998 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.571 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 2.0299999999999998 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 1.2 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 1.28 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68999999999999995 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 1.3100000000000001 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.8799999999999999 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 1.3600000000000001 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.503 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.9299999999999999 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 151' ' ' ALA . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 1.3400000000000001 109.16 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.98 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 1.3799999999999999 109.58 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 1.3999999999999999 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.7400000000000002 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.4099999999999999 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 1.28 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 1.1499999999999999 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 1.2 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 1.1599999999999999 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 1.2 109.434 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 1.3200000000000001 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.3399999999999999 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 1.26 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 1.3600000000000001 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.63 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 1.0700000000000001 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 1.1799999999999999 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 1.1399999999999999 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.71 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 1.22 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.5499999999999998 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.96 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 2.46 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 2.4199999999999999 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 1.1599999999999999 108.347 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.95 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.41999999999999998 109.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.52000000000000002 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 1.1599999999999999 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 1.22 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.6499999999999999 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 2.1000000000000001 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.8400000000000001 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.7800000000000002 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 3.2400000000000002 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 2.1099999999999999 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 1.0600000000000001 110.114 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 2.0899999999999999 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.8799999999999999 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.649 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 1.27 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 1.1799999999999999 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.5800000000000001 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 1.28 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 1.28 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.69999999999999996 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 1.1899999999999999 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 1.25 107.205 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 1.29 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.92000000000000004 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 1.3100000000000001 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 1.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.9199999999999999 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 1.27 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 1.3400000000000001 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 2.0699999999999998 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.8599999999999999 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 1.3 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.48 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.489 ' ND2' ' HZ2' ' A' ' 20' ' ' LYS . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.6200000000000001 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.3999999999999999 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.54 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 1.25 109.906 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 1.26 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 1.1799999999999999 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.2200000000000002 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.546 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 1.2 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 1.48 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.8199999999999998 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 2.1099999999999999 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 228' ' ' TYR . 52.5 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 2.6499999999999999 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 1.29 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 226' ' ' GLN . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 1.4199999999999999 109.988 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 1.26 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 2.1499999999999999 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 2.1099999999999999 109.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 3.1699999999999999 109.949 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.0600000000000001 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.6499999999999999 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.47 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 3.0 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.6299999999999999 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 3.1600000000000001 109.602 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 4.0700000000000003 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.5 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.8 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92000000000000004 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.5 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 1.3999999999999999 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 1.26 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.95 108.931 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.93999999999999995 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78000000000000003 109.971 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 11' ' ' ILE . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 1.29 109.267 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.1499999999999999 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.5 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 2.3599999999999999 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 1.1599999999999999 111.579 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 1.24 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 1.3100000000000001 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 1.3100000000000001 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 2.3500000000000001 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.5800000000000001 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.1400000000000001 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.9299999999999999 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 1.28 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 1.3700000000000001 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 1.3300000000000001 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.3700000000000001 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 3.1899999999999999 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.8100000000000001 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.8300000000000001 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.3500000000000001 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.6100000000000001 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 1.3300000000000001 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.9399999999999999 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 1.3300000000000001 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 3.1499999999999999 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.92000000000000004 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 1.4099999999999999 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 1.22 108.451 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.58999999999999997 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 3.3900000000000001 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 1.26 108.44 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.9900000000000002 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 1.1399999999999999 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.8400000000000001 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 1.22 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 2.0 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.99 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 1.24 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.463 ' CD1' HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 1.21 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 1.53 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 1.24 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 2.3199999999999998 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 1.1699999999999999 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.57999999999999996 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.3899999999999999 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 1.3600000000000001 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.581 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 1.1399999999999999 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.59999999999999998 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.5899999999999999 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2000000000000002 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 2.3599999999999999 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 1.24 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 1.24 109.928 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.80000000000000004 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.56000000000000005 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 17.0 m170 -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 2.0600000000000001 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 1.24 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 2.4500000000000002 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 1.21 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 1.1200000000000001 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.3100000000000001 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.3500000000000001 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.1600000000000001 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 1.24 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.79 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 1.1399999999999999 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 1.3200000000000001 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 1.3700000000000001 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 1.3999999999999999 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 1.23 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.5099999999999998 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.5900000000000001 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 2.3799999999999999 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.6200000000000001 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.8899999999999999 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 1.27 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 1.1599999999999999 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 1.25 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.1299999999999999 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 2.02 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 1.1799999999999999 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 1.1899999999999999 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2000000000000002 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.85999999999999999 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 2.0 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 1.3200000000000001 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.431 ' HG ' ' H ' ' A' ' 114' ' ' ALA . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 2.1400000000000001 110.201 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' H ' ' HG ' ' A' ' 113' ' ' SER . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.3799999999999999 110.244 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.3500000000000001 108.917 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.71 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.8300000000000001 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.5800000000000001 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.27 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.5800000000000001 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.9199999999999999 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2000000000000002 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.5299999999999998 106.341 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 1.45 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 1.5 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.3500000000000001 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 1.23 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.73 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.3200000000000001 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 1.2 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.48999999999999999 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 3.1099999999999999 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.527 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.9500000000000002 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.73 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 1.22 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.7799999999999998 110.347 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 4.8 m120 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 2.0299999999999998 109.155 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 1.2 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 1.28 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68999999999999995 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 1.3100000000000001 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.8799999999999999 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 1.3600000000000001 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.9299999999999999 108.975 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 1.3400000000000001 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.98 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 1.3799999999999999 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 1.3999999999999999 108.96 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.7400000000000002 109.334 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.4099999999999999 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 1.28 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 1.1499999999999999 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 1.2 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 1.1599999999999999 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.2 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 1.3200000000000001 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.3399999999999999 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 1.26 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 1.3600000000000001 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.63 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 1.0700000000000001 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 1.1399999999999999 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.71 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 1.22 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.5499999999999998 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.96 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 2.46 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 2.4199999999999999 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 1.1599999999999999 108.714 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.95 109.785 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.41999999999999998 109.571 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.52000000000000002 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 1.1599999999999999 108.861 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 1.22 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.432 ' OD2' ' OG1' ' A' ' 209' ' ' THR . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.2400000000000002 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.6499999999999999 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 2.1000000000000001 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.8400000000000001 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.498 ' CG ' ' NH1' ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.7800000000000002 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 3.2400000000000002 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 1.0600000000000001 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 2.0899999999999999 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.614 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.8799999999999999 110.302 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.614 ' N ' ' HG ' ' A' ' 191' ' ' SER . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 2.0099999999999998 110.989 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 1.27 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 1.1799999999999999 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.5800000000000001 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.1399999999999999 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 1.28 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 1.28 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.69999999999999996 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 1.1899999999999999 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 1.25 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 1.29 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.92000000000000004 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 1.3100000000000001 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 1.0 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.9199999999999999 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 1.27 110.397 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.432 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 1.3400000000000001 110.309 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 2.0699999999999998 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 210' ' ' SER . 26.9 mm100 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.8599999999999999 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 1.3 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.48 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.6200000000000001 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.3999999999999999 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.54 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 1.25 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 1.26 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 1.1799999999999999 108.612 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.2200000000000002 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 1.2 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 1.48 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.8199999999999998 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 2.1099999999999999 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 6.9 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.6499999999999999 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 1.29 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 1.4199999999999999 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 1.26 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 2.1499999999999999 110.094 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.81999999999999995 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 2.1099999999999999 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 3.1699999999999999 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.0600000000000001 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.6499999999999999 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.47 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 3.0 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.6299999999999999 109.901 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 3.1600000000000001 109.663 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 4.0700000000000003 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.5 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.8 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92000000000000004 108.709 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.5 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 1.3999999999999999 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 1.26 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.95 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.93999999999999995 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78000000000000003 109.801 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 1.29 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 1.1499999999999999 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.71999999999999997 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.5 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 2.3599999999999999 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 1.1599999999999999 110.949 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 1.24 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 1.3100000000000001 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 1.3100000000000001 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 2.3500000000000001 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.5800000000000001 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.1400000000000001 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.9299999999999999 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 1.28 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 1.3700000000000001 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 1.3300000000000001 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.3700000000000001 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 3.1899999999999999 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.8100000000000001 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.8300000000000001 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 31' ' ' ILE . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 1.3400000000000001 110.145 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.3500000000000001 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.6100000000000001 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.4700000000000002 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 2.0699999999999998 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 1.3300000000000001 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.9399999999999999 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 1.3300000000000001 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 3.1499999999999999 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.92000000000000004 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 1.4099999999999999 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 1.22 108.458 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.58999999999999997 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' A' ' 51' ' ' SER . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 3.3900000000000001 108.87 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 1.26 108.133 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.9900000000000002 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 1.1399999999999999 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.8400000000000001 108.092 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 1.22 109.459 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 2.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.99 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 1.24 109.341 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 1.21 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 1.53 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 1.24 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 64' ' ' THR . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 2.3199999999999998 107.762 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 1.1699999999999999 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.57999999999999996 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.3899999999999999 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 1.3600000000000001 110.081 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 1.1399999999999999 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.59999999999999998 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.5899999999999999 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2000000000000002 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 2.3599999999999999 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 1.24 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 1.24 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.80000000000000004 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.56000000000000005 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 2.0600000000000001 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 1.24 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 2.4500000000000002 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 1.21 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 1.1200000000000001 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.3100000000000001 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.3500000000000001 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.1600000000000001 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 1.24 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.79 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 89' ' ' ILE . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 1.1399999999999999 107.789 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 1.3200000000000001 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 1.3700000000000001 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 1.3999999999999999 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 1.23 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.5099999999999998 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.5900000000000001 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 2.3799999999999999 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.6200000000000001 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.8899999999999999 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 1.27 109.848 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 1.1599999999999999 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.602 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 1.25 109.889 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 1.1299999999999999 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 1.0800000000000001 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 2.02 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 1.1799999999999999 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 1.1899999999999999 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2000000000000002 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.85999999999999999 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 2.0 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 1.3200000000000001 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 2.1400000000000001 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.3799999999999999 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.3500000000000001 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.71 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.8300000000000001 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.5800000000000001 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.7999999999999998 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.27 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.5800000000000001 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.9199999999999999 108.763 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2000000000000002 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.5299999999999998 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 1.45 109.228 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 1.5 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.3500000000000001 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 1.23 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.73 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.3200000000000001 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.2 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.48999999999999999 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 3.1099999999999999 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.435 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.9500000000000002 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.73 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 1.22 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.7799999999999998 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 2.0299999999999998 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 1.2 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 1.28 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68999999999999995 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 1.3100000000000001 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.8799999999999999 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 146' ' ' ILE . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 1.3600000000000001 108.495 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.9299999999999999 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 1.3400000000000001 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.98 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 1.3799999999999999 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 1.3999999999999999 108.542 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.7400000000000002 109.645 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.4099999999999999 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 1.28 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 1.1499999999999999 108.164 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 1.2 109.259 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 1.1599999999999999 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 1.2 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 1.3200000000000001 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.3399999999999999 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 1.26 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 1.3600000000000001 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.63 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 1.1799999999999999 110.087 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 1.1399999999999999 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.71 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 1.22 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' LYS . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.5499999999999998 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.96 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 2.46 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 2.4199999999999999 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 1.1599999999999999 109.209 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.95 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.41999999999999998 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.52000000000000002 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 1.1599999999999999 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 1.22 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.2400000000000002 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.6499999999999999 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 2.1000000000000001 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.8400000000000001 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.7800000000000002 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 3.2400000000000002 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 2.1099999999999999 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 1.0600000000000001 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 2.0899999999999999 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.8799999999999999 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 2.0099999999999998 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 1.27 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 1.1799999999999999 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.5800000000000001 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 1.1399999999999999 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 1.28 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 1.28 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.69999999999999996 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 1.1899999999999999 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 203' ' ' VAL . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 1.25 106.708 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 1.29 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.92000000000000004 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 1.3100000000000001 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.9199999999999999 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 1.27 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 1.3400000000000001 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 2.0699999999999998 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.8599999999999999 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 1.3 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.48 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.6200000000000001 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.444 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.3999999999999999 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.54 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 1.25 110.491 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 1.26 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 1.1799999999999999 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.2200000000000002 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 1.2 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 1.48 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.8199999999999998 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 2.1099999999999999 109.359 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 2.6499999999999999 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 1.29 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.26 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.415 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.1499999999999999 110.19 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.81999999999999995 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 2.1099999999999999 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 3.1699999999999999 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.0600000000000001 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.6499999999999999 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.47 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 3.0 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.6299999999999999 109.815 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 3.1600000000000001 109.74 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 4.0700000000000003 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.5 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.8 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92000000000000004 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.5 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 1.3999999999999999 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 1.26 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.95 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.93999999999999995 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78000000000000003 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 1.29 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 1.1499999999999999 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.71999999999999997 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.5 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 2.3599999999999999 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 1.1599999999999999 111.507 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 1.24 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 1.3100000000000001 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 1.3100000000000001 110.154 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 2.3500000000000001 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.5800000000000001 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.1400000000000001 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.9299999999999999 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 1.28 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 1.3700000000000001 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 1.3300000000000001 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.3700000000000001 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 3.1899999999999999 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.8100000000000001 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.8300000000000001 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 1.3400000000000001 110.192 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.3500000000000001 108.94 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.6100000000000001 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.4700000000000002 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 1.3300000000000001 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.9399999999999999 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 100' ' ' ALA . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 1.3300000000000001 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 3.1499999999999999 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.92000000000000004 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 1.4099999999999999 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 1.22 107.656 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.58999999999999997 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 3.3900000000000001 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.9900000000000002 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 1.1399999999999999 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.8400000000000001 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 1.22 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 2.0 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.99 108.898 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 1.24 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 1.21 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 1.53 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 1.24 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 2.3199999999999998 107.125 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 1.1699999999999999 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.57999999999999996 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.3899999999999999 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 1.3600000000000001 109.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.53 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 1.1399999999999999 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.59999999999999998 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.5899999999999999 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2000000000000002 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.3599999999999999 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 1.24 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 1.24 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.80000000000000004 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.56000000000000005 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 2.0600000000000001 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 1.24 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 2.4500000000000002 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 1.21 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 1.1200000000000001 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.3500000000000001 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.1600000000000001 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 1.24 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.79 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 1.3200000000000001 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 1.3700000000000001 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 1.3999999999999999 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 1.23 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.5099999999999998 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.5900000000000001 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 2.3799999999999999 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.444 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.6200000000000001 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.8899999999999999 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 1.27 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 1.1599999999999999 109.047 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 1.25 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.1299999999999999 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 1.0800000000000001 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 2.02 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 108' ' ' ILE . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 1.1899999999999999 108.457 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2000000000000002 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.85999999999999999 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 2.0 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 1.3200000000000001 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 2.1400000000000001 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.3799999999999999 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.3500000000000001 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.71 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.8300000000000001 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.5800000000000001 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.27 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.5800000000000001 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.9199999999999999 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2000000000000002 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.5299999999999998 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 1.45 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 1.5 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.3500000000000001 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 1.23 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.73 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.3200000000000001 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.2 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.48999999999999999 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 3.1099999999999999 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.9500000000000002 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.73 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 1.22 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 2.0299999999999998 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 1.2 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 1.28 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68999999999999995 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 1.3100000000000001 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.8799999999999999 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 1.3600000000000001 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.9299999999999999 108.855 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 151' ' ' ALA . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.3400000000000001 109.326 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.98 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 1.3799999999999999 108.812 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 1.3999999999999999 109.273 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.7400000000000002 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.4099999999999999 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 1.28 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 1.1499999999999999 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 1.2 108.617 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 1.1599999999999999 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 1.2 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 1.3200000000000001 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.3399999999999999 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 1.26 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 1.3600000000000001 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.63 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 1.0700000000000001 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 1.1799999999999999 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.71 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 1.22 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.5499999999999998 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.96 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 2.46 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 2.4199999999999999 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 1.1599999999999999 108.8 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.95 109.734 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.41999999999999998 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.52000000000000002 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 1.22 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.2400000000000002 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.6499999999999999 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 2.1000000000000001 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.8400000000000001 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.438 ' O ' ' OG1' ' A' ' 187' ' ' THR . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.7800000000000002 109.318 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 3.2400000000000002 109.327 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 2.1099999999999999 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 1.0600000000000001 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 2.0899999999999999 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.8799999999999999 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 2.0099999999999998 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 1.27 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 1.1799999999999999 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.5800000000000001 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 1.28 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 1.28 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.69999999999999996 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 1.1899999999999999 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 1.25 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 1.29 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.92000000000000004 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 1.3100000000000001 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 1.0 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.9199999999999999 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 1.27 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 1.3400000000000001 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 2.0699999999999998 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.8599999999999999 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 1.3 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.48 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.6200000000000001 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.3999999999999999 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.54 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 1.25 109.224 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 1.26 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 1.1799999999999999 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.2200000000000002 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 1.2 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 1.48 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.8199999999999998 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 223' ' ' VAL . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 2.1099999999999999 108.433 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 2.6499999999999999 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 1.29 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.418 ' N ' ' CG1' ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 1.4199999999999999 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 1.26 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 2.1499999999999999 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.81999999999999995 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 2.1099999999999999 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 3.1699999999999999 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.0600000000000001 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.6499999999999999 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.47 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 3.0 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.6299999999999999 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 3.1600000000000001 108.948 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 4.0700000000000003 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.5 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.8 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92000000000000004 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.5 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 5' ' ' ILE . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 1.3999999999999999 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 1.26 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.95 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.93999999999999995 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78000000000000003 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 1.29 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 1.1499999999999999 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.71999999999999997 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.5 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 2.3599999999999999 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 1.1599999999999999 110.773 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 1.24 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 1.3100000000000001 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 1.3100000000000001 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 2.3500000000000001 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.1400000000000001 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.9299999999999999 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 1.28 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 1.3700000000000001 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 1.3300000000000001 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.3700000000000001 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 3.1899999999999999 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.8100000000000001 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.8300000000000001 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.3400000000000001 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.3500000000000001 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.6100000000000001 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.4700000000000002 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 2.0699999999999998 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 1.3300000000000001 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.438 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 13.5 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.9399999999999999 110.587 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 1.3300000000000001 109.341 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' NH2' ' NE2' ' A' ' 38' ' ' GLN . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 3.1499999999999999 109.051 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.92000000000000004 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 1.4099999999999999 109.013 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 1.22 108.236 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.58999999999999997 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 3.3900000000000001 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 1.26 108.12 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.9900000000000002 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 1.1399999999999999 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.8400000000000001 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 1.22 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 2.0 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.99 108.854 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 1.24 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 1.21 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 1.53 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 1.24 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 2.3199999999999998 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 1.1699999999999999 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.57999999999999996 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.3899999999999999 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 1.3600000000000001 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.1399999999999999 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.59999999999999998 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.5899999999999999 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2000000000000002 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 2.3599999999999999 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 1.24 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 1.24 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.80000000000000004 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.56000000000000005 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 2.0600000000000001 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 1.24 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 2.4500000000000002 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 1.21 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 1.1200000000000001 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.3100000000000001 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.3500000000000001 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.1600000000000001 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 1.24 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.79 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 1.1399999999999999 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 90' ' ' ILE . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 1.3200000000000001 110.358 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 110.188 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 1.3999999999999999 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 1.23 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.5099999999999998 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 91' ' ' ALA . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.5900000000000001 112.155 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 2.3799999999999999 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.6200000000000001 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.8899999999999999 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 1.27 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 1.1599999999999999 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 1.25 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 1.1299999999999999 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 1.0800000000000001 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 2.02 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 1.1799999999999999 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 1.1899999999999999 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2000000000000002 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.85999999999999999 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 2.0 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 1.3200000000000001 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 2.1400000000000001 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.3799999999999999 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.3500000000000001 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.71 108.244 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.5800000000000001 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.7999999999999998 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.27 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.5800000000000001 109.093 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.9199999999999999 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2000000000000002 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.5299999999999998 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 1.45 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 1.5 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.3500000000000001 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 1.23 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.73 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.3200000000000001 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 1.2 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.48999999999999999 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 3.1099999999999999 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.9500000000000002 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.73 108.227 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 1.22 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.7799999999999998 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 2.0299999999999998 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 1.2 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 1.28 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68999999999999995 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 1.3100000000000001 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.8799999999999999 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 1.3600000000000001 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.414 ' N ' ' CG2' ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.9299999999999999 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.3400000000000001 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.98 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.3799999999999999 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 1.3999999999999999 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.7400000000000002 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.4099999999999999 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 1.28 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 157' ' ' ILE . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 1.1499999999999999 108.104 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 1.2 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 1.1599999999999999 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 1.2 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 1.3200000000000001 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.3399999999999999 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 1.26 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 1.3600000000000001 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.63 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 1.1799999999999999 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 1.1399999999999999 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.71 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 1.22 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.5499999999999998 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.96 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 2.46 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 2.4199999999999999 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 1.1599999999999999 108.91 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.95 109.637 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.41999999999999998 109.623 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.52000000000000002 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 1.1599999999999999 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 1.22 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.2400000000000002 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.6499999999999999 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 2.1000000000000001 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.8400000000000001 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.406 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.7800000000000002 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 3.2400000000000002 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 2.1099999999999999 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.0600000000000001 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 2.0899999999999999 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.8799999999999999 110.063 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 2.0099999999999998 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 1.27 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 1.1799999999999999 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.5800000000000001 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.1399999999999999 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 1.28 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 1.28 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.69999999999999996 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 1.1899999999999999 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 1.25 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 1.29 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.92000000000000004 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 1.3100000000000001 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.9199999999999999 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 1.27 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 1.3400000000000001 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 2.0699999999999998 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.8599999999999999 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 1.3 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.48 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.6200000000000001 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.3999999999999999 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.54 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 1.25 110.496 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 1.26 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.2200000000000002 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 1.2 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 1.48 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.8199999999999998 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 2.1099999999999999 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 2.6499999999999999 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 1.29 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 1.4199999999999999 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 1.26 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 2.1499999999999999 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.81999999999999995 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 3.1699999999999999 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.0600000000000001 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.6499999999999999 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.47 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 3.0 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.6299999999999999 109.217 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 3.1600000000000001 110.559 -178.774 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 4.0700000000000003 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.5 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.8 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92000000000000004 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' LEU . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.5 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.3999999999999999 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 1.26 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.95 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.93999999999999995 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78000000000000003 109.712 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 1.29 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 1.1499999999999999 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.71999999999999997 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.5 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 2.3599999999999999 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 1.1599999999999999 111.003 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 1.24 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 1.3100000000000001 110.162 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 1.3100000000000001 110.199 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 2.3500000000000001 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.5800000000000001 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.1400000000000001 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.9299999999999999 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 1.28 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 1.3700000000000001 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.3700000000000001 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 3.1899999999999999 109.239 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.8100000000000001 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.8300000000000001 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 1.3400000000000001 109.962 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.3500000000000001 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.6100000000000001 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.4700000000000002 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 2.0699999999999998 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 1.3300000000000001 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.9399999999999999 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 1.3300000000000001 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 3.1499999999999999 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.92000000000000004 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 1.4099999999999999 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 1.22 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.58999999999999997 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.416 ' O ' ' OG ' ' A' ' 51' ' ' SER . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 3.3900000000000001 106.251 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 1.26 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.9900000000000002 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 1.1399999999999999 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.8400000000000001 108.431 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 1.22 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 2.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.99 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 1.24 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 1.21 109.236 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 1.53 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 1.24 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 2.3199999999999998 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 1.1699999999999999 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.57999999999999996 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.3899999999999999 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 1.3600000000000001 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 1.1399999999999999 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.59999999999999998 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.5899999999999999 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2000000000000002 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 2.3599999999999999 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 1.24 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 1.24 110.001 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.80000000000000004 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.56000000000000005 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 29.9 m170 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 2.0600000000000001 109.785 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 1.24 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 2.4500000000000002 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 1.21 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 1.1200000000000001 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.3100000000000001 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.1600000000000001 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 1.24 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.79 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 1.1399999999999999 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 1.3200000000000001 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 1.3700000000000001 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 1.3999999999999999 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 93' ' ' ILE . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 1.23 111.098 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.5099999999999998 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.5900000000000001 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 2.3799999999999999 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.6200000000000001 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.8899999999999999 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 1.27 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 1.1599999999999999 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 1.25 110.483 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 1.1299999999999999 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 1.0800000000000001 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 2.02 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 109' ' ' GLU . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 1.1799999999999999 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 1.1899999999999999 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2000000000000002 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.85999999999999999 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 2.0 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 1.3200000000000001 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 2.1400000000000001 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.3799999999999999 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.3500000000000001 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.71 108.913 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.8300000000000001 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.5800000000000001 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.7999999999999998 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.27 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.5800000000000001 109.416 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.9199999999999999 109.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2000000000000002 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.5299999999999998 106.344 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 1.45 109.022 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 1.5 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.3500000000000001 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.23 108.977 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.73 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.3200000000000001 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 1.2 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.48999999999999999 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.519 ' HZ3' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 3.1099999999999999 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.9500000000000002 108.433 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.73 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 1.22 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.519 HH11 ' HZ3' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.7799999999999998 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 2.0299999999999998 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 1.2 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 1.28 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68999999999999995 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 1.3100000000000001 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.8799999999999999 109.125 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 1.3600000000000001 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.9299999999999999 109.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.98 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 1.3799999999999999 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 1.3999999999999999 109.043 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.7400000000000002 109.128 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.4099999999999999 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 1.28 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 1.1499999999999999 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 1.2 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 1.1599999999999999 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 1.2 109.697 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 1.3200000000000001 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 1.26 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 1.3600000000000001 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.63 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 1.0700000000000001 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 1.1799999999999999 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 1.1399999999999999 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.71 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 1.22 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.5499999999999998 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.96 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 2.46 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 2.4199999999999999 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 1.1599999999999999 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.95 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.41999999999999998 109.272 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.52000000000000002 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 1.1599999999999999 106.771 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 1.22 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.2400000000000002 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.6499999999999999 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 2.1000000000000001 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.8400000000000001 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.7800000000000002 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 3.2400000000000002 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 1.0600000000000001 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 2.0899999999999999 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.8799999999999999 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 192' ' ' ILE . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.0099999999999998 110.013 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 1.27 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 1.1799999999999999 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.5800000000000001 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 1.1399999999999999 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.28 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 1.28 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.69999999999999996 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 1.1899999999999999 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 1.25 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 1.29 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.92000000000000004 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 203' ' ' VAL . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 1.3100000000000001 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 1.0 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.9199999999999999 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 1.27 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 1.3400000000000001 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 2.0699999999999998 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.8599999999999999 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 1.3 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.446 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.48 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.6200000000000001 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.3999999999999999 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.54 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 1.25 110.551 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 1.26 108.606 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 1.1799999999999999 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.2200000000000002 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 1.2 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 1.48 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.8199999999999998 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 2.1099999999999999 109.424 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.562 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 22.2 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 2.6499999999999999 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 1.29 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 1.4199999999999999 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 1.26 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 2.1499999999999999 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 2.1099999999999999 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 3.1699999999999999 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.0600000000000001 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.6499999999999999 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.47 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 3.0 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.6299999999999999 110.015 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 3.1600000000000001 110.18 -179.411 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 4.0700000000000003 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.5 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.8 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92000000000000004 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.5 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 1.3999999999999999 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 1.26 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.95 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.93999999999999995 114.455 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78000000000000003 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 1.29 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 1.1499999999999999 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.71999999999999997 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.5 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 2.3599999999999999 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 1.1599999999999999 110.645 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 1.24 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 1.3100000000000001 111.071 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 1.3100000000000001 109.977 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 2.3500000000000001 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.5800000000000001 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.1400000000000001 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.9299999999999999 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 1.28 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 1.3700000000000001 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 1.3300000000000001 110.02 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.3700000000000001 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 3.1899999999999999 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.8100000000000001 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.8300000000000001 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 1.3400000000000001 110.27 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.3500000000000001 109.454 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.6100000000000001 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 2.0699999999999998 108.491 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 1.3300000000000001 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.9399999999999999 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 1.3300000000000001 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.92000000000000004 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 1.4099999999999999 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 1.22 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.58999999999999997 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' A' ' 51' ' ' SER . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 3.3900000000000001 107.506 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 1.26 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.9900000000000002 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 1.1399999999999999 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.8400000000000001 108.859 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 1.22 109.511 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.463 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 2.0 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.99 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 1.24 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 1.21 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 1.53 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 1.24 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 64' ' ' THR . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 2.3199999999999998 108.468 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 1.1699999999999999 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.57999999999999996 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.3899999999999999 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 1.3600000000000001 110.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 1.1399999999999999 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.59999999999999998 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.5899999999999999 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2000000000000002 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 2.3599999999999999 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 1.24 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 1.24 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.80000000000000004 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.56000000000000005 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 2.0600000000000001 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 1.24 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 2.4500000000000002 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 1.21 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.1600000000000001 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 1.24 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.79 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 1.1399999999999999 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 90' ' ' ILE . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 1.3200000000000001 111.038 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 1.3700000000000001 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 1.3999999999999999 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 1.23 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.5099999999999998 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.5900000000000001 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 2.3799999999999999 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.6200000000000001 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.8899999999999999 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 1.27 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 1.1599999999999999 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 1.25 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 1.1299999999999999 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 1.0800000000000001 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 16.0 t60 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 2.02 109.735 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 1.1799999999999999 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 1.1899999999999999 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2000000000000002 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.85999999999999999 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 2.0 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 1.3200000000000001 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 2.1400000000000001 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.3799999999999999 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.3500000000000001 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.71 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.8300000000000001 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 122' ' ' TYR . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.5800000000000001 109.385 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.7999999999999998 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.27 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.5800000000000001 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.9199999999999999 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2000000000000002 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.5299999999999998 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 1.45 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 1.5 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 1.23 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.73 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.3200000000000001 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 1.2 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.48999999999999999 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 3.1099999999999999 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.9500000000000002 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.73 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 1.22 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.7799999999999998 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 2.0299999999999998 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 1.2 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 1.28 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68999999999999995 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 1.3100000000000001 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.8799999999999999 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 1.3600000000000001 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.9299999999999999 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.98 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 1.3799999999999999 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 1.3999999999999999 109.701 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.7400000000000002 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.4099999999999999 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 1.1499999999999999 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 1.2 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 1.1599999999999999 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 1.2 109.998 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 1.3200000000000001 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.3399999999999999 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 1.26 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 1.3600000000000001 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.63 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 1.0700000000000001 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 1.1799999999999999 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 1.1399999999999999 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.71 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 1.22 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.728 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.5499999999999998 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.96 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 2.46 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 2.4199999999999999 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 1.1599999999999999 108.285 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.95 108.28 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.41999999999999998 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.52000000000000002 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 1.1599999999999999 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 1.22 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.2400000000000002 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.6499999999999999 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 2.1000000000000001 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.8400000000000001 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.7800000000000002 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 3.2400000000000002 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 2.1099999999999999 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 1.0600000000000001 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 2.0899999999999999 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.8799999999999999 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 2.0099999999999998 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 1.27 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 1.1799999999999999 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.5800000000000001 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 1.1399999999999999 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 1.28 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 1.28 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.69999999999999996 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 1.1899999999999999 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 1.25 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 1.29 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.92000000000000004 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 1.3100000000000001 108.027 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 1.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.9199999999999999 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 1.27 110.435 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 1.3400000000000001 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 2.0699999999999998 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 1.3 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.48 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.6200000000000001 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.3999999999999999 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.54 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 1.25 110.131 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 1.26 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 1.1799999999999999 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.2200000000000002 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 1.2 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 1.48 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.8199999999999998 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 2.1099999999999999 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 2.6499999999999999 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 1.29 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 1.4199999999999999 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 1.26 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 2.1499999999999999 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.81999999999999995 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 2.1099999999999999 110.236 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 3.1699999999999999 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.0600000000000001 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.6499999999999999 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.47 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 3.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.6299999999999999 110.01 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 3.1600000000000001 110.095 -178.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 4.0700000000000003 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.5 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.8 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.421 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92000000000000004 109.134 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.5 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 1.3999999999999999 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 1.26 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.95 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.93999999999999995 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78000000000000003 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 1.29 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 1.1499999999999999 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.71999999999999997 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.5 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 2.3599999999999999 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 1.1599999999999999 111.146 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 1.24 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 1.3100000000000001 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 1.3100000000000001 109.743 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 2.3500000000000001 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.5800000000000001 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.1400000000000001 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.9299999999999999 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 1.28 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 1.3700000000000001 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 1.3300000000000001 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.3700000000000001 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 3.1899999999999999 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.8100000000000001 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.8300000000000001 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 1.3400000000000001 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 34' ' ' ASP . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.3500000000000001 108.808 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.6100000000000001 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 32' ' ' SER . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.4700000000000002 110.329 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 2.0699999999999998 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 1.3300000000000001 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.9399999999999999 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 1.3300000000000001 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 3.1499999999999999 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.92000000000000004 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 1.4099999999999999 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 1.22 108.76 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.58999999999999997 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.497 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 3.3900000000000001 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 1.26 109.086 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.9900000000000002 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 1.1399999999999999 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.8400000000000001 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 1.22 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 2.0 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.99 109.271 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 1.24 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 1.21 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 1.53 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 1.24 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 64' ' ' THR . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 2.3199999999999998 107.707 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.1699999999999999 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.57999999999999996 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.3899999999999999 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 1.3600000000000001 110.059 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 1.1399999999999999 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.59999999999999998 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.5899999999999999 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2000000000000002 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 2.3599999999999999 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 1.24 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 1.24 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.80000000000000004 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.56000000000000005 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 2.0600000000000001 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 77' ' ' ILE . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 1.24 109.198 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 2.4500000000000002 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 1.21 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 1.1200000000000001 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.3500000000000001 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.1600000000000001 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 1.24 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.497 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.79 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 1.1399999999999999 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 1.3200000000000001 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 1.3700000000000001 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 1.3999999999999999 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 1.23 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.5099999999999998 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.5900000000000001 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 2.3799999999999999 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.6200000000000001 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.8899999999999999 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 1.27 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 1.1599999999999999 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 1.25 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 1.1299999999999999 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 1.0800000000000001 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 2.02 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 1.1799999999999999 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 1.1899999999999999 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2000000000000002 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.85999999999999999 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 2.0 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 1.3200000000000001 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 2.1400000000000001 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.3799999999999999 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.3500000000000001 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.71 108.488 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.8300000000000001 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.5800000000000001 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.7999999999999998 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.27 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.5800000000000001 109.12 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.9199999999999999 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2000000000000002 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.5299999999999998 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 1.45 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 1.5 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.3500000000000001 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 1.23 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.73 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.3200000000000001 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 1.2 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.48999999999999999 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 3.1099999999999999 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.443 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.9500000000000002 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.73 108.989 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 1.22 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.0 m-20 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 2.0299999999999998 109.194 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.2 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 1.28 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68999999999999995 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 1.3100000000000001 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.8799999999999999 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 1.3600000000000001 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.9299999999999999 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 1.3400000000000001 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.98 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 1.3799999999999999 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 1.3999999999999999 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.7400000000000002 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.4099999999999999 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 1.28 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 1.1499999999999999 107.969 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 1.2 109.824 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 1.1599999999999999 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 1.2 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 1.3200000000000001 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.3399999999999999 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 1.26 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 1.3600000000000001 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.63 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 1.0700000000000001 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 1.1799999999999999 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 1.1399999999999999 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.71 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 1.22 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.6 m120 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.5499999999999998 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 172' ' ' ASN . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 2.46 109.56 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 2.4199999999999999 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 1.1599999999999999 108.656 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.95 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.41999999999999998 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.52000000000000002 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 1.1599999999999999 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 1.22 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.2400000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.6499999999999999 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 2.1000000000000001 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.8400000000000001 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.7800000000000002 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 3.2400000000000002 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 2.1099999999999999 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.0899999999999999 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.8799999999999999 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 2.0099999999999998 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 1.27 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 1.1799999999999999 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.5800000000000001 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 1.1399999999999999 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 1.28 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.557 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.69999999999999996 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 1.1899999999999999 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 202' ' ' ILE . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 1.25 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 1.29 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.92000000000000004 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.476 ' HG1' ' CG ' ' A' ' 182' ' ' ASP . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 1.3100000000000001 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.964 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 205' ' ' THR . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.9199999999999999 113.194 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 1.27 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 1.3400000000000001 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 2.0699999999999998 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.8599999999999999 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 1.3 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.48 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.6200000000000001 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.3999999999999999 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.54 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 1.25 111.238 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 1.26 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 1.1799999999999999 109.046 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.2200000000000002 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 1.2 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.8199999999999998 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.54 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.3 OUTLIER 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 2.1099999999999999 109.248 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 2.6499999999999999 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 1.29 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 1.4199999999999999 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 1.26 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 2.1499999999999999 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.81999999999999995 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 2.1099999999999999 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 3.1699999999999999 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.0600000000000001 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.6499999999999999 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.47 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 3.0 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.6299999999999999 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 3.1600000000000001 108.999 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 4.0700000000000003 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.5 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.8 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92000000000000004 108.181 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.5 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 1.3999999999999999 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 1.26 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.95 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.93999999999999995 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78000000000000003 110.69 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 1.29 109.725 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 1.1499999999999999 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.71999999999999997 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.5 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 2.3599999999999999 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 1.1599999999999999 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 1.24 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.603 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 1.3100000000000001 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 2.3500000000000001 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.5800000000000001 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.9299999999999999 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 1.28 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 1.3700000000000001 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 1.3300000000000001 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.3700000000000001 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 3.1899999999999999 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.8100000000000001 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.8300000000000001 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 1.3400000000000001 110.154 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.3500000000000001 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.6100000000000001 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.4700000000000002 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 2.0699999999999998 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 1.3300000000000001 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.9399999999999999 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 1.3300000000000001 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 3.1499999999999999 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.92000000000000004 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 1.4099999999999999 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 1.22 107.999 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.58999999999999997 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 3.3900000000000001 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 1.26 108.477 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.9900000000000002 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 1.1399999999999999 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.8400000000000001 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 1.22 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 2.0 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.99 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 1.24 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 57' ' ' ILE . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 1.21 109.107 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 1.53 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 1.24 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 64' ' ' THR . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 2.3199999999999998 108.36 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 1.1699999999999999 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.57999999999999996 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.3899999999999999 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 1.3600000000000001 110.227 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.59999999999999998 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2000000000000002 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 2.3599999999999999 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 1.24 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 1.24 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.80000000000000004 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.56000000000000005 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 2.0600000000000001 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 1.24 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 2.4500000000000002 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 1.21 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 1.1200000000000001 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.3100000000000001 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 1.24 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.79 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 1.1399999999999999 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 1.3700000000000001 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 1.3999999999999999 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 1.23 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.5099999999999998 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.5900000000000001 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 2.3799999999999999 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.423 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.6200000000000001 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.8899999999999999 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 1.27 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 1.1599999999999999 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 1.25 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 1.1299999999999999 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 1.0800000000000001 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 2.02 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 1.1799999999999999 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 1.1899999999999999 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2000000000000002 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.85999999999999999 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 2.0 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 1.3200000000000001 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 2.1400000000000001 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.3799999999999999 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.3500000000000001 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.71 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.8300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 122' ' ' TYR . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 110.059 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.7999999999999998 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 120' ' ' ASP . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.27 109.988 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.5800000000000001 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.9199999999999999 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2000000000000002 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.5299999999999998 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 1.45 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 1.5 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 1.23 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.73 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.3200000000000001 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 1.2 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.48999999999999999 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 3.1099999999999999 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.9500000000000002 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.73 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.22 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.7799999999999998 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.3 m120 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 2.0299999999999998 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 1.2 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 1.28 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68999999999999995 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 1.3100000000000001 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.8799999999999999 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 146' ' ' ILE . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 1.3600000000000001 109.127 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.9299999999999999 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 1.3400000000000001 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.98 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 1.3799999999999999 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 1.3999999999999999 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.7400000000000002 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.4099999999999999 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 1.28 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 1.1499999999999999 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 1.1599999999999999 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 1.2 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 1.3200000000000001 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.3399999999999999 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 1.26 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 1.3600000000000001 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.63 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 1.0700000000000001 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 1.1799999999999999 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 1.1399999999999999 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.71 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 1.22 109.117 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.5499999999999998 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.96 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 2.46 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 2.4199999999999999 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 1.1599999999999999 108.366 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.95 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.41999999999999998 109.245 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.52000000000000002 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 1.1599999999999999 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 1.22 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.2400000000000002 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.6499999999999999 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 2.1000000000000001 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.8400000000000001 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.7800000000000002 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 3.2400000000000002 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 2.1099999999999999 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 1.0600000000000001 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 2.0899999999999999 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.8799999999999999 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 2.0099999999999998 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 1.27 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 1.1799999999999999 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.5800000000000001 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 1.1399999999999999 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 1.28 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 1.28 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.69999999999999996 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 1.1899999999999999 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 1.25 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 1.29 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.92000000000000004 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 1.3100000000000001 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.9199999999999999 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 1.27 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 1.3400000000000001 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 2.0699999999999998 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.8599999999999999 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 1.3 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.48 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.603 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 9.1 m120 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.6200000000000001 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.3999999999999999 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.54 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 1.25 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 1.26 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 1.1799999999999999 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.2200000000000002 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 1.2 110.698 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 1.48 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.8199999999999998 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.4 OUTLIER 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 2.1099999999999999 109.859 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 2.6499999999999999 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 1.29 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 1.4199999999999999 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 1.26 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 2.1499999999999999 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 2.1099999999999999 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 3.1699999999999999 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.0600000000000001 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.6499999999999999 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.47 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 3.0 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.6299999999999999 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 3.1600000000000001 109.868 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 4.0700000000000003 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.5 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.8 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92000000000000004 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.5 108.785 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 1.3999999999999999 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 1.26 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.95 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.93999999999999995 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78000000000000003 110.07 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 1.29 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 1.1499999999999999 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.71999999999999997 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.5 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 2.3599999999999999 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 1.1599999999999999 111.091 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 1.24 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 1.3100000000000001 110.829 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 1.3100000000000001 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 2.3500000000000001 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.5800000000000001 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.1400000000000001 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.9299999999999999 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 1.28 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 1.3700000000000001 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 1.3300000000000001 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.3700000000000001 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.489 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 3.1899999999999999 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.8100000000000001 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.8300000000000001 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 1.3400000000000001 110.52 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.3500000000000001 109.015 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.6100000000000001 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.4700000000000002 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 2.0699999999999998 108.754 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 1.3300000000000001 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.9399999999999999 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 1.3300000000000001 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 3.1499999999999999 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.92000000000000004 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 1.4099999999999999 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 1.22 108.026 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.58999999999999997 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.422 ' O ' ' OG ' ' A' ' 51' ' ' SER . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 3.3900000000000001 108.737 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 1.26 107.996 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.9900000000000002 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 1.1399999999999999 109.069 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.8400000000000001 107.812 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 1.22 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 2.0 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.99 109.217 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 1.24 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 1.21 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 1.53 110.269 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 1.24 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 2.3199999999999998 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 1.1699999999999999 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.57999999999999996 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.3899999999999999 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 1.3600000000000001 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 1.1399999999999999 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.59999999999999998 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.5899999999999999 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2000000000000002 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 2.3599999999999999 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 1.24 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 1.24 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.80000000000000004 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.56000000000000005 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 2.0600000000000001 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 1.24 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 2.4500000000000002 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 1.21 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 1.1200000000000001 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.3100000000000001 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.3500000000000001 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 1.24 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.79 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 1.1399999999999999 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 1.3700000000000001 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 1.3999999999999999 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 1.23 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.5099999999999998 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.5900000000000001 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 2.3799999999999999 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.6200000000000001 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.8899999999999999 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.72 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 1.27 109.816 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.1599999999999999 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.72 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 1.25 110.191 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 2.02 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 1.1799999999999999 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 1.1899999999999999 109.636 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2000000000000002 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.85999999999999999 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 2.0 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 1.3200000000000001 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 2.1400000000000001 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.3799999999999999 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.3500000000000001 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.71 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.8300000000000001 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.7999999999999998 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.27 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.5800000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.9199999999999999 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.5299999999999998 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 1.45 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 1.5 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 1.23 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.73 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.3200000000000001 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 1.2 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.48999999999999999 109.152 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 3.1099999999999999 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.9500000000000002 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.73 109.107 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 1.22 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.7799999999999998 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 2.0299999999999998 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 1.2 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 1.28 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68999999999999995 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 1.3100000000000001 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.8799999999999999 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 1.3600000000000001 109.032 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.9299999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 1.3400000000000001 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.591 ' HG ' HD22 ' A' ' 172' ' ' ASN . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.98 109.136 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 1.3799999999999999 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 1.3999999999999999 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.7400000000000002 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.4099999999999999 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 1.28 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 1.1499999999999999 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 1.2 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 1.1599999999999999 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 1.2 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 1.3200000000000001 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.3399999999999999 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 1.26 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 1.3600000000000001 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.63 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 1.1799999999999999 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 1.1399999999999999 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.71 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 1.22 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.591 HD22 ' HG ' ' A' ' 150' ' ' SER . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.5499999999999998 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.96 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 2.46 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 2.4199999999999999 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 1.1599999999999999 110.103 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.95 110.532 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.41999999999999998 110.131 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.52000000000000002 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 1.1599999999999999 107.598 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 1.22 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.2400000000000002 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.6499999999999999 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 2.1000000000000001 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.8400000000000001 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.7800000000000002 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 3.2400000000000002 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 2.1099999999999999 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 1.0600000000000001 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 2.0899999999999999 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.8799999999999999 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 2.0099999999999998 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 1.27 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 1.1799999999999999 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.5800000000000001 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.1399999999999999 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 1.28 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 1.28 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.69999999999999996 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 1.1899999999999999 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 1.25 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 1.29 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.92000000000000004 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 1.3100000000000001 108.551 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 1.0 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.9199999999999999 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 1.27 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 2.0699999999999998 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.8599999999999999 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 1.3 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.48 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.6200000000000001 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.54 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 1.25 109.97 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 1.26 108.107 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 1.1799999999999999 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.2200000000000002 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 1.2 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 1.48 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.8199999999999998 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.493 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.2 OUTLIER 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 2.1099999999999999 109.165 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 6.8 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 2.6499999999999999 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 1.29 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.415 ' HH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 1.4199999999999999 109.712 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 1.26 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 2.1499999999999999 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 111.688 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 2.1099999999999999 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 3.1699999999999999 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.0600000000000001 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.6499999999999999 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.47 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 3.0 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.6299999999999999 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 3.1600000000000001 109.565 179.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.439 ' H1 ' ' H ' ' A' ' 2' ' ' ILE . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 4.0700000000000003 109.593 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.439 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.5 109.18 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.8 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.703 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92000000000000004 108.293 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.5 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 1.3999999999999999 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 1.26 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.95 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.93999999999999995 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78000000000000003 109.92 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 1.29 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 1.1499999999999999 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.71999999999999997 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.5 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 2.3599999999999999 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 1.1599999999999999 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 1.24 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 1.3100000000000001 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 2.3500000000000001 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.1400000000000001 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.9299999999999999 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 1.28 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 1.3700000000000001 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 1.3300000000000001 109.386 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.3700000000000001 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 3.1899999999999999 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.8100000000000001 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.8300000000000001 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 1.3400000000000001 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.3500000000000001 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.6100000000000001 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.4700000000000002 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 2.0699999999999998 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 1.3300000000000001 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.9399999999999999 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 44' ' ' LEU . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.798 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.515 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 3.1499999999999999 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.92000000000000004 109.472 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 40' ' ' VAL . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 1.4099999999999999 109.236 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 1.22 108.971 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.58999999999999997 108.607 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 3.3900000000000001 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 1.26 108.261 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.9900000000000002 109.249 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 1.1399999999999999 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.8400000000000001 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 1.22 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 2.0 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.99 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 1.24 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 1.21 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 1.53 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 1.24 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 2.3199999999999998 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 1.1699999999999999 108.396 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.57999999999999996 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.3899999999999999 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 1.3600000000000001 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.59999999999999998 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.5899999999999999 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2000000000000002 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 2.3599999999999999 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 1.24 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 1.24 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.80000000000000004 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.56000000000000005 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 2.0600000000000001 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 1.24 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 2.4500000000000002 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 1.21 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 1.1200000000000001 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.3100000000000001 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.3500000000000001 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.1600000000000001 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 1.24 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.79 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 1.1399999999999999 108.196 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 1.3200000000000001 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 1.3700000000000001 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 1.3999999999999999 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 1.23 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.5099999999999998 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.5900000000000001 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 2.3799999999999999 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.6200000000000001 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.8899999999999999 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 1.27 109.707 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 1.1599999999999999 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.652 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 1.25 110.442 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 1.1299999999999999 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 1.0800000000000001 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.42 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 32.4 t60 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 2.02 109.448 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 1.1799999999999999 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 1.1899999999999999 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2000000000000002 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.85999999999999999 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 2.0 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 1.3200000000000001 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 2.1400000000000001 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.3799999999999999 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.3500000000000001 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.71 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.8300000000000001 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.5800000000000001 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.7999999999999998 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.27 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.5800000000000001 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.9199999999999999 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2000000000000002 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.5299999999999998 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 1.45 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 1.5 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.3500000000000001 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 1.23 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.73 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.3200000000000001 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 1.2 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.48999999999999999 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 3.1099999999999999 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.9500000000000002 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.73 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 1.22 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.7799999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 2.0299999999999998 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 1.2 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 1.28 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68999999999999995 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 1.3100000000000001 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.8799999999999999 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 1.3600000000000001 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.9299999999999999 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 1.3400000000000001 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.424 ' HG ' ' ND2' ' A' ' 172' ' ' ASN . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.98 109.495 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 1.3799999999999999 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 1.3999999999999999 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.7400000000000002 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.4099999999999999 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 1.28 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 1.1499999999999999 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 1.2 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 1.1599999999999999 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 1.2 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 1.3200000000000001 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.3399999999999999 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 1.26 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 1.3600000000000001 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.63 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 1.0700000000000001 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 1.1799999999999999 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 1.1399999999999999 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.71 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 1.22 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' HG ' ' A' ' 150' ' ' SER . 50.8 m-80 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.5499999999999998 108.376 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.96 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 2.46 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 2.4199999999999999 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 1.1599999999999999 108.472 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.95 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.41999999999999998 108.908 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.52000000000000002 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 1.1599999999999999 106.741 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 1.22 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.2400000000000002 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.6499999999999999 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 2.1000000000000001 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.8400000000000001 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.7800000000000002 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 3.2400000000000002 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 2.1099999999999999 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 1.0600000000000001 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 2.0899999999999999 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.8799999999999999 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 2.0099999999999998 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 1.27 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 1.1799999999999999 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.5800000000000001 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 1.1399999999999999 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 1.28 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 1.28 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.69999999999999996 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 1.1899999999999999 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 1.25 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 1.29 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.92000000000000004 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 1.3100000000000001 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 1.0 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.9199999999999999 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 1.27 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 1.3400000000000001 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 2.0699999999999998 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 210' ' ' SER . 15.3 mm100 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.8599999999999999 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 1.3 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.48 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.6200000000000001 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.3999999999999999 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.54 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 1.25 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 1.26 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.2200000000000002 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 1.2 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 1.48 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.8199999999999998 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.703 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 2.1099999999999999 109.333 -179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 2.6499999999999999 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 1.29 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 1.4199999999999999 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 1.26 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 2.1499999999999999 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.81999999999999995 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 2.1099999999999999 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 3.1699999999999999 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.0600000000000001 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.6499999999999999 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.47 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 3.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.6299999999999999 109.167 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 13.8 mmm-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 3.1600000000000001 109.648 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 4.0700000000000003 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.5 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.8 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92000000000000004 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.5 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 1.3999999999999999 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 1.26 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.95 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.93999999999999995 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78000000000000003 109.475 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 1.29 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 1.1499999999999999 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.71999999999999997 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.5 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 2.3599999999999999 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 1.1599999999999999 111.188 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 1.24 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 1.3100000000000001 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 1.3100000000000001 110.588 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 2.3500000000000001 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.5800000000000001 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.1400000000000001 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.9299999999999999 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 1.28 109.394 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 1.3700000000000001 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 1.3300000000000001 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 3.1899999999999999 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.8100000000000001 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.8300000000000001 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 1.3400000000000001 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HG ' HE21 ' A' ' 35' ' ' GLN . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.3500000000000001 109.53 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.6100000000000001 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.4700000000000002 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.427 HE21 ' HG ' ' A' ' 32' ' ' SER . 7.2 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 2.0699999999999998 108.803 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 1.3300000000000001 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.9399999999999999 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 1.3300000000000001 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 3.1499999999999999 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.92000000000000004 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 1.4099999999999999 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 1.22 108.266 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.58999999999999997 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 3.3900000000000001 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 1.26 108.151 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.9900000000000002 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 1.1399999999999999 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.8400000000000001 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 1.22 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 2.0 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.99 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 1.24 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 1.21 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 1.53 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 1.24 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 64' ' ' THR . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 2.3199999999999998 107.934 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 1.1699999999999999 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.57999999999999996 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.3899999999999999 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 1.3600000000000001 110.089 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 1.1399999999999999 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.59999999999999998 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.5899999999999999 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2000000000000002 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 2.3599999999999999 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 1.24 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 1.24 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.80000000000000004 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.56000000000000005 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 2.0600000000000001 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 1.24 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 2.4500000000000002 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 1.21 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 1.1200000000000001 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.3100000000000001 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.1600000000000001 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 1.24 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.79 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 1.1399999999999999 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 1.3200000000000001 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 1.3700000000000001 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 1.3999999999999999 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 1.23 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.5099999999999998 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.5900000000000001 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 2.3799999999999999 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.6200000000000001 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.8899999999999999 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 1.27 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 1.1599999999999999 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 1.25 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 1.1299999999999999 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 1.0800000000000001 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 2.02 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 1.1799999999999999 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 1.1899999999999999 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2000000000000002 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.85999999999999999 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 2.0 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 1.3200000000000001 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 2.1400000000000001 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.3799999999999999 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.3500000000000001 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.71 108.555 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.8300000000000001 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.5800000000000001 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.7999999999999998 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.27 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.5800000000000001 109.184 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.9199999999999999 108.431 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2000000000000002 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.5299999999999998 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 1.45 107.97 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 1.5 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 1.23 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.73 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.3200000000000001 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 1.2 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.48999999999999999 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.513 ' HZ3' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 3.1099999999999999 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.9500000000000002 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.73 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 1.22 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.513 ' NH2' ' HZ3' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.7799999999999998 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 2.0299999999999998 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 1.2 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 1.28 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68999999999999995 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 1.3100000000000001 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.8799999999999999 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.411 HD11 HG22 ' A' ' 146' ' ' ILE . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 1.3600000000000001 109.302 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.403 ' CD1' ' H ' ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.9299999999999999 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 1.3400000000000001 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.98 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 1.3799999999999999 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 153' ' ' GLN . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 1.3999999999999999 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.467 ' N ' ' CG2' ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.7400000000000002 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.4099999999999999 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 1.28 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 1.1499999999999999 107.464 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 1.2 109.588 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 1.1599999999999999 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 1.2 109.615 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 1.3200000000000001 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.3399999999999999 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 1.26 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 1.3600000000000001 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.63 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 1.0700000000000001 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 1.1799999999999999 109.561 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 1.1399999999999999 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.71 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 1.22 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.41 ' C ' ' H ' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.5499999999999998 109.803 -179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.96 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 172' ' ' ASN . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 2.46 108.812 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 2.4199999999999999 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 1.1599999999999999 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.95 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.41999999999999998 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.52000000000000002 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 1.1599999999999999 107.462 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 1.22 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.2400000000000002 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.6499999999999999 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 2.1000000000000001 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.8400000000000001 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.7800000000000002 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 3.2400000000000002 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 2.1099999999999999 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 1.0600000000000001 109.522 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 2.0899999999999999 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.8799999999999999 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 2.0099999999999998 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 1.27 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 1.1799999999999999 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.5800000000000001 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 1.1399999999999999 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 1.28 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 1.28 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.69999999999999996 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 1.1899999999999999 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 1.25 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 1.29 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.92000000000000004 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 1.3100000000000001 108.361 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 1.0 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.9199999999999999 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 1.27 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 1.3400000000000001 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 2.0699999999999998 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.8599999999999999 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 1.3 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.6200000000000001 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.3999999999999999 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.54 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 1.25 110.426 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 1.26 107.429 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 1.1799999999999999 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.2200000000000002 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.557 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 1.2 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 1.48 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.8199999999999998 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 2.1099999999999999 109.301 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 2.6499999999999999 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 1.29 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 1.4199999999999999 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 1.26 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 2.1499999999999999 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.81999999999999995 111.495 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 2.1099999999999999 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 3.1699999999999999 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.0600000000000001 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.6499999999999999 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.47 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 3.0 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.6299999999999999 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -57.53 -32.22 66.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 3.1600000000000001 109.204 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.37 -60.28 2.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 2.0899999999999999 109.572 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.7 -59.94 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 2.5699999999999998 109.722 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -45.49 -62.21 1.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 3.5899999999999999 110.294 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.48 -23.99 66.27 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 1.76 110.412 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -67.77 -23.4 65.22 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.925 -1.109 . . . . 3.21 108.01 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.16 -53.83 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.882 -0.784 . . . . 2.3500000000000001 108.882 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.58 -28.91 61.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 2.3999999999999999 108.947 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 t -77.0 -27.8 54.83 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.52 -0.738 . . . . 3.0299999999999998 109.649 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 3.4100000000000001 109.286 -179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 4.0700000000000003 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.5 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.8 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92000000000000004 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.5 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 1.3999999999999999 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 1.26 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.95 108.805 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' N ' ' HG ' ' A' ' 8' ' ' SER . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.93999999999999995 113.847 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78000000000000003 109.628 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 1.29 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 1.1499999999999999 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.71999999999999997 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.5 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 2.3599999999999999 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.1599999999999999 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 1.24 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 1.3100000000000001 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 1.3100000000000001 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 2.3500000000000001 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.5800000000000001 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.9299999999999999 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 1.28 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 1.3700000000000001 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 26' ' ' ILE . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 1.3300000000000001 108.882 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.3700000000000001 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 3.1899999999999999 108.422 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.8100000000000001 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.8300000000000001 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 1.3400000000000001 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.3500000000000001 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.6100000000000001 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.4700000000000002 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 2.0699999999999998 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 1.3300000000000001 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.9399999999999999 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 1.3300000000000001 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 3.1499999999999999 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.92000000000000004 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 1.4099999999999999 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 1.22 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.58999999999999997 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 3.3900000000000001 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 1.26 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.9900000000000002 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.8400000000000001 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 1.22 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 2.0 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.99 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 1.24 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 1.21 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 1.53 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 1.24 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 2.3199999999999998 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 1.1699999999999999 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.57999999999999996 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.3899999999999999 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 1.3600000000000001 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 1.1399999999999999 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.59999999999999998 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.5899999999999999 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2000000000000002 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 2.3599999999999999 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 1.24 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 1.24 109.758 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.80000000000000004 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.56000000000000005 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 19.3 m170 -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 2.0600000000000001 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 1.24 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 2.4500000000000002 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 1.21 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 1.1200000000000001 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.3100000000000001 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 1.24 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.79 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 1.1399999999999999 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 1.3200000000000001 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 1.3700000000000001 110.093 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 1.3999999999999999 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.23 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.5099999999999998 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.5900000000000001 112.267 -176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 2.3799999999999999 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.6200000000000001 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.8899999999999999 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 1.27 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.418 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 1.1599999999999999 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 1.25 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 1.1299999999999999 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 1.0800000000000001 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 2.02 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' O ' ' N ' ' A' ' 109' ' ' GLU . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 1.1799999999999999 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 1.1899999999999999 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 106' ' ' GLU . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2000000000000002 110.312 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.85999999999999999 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 2.0 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 1.3200000000000001 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 114' ' ' ALA . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 2.1400000000000001 109.651 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.641 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.3799999999999999 110.079 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.3500000000000001 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.71 108.339 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.8300000000000001 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.7999999999999998 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.27 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.5800000000000001 110.077 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 127' ' ' ALA . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.9199999999999999 108.342 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2000000000000002 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.5299999999999998 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 1.45 107.626 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 1.5 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.3500000000000001 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 1.23 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.452 HH22 ' HZ3' ' A' ' 135' ' ' LYS . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.73 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.3200000000000001 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 1.2 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.48999999999999999 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.452 ' HZ3' HH22 ' A' ' 131' ' ' ARG . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 3.1099999999999999 109.144 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.471 ' HG2' HH11 ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.9500000000000002 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.73 109.13 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 1.22 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.7799999999999998 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.6 m120 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 2.0299999999999998 109.171 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 141' ' ' ILE . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 1.2 109.167 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 1.28 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68999999999999995 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.406 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 1.3100000000000001 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.406 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.8799999999999999 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 1.3600000000000001 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.9299999999999999 109.354 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 1.3400000000000001 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.98 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 1.3799999999999999 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.7400000000000002 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.4099999999999999 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 1.28 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 1.1499999999999999 108.297 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 1.2 109.489 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 1.1599999999999999 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 1.2 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 1.3200000000000001 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 1.26 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 1.3600000000000001 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.63 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 1.0700000000000001 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 1.1799999999999999 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 1.1399999999999999 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.71 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 1.22 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.5499999999999998 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.96 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 2.46 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 2.4199999999999999 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 1.1599999999999999 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.95 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.41999999999999998 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.52000000000000002 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 1.1599999999999999 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 1.22 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.2400000000000002 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.6499999999999999 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 2.1000000000000001 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.8400000000000001 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.7800000000000002 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 3.2400000000000002 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 2.1099999999999999 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 2.0899999999999999 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.8799999999999999 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 192' ' ' ILE . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 2.0099999999999998 109.746 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 1.27 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 1.1799999999999999 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.512 ' NE ' ' OG ' ' A' ' 191' ' ' SER . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.5800000000000001 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 1.1399999999999999 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 1.28 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 1.28 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.69999999999999996 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 1.1899999999999999 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 1.25 107.234 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 1.29 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.92000000000000004 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 203' ' ' VAL . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 1.3100000000000001 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 1.0 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.9199999999999999 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 1.27 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 2.0699999999999998 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.8599999999999999 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 1.3 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.469 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.48 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.6200000000000001 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.3999999999999999 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.54 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 1.25 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 1.26 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 1.1799999999999999 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.2200000000000002 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 1.2 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 1.48 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 224' ' ' ASN . 2.2 t-20 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.8199999999999998 107.484 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 2.1099999999999999 109.193 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 2.6499999999999999 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 1.29 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 1.4199999999999999 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 1.26 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 230' ' ' ASN . 0.2 OUTLIER 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 2.1499999999999999 110.128 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.81999999999999995 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 2.1099999999999999 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 3.1699999999999999 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.0600000000000001 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.6499999999999999 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.47 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 3.0 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.6299999999999999 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -57.28 -40.86 78.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 3.1600000000000001 109.384 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.73 -56.3 4.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 2.0899999999999999 109.887 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.25 -56.85 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 2.5699999999999998 110.359 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -48.45 -55.21 11.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 3.5899999999999999 110.241 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.57 -26.58 68.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.235 -0.915 . . . . 1.76 110.971 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -67.09 -22.64 65.81 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.483 -1.303 . . . . 3.21 107.483 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.06 -33.6 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 109.15 -0.685 . . . . 2.3500000000000001 109.15 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.18 65.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 2.3999999999999999 109.271 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.4 p -76.07 -37.78 57.82 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.304 -0.873 . . . . 3.0299999999999998 109.509 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 3.4100000000000001 109.435 179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 4.0700000000000003 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.5 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.8 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92000000000000004 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.5 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 1.3999999999999999 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 1.26 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.95 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.93999999999999995 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78000000000000003 109.091 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 1.29 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 1.1499999999999999 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.71999999999999997 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.5 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 2.3599999999999999 109.888 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 1.1599999999999999 110.801 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 1.24 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 1.3100000000000001 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 1.3100000000000001 110.191 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 2.3500000000000001 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.5800000000000001 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.1400000000000001 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.9299999999999999 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 1.28 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 1.3700000000000001 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 1.3300000000000001 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 3.1899999999999999 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.8100000000000001 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.8300000000000001 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 1.3400000000000001 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.3500000000000001 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.6100000000000001 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.4700000000000002 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 2.0699999999999998 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 1.3300000000000001 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.9399999999999999 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 1.3300000000000001 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 3.1499999999999999 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.92000000000000004 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 1.4099999999999999 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 1.22 107.995 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.58999999999999997 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 3.3900000000000001 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 1.26 107.787 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.9900000000000002 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 1.1399999999999999 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.8400000000000001 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 1.22 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.698 HE22 ' ND2' ' A' ' 140' ' ' ASN . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 2.0 109.477 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.99 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 1.24 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 1.21 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 1.53 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 1.24 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 2.3199999999999998 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 1.1699999999999999 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.57999999999999996 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.3899999999999999 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 1.3600000000000001 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.547 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 1.1399999999999999 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.59999999999999998 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.553 ' C ' ' H ' ' A' ' 69' ' ' LYS . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.5899999999999999 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.495 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2000000000000002 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 2.3599999999999999 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 1.24 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 1.24 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.80000000000000004 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.56000000000000005 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 2.0600000000000001 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 77' ' ' ILE . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 1.24 108.263 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 2.4500000000000002 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 1.21 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 1.1200000000000001 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.3500000000000001 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.1600000000000001 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 1.24 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.79 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 1.1399999999999999 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 1.3200000000000001 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 1.3700000000000001 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 1.3999999999999999 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 93' ' ' ILE . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 1.23 110.12 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.5099999999999998 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.5900000000000001 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 2.3799999999999999 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.6200000000000001 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.8899999999999999 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 1.27 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 1.1599999999999999 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 1.25 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 1.1299999999999999 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 1.0800000000000001 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 2.02 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 1.1799999999999999 110.02 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 1.1899999999999999 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2000000000000002 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.85999999999999999 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 2.0 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 1.3200000000000001 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 2.1400000000000001 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.3799999999999999 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.3500000000000001 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.71 108.534 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.8300000000000001 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.5800000000000001 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.27 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.5800000000000001 109.517 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.9199999999999999 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2000000000000002 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.472 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.5299999999999998 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 1.45 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 1.5 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.3500000000000001 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 1.23 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.73 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.3200000000000001 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 133' ' ' ILE . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 1.2 109.432 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.48999999999999999 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 3.1099999999999999 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.9500000000000002 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.73 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 1.22 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.7799999999999998 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.698 ' ND2' HE22 ' A' ' 53' ' ' GLN . 13.5 m120 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 2.0299999999999998 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 1.2 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 1.28 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68999999999999995 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 1.3100000000000001 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.515 ' CB ' ' ND2' ' A' ' 140' ' ' ASN . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.8799999999999999 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 1.3600000000000001 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.9299999999999999 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 1.3400000000000001 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.98 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 1.3799999999999999 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 1.3999999999999999 109.573 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.7400000000000002 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.4099999999999999 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 1.28 109.179 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 1.1499999999999999 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 1.2 109.983 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 1.1599999999999999 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 1.2 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 1.3200000000000001 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.3399999999999999 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 1.26 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 1.3600000000000001 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' A' ' 168' ' ' THR . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.63 113.158 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 1.0700000000000001 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.568 ' HG1' ' CD2' ' A' ' 189' ' ' HIS . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 1.1799999999999999 109.367 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 1.1399999999999999 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.71 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 1.22 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.675 ' N ' HD21 ' A' ' 172' ' ' ASN . 0.0 OUTLIER -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.5499999999999998 109.989 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.96 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 2.46 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 2.4199999999999999 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 1.1599999999999999 109.386 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.95 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.41999999999999998 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.52000000000000002 110.218 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 1.1599999999999999 107.383 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 1.22 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.2400000000000002 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.6499999999999999 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 2.1000000000000001 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.8400000000000001 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.7800000000000002 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 3.2400000000000002 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 2.1099999999999999 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.568 ' CD2' ' HG1' ' A' ' 168' ' ' THR . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 1.0600000000000001 109.174 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 2.0899999999999999 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.8799999999999999 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 2.0099999999999998 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 1.27 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 1.1799999999999999 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.5800000000000001 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 1.1399999999999999 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 1.28 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 1.28 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.69999999999999996 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 1.1899999999999999 111.664 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 1.25 106.92 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 1.29 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.92000000000000004 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.449 ' H ' ' C ' ' A' ' 203' ' ' VAL . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 1.3100000000000001 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 1.0 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.9199999999999999 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 1.27 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 1.3400000000000001 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 2.0699999999999998 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.8599999999999999 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 1.3 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.48 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.682 HD21 ' H ' ' A' ' 215' ' ' ASP . 0.4 OUTLIER -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.6200000000000001 109.69 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.682 ' H ' HD21 ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.3999999999999999 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.54 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 1.25 110.379 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 1.26 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 1.1799999999999999 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.2200000000000002 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 1.2 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 1.48 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.8199999999999998 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 223' ' ' VAL . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 2.1099999999999999 109.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 2.6499999999999999 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 1.29 109.096 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 1.4199999999999999 109.217 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 1.26 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 2.1499999999999999 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.81999999999999995 112.214 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 2.1099999999999999 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 3.1699999999999999 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.0600000000000001 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.6499999999999999 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.47 109.193 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 3.0 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.6299999999999999 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 -56.6 -31.93 64.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 3.1600000000000001 108.263 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.71 -60.26 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.69 -0.631 . . . . 2.0899999999999999 109.956 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.15 -53.4 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 2.5699999999999998 110.147 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.92 -57.24 9.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 3.5899999999999999 109.877 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.54 -25.55 68.03 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.447 -0.783 . . . . 1.76 111.007 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.6 -22.03 66.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.107 -1.442 . . . . 3.21 107.107 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.8 -41.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.106 -0.702 . . . . 2.3500000000000001 109.106 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.75 -30.06 66.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 2.3999999999999999 109.296 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 -25.21 40.19 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.926 . . . . 3.0299999999999998 109.449 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 3.4100000000000001 110.158 -179.175 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.49 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 4.0700000000000003 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.5 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.8 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92000000000000004 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.425 ' O ' ' O ' ' A' ' 6' ' ' LEU . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.5 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 1.3999999999999999 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 1.26 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.95 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.93999999999999995 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78000000000000003 109.218 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 11' ' ' ILE . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 1.29 109.301 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 1.1499999999999999 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.71999999999999997 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.5 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 2.3599999999999999 110.039 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 1.1599999999999999 111.229 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 1.24 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 1.3100000000000001 111.309 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 1.3100000000000001 109.531 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.489 ' HZ2' ' ND2' ' A' ' 214' ' ' ASN . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 2.3500000000000001 109.271 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.5800000000000001 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.1400000000000001 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.9299999999999999 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 1.28 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 1.3700000000000001 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 1.3300000000000001 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.467 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 3.1899999999999999 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.8100000000000001 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.8300000000000001 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 1.3400000000000001 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.3500000000000001 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.6100000000000001 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.4700000000000002 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 2.0699999999999998 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 1.3300000000000001 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.9399999999999999 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 1.3300000000000001 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 3.1499999999999999 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.92000000000000004 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 1.4099999999999999 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 1.22 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.58999999999999997 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 3.3900000000000001 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 1.26 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.9900000000000002 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 109.371 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.8400000000000001 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 1.22 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 2.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.99 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 1.24 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 1.21 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 1.53 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 1.24 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 2.3199999999999998 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 1.1699999999999999 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.57999999999999996 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.3899999999999999 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 1.3600000000000001 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 1.1399999999999999 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.59999999999999998 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.5899999999999999 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 2.3599999999999999 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 1.24 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 1.24 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.80000000000000004 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.56000000000000005 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 2.0600000000000001 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 1.24 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 2.4500000000000002 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 1.21 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 1.1200000000000001 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.3100000000000001 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 1.24 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.79 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 1.1399999999999999 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 1.3200000000000001 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 1.3700000000000001 110.449 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 1.3999999999999999 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 1.23 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.5099999999999998 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 91' ' ' ALA . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.5900000000000001 112.048 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 2.3799999999999999 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.6200000000000001 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.8899999999999999 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 1.27 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 1.1599999999999999 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 1.25 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 1.1299999999999999 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 1.0800000000000001 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 2.02 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 1.1799999999999999 109.978 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 1.1899999999999999 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2000000000000002 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.85999999999999999 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 2.0 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 1.3200000000000001 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 2.1400000000000001 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.3799999999999999 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.3500000000000001 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.71 108.386 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.8300000000000001 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.5800000000000001 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.7999999999999998 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.27 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.5800000000000001 109.82 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.9199999999999999 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2000000000000002 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.5299999999999998 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 1.45 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 1.5 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.3500000000000001 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 1.23 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.73 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.3200000000000001 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 1.2 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.48999999999999999 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 3.1099999999999999 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.9500000000000002 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.73 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 1.22 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.449 ' HG2' HH11 ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.7799999999999998 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.571 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 2.0299999999999998 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 1.2 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 1.28 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68999999999999995 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 1.3100000000000001 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.8799999999999999 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 1.3600000000000001 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.503 ' H ' ' CD1' ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.9299999999999999 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 151' ' ' ALA . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 1.3400000000000001 109.16 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.98 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 1.3799999999999999 109.58 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 1.3999999999999999 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.7400000000000002 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.4099999999999999 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 1.28 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 1.1499999999999999 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 1.2 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 1.1599999999999999 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 1.2 109.434 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 1.3200000000000001 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.3399999999999999 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 1.26 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 1.3600000000000001 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.63 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 1.0700000000000001 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 1.1799999999999999 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 1.1399999999999999 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.71 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 1.22 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.5499999999999998 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.96 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 2.46 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 2.4199999999999999 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 1.1599999999999999 108.347 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.95 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.41999999999999998 109.081 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.52000000000000002 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 1.1599999999999999 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 1.22 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.6499999999999999 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 2.1000000000000001 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.8400000000000001 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.7800000000000002 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 3.2400000000000002 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 2.1099999999999999 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 1.0600000000000001 110.114 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 2.0899999999999999 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.8799999999999999 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 2.0099999999999998 109.649 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 1.27 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 1.1799999999999999 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.5800000000000001 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 1.1399999999999999 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 1.28 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 1.28 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.69999999999999996 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 1.1899999999999999 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 1.25 107.205 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 1.29 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.92000000000000004 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 1.3100000000000001 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 1.0 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.9199999999999999 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 1.27 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 1.3400000000000001 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 2.0699999999999998 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.8599999999999999 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 1.3 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.48 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.489 ' ND2' ' HZ2' ' A' ' 20' ' ' LYS . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.6200000000000001 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.3999999999999999 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.54 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 1.25 109.906 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 1.26 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 1.1799999999999999 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.2200000000000002 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.546 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 1.2 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 1.48 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.8199999999999998 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 2.1099999999999999 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 228' ' ' TYR . 52.5 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 2.6499999999999999 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 1.29 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 226' ' ' GLN . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 1.4199999999999999 109.988 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 1.26 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 2.1499999999999999 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 2.1099999999999999 109.26 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 3.1699999999999999 109.949 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.0600000000000001 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.6499999999999999 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.47 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 3.0 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.6299999999999999 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.411 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 -56.62 -38.68 72.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 3.1600000000000001 109.602 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.98 -46.07 31.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 2.0899999999999999 109.541 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.89 -55.19 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 2.5699999999999998 109.661 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -52.72 6.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 3.5899999999999999 110.398 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.66 -28.79 68.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.161 -0.962 . . . . 1.76 111.039 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -66.63 -24.42 66.3 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.578 -1.326 . . . . 3.21 107.828 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.85 -43.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.733 -0.839 . . . . 2.3500000000000001 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -37.59 65.85 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.448 -0.783 . . . . 2.3999999999999999 109.48 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -78.8 -29.24 44.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 3.0299999999999998 110.206 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.067 -1.021 . . . . 3.4100000000000001 110.219 -179.312 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 4.0700000000000003 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.5 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.8 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92000000000000004 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.5 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 1.3999999999999999 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 1.26 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.95 108.931 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.93999999999999995 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78000000000000003 109.971 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 11' ' ' ILE . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 1.29 109.267 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 1.1499999999999999 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.5 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 2.3599999999999999 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 215' ' ' ASP . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 1.1599999999999999 111.579 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 1.24 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 1.3100000000000001 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 1.3100000000000001 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 2.3500000000000001 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.5800000000000001 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.1400000000000001 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.9299999999999999 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 1.28 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 1.3700000000000001 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 1.3300000000000001 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.3700000000000001 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 3.1899999999999999 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.8100000000000001 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.8300000000000001 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 1.3400000000000001 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.3500000000000001 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.6100000000000001 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 2.0699999999999998 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 1.3300000000000001 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.9399999999999999 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 1.3300000000000001 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 3.1499999999999999 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.92000000000000004 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 1.4099999999999999 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 1.22 108.451 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.58999999999999997 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 3.3900000000000001 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 1.26 108.44 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.9900000000000002 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 1.1399999999999999 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.8400000000000001 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 1.22 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 2.0 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.99 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 1.24 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.463 ' CD1' HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 1.21 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 1.53 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 1.24 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 2.3199999999999998 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 1.1699999999999999 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.57999999999999996 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.3899999999999999 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 1.3600000000000001 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.581 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 1.1399999999999999 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.59999999999999998 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.5899999999999999 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2000000000000002 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.573 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 2.3599999999999999 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 1.24 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 1.24 109.928 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.80000000000000004 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.56000000000000005 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 17.0 m170 -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 2.0600000000000001 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 1.24 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 2.4500000000000002 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 1.21 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 1.1200000000000001 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.3100000000000001 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.3500000000000001 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.1600000000000001 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 1.24 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.79 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 1.1399999999999999 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 1.3200000000000001 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 1.3700000000000001 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 1.3999999999999999 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 1.23 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.5099999999999998 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.5900000000000001 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 2.3799999999999999 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.6200000000000001 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.8899999999999999 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 1.27 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 1.1599999999999999 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 1.25 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 1.1299999999999999 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 1.0800000000000001 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 2.02 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 1.1799999999999999 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 1.1899999999999999 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2000000000000002 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.85999999999999999 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 2.0 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 1.3200000000000001 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.431 ' HG ' ' H ' ' A' ' 114' ' ' ALA . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 2.1400000000000001 110.201 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' H ' ' HG ' ' A' ' 113' ' ' SER . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.3799999999999999 110.244 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.3500000000000001 108.917 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.71 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.8300000000000001 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.5800000000000001 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.27 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.5800000000000001 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.9199999999999999 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2000000000000002 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.5299999999999998 106.341 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 1.45 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 1.5 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.3500000000000001 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 1.23 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.73 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.3200000000000001 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 1.2 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.48999999999999999 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 3.1099999999999999 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.527 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.9500000000000002 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.73 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 1.22 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.7799999999999998 110.347 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 4.8 m120 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 2.0299999999999998 109.155 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 1.2 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 1.28 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68999999999999995 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 1.3100000000000001 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.8799999999999999 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 1.3600000000000001 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.9299999999999999 108.975 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 1.3400000000000001 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.98 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 1.3799999999999999 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 1.3999999999999999 108.96 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.7400000000000002 109.334 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.4099999999999999 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 1.28 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 1.1499999999999999 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 1.2 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 1.1599999999999999 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 1.2 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 1.3200000000000001 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.3399999999999999 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 1.26 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 1.3600000000000001 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.63 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 1.0700000000000001 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 1.1799999999999999 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 1.1399999999999999 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.71 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 1.22 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.5499999999999998 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.96 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 2.46 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 2.4199999999999999 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 1.1599999999999999 108.714 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.95 109.785 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.41999999999999998 109.571 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.52000000000000002 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 1.1599999999999999 108.861 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 1.22 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.432 ' OD2' ' OG1' ' A' ' 209' ' ' THR . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.2400000000000002 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.6499999999999999 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 2.1000000000000001 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.8400000000000001 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.498 ' CG ' ' NH1' ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.7800000000000002 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 3.2400000000000002 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 2.1099999999999999 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 1.0600000000000001 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 2.0899999999999999 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.614 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.8799999999999999 110.302 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.614 ' N ' ' HG ' ' A' ' 191' ' ' SER . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 2.0099999999999998 110.989 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 1.27 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 1.1799999999999999 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.5800000000000001 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 1.1399999999999999 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 1.28 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 1.28 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.69999999999999996 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 1.1899999999999999 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 1.25 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 1.29 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.92000000000000004 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 1.3100000000000001 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 1.0 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.9199999999999999 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 1.27 110.397 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.432 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 1.3400000000000001 110.309 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 2.0699999999999998 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 210' ' ' SER . 26.9 mm100 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.8599999999999999 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 1.3 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.48 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.6200000000000001 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.3999999999999999 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.54 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 1.25 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 1.26 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 1.1799999999999999 108.612 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.2200000000000002 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.55 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 1.2 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 1.48 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.8199999999999998 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 2.1099999999999999 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 6.9 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 2.6499999999999999 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 1.29 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 1.4199999999999999 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 1.26 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 2.1499999999999999 110.094 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.81999999999999995 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 2.1099999999999999 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 3.1699999999999999 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.0600000000000001 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.6499999999999999 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.47 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 3.0 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.6299999999999999 109.901 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -53.7 -40.93 66.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 3.1600000000000001 109.663 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.54 -59.8 2.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 2.0899999999999999 109.911 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.7 t -59.61 -48.44 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.5699999999999998 110.264 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.423 ' CB ' ' O ' ' A' ' 239' ' ' MET . 3.1 tm0? -55.52 -61.44 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 3.5899999999999999 110.198 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.24 -26.51 68.82 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.495 -0.753 . . . . 1.76 111.21 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -70.37 -20.11 62.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.672 -1.267 . . . . 3.21 108.461 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.0 -34.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.84 -0.8 . . . . 2.3500000000000001 108.84 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.44 -38.93 68.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.444 -0.785 . . . . 2.3999999999999999 109.791 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.95 -32.92 51.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 3.0299999999999998 109.827 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.044 -1.035 . . . . 3.4100000000000001 109.253 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 4.0700000000000003 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.5 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.8 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92000000000000004 108.709 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' A' ' 6' ' ' LEU . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.5 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 1.3999999999999999 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 1.26 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.95 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.93999999999999995 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78000000000000003 109.801 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 1.29 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 1.1499999999999999 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.71999999999999997 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.5 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 2.3599999999999999 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 1.1599999999999999 110.949 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 1.24 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 1.3100000000000001 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 1.3100000000000001 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 2.3500000000000001 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.5800000000000001 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.1400000000000001 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.9299999999999999 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 1.28 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 1.3700000000000001 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 1.3300000000000001 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.3700000000000001 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 3.1899999999999999 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.8100000000000001 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.8300000000000001 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 31' ' ' ILE . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 1.3400000000000001 110.145 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.3500000000000001 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.6100000000000001 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.4700000000000002 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 2.0699999999999998 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 1.3300000000000001 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.9399999999999999 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 1.3300000000000001 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 3.1499999999999999 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.92000000000000004 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 1.4099999999999999 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 1.22 108.458 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.58999999999999997 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' A' ' 51' ' ' SER . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 3.3900000000000001 108.87 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 1.26 108.133 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.9900000000000002 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 1.1399999999999999 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.8400000000000001 108.092 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 1.22 109.459 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 2.0 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.99 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 1.24 109.341 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.435 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 1.21 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 1.53 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 1.24 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 64' ' ' THR . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 2.3199999999999998 107.762 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 1.1699999999999999 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.57999999999999996 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.3899999999999999 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 1.3600000000000001 110.081 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.536 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 1.1399999999999999 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.59999999999999998 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.5899999999999999 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2000000000000002 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.575 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 2.3599999999999999 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 1.24 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 1.24 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.80000000000000004 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.56000000000000005 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 2.0600000000000001 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 1.24 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 2.4500000000000002 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 1.21 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 1.1200000000000001 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.3100000000000001 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.3500000000000001 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.1600000000000001 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 1.24 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.79 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 89' ' ' ILE . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 1.1399999999999999 107.789 177.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 1.3200000000000001 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 1.3700000000000001 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 1.3999999999999999 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 1.23 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.5099999999999998 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.5900000000000001 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 2.3799999999999999 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.6200000000000001 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.8899999999999999 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.602 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 1.27 109.848 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 1.1599999999999999 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.602 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 1.25 109.889 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 1.1299999999999999 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 1.0800000000000001 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 2.02 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 1.1799999999999999 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 1.1899999999999999 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2000000000000002 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.85999999999999999 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 2.0 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 1.3200000000000001 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 2.1400000000000001 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.3799999999999999 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.3500000000000001 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.71 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.8300000000000001 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.5800000000000001 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.7999999999999998 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.27 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.5800000000000001 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.9199999999999999 108.763 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2000000000000002 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.5299999999999998 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 1.45 109.228 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 1.5 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.3500000000000001 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 1.23 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.73 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.3200000000000001 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.2 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.48999999999999999 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 3.1099999999999999 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.435 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.9500000000000002 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.73 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 1.22 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.7799999999999998 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 2.0299999999999998 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 1.2 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 1.28 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68999999999999995 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 1.3100000000000001 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.8799999999999999 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 146' ' ' ILE . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 1.3600000000000001 108.495 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.9299999999999999 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 1.3400000000000001 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.98 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 1.3799999999999999 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 1.3999999999999999 108.542 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.7400000000000002 109.645 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.4099999999999999 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 1.28 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 1.1499999999999999 108.164 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 1.2 109.259 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 1.1599999999999999 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 1.2 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 1.3200000000000001 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.3399999999999999 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 1.26 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 1.3600000000000001 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.63 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 1.1799999999999999 110.087 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 1.1399999999999999 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.71 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 1.22 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 174' ' ' LYS . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.5499999999999998 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.96 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 2.46 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 2.4199999999999999 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 1.1599999999999999 109.209 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.95 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.41999999999999998 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.52000000000000002 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 1.1599999999999999 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 1.22 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.2400000000000002 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.6499999999999999 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 2.1000000000000001 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.8400000000000001 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.7800000000000002 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 3.2400000000000002 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 2.1099999999999999 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 1.0600000000000001 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 2.0899999999999999 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.8799999999999999 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 2.0099999999999998 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 1.27 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 1.1799999999999999 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.5800000000000001 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 1.1399999999999999 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 1.28 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 1.28 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.69999999999999996 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 1.1899999999999999 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 203' ' ' VAL . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 1.25 106.708 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 1.29 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.92000000000000004 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 1.3100000000000001 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 1.0 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.9199999999999999 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 1.27 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 1.3400000000000001 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 2.0699999999999998 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.8599999999999999 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 1.3 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.418 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.48 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.6200000000000001 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.444 ' OD1' ' ND2' ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.3999999999999999 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.54 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 1.25 110.491 -179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 1.26 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 1.1799999999999999 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.2200000000000002 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 1.2 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 1.48 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.8199999999999998 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 2.1099999999999999 109.359 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 2.6499999999999999 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 1.29 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 1.26 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.415 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 2.1499999999999999 110.19 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.81999999999999995 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 2.1099999999999999 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 3.1699999999999999 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.0600000000000001 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.6499999999999999 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.47 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 3.0 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.428 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.6299999999999999 109.815 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.455 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER -55.89 -48.71 75.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 3.1600000000000001 109.74 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.85 -47.48 25.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 2.0899999999999999 110.456 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.78 -47.63 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.065 . . . . 2.5699999999999998 110.425 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 239' ' ' MET . 9.1 tm0? -53.87 -58.09 8.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 3.5899999999999999 110.694 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.81 -23.11 59.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.153 -0.967 . . . . 1.76 110.002 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.99 -25.8 65.6 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.459 -1.312 . . . . 3.21 107.459 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.53 -53.22 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.052 -0.721 . . . . 2.3500000000000001 109.052 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.32 -27.85 69.31 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.396 -0.815 . . . . 2.3999999999999999 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.8 p -77.34 -25.41 51.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.849 . . . . 3.0299999999999998 109.927 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 3.4100000000000001 110.219 -179.454 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 4.0700000000000003 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.5 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.8 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92000000000000004 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.5 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 1.3999999999999999 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 1.26 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.95 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.93999999999999995 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78000000000000003 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 1.29 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 1.1499999999999999 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.71999999999999997 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.5 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 2.3599999999999999 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 1.1599999999999999 111.507 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 1.24 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 1.3100000000000001 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 1.3100000000000001 110.154 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 2.3500000000000001 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.5800000000000001 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.1400000000000001 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.9299999999999999 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 1.28 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 1.3700000000000001 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 1.3300000000000001 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.3700000000000001 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' HG2' HH11 ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 3.1899999999999999 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.8100000000000001 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.8300000000000001 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 1.3400000000000001 110.192 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.3500000000000001 108.94 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.6100000000000001 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.4700000000000002 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 2.0699999999999998 108.871 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 1.3300000000000001 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.9399999999999999 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' A' ' 100' ' ' ALA . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 1.3300000000000001 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG2' HH11 ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 3.1499999999999999 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.92000000000000004 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 1.4099999999999999 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 1.22 107.656 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.58999999999999997 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 3.3900000000000001 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 1.26 108.514 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.9900000000000002 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 1.1399999999999999 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.8400000000000001 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 1.22 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 2.0 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.99 108.898 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 1.24 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 1.21 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 1.53 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 1.24 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 2.3199999999999998 107.125 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 1.1699999999999999 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.57999999999999996 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.3899999999999999 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 1.3600000000000001 109.58 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.53 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 1.1399999999999999 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.59999999999999998 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.5899999999999999 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2000000000000002 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 2.3599999999999999 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 1.24 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 1.24 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.80000000000000004 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.56000000000000005 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 2.0600000000000001 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 1.24 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 2.4500000000000002 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 1.21 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 1.1200000000000001 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.3500000000000001 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.1600000000000001 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 1.24 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.79 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 1.1399999999999999 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 1.3200000000000001 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 1.3700000000000001 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 1.3999999999999999 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 1.23 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.5099999999999998 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.5900000000000001 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 2.3799999999999999 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.444 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.6200000000000001 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.8899999999999999 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 1.27 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.476 ' N ' ' OE1' ' A' ' 39' ' ' GLU . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 1.1599999999999999 109.047 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 1.25 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.1299999999999999 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 1.0800000000000001 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 2.02 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 1.1799999999999999 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 108' ' ' ILE . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 1.1899999999999999 108.457 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2000000000000002 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.85999999999999999 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 2.0 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 1.3200000000000001 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 2.1400000000000001 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.3799999999999999 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.3500000000000001 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.71 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.8300000000000001 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.5800000000000001 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.27 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.5800000000000001 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.9199999999999999 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2000000000000002 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.5299999999999998 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 1.45 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 1.5 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.3500000000000001 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 1.23 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.73 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.3200000000000001 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.2 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.48999999999999999 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 3.1099999999999999 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.9500000000000002 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.73 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 1.22 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 2.0299999999999998 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 1.2 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 1.28 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68999999999999995 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 1.3100000000000001 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.8799999999999999 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 1.3600000000000001 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.9299999999999999 108.855 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 151' ' ' ALA . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 1.3400000000000001 109.326 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.98 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 1.3799999999999999 108.812 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 1.3999999999999999 109.273 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.7400000000000002 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.4099999999999999 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 1.28 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 1.1499999999999999 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 1.2 108.617 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 1.1599999999999999 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 1.2 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 1.3200000000000001 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.3399999999999999 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 1.26 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 1.3600000000000001 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.63 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 1.0700000000000001 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 1.1799999999999999 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.71 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 1.22 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.5499999999999998 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.96 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 2.46 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 2.4199999999999999 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 1.1599999999999999 108.8 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.95 109.734 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.41999999999999998 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.52000000000000002 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 1.1599999999999999 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 1.22 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.2400000000000002 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.6499999999999999 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 2.1000000000000001 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.8400000000000001 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.438 ' O ' ' OG1' ' A' ' 187' ' ' THR . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.7800000000000002 109.318 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 186' ' ' ARG . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 3.2400000000000002 109.327 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 2.1099999999999999 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 1.0600000000000001 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 2.0899999999999999 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.8799999999999999 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 2.0099999999999998 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 1.27 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 1.1799999999999999 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.5800000000000001 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 1.1399999999999999 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 1.28 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 1.28 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.69999999999999996 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 1.1899999999999999 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 1.25 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 1.29 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.92000000000000004 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 1.3100000000000001 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 1.0 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.9199999999999999 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 1.27 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 1.3400000000000001 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 2.0699999999999998 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.8599999999999999 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 1.3 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.48 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.6200000000000001 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.3999999999999999 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.54 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 1.25 109.224 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 1.26 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 1.1799999999999999 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.2200000000000002 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 1.2 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 1.48 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.8199999999999998 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 223' ' ' VAL . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 2.1099999999999999 108.433 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 2.6499999999999999 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 1.29 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.418 ' N ' ' CG1' ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 1.4199999999999999 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 1.26 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 2.1499999999999999 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.81999999999999995 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 2.1099999999999999 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 3.1699999999999999 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.0600000000000001 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.6499999999999999 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.47 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 3.0 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.6299999999999999 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -54.61 -41.3 69.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 3.1600000000000001 108.948 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.11 -35.54 59.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 2.0899999999999999 109.886 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.8 -50.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 2.5699999999999998 111.306 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -62.77 -50.79 69.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.671 -1.268 . . . . 3.5899999999999999 109.619 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -62.78 -25.89 68.45 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.004 -1.06 . . . . 1.76 110.212 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.31 -23.24 63.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.865 -1.161 . . . . 3.21 107.865 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -73.82 -41.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.345 -0.983 . . . . 2.3500000000000001 108.345 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.14 -36.92 63.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -0.86 . . . . 2.3999999999999999 108.843 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 -27.07 50.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 3.0299999999999998 109.489 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 3.4100000000000001 109.718 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 4.0700000000000003 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.5 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.8 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92000000000000004 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.5 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 5' ' ' ILE . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 1.3999999999999999 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 1.26 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.95 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.93999999999999995 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78000000000000003 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 1.29 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 1.1499999999999999 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.71999999999999997 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.5 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 2.3599999999999999 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 1.1599999999999999 110.773 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 1.24 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 1.3100000000000001 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 1.3100000000000001 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 2.3500000000000001 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.1400000000000001 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.9299999999999999 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 1.28 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 1.3700000000000001 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 1.3300000000000001 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.3700000000000001 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 3.1899999999999999 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.8100000000000001 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.8300000000000001 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 1.3400000000000001 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.3500000000000001 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.6100000000000001 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.4700000000000002 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 2.0699999999999998 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 1.3300000000000001 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.438 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 13.5 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.9399999999999999 110.587 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 44' ' ' LEU . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 1.3300000000000001 109.341 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' NH2' ' NE2' ' A' ' 38' ' ' GLN . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 3.1499999999999999 109.051 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.92000000000000004 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 1.4099999999999999 109.013 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 1.22 108.236 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.58999999999999997 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 3.3900000000000001 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 1.26 108.12 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.9900000000000002 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 1.1399999999999999 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.8400000000000001 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 1.22 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 2.0 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.99 108.854 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 1.24 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 1.21 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 1.53 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 1.24 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 2.3199999999999998 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 1.1699999999999999 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.57999999999999996 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.3899999999999999 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 1.3600000000000001 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 1.1399999999999999 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.59999999999999998 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.5899999999999999 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2000000000000002 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.597 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 2.3599999999999999 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 1.24 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 1.24 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.80000000000000004 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.56000000000000005 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 2.0600000000000001 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 1.24 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 2.4500000000000002 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 1.21 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 1.1200000000000001 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.3100000000000001 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.3500000000000001 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.1600000000000001 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 1.24 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.79 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 1.1399999999999999 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 HG22 HD11 ' A' ' 90' ' ' ILE . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 1.3200000000000001 110.358 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 1.3700000000000001 110.188 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 1.3999999999999999 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 1.23 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.5099999999999998 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 91' ' ' ALA . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.5900000000000001 112.155 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 2.3799999999999999 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.6200000000000001 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.8899999999999999 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 1.27 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 1.1599999999999999 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 1.25 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 1.1299999999999999 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 1.0800000000000001 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 2.02 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 1.1799999999999999 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 1.1899999999999999 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2000000000000002 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.85999999999999999 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 2.0 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 1.3200000000000001 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 2.1400000000000001 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.3799999999999999 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.3500000000000001 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.71 108.244 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.5800000000000001 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.7999999999999998 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.27 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.5800000000000001 109.093 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.9199999999999999 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2000000000000002 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.5299999999999998 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 1.45 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 1.5 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.3500000000000001 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 1.23 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.73 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.3200000000000001 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 1.2 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.48999999999999999 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 3.1099999999999999 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.9500000000000002 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.73 108.227 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 1.22 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.7799999999999998 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 2.0299999999999998 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 1.2 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 1.28 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68999999999999995 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 1.3100000000000001 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.8799999999999999 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 1.3600000000000001 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.414 ' N ' ' CG2' ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.9299999999999999 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.3400000000000001 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.98 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 1.3799999999999999 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 1.3999999999999999 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.7400000000000002 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.4099999999999999 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 1.28 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 157' ' ' ILE . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 1.1499999999999999 108.104 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 1.2 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 1.1599999999999999 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 1.2 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 1.3200000000000001 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.3399999999999999 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 1.26 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 1.3600000000000001 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.63 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 1.1799999999999999 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 1.1399999999999999 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.71 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 1.22 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.5499999999999998 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.96 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 2.46 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 2.4199999999999999 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 1.1599999999999999 108.91 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.95 109.637 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.41999999999999998 109.623 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.52000000000000002 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 1.1599999999999999 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 1.22 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.2400000000000002 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.6499999999999999 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 2.1000000000000001 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.8400000000000001 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.406 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.7800000000000002 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 3.2400000000000002 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 2.1099999999999999 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.0600000000000001 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 2.0899999999999999 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.8799999999999999 110.063 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 2.0099999999999998 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 1.27 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 1.1799999999999999 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.5800000000000001 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.1399999999999999 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 1.28 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 1.28 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.69999999999999996 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 1.1899999999999999 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 1.25 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 1.29 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.92000000000000004 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 1.3100000000000001 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.9199999999999999 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 1.27 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 1.3400000000000001 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 2.0699999999999998 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.8599999999999999 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 1.3 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.402 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.48 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.6200000000000001 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.3999999999999999 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.54 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 1.25 110.496 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 1.26 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 1.1799999999999999 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.2200000000000002 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 1.2 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 1.48 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.8199999999999998 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 2.1099999999999999 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 2.6499999999999999 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 1.29 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 1.4199999999999999 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 1.26 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 2.1499999999999999 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.81999999999999995 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 3.1699999999999999 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.0600000000000001 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.6499999999999999 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.47 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 3.0 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 243' ' ' GLN . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.6299999999999999 109.217 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -48.27 -45.38 34.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 3.1600000000000001 110.559 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.58 -54.63 6.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 2.0899999999999999 110.608 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.83 -48.6 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 2.5699999999999998 110.655 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.4 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.838 -1.164 . . . . 3.5899999999999999 109.726 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.91 -32.52 73.81 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.683 -1.261 . . . . 1.76 109.067 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.192 -1.003 . . . . 3.21 108.449 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.39 -41.61 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.193 -1.04 . . . . 2.3500000000000001 108.193 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.02 92.5 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.65 -0.656 . . . . 2.3999999999999999 109.397 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -75.93 -31.56 59.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 3.0299999999999998 109.584 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.885 -1.154 . . . . 3.4100000000000001 107.885 179.137 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.581 ' N ' ' SD ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 4.0700000000000003 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.5 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.8 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92000000000000004 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 6' ' ' LEU . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.5 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 1.3999999999999999 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 1.26 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.95 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.93999999999999995 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78000000000000003 109.712 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 1.29 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 1.1499999999999999 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.71999999999999997 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.5 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 2.3599999999999999 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 1.1599999999999999 111.003 -178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 1.24 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 1.3100000000000001 110.162 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 1.3100000000000001 110.199 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 2.3500000000000001 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.5800000000000001 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.1400000000000001 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.9299999999999999 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 1.28 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 1.3700000000000001 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 1.3300000000000001 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.3700000000000001 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 3.1899999999999999 109.239 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.8100000000000001 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.8300000000000001 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 1.3400000000000001 109.962 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.3500000000000001 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.6100000000000001 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.4700000000000002 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 2.0699999999999998 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 1.3300000000000001 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.9399999999999999 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 1.3300000000000001 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 3.1499999999999999 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.92000000000000004 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 1.4099999999999999 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 1.22 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.58999999999999997 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.416 ' O ' ' OG ' ' A' ' 51' ' ' SER . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 3.3900000000000001 106.251 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 1.26 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.9900000000000002 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 1.1399999999999999 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.8400000000000001 108.431 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 1.22 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 2.0 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.99 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 1.24 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 1.21 109.236 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 1.53 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 1.24 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 2.3199999999999998 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 1.1699999999999999 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.57999999999999996 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.3899999999999999 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 1.3600000000000001 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 1.1399999999999999 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.59999999999999998 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.5899999999999999 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2000000000000002 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 2.3599999999999999 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 1.24 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 1.24 110.001 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.80000000000000004 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.56000000000000005 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 29.9 m170 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 2.0600000000000001 109.785 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 1.24 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 2.4500000000000002 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 1.21 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 1.1200000000000001 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.3100000000000001 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.1600000000000001 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 1.24 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.79 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 1.1399999999999999 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 1.3200000000000001 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 1.3700000000000001 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 1.3999999999999999 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.428 HG22 HD11 ' A' ' 93' ' ' ILE . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 1.23 111.098 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.5099999999999998 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.5900000000000001 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 2.3799999999999999 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.6200000000000001 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.8899999999999999 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 1.27 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 1.1599999999999999 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 1.25 110.483 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 1.1299999999999999 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 1.0800000000000001 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 2.02 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 109' ' ' GLU . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 1.1799999999999999 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 1.1899999999999999 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2000000000000002 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.85999999999999999 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 2.0 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 1.3200000000000001 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 2.1400000000000001 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.3799999999999999 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.3500000000000001 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.71 108.913 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.8300000000000001 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.5800000000000001 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.7999999999999998 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.27 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.5800000000000001 109.416 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.9199999999999999 109.04 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2000000000000002 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.5299999999999998 106.344 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 1.45 109.022 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 1.5 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.3500000000000001 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 1.23 108.977 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.73 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.3200000000000001 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 1.2 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.48999999999999999 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.519 ' HZ3' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 3.1099999999999999 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.9500000000000002 108.433 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.73 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 1.22 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.519 HH11 ' HZ3' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.7799999999999998 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 2.0299999999999998 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 1.2 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 1.28 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68999999999999995 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 1.3100000000000001 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.8799999999999999 109.125 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 1.3600000000000001 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.9299999999999999 109.042 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 1.3400000000000001 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.98 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 1.3799999999999999 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 1.3999999999999999 109.043 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.7400000000000002 109.128 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.4099999999999999 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 1.28 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 1.1499999999999999 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 1.2 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 1.1599999999999999 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 1.2 109.697 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 1.3200000000000001 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 1.26 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 1.3600000000000001 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.63 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 1.0700000000000001 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 1.1799999999999999 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 1.1399999999999999 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.71 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 1.22 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.5499999999999998 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.96 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 2.46 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 2.4199999999999999 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 177' ' ' LEU . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 1.1599999999999999 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.416 ' N ' ' CG1' ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.95 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.41999999999999998 109.272 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.52000000000000002 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 1.1599999999999999 106.771 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 1.22 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.2400000000000002 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.6499999999999999 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 2.1000000000000001 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.8400000000000001 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.7800000000000002 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 3.2400000000000002 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 2.1099999999999999 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 1.0600000000000001 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 2.0899999999999999 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.8799999999999999 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 192' ' ' ILE . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.0099999999999998 110.013 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 1.27 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 1.1799999999999999 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.517 ' NH1' ' CG ' ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.5800000000000001 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 1.1399999999999999 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.28 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 1.28 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.69999999999999996 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 1.1899999999999999 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 1.25 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 1.29 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.92000000000000004 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 203' ' ' VAL . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 1.3100000000000001 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 1.0 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.9199999999999999 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 1.27 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 1.3400000000000001 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 2.0699999999999998 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.8599999999999999 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . 0.446 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 1.3 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.446 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.48 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.6200000000000001 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.3999999999999999 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.54 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 1.25 110.551 -179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 1.26 108.606 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 1.1799999999999999 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.2200000000000002 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 1.2 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 1.48 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.8199999999999998 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 2.1099999999999999 109.424 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.562 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 22.2 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 2.6499999999999999 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 1.29 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 1.4199999999999999 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 1.26 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 2.1499999999999999 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 2.1099999999999999 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 3.1699999999999999 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.0600000000000001 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.6499999999999999 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.47 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 3.0 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.421 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.6299999999999999 110.015 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -57.53 -45.91 84.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 3.1600000000000001 110.18 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.57 16.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.02 . . . . 2.0899999999999999 110.578 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.8 t -69.81 -53.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 2.5699999999999998 110.547 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 239' ' ' MET . 4.9 tp-100 -55.78 -50.22 71.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 3.5899999999999999 109.868 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -62.63 -21.68 65.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.792 -1.193 . . . . 1.76 109.368 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -64.22 -29.4 70.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.262 -1.385 . . . . 3.21 107.262 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.67 -49.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.211 -1.033 . . . . 2.3500000000000001 108.211 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.2 84.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.716 . . . . 2.3999999999999999 109.107 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.7 t -77.21 -18.8 57.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.368 -0.833 . . . . 3.0299999999999998 109.773 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 3.4100000000000001 109.375 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 4.0700000000000003 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.5 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.8 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92000000000000004 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.5 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 1.3999999999999999 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 1.26 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.95 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.93999999999999995 114.455 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78000000000000003 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 1.29 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 1.1499999999999999 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.71999999999999997 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.5 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 2.3599999999999999 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 1.1599999999999999 110.645 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 1.24 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 1.3100000000000001 111.071 -177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 1.3100000000000001 109.977 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 2.3500000000000001 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.5800000000000001 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.1400000000000001 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.9299999999999999 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 1.28 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 1.3700000000000001 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 1.3300000000000001 110.02 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.3700000000000001 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 3.1899999999999999 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.8100000000000001 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.8300000000000001 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 1.3400000000000001 110.27 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.3500000000000001 109.454 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.6100000000000001 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 2.0699999999999998 108.491 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 1.3300000000000001 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.9399999999999999 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 1.3300000000000001 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.92000000000000004 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 1.4099999999999999 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 1.22 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.58999999999999997 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' O ' ' OG ' ' A' ' 51' ' ' SER . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 3.3900000000000001 107.506 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 1.26 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.9900000000000002 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 1.1399999999999999 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' A' ' 52' ' ' ALA . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.8400000000000001 108.859 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.434 ' N ' ' HG ' ' A' ' 51' ' ' SER . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 1.22 109.511 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.463 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 2.0 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.99 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 1.24 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 1.21 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 1.53 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 1.24 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 64' ' ' THR . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 2.3199999999999998 108.468 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 1.1699999999999999 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.57999999999999996 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.3899999999999999 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 1.3600000000000001 110.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 1.1399999999999999 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.59999999999999998 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.5899999999999999 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.51 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2000000000000002 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 2.3599999999999999 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 1.24 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 1.24 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.80000000000000004 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.56000000000000005 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 2.0600000000000001 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 1.24 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 2.4500000000000002 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 1.21 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 1.1200000000000001 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.1600000000000001 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 1.24 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.79 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 1.1399999999999999 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 90' ' ' ILE . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 1.3200000000000001 111.038 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 1.3700000000000001 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 1.3999999999999999 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 1.23 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.5099999999999998 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.5900000000000001 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 2.3799999999999999 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.6200000000000001 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.8899999999999999 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 1.27 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 1.1599999999999999 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 1.25 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 1.1299999999999999 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 1.0800000000000001 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 16.0 t60 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 2.02 109.735 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 1.1799999999999999 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 1.1899999999999999 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2000000000000002 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.85999999999999999 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 2.0 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 1.3200000000000001 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 2.1400000000000001 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.3799999999999999 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.3500000000000001 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.71 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.8300000000000001 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 122' ' ' TYR . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.5800000000000001 109.385 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.7999999999999998 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.27 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.5800000000000001 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.9199999999999999 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2000000000000002 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.5299999999999998 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 1.45 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 1.5 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 1.23 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.73 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.3200000000000001 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 1.2 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.48999999999999999 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 3.1099999999999999 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 140' ' ' ASN . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.9500000000000002 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.73 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 1.22 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.7799999999999998 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 2.0299999999999998 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 1.2 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 1.28 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68999999999999995 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 1.3100000000000001 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.8799999999999999 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 1.3600000000000001 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.9299999999999999 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 1.3400000000000001 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.98 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 1.3799999999999999 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 1.3999999999999999 109.701 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.7400000000000002 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.4099999999999999 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 1.28 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 1.1499999999999999 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 1.2 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 1.1599999999999999 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 1.2 109.998 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 1.3200000000000001 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.3399999999999999 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 1.26 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 1.3600000000000001 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.63 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 1.0700000000000001 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 1.1799999999999999 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 1.1399999999999999 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.71 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 1.22 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.728 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.5499999999999998 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.96 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 2.46 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 2.4199999999999999 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 1.1599999999999999 108.285 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.95 108.28 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.41999999999999998 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.52000000000000002 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 1.1599999999999999 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 1.22 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.2400000000000002 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.6499999999999999 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 2.1000000000000001 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.8400000000000001 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.7800000000000002 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 3.2400000000000002 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 2.1099999999999999 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 1.0600000000000001 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 2.0899999999999999 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.8799999999999999 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 2.0099999999999998 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 1.27 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 1.1799999999999999 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.5800000000000001 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 1.1399999999999999 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 1.28 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.473 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 1.28 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.69999999999999996 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 1.1899999999999999 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 1.25 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 1.29 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.92000000000000004 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 1.3100000000000001 108.027 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 1.0 113.387 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.9199999999999999 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 1.27 110.435 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 1.3400000000000001 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 2.0699999999999998 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.8599999999999999 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 1.3 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.48 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.6200000000000001 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.3999999999999999 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.54 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 1.25 110.131 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 1.26 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 1.1799999999999999 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.2200000000000002 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 1.2 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 1.48 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.8199999999999998 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 2.1099999999999999 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 2.6499999999999999 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 1.29 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 1.4199999999999999 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 1.26 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 2.1499999999999999 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.81999999999999995 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 2.1099999999999999 110.236 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 3.1699999999999999 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.0600000000000001 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.6499999999999999 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.47 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 3.0 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.6299999999999999 110.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -50.41 -51.35 47.14 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 3.1600000000000001 110.095 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.24 2.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 2.0899999999999999 111.594 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.43 -50.56 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.026 -1.046 . . . . 2.5699999999999998 111.593 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 6.3 tp60 -55.57 -39.19 70.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.848 -1.158 . . . . 3.5899999999999999 109.565 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -26.33 67.84 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.907 -1.121 . . . . 1.76 108.741 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -69.85 -20.86 63.4 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.289 -0.882 . . . . 3.21 108.717 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.05 -50.53 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 2.3500000000000001 109.034 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.74 68.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.298 -0.876 . . . . 2.3999999999999999 108.967 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.5 t -77.3 -34.38 55.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 3.0299999999999998 109.512 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 3.4100000000000001 109.308 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 4.0700000000000003 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.5 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.8 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92000000000000004 109.134 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.5 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 1.3999999999999999 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 1.26 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.95 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.93999999999999995 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78000000000000003 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 1.29 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 1.1499999999999999 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.71999999999999997 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.5 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 2.3599999999999999 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 1.1599999999999999 111.146 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 1.24 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 1.3100000000000001 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 1.3100000000000001 109.743 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 2.3500000000000001 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.5800000000000001 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.1400000000000001 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.9299999999999999 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 1.28 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 1.3700000000000001 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 1.3300000000000001 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.3700000000000001 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 3.1899999999999999 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.8100000000000001 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.8300000000000001 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 1.3400000000000001 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 34' ' ' ASP . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.3500000000000001 108.808 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.6100000000000001 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 32' ' ' SER . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.4700000000000002 110.329 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 2.0699999999999998 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 1.3300000000000001 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.9399999999999999 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 1.3300000000000001 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 3.1499999999999999 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.92000000000000004 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 1.4099999999999999 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 1.22 108.76 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.58999999999999997 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.497 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 3.3900000000000001 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 1.26 109.086 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.9900000000000002 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 1.1399999999999999 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.8400000000000001 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 1.22 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 2.0 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.99 109.271 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 1.24 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 1.21 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 1.53 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 1.24 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.425 ' O ' ' OG1' ' A' ' 64' ' ' THR . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 2.3199999999999998 107.707 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 1.1699999999999999 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.57999999999999996 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.3899999999999999 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 1.3600000000000001 110.059 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 1.1399999999999999 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.59999999999999998 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.5899999999999999 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2000000000000002 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 2.3599999999999999 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 1.24 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 1.24 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.80000000000000004 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.56000000000000005 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 2.0600000000000001 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 77' ' ' ILE . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 1.24 109.198 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 2.4500000000000002 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 1.21 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 1.1200000000000001 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.3500000000000001 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.1600000000000001 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 1.24 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.497 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.79 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 1.1399999999999999 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 1.3200000000000001 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 1.3700000000000001 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 1.3999999999999999 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 1.23 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.5099999999999998 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.5900000000000001 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 2.3799999999999999 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.6200000000000001 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.8899999999999999 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 1.27 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 1.1599999999999999 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 1.25 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 1.1299999999999999 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 1.0800000000000001 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 2.02 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 1.1799999999999999 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 1.1899999999999999 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2000000000000002 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.85999999999999999 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 2.0 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 1.3200000000000001 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 2.1400000000000001 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.3799999999999999 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.3500000000000001 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.71 108.488 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.8300000000000001 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.5800000000000001 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.7999999999999998 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.27 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.5800000000000001 109.12 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.9199999999999999 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2000000000000002 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.5299999999999998 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 1.45 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 1.5 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.3500000000000001 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 1.23 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.73 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.3200000000000001 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 1.2 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.48999999999999999 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 3.1099999999999999 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.443 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.9500000000000002 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.73 108.989 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 1.22 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.7799999999999998 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.0 m-20 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 2.0299999999999998 109.194 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 1.2 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 1.28 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68999999999999995 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 1.3100000000000001 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.8799999999999999 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 1.3600000000000001 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.9299999999999999 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 1.3400000000000001 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.98 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 1.3799999999999999 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 1.3999999999999999 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.7400000000000002 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.4099999999999999 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 1.28 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 1.1499999999999999 107.969 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 1.2 109.824 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 1.1599999999999999 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 1.2 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 1.3200000000000001 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.3399999999999999 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 1.26 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 1.3600000000000001 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.63 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 1.0700000000000001 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 1.1799999999999999 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 1.1399999999999999 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.71 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 1.22 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.431 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.6 m120 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.5499999999999998 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.538 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 172' ' ' ASN . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 2.46 109.56 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 2.4199999999999999 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 1.1599999999999999 108.656 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.95 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.41999999999999998 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.52000000000000002 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 1.1599999999999999 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 1.22 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.2400000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.6499999999999999 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 2.1000000000000001 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.8400000000000001 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.7800000000000002 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 3.2400000000000002 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 2.1099999999999999 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 1.0600000000000001 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 2.0899999999999999 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.8799999999999999 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 2.0099999999999998 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 1.27 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 1.1799999999999999 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.5800000000000001 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 1.1399999999999999 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 1.28 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.557 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 1.28 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.69999999999999996 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 1.1899999999999999 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 202' ' ' ILE . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 1.25 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 1.29 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.92000000000000004 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.476 ' HG1' ' CG ' ' A' ' 182' ' ' ASP . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 1.3100000000000001 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 1.0 112.964 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 205' ' ' THR . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.9199999999999999 113.194 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 1.27 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 1.3400000000000001 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 2.0699999999999998 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.8599999999999999 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 1.3 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.48 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.6200000000000001 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.3999999999999999 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.54 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 1.25 111.238 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 1.26 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 1.1799999999999999 109.046 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.2200000000000002 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 1.2 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.8199999999999998 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.54 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.3 OUTLIER 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 2.1099999999999999 109.248 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 2.6499999999999999 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 1.29 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 1.4199999999999999 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 1.26 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 2.1499999999999999 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.81999999999999995 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 2.1099999999999999 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 3.1699999999999999 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.0600000000000001 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.6499999999999999 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.47 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 3.0 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.6299999999999999 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -55.4 -34.52 64.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 3.1600000000000001 108.999 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.4 -56.97 4.26 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.859 . . . . 2.0899999999999999 109.65 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.91 -57.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 2.5699999999999998 110.008 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 243' ' ' GLN . 5.6 tp60 -50.0 -59.36 3.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 3.5899999999999999 109.881 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.23 -24.32 67.82 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.475 -0.765 . . . . 1.76 110.999 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.73 -23.71 67.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.59 -1.263 . . . . 3.21 107.59 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.84 -52.98 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.81 -0.811 . . . . 2.3500000000000001 108.81 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.83 -31.97 63.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.099 -1.074 . . . . 2.3999999999999999 108.099 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.0 p -79.38 -22.83 43.83 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.716 -0.615 . . . . 3.0299999999999998 109.58 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.857 . . . . 3.4100000000000001 108.992 -179.452 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 4.0700000000000003 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.5 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.8 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92000000000000004 108.181 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.5 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 1.3999999999999999 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 1.26 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.95 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.93999999999999995 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 222' ' ' ALA . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78000000000000003 110.69 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 1.29 109.725 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 1.1499999999999999 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.71999999999999997 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.5 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 2.3599999999999999 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 1.1599999999999999 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 1.24 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.603 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 1.3100000000000001 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 1.3100000000000001 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 2.3500000000000001 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.5800000000000001 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.9299999999999999 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 1.28 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 1.3700000000000001 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 1.3300000000000001 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.3700000000000001 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 3.1899999999999999 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.8100000000000001 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.8300000000000001 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 1.3400000000000001 110.154 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.3500000000000001 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.6100000000000001 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.4700000000000002 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 2.0699999999999998 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 1.3300000000000001 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.9399999999999999 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 1.3300000000000001 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 3.1499999999999999 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.92000000000000004 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 1.4099999999999999 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 1.22 107.999 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.58999999999999997 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 3.3900000000000001 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 1.26 108.477 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.9900000000000002 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 1.1399999999999999 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.8400000000000001 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 1.22 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 2.0 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.99 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 1.24 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 57' ' ' ILE . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 1.21 109.107 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 1.53 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 1.24 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.414 ' O ' ' OG1' ' A' ' 64' ' ' THR . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 2.3199999999999998 108.36 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 1.1699999999999999 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.57999999999999996 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.3899999999999999 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 1.3600000000000001 110.227 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.543 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.59999999999999998 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2000000000000002 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 2.3599999999999999 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 1.24 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 1.24 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.80000000000000004 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.56000000000000005 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 2.0600000000000001 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 1.24 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 2.4500000000000002 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 1.21 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 1.1200000000000001 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.3100000000000001 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 1.24 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.79 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 1.1399999999999999 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 1.3700000000000001 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 1.3999999999999999 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 1.23 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.5099999999999998 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.5900000000000001 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 2.3799999999999999 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.6200000000000001 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.8899999999999999 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 1.27 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 1.1599999999999999 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 1.25 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 1.1299999999999999 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 1.0800000000000001 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 2.02 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 1.1799999999999999 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 1.1899999999999999 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2000000000000002 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.85999999999999999 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 2.0 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 1.3200000000000001 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 2.1400000000000001 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.3799999999999999 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.3500000000000001 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.71 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.8300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 122' ' ' TYR . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 110.059 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.7999999999999998 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 120' ' ' ASP . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.27 109.988 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.5800000000000001 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.9199999999999999 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2000000000000002 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.532 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.5299999999999998 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 1.45 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 1.5 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 1.23 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.73 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.3200000000000001 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 1.2 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.48999999999999999 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 3.1099999999999999 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.493 ' NH2' ' OD1' ' A' ' 132' ' ' ASP . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.9500000000000002 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.73 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.22 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.7799999999999998 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.3 m120 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 2.0299999999999998 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 1.2 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 1.28 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68999999999999995 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 1.3100000000000001 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.8799999999999999 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 146' ' ' ILE . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 1.3600000000000001 109.127 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.9299999999999999 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 1.3400000000000001 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.98 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 1.3799999999999999 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 1.3999999999999999 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.7400000000000002 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.4099999999999999 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 1.28 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 1.1499999999999999 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 1.2 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 1.1599999999999999 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 1.2 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 1.3200000000000001 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.3399999999999999 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 1.26 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 1.3600000000000001 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.63 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 1.0700000000000001 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 1.1799999999999999 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 1.1399999999999999 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.71 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 1.22 109.117 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.5499999999999998 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.96 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 2.46 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 2.4199999999999999 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 1.1599999999999999 108.366 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.95 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.41999999999999998 109.245 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.52000000000000002 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 1.1599999999999999 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 1.22 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.2400000000000002 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.6499999999999999 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 2.1000000000000001 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.8400000000000001 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.7800000000000002 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 3.2400000000000002 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 2.1099999999999999 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 1.0600000000000001 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 2.0899999999999999 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.8799999999999999 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 2.0099999999999998 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 1.27 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 1.1799999999999999 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.5800000000000001 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 1.1399999999999999 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 1.28 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 1.28 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.69999999999999996 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 1.1899999999999999 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 1.25 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 1.29 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.92000000000000004 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 1.3100000000000001 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 1.0 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.9199999999999999 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 1.27 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 1.3400000000000001 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 2.0699999999999998 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.8599999999999999 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 1.3 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.48 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.603 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 9.1 m120 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.6200000000000001 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.3999999999999999 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.54 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 1.25 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 1.26 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 1.1799999999999999 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.2200000000000002 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.404 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 1.2 110.698 179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 1.48 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.8199999999999998 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.41 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.4 OUTLIER 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 2.1099999999999999 109.859 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 2.6499999999999999 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 1.29 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 1.4199999999999999 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 1.26 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 2.1499999999999999 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 2.1099999999999999 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 3.1699999999999999 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.0600000000000001 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.6499999999999999 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.47 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 3.0 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.6299999999999999 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.87 -32.89 69.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 3.1600000000000001 109.868 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.4 -52.95 8.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 2.0899999999999999 110.73 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.38 -56.78 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.001 -1.062 . . . . 2.5699999999999998 110.404 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -50.46 -57.48 7.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.271 -0.893 . . . . 3.5899999999999999 110.135 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.93 -23.2 67.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.439 -0.788 . . . . 1.76 110.942 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.34 -25.78 67.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.304 -1.369 . . . . 3.21 107.304 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.32 -47.3 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.967 -1.123 . . . . 2.3500000000000001 107.967 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.98 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.259 -1.015 . . . . 2.3999999999999999 108.259 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.8 t -75.17 -22.73 57.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.873 -0.788 . . . . 3.0299999999999998 108.873 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.465 -0.772 . . . . 3.4100000000000001 109.155 179.768 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 4.0700000000000003 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.5 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.8 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92000000000000004 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.5 108.785 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 1.3999999999999999 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 1.26 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.95 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.93999999999999995 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78000000000000003 110.07 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 1.29 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 1.1499999999999999 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.71999999999999997 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.5 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 2.3599999999999999 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 1.1599999999999999 111.091 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 1.24 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 1.3100000000000001 110.829 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 1.3100000000000001 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 2.3500000000000001 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.5800000000000001 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.1400000000000001 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.9299999999999999 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 1.28 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 1.3700000000000001 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 1.3300000000000001 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.3700000000000001 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 3.1899999999999999 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.8100000000000001 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.8300000000000001 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 1.3400000000000001 110.52 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.3500000000000001 109.015 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.6100000000000001 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.4700000000000002 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 2.0699999999999998 108.754 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 1.3300000000000001 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.9399999999999999 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 1.3300000000000001 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 3.1499999999999999 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.92000000000000004 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 1.4099999999999999 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 1.22 108.026 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.58999999999999997 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.422 ' O ' ' OG ' ' A' ' 51' ' ' SER . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 3.3900000000000001 108.737 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 1.26 107.996 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.9900000000000002 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 1.1399999999999999 109.069 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.8400000000000001 107.812 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 1.22 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 2.0 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.99 109.217 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 1.24 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 1.21 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 1.53 110.269 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 1.24 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 2.3199999999999998 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 1.1699999999999999 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.57999999999999996 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.3899999999999999 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 1.3600000000000001 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 1.1399999999999999 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.59999999999999998 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.5899999999999999 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2000000000000002 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 2.3599999999999999 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 1.24 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 1.24 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.80000000000000004 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.56000000000000005 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 2.0600000000000001 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 1.24 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 2.4500000000000002 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 1.21 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 1.1200000000000001 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.3100000000000001 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.3500000000000001 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 1.24 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.79 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 1.1399999999999999 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 1.3200000000000001 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 1.3700000000000001 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 1.3999999999999999 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 1.23 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.5099999999999998 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.5900000000000001 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 2.3799999999999999 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.6200000000000001 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.8899999999999999 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.72 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 1.27 109.816 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.1599999999999999 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.72 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 1.25 110.191 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 1.1299999999999999 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 2.02 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 1.1799999999999999 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 1.1899999999999999 109.636 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2000000000000002 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.85999999999999999 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 2.0 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 1.3200000000000001 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 2.1400000000000001 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.3799999999999999 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.3500000000000001 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.71 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.8300000000000001 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.7999999999999998 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.27 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.5800000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.9199999999999999 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.531 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.5299999999999998 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 1.45 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 1.5 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 1.23 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.73 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.3200000000000001 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 1.2 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.48999999999999999 109.152 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 3.1099999999999999 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.9500000000000002 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.73 109.107 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 1.22 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.7799999999999998 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.542 ' N ' HD21 ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 2.0299999999999998 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 1.2 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 1.28 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68999999999999995 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 1.3100000000000001 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.8799999999999999 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 1.3600000000000001 109.032 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.9299999999999999 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 1.3400000000000001 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.591 ' HG ' HD22 ' A' ' 172' ' ' ASN . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.98 109.136 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 1.3799999999999999 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 1.3999999999999999 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.7400000000000002 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.4099999999999999 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 1.28 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 1.1499999999999999 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 1.2 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 1.1599999999999999 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 1.2 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 1.3200000000000001 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.3399999999999999 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 1.26 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 1.3600000000000001 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.63 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 1.1799999999999999 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 1.1399999999999999 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.71 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 1.22 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.591 HD22 ' HG ' ' A' ' 150' ' ' SER . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.5499999999999998 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.96 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 2.46 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 2.4199999999999999 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 1.1599999999999999 110.103 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.95 110.532 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.41999999999999998 110.131 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.52000000000000002 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 1.1599999999999999 107.598 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 1.22 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.2400000000000002 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.6499999999999999 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 2.1000000000000001 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.8400000000000001 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.7800000000000002 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 3.2400000000000002 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 2.1099999999999999 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 1.0600000000000001 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 2.0899999999999999 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.8799999999999999 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 2.0099999999999998 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 1.27 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 1.1799999999999999 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.5800000000000001 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 1.1399999999999999 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.526 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 1.28 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 1.28 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.69999999999999996 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 1.1899999999999999 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 1.25 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 1.29 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.92000000000000004 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 1.3100000000000001 108.551 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 1.0 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.9199999999999999 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 1.27 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 1.3400000000000001 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 2.0699999999999998 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.8599999999999999 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 1.3 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.48 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.6200000000000001 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.54 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 1.25 109.97 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 1.26 108.107 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 1.1799999999999999 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.2200000000000002 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.549 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 1.2 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 1.48 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.8199999999999998 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.493 ' C ' HD21 ' A' ' 225' ' ' ASN . 0.2 OUTLIER 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 2.1099999999999999 109.165 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 6.8 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 2.6499999999999999 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 1.29 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.415 ' HH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 1.4199999999999999 109.712 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 1.26 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 2.1499999999999999 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 111.688 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 2.1099999999999999 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 3.1699999999999999 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.0600000000000001 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.6499999999999999 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.47 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 3.0 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.6299999999999999 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -58.09 -25.72 61.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 3.1600000000000001 109.565 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.07 -62.05 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 2.0899999999999999 109.864 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.5 t -62.7 -51.05 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.095 -1.003 . . . . 2.5699999999999998 109.833 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -48.42 -59.01 3.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 3.5899999999999999 109.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -63.62 -23.38 67.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 1.76 110.551 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -66.31 -25.03 66.65 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.832 -1.168 . . . . 3.21 107.973 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.78 -53.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.713 -0.847 . . . . 2.3500000000000001 108.713 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.49 72.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.836 -0.802 . . . . 2.3999999999999999 108.836 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.2 p -74.45 -21.45 59.59 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.47 -0.769 . . . . 3.0299999999999998 109.158 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.49 -0.756 . . . . 3.4100000000000001 108.998 -179.702 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' H1 ' ' H ' ' A' ' 2' ' ' ILE . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 4.0700000000000003 109.593 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.439 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.5 109.18 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.8 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.703 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92000000000000004 108.293 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.5 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 1.3999999999999999 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 1.26 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.95 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.93999999999999995 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78000000000000003 109.92 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 1.29 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 1.1499999999999999 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.71999999999999997 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.5 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 2.3599999999999999 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 1.1599999999999999 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 1.24 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 1.3100000000000001 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 1.3100000000000001 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 2.3500000000000001 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.1400000000000001 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.9299999999999999 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 1.28 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 1.3700000000000001 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 1.3300000000000001 109.386 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.3700000000000001 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 3.1899999999999999 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.8100000000000001 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.8300000000000001 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 1.3400000000000001 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.514 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.3500000000000001 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.6100000000000001 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.4700000000000002 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 2.0699999999999998 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 1.3300000000000001 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.9399999999999999 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 44' ' ' LEU . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 1.3300000000000001 109.798 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.515 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 3.1499999999999999 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.92000000000000004 109.472 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 40' ' ' VAL . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 1.4099999999999999 109.236 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 1.22 108.971 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.58999999999999997 108.607 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 3.3900000000000001 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 1.26 108.261 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 46' ' ' GLY . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.9900000000000002 109.249 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 1.1399999999999999 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.8400000000000001 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 1.22 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 2.0 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.99 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 1.24 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 1.21 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 1.53 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 1.24 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 2.3199999999999998 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 1.1699999999999999 108.396 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.57999999999999996 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.3899999999999999 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 1.3600000000000001 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.59999999999999998 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.5899999999999999 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2000000000000002 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 2.3599999999999999 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 1.24 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 1.24 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.80000000000000004 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.56000000000000005 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 2.0600000000000001 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 1.24 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 2.4500000000000002 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 1.21 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 1.1200000000000001 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.3100000000000001 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.3500000000000001 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.1600000000000001 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 1.24 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.79 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 1.1399999999999999 108.196 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 1.3200000000000001 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 1.3700000000000001 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 1.3999999999999999 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 1.23 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.5099999999999998 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.5900000000000001 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 2.3799999999999999 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.6200000000000001 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.8899999999999999 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 1.27 109.707 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 1.1599999999999999 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.652 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 1.25 110.442 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 1.1299999999999999 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 1.0800000000000001 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 32.4 t60 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 2.02 109.448 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 1.1799999999999999 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 1.1899999999999999 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2000000000000002 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.85999999999999999 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 2.0 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 1.3200000000000001 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 2.1400000000000001 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.3799999999999999 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.3500000000000001 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.71 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.8300000000000001 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.5800000000000001 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.7999999999999998 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.27 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.5800000000000001 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.9199999999999999 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2000000000000002 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.5299999999999998 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 1.45 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 1.5 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.3500000000000001 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 1.23 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.73 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.3200000000000001 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 1.2 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.48999999999999999 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 3.1099999999999999 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.9500000000000002 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.73 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 1.22 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.7799999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.568 ' ND2' ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 2.0299999999999998 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 1.2 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 1.28 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68999999999999995 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 1.3100000000000001 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.8799999999999999 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 1.3600000000000001 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CD1' ' N ' ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.9299999999999999 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 1.3400000000000001 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.424 ' HG ' ' ND2' ' A' ' 172' ' ' ASN . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.98 109.495 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 1.3799999999999999 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 1.3999999999999999 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.7400000000000002 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.4099999999999999 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 1.28 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 1.1499999999999999 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 1.2 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 1.1599999999999999 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 1.2 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 1.3200000000000001 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.3399999999999999 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 1.26 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 1.3600000000000001 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.63 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 1.0700000000000001 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 1.1799999999999999 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 1.1399999999999999 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.71 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 1.22 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.424 ' ND2' ' HG ' ' A' ' 150' ' ' SER . 50.8 m-80 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.5499999999999998 108.376 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.96 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 2.46 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 2.4199999999999999 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 1.1599999999999999 108.472 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.95 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.41999999999999998 108.908 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.52000000000000002 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 1.1599999999999999 106.741 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 1.22 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.2400000000000002 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.6499999999999999 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 2.1000000000000001 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.8400000000000001 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.605 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.7800000000000002 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 3.2400000000000002 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 2.1099999999999999 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 1.0600000000000001 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 2.0899999999999999 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.8799999999999999 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 2.0099999999999998 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 1.27 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 1.1799999999999999 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.5800000000000001 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 1.1399999999999999 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 1.28 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 1.28 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.69999999999999996 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 1.1899999999999999 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 1.25 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 1.29 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.92000000000000004 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 1.3100000000000001 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 1.0 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.9199999999999999 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 1.27 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 1.3400000000000001 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 2.0699999999999998 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 210' ' ' SER . 15.3 mm100 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.8599999999999999 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 1.3 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.48 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.6200000000000001 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.3999999999999999 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.54 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 1.25 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 1.26 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 1.1799999999999999 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.2200000000000002 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 221' ' ' ASP . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 1.2 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 1.48 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.8199999999999998 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.703 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 2.1099999999999999 109.333 -179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 2.6499999999999999 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 1.29 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 1.4199999999999999 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 1.26 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 2.1499999999999999 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.81999999999999995 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 2.1099999999999999 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 3.1699999999999999 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.0600000000000001 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.6499999999999999 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.47 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 3.0 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.6299999999999999 109.167 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 13.8 mmm-85 -51.03 -41.73 60.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 3.1600000000000001 109.648 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.93 -61.67 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 2.0899999999999999 110.808 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.6 t -67.96 -49.19 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.038 -1.039 . . . . 2.5699999999999998 110.942 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.3 tt0 -54.14 -44.35 71.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.822 -1.174 . . . . 3.5899999999999999 110.406 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.24 -29.76 71.03 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.866 -1.146 . . . . 1.76 109.926 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -68.59 -19.81 64.48 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.95 -1.093 . . . . 3.21 108.702 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.45 -43.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 2.3500000000000001 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.76 69.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 2.3999999999999999 109.301 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.2 t -75.66 -24.88 56.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.317 -0.864 . . . . 3.0299999999999998 109.659 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 3.4100000000000001 110.302 -179.618 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 3.6600000000000001 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.1200000000000001 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.45 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92000000000000004 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 5' ' ' ILE . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.05 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.88 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.5 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.85999999999999999 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78000000000000003 109.475 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 0.73999999999999999 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 0.45000000000000001 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.64000000000000001 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.45000000000000001 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 1.8799999999999999 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 0.58999999999999997 111.188 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 0.64000000000000001 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 0.73999999999999999 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 160' ' ' ALA . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 0.73999999999999999 110.588 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 1.8700000000000001 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.5800000000000001 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.1400000000000001 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.9299999999999999 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.448 ' CD1' ' HZ3' ' A' ' 135' ' ' LYS . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.68000000000000005 109.394 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 0.83999999999999997 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 0.79000000000000004 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 2.6200000000000001 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.3500000000000001 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.3500000000000001 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 0.78000000000000003 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.04 109.53 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.05 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.4700000000000002 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 1.46 108.803 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.77000000000000002 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.29 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.76000000000000001 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 2.6600000000000001 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.75 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.82999999999999996 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 0.78000000000000003 108.266 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.56999999999999995 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 2.8300000000000001 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 0.65000000000000002 108.151 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.5699999999999998 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.51000000000000001 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.3600000000000001 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 0.59999999999999998 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.3799999999999999 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.59999999999999998 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.53000000000000003 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.98999999999999999 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 0.58999999999999997 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 1.8100000000000001 107.934 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 0.47999999999999998 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.57999999999999996 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.3899999999999999 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.81999999999999995 110.089 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 0.98999999999999999 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.55000000000000004 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.5899999999999999 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2000000000000002 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 1.79 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 0.64000000000000001 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.57999999999999996 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.62 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.52000000000000002 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 1.29 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 0.55000000000000004 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 1.8899999999999999 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 0.53000000000000003 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 0.42999999999999999 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.3100000000000001 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.1600000000000001 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 0.59999999999999998 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.28 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 0.57999999999999996 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 0.78000000000000003 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 0.85999999999999999 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.79000000000000004 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 0.70999999999999996 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.0499999999999998 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.5900000000000001 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 1.8899999999999999 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.3100000000000001 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.28 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.62 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 0.46999999999999997 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 0.56000000000000005 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.47999999999999998 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.44 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 1.4199999999999999 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.60999999999999999 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.64000000000000001 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2000000000000002 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.81999999999999995 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 1.27 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 0.91000000000000003 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 1.73 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.04 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.03 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.26 108.555 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.8300000000000001 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.5800000000000001 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.7999999999999998 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.02 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 118' ' ' LEU . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.0600000000000001 109.184 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.3900000000000001 108.431 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2000000000000002 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.0899999999999999 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 0.85999999999999999 107.97 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 0.90000000000000002 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.57999999999999996 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.2200000000000002 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.3200000000000001 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 0.5 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.44 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 2.71 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.2000000000000002 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.1299999999999999 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.54000000000000004 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.451 ' NH2' ' NZ ' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.3199999999999998 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 1.26 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.62 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.67000000000000004 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68000000000000005 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 0.77000000000000002 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.3999999999999999 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 0.87 109.302 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.793 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.3200000000000001 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.77000000000000002 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.5700000000000001 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 0.81999999999999995 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 0.81999999999999995 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.1099999999999999 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.4099999999999999 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 0.56999999999999995 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 158' ' ' LEU . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 0.42999999999999999 107.464 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 0.56000000000000005 109.588 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 0.54000000000000004 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 0.62 109.615 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 0.80000000000000004 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.3399999999999999 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.73999999999999999 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.59999999999999998 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.63 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.5 109.561 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 0.51000000000000001 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.1699999999999999 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 0.60999999999999999 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.1200000000000001 109.803 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.3400000000000001 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 1.8999999999999999 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 0.47999999999999998 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.3899999999999999 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.38 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.46000000000000002 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.604 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 0.58999999999999997 107.462 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 0.67000000000000004 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.2400000000000002 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.1100000000000001 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 1.6299999999999999 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.2400000000000002 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 2.9199999999999999 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 1.6000000000000001 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.424 ' CD2' HG21 ' A' ' 168' ' ' THR . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.92000000000000004 109.522 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 1.5900000000000001 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.4199999999999999 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 1.4099999999999999 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 0.85999999999999999 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 0.58999999999999997 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.0600000000000001 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 0.72999999999999998 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.67000000000000004 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 0.64000000000000001 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.58999999999999997 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 0.55000000000000004 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 0.63 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 0.77000000000000002 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.87 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.604 HG21 ' CG2' ' A' ' 180' ' ' ILE . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 0.89000000000000001 108.361 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 0.93000000000000005 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.6000000000000001 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 0.75 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.83999999999999997 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 1.6100000000000001 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.2999999999999998 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 0.76000000000000001 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.1899999999999999 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.3999999999999999 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.3 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 0.53000000000000003 110.426 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 0.59999999999999998 107.429 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 0.56999999999999995 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.2200000000000002 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 0.75 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 0.92000000000000004 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.3599999999999999 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 1.4199999999999999 109.301 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 1.97 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 0.65000000000000002 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 0.96999999999999997 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 0.67000000000000004 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 1.45 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.465 ' HG3' HD12 ' A' ' 219' ' ' ILE . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.81999999999999995 111.495 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 1.6200000000000001 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 2.6000000000000001 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.0600000000000001 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.04 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 2.6000000000000001 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.23 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 2.6699999999999999 109.204 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 3.6600000000000001 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.1200000000000001 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.45 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92000000000000004 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.05 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.88 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 0.78000000000000003 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.5 108.805 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.85999999999999999 113.847 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.768 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78000000000000003 109.628 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 0.73999999999999999 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 0.45000000000000001 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.64000000000000001 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.45000000000000001 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 1.8799999999999999 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.58999999999999997 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 0.64000000000000001 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 0.73999999999999999 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 0.73999999999999999 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 1.8700000000000001 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.5800000000000001 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.9299999999999999 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.68000000000000005 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 0.83999999999999997 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.79000000000000004 108.882 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.3700000000000001 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 2.6200000000000001 108.422 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.3500000000000001 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.3500000000000001 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 0.78000000000000003 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.04 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.05 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.4700000000000002 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 1.46 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 0.77000000000000002 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.29 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.76000000000000001 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 2.6600000000000001 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.75 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 0.82999999999999996 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 0.78000000000000003 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.56999999999999995 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 2.8300000000000001 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 0.65000000000000002 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.5699999999999998 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 0.51000000000000001 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.3600000000000001 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 0.59999999999999998 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 1.3600000000000001 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.3799999999999999 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.59999999999999998 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 0.53000000000000003 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.98999999999999999 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 0.58999999999999997 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 1.8100000000000001 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 0.47999999999999998 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.57999999999999996 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.3899999999999999 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 0.98999999999999999 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.55000000000000004 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.5899999999999999 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2000000000000002 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 1.79 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 0.57999999999999996 109.758 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.62 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.52000000000000002 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 1.29 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.55000000000000004 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 1.8899999999999999 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 0.53000000000000003 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 0.42999999999999999 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.3100000000000001 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 0.59999999999999998 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.28 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 0.57999999999999996 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 0.78000000000000003 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 0.85999999999999999 110.093 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 0.79000000000000004 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 0.70999999999999996 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.0499999999999998 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.5900000000000001 112.267 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 1.8899999999999999 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.3100000000000001 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 0.62 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.46999999999999997 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 0.56000000000000005 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.47999999999999998 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.44 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 1.4199999999999999 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.60999999999999999 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 0.64000000000000001 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2000000000000002 110.312 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.81999999999999995 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 1.27 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 0.91000000000000003 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 1.73 109.651 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.04 110.079 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.03 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 123' ' ' LEU . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.26 108.339 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.8300000000000001 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.7999999999999998 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.02 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 118' ' ' LEU . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 110.077 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.3900000000000001 108.342 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2000000000000002 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.0899999999999999 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 0.85999999999999999 107.626 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 0.90000000000000002 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.3500000000000001 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 0.57999999999999996 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 131' ' ' ARG . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.2200000000000002 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.3200000000000001 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 0.5 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.44 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 2.71 109.144 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.2000000000000002 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.1299999999999999 109.13 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.54000000000000004 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.3199999999999998 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 1.26 109.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.62 109.167 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 0.67000000000000004 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68000000000000005 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 0.77000000000000002 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.3999999999999999 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 0.87 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.3200000000000001 109.354 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.77000000000000002 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.5700000000000001 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 0.81999999999999995 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.81999999999999995 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.1099999999999999 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.4099999999999999 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.56999999999999995 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 158' ' ' LEU . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 0.42999999999999999 108.297 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 0.56000000000000005 109.489 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 0.54000000000000004 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.62 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 0.80000000000000004 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.73999999999999999 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.59999999999999998 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 0.63 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.5 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 0.51000000000000001 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.1699999999999999 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 0.60999999999999999 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.1200000000000001 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.3400000000000001 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 1.97 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 1.8999999999999999 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.47999999999999998 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.3899999999999999 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.38 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.46000000000000002 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 0.58999999999999997 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.2400000000000002 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.1100000000000001 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 1.6299999999999999 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.47 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.2400000000000002 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 2.9199999999999999 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 1.6000000000000001 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.92000000000000004 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 1.5900000000000001 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.4199999999999999 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 1.4099999999999999 109.746 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 0.85999999999999999 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 0.58999999999999997 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 195' ' ' ARG . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.0600000000000001 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 0.72999999999999998 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 0.67000000000000004 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 0.64000000000000001 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.58999999999999997 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 0.55000000000000004 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 0.63 107.234 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 0.77000000000000002 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.87 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 181' ' ' THR . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 0.89000000000000001 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 0.93000000000000005 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.6000000000000001 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 0.75 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 0.83999999999999997 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 1.6100000000000001 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.2999999999999998 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 0.76000000000000001 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.0099999999999998 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.1899999999999999 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.3999999999999999 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 0.53000000000000003 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 0.59999999999999998 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.56999999999999995 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.2200000000000002 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 0.75 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 0.92000000000000004 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.3599999999999999 107.484 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 1.4199999999999999 109.193 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.97 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.65000000000000002 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 0.96999999999999997 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 0.67000000000000004 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 1.45 110.128 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.81999999999999995 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 1.6200000000000001 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 2.6000000000000001 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.0600000000000001 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.1399999999999999 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.04 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 2.6000000000000001 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.23 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 109.384 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 3.6600000000000001 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.1200000000000001 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.45 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92000000000000004 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.05 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 0.88 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.78000000000000003 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.5 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.85999999999999999 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.817 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78000000000000003 109.091 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 0.73999999999999999 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.45000000000000001 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.64000000000000001 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.45000000000000001 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 1.8799999999999999 109.888 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.58999999999999997 110.801 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 0.64000000000000001 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.73999999999999999 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 0.73999999999999999 110.191 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 1.8700000000000001 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.5800000000000001 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.1400000000000001 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.9299999999999999 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.68000000000000005 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 0.83999999999999997 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.79000000000000004 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 2.6200000000000001 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.3500000000000001 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.3500000000000001 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 0.78000000000000003 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.04 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.05 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.4700000000000002 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 0.77000000000000002 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.29 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 2.6600000000000001 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.75 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 0.82999999999999996 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 0.78000000000000003 107.995 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.56999999999999995 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 2.8300000000000001 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 0.65000000000000002 107.787 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.5699999999999998 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.3600000000000001 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 0.59999999999999998 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 1.3600000000000001 109.477 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.3799999999999999 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.59999999999999998 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 0.53000000000000003 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 0.98999999999999999 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.58999999999999997 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 1.8100000000000001 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 0.47999999999999998 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.57999999999999996 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.3899999999999999 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 0.81999999999999995 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.98999999999999999 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.55000000000000004 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 65' ' ' PHE . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.5899999999999999 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2000000000000002 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 1.79 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.64000000000000001 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 0.57999999999999996 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.62 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.52000000000000002 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 1.29 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 0.55000000000000004 108.263 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 1.8899999999999999 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 0.53000000000000003 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 0.42999999999999999 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.3500000000000001 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.1600000000000001 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 0.59999999999999998 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 0.57999999999999996 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 0.78000000000000003 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.85999999999999999 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.79000000000000004 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.70999999999999996 110.12 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.0499999999999998 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.5900000000000001 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 1.8899999999999999 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.3100000000000001 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.28 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 0.62 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.46999999999999997 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 0.56000000000000005 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 0.47999999999999998 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 0.44 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 1.4199999999999999 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 107' ' ' VAL . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 0.60999999999999999 110.02 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.64000000000000001 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2000000000000002 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.81999999999999995 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 1.27 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 0.91000000000000003 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 1.73 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.04 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.03 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 123' ' ' LEU . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.26 108.534 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.8300000000000001 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.5800000000000001 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.02 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 118' ' ' LEU . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.0600000000000001 109.517 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.3900000000000001 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2000000000000002 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.0899999999999999 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 0.85999999999999999 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 0.90000000000000002 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.3500000000000001 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 0.57999999999999996 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.2200000000000002 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.3200000000000001 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 0.5 109.432 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.44 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 2.71 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.2000000000000002 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.1299999999999999 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 0.54000000000000004 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.3199999999999998 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 80.0 m-20 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 1.26 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 0.62 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 0.67000000000000004 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68000000000000005 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 0.77000000000000002 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 139' ' ' ARG . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.3999999999999999 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 0.87 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.3200000000000001 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 0.77000000000000002 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.5700000000000001 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.81999999999999995 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.694 HD12 HD22 ' A' ' 172' ' ' ASN . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 0.81999999999999995 109.573 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.1099999999999999 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.4099999999999999 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 0.56999999999999995 109.179 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 0.42999999999999999 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 0.56000000000000005 109.983 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 0.54000000000000004 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 0.62 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 0.80000000000000004 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.3399999999999999 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.65000000000000002 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.73999999999999999 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.59999999999999998 113.158 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.63 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.5 109.367 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.51000000000000001 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 0.60999999999999999 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.694 HD22 HD12 ' A' ' 152' ' ' ILE . 42.0 p-10 -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.1200000000000001 109.989 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.3400000000000001 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 1.97 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 1.8999999999999999 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 172' ' ' ASN . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 0.47999999999999998 109.386 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.3899999999999999 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.46000000000000002 110.218 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.486 ' CG2' HG21 ' A' ' 205' ' ' THR . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 0.58999999999999997 107.383 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.2400000000000002 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.1100000000000001 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 1.6299999999999999 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.47 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.2400000000000002 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 2.9199999999999999 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 1.6000000000000001 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.92000000000000004 109.174 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 1.5900000000000001 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.4199999999999999 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 1.4099999999999999 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 0.85999999999999999 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 0.58999999999999997 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.0600000000000001 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 0.72999999999999998 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.67000000000000004 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 0.64000000000000001 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.58999999999999997 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 0.55000000000000004 111.664 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 6' ' ' LEU . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 0.63 106.92 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 0.77000000000000002 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.87 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.486 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 0.89000000000000001 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 0.93000000000000005 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.6000000000000001 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 0.75 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 0.83999999999999997 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 1.6100000000000001 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.2999999999999998 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 0.76000000000000001 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.0099999999999998 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 36.3 t-20 -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.1899999999999999 109.69 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.3999999999999999 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.3 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.582 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 0.53000000000000003 110.379 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 0.59999999999999998 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 0.56999999999999995 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.2200000000000002 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 0.75 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 0.92000000000000004 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.3599999999999999 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 1.4199999999999999 109.791 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 1.97 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 228' ' ' TYR . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 0.65000000000000002 109.096 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 227' ' ' VAL . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 0.96999999999999997 109.217 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 0.67000000000000004 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 1.45 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 236' ' ' ILE . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.81999999999999995 112.214 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 1.6200000000000001 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 2.6000000000000001 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.0600000000000001 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.1399999999999999 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 231' ' ' PRO . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.04 109.193 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 2.6000000000000001 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.23 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 2.6699999999999999 108.263 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 3.6600000000000001 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.1200000000000001 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.45 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92000000000000004 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.05 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 0.88 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 0.78000000000000003 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.5 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.85999999999999999 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.838 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78000000000000003 109.218 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 0.73999999999999999 109.301 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 0.45000000000000001 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.64000000000000001 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.45000000000000001 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HZ3' ' HA ' ' A' ' 215' ' ' ASP . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 1.8799999999999999 110.039 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.58999999999999997 111.229 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 0.64000000000000001 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 0.73999999999999999 111.309 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' ALA . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 109.531 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 1.8700000000000001 109.271 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.5800000000000001 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.1400000000000001 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.9299999999999999 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.68000000000000005 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 0.83999999999999997 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 0.79000000000000004 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 2.6200000000000001 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.3500000000000001 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.3500000000000001 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.78000000000000003 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.04 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.05 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.4700000000000002 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 1.46 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.77000000000000002 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.29 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.76000000000000001 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 2.6600000000000001 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.75 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 0.82999999999999996 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 0.78000000000000003 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.56999999999999995 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 2.8300000000000001 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 0.65000000000000002 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.5699999999999998 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.51000000000000001 109.371 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.3600000000000001 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 0.59999999999999998 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 1.3600000000000001 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 0.59999999999999998 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.53000000000000003 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.98999999999999999 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 0.58999999999999997 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 1.8100000000000001 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 0.47999999999999998 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.57999999999999996 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.3899999999999999 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 0.81999999999999995 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 0.98999999999999999 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.55000000000000004 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.5899999999999999 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 1.79 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 0.64000000000000001 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 0.57999999999999996 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.62 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.52000000000000002 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 1.29 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 0.55000000000000004 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 1.8899999999999999 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 0.53000000000000003 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 0.42999999999999999 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.3100000000000001 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 0.59999999999999998 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.28 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 0.57999999999999996 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.78000000000000003 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 0.85999999999999999 110.449 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 0.70999999999999996 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.0499999999999998 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.5900000000000001 112.048 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 1.8899999999999999 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.3100000000000001 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.28 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 0.62 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.46999999999999997 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 0.56000000000000005 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 0.47999999999999998 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.44 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 1.4199999999999999 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 107' ' ' VAL . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 0.60999999999999999 109.978 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.64000000000000001 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2000000000000002 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.81999999999999995 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 1.27 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 0.91000000000000003 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 1.73 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.04 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.03 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 123' ' ' LEU . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.26 108.386 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.8300000000000001 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.5800000000000001 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.7999999999999998 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.02 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 118' ' ' LEU . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 109.82 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.3900000000000001 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2000000000000002 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.0899999999999999 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 0.85999999999999999 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 0.90000000000000002 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.3500000000000001 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.57999999999999996 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.2200000000000002 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.3200000000000001 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.5 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.44 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 2.71 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.2000000000000002 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.1299999999999999 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 0.54000000000000004 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.3199999999999998 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 1.26 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 0.62 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 0.67000000000000004 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68000000000000005 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 0.77000000000000002 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.3999999999999999 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 0.87 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.3200000000000001 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 0.77000000000000002 109.16 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.5700000000000001 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 0.81999999999999995 109.58 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.81999999999999995 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.1099999999999999 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.4099999999999999 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 0.56999999999999995 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 0.42999999999999999 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 0.56000000000000005 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 0.54000000000000004 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.62 109.434 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 0.80000000000000004 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.3399999999999999 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 0.65000000000000002 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 0.73999999999999999 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.59999999999999998 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.63 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.5 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 0.51000000000000001 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.1699999999999999 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.60999999999999999 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.1200000000000001 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.3400000000000001 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 1.97 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 1.8999999999999999 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 0.47999999999999998 108.347 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.3899999999999999 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.38 109.081 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.46000000000000002 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 0.58999999999999997 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 0.67000000000000004 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.1100000000000001 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 1.6299999999999999 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.47 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.2400000000000002 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 2.9199999999999999 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 1.6000000000000001 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 192' ' ' ILE . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 0.92000000000000004 110.114 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 1.5900000000000001 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.4199999999999999 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 189' ' ' HIS . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 1.4099999999999999 109.649 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 0.85999999999999999 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 0.58999999999999997 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.0600000000000001 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.72999999999999998 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.67000000000000004 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 0.64000000000000001 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.58999999999999997 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 0.55000000000000004 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 203' ' ' VAL . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 0.63 107.205 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 0.77000000000000002 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.87 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 0.89000000000000001 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 0.93000000000000005 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.6000000000000001 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 0.75 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.83999999999999997 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 1.6100000000000001 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.2999999999999998 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 0.76000000000000001 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.0099999999999998 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.1899999999999999 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.3999999999999999 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.3 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 16' ' ' ALA . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 0.53000000000000003 109.906 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 0.59999999999999998 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 0.56999999999999995 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.2200000000000002 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 0.75 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 0.92000000000000004 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.3599999999999999 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 1.4199999999999999 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 8.7 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 1.97 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 0.65000000000000002 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 0.96999999999999997 109.988 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 0.67000000000000004 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 1.45 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 233' ' ' ASN . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 1.6200000000000001 109.26 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.437 ' H ' HG22 ' A' ' 232' ' ' THR . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 2.6000000000000001 109.949 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.0600000000000001 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.1399999999999999 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.04 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 2.6000000000000001 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.23 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 2.6699999999999999 109.602 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 3.6600000000000001 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.1200000000000001 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.45 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92000000000000004 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.05 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.88 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 0.78000000000000003 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.5 108.931 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.85999999999999999 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78000000000000003 109.971 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 0.73999999999999999 109.267 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 0.45000000000000001 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.64000000000000001 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.45000000000000001 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 1.8799999999999999 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 0.58999999999999997 111.579 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 0.64000000000000001 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 0.73999999999999999 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 0.73999999999999999 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 1.8700000000000001 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.5800000000000001 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.1400000000000001 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.9299999999999999 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.68000000000000005 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 0.83999999999999997 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 0.79000000000000004 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.3700000000000001 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 2.6200000000000001 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.3500000000000001 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.3500000000000001 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.78000000000000003 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.04 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.05 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 1.46 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.77000000000000002 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.29 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 0.76000000000000001 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 2.6600000000000001 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.75 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.82999999999999996 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 0.78000000000000003 108.451 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.56999999999999995 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 2.8300000000000001 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 0.65000000000000002 108.44 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.5699999999999998 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 0.51000000000000001 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.3600000000000001 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 0.59999999999999998 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 1.3600000000000001 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.3799999999999999 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.59999999999999998 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.527 HD12 HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 0.53000000000000003 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.98999999999999999 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 0.58999999999999997 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 1.8100000000000001 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 0.47999999999999998 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.57999999999999996 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.3899999999999999 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 0.81999999999999995 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 0.98999999999999999 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.55000000000000004 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.5899999999999999 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2000000000000002 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 1.79 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 0.64000000000000001 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 0.57999999999999996 109.928 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.62 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.52000000000000002 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 1.29 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 0.55000000000000004 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 1.8899999999999999 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.53000000000000003 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 0.42999999999999999 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.3100000000000001 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.3500000000000001 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.1600000000000001 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 0.59999999999999998 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.28 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 0.57999999999999996 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 0.78000000000000003 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.85999999999999999 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.79000000000000004 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 0.70999999999999996 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.0499999999999998 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.5900000000000001 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 1.8899999999999999 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.3100000000000001 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.28 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 0.62 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 0.56000000000000005 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.47999999999999998 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.44 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 1.4199999999999999 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 0.60999999999999999 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.64000000000000001 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2000000000000002 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.81999999999999995 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 1.27 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.91000000000000003 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 1.73 110.201 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.04 110.244 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD21 HH21 ' A' ' 126' ' ' ARG . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.03 108.917 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.26 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.8300000000000001 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.5800000000000001 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.02 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.3900000000000001 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2000000000000002 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.411 HH21 HD21 ' A' ' 115' ' ' LEU . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.0899999999999999 106.341 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 0.85999999999999999 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 0.90000000000000002 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.3500000000000001 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 0.57999999999999996 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.2200000000000002 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.3200000000000001 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.5 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.44 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HE2' HH11 ' A' ' 139' ' ' ARG . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 2.71 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.527 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.2000000000000002 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.1299999999999999 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.54000000000000004 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.412 HH11 ' HE2' ' A' ' 135' ' ' LYS . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.3199999999999998 110.347 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 1.26 109.155 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 0.62 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.67000000000000004 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68000000000000005 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 0.77000000000000002 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 0.87 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 147' ' ' ILE . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.3200000000000001 108.975 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 0.77000000000000002 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.5700000000000001 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.81999999999999995 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' GLN . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 0.81999999999999995 108.96 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' ILE . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.1099999999999999 109.334 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.4099999999999999 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.42999999999999999 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 0.56000000000000005 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 0.54000000000000004 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.62 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 0.80000000000000004 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.3399999999999999 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 0.65000000000000002 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 0.73999999999999999 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.59999999999999998 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 0.63 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 0.5 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 0.51000000000000001 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.1699999999999999 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.1200000000000001 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.3400000000000001 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 1.97 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 1.8999999999999999 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 178' ' ' GLY . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 0.47999999999999998 108.714 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.473 ' N ' HG12 ' A' ' 176' ' ' VAL . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.3899999999999999 109.785 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.38 109.571 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.46000000000000002 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 220' ' ' LEU . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 0.58999999999999997 108.861 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 0.67000000000000004 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.2400000000000002 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.1100000000000001 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 1.6299999999999999 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.47 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.2400000000000002 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 2.9199999999999999 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 1.6000000000000001 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.92000000000000004 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 1.5900000000000001 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.4199999999999999 110.302 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 1.4099999999999999 110.989 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 0.85999999999999999 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 0.58999999999999997 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.0600000000000001 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.72999999999999998 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 0.67000000000000004 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 0.64000000000000001 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.58999999999999997 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 0.55000000000000004 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.63 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 0.77000000000000002 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.87 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 0.89000000000000001 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 0.93000000000000005 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.6000000000000001 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 0.75 110.397 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 0.83999999999999997 110.309 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.574 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 1.6100000000000001 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 210' ' ' SER . 82.4 mm-40 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.2999999999999998 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 0.76000000000000001 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.0099999999999998 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.1899999999999999 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.3999999999999999 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.3 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 0.53000000000000003 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 0.59999999999999998 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 180' ' ' ILE . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.56999999999999995 108.612 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.2200000000000002 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 0.75 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 0.92000000000000004 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.3599999999999999 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 1.4199999999999999 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 54.7 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.97 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 0.65000000000000002 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 0.96999999999999997 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 0.67000000000000004 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 1.45 110.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.81999999999999995 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 1.6200000000000001 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 2.6000000000000001 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.0600000000000001 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.1399999999999999 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.04 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 2.6000000000000001 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.23 109.901 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 2.6699999999999999 109.663 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 3.6600000000000001 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.1200000000000001 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.45 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92000000000000004 108.709 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.05 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.88 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 0.78000000000000003 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.5 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.85999999999999999 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78000000000000003 109.801 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 0.73999999999999999 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 0.45000000000000001 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.64000000000000001 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.45000000000000001 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 1.8799999999999999 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.58999999999999997 110.949 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 0.64000000000000001 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 0.73999999999999999 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 0.73999999999999999 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 1.8700000000000001 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.5800000000000001 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.1400000000000001 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.9299999999999999 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 0.68000000000000005 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 0.83999999999999997 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.79000000000000004 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.3700000000000001 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 2.6200000000000001 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.3500000000000001 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.3500000000000001 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 0.78000000000000003 110.145 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.04 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.05 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.4700000000000002 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 1.46 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.77000000000000002 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.29 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 0.76000000000000001 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 2.6600000000000001 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.75 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 0.82999999999999996 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 0.78000000000000003 108.458 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.56999999999999995 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 2.8300000000000001 108.87 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 0.65000000000000002 108.133 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.5699999999999998 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 0.51000000000000001 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.3600000000000001 108.092 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 0.59999999999999998 109.459 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 1.3600000000000001 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.3799999999999999 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.59999999999999998 109.341 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.53000000000000003 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.98999999999999999 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 0.58999999999999997 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 1.8100000000000001 107.762 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 0.47999999999999998 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.57999999999999996 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.3899999999999999 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.81999999999999995 110.081 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 0.98999999999999999 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.55000000000000004 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.5899999999999999 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2000000000000002 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 1.79 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.64000000000000001 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 0.57999999999999996 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.62 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.52000000000000002 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 1.29 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 0.55000000000000004 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 1.8899999999999999 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 0.53000000000000003 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 0.42999999999999999 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.3100000000000001 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.3500000000000001 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.1600000000000001 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.59999999999999998 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.28 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 0.57999999999999996 107.789 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 0.78000000000000003 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.85999999999999999 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 0.79000000000000004 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.70999999999999996 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.0499999999999998 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.5900000000000001 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 1.8899999999999999 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.3100000000000001 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.28 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.62 109.848 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.46999999999999997 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 0.56000000000000005 109.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.47999999999999998 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 0.44 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 1.4199999999999999 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.60999999999999999 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2000000000000002 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.81999999999999995 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 1.27 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 0.91000000000000003 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.73 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.04 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.03 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.26 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.8300000000000001 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.5800000000000001 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.7999999999999998 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.02 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.0600000000000001 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.3900000000000001 108.763 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2000000000000002 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.0899999999999999 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 0.85999999999999999 109.228 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.90000000000000002 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.3500000000000001 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.57999999999999996 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.2200000000000002 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.3200000000000001 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 0.5 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.44 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 2.71 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.449 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.2000000000000002 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.1299999999999999 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 0.54000000000000004 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.3199999999999998 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 1.26 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 0.62 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.67000000000000004 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68000000000000005 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 0.77000000000000002 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 0.87 108.495 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.3200000000000001 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.77000000000000002 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.5700000000000001 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.81999999999999995 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.81999999999999995 108.542 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 152' ' ' ILE . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.1099999999999999 109.645 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.4099999999999999 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.56999999999999995 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 158' ' ' LEU . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 0.42999999999999999 108.164 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 0.56000000000000005 109.259 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 0.54000000000000004 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 0.62 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 0.80000000000000004 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.3399999999999999 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 0.65000000000000002 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 0.73999999999999999 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.59999999999999998 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.63 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 168' ' ' THR . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.5 110.087 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 0.51000000000000001 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.1699999999999999 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 0.60999999999999999 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.1200000000000001 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.3400000000000001 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 1.97 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 1.8999999999999999 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 172' ' ' ASN . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 0.47999999999999998 109.209 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.3899999999999999 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.38 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.46000000000000002 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 0.58999999999999997 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.67000000000000004 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.2400000000000002 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.1100000000000001 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 1.6299999999999999 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.456 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.47 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.2400000000000002 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.456 ' N ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 2.9199999999999999 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 1.6000000000000001 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.92000000000000004 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 1.5900000000000001 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.4199999999999999 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 1.4099999999999999 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 0.85999999999999999 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 0.58999999999999997 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.0600000000000001 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.72999999999999998 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 0.64000000000000001 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.58999999999999997 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 0.55000000000000004 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 0.63 106.708 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 0.77000000000000002 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.87 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 0.89000000000000001 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 0.93000000000000005 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.6000000000000001 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 0.75 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 0.83999999999999997 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 1.6100000000000001 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.2999999999999998 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.454 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.0099999999999998 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.1899999999999999 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CG ' HD22 ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.3999999999999999 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.3 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 16' ' ' ALA . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 0.53000000000000003 110.491 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 0.59999999999999998 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 0.56999999999999995 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.2200000000000002 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 0.75 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 0.92000000000000004 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.3599999999999999 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 1.97 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 0.65000000000000002 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 0.96999999999999997 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 0.67000000000000004 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 1.45 110.19 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.81999999999999995 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 1.6200000000000001 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 2.6000000000000001 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.0600000000000001 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.1399999999999999 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.04 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 2.6000000000000001 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.23 109.815 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 2.6699999999999999 109.74 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 3.6600000000000001 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.45 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92000000000000004 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.05 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.88 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.78000000000000003 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.5 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.85999999999999999 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78000000000000003 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 0.73999999999999999 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.45000000000000001 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.64000000000000001 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.45000000000000001 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 1.8799999999999999 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 0.58999999999999997 111.507 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 0.64000000000000001 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.73999999999999999 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 0.73999999999999999 110.154 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 1.8700000000000001 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.5800000000000001 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.1400000000000001 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.9299999999999999 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 0.68000000000000005 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 0.83999999999999997 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.79000000000000004 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.3700000000000001 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 2.6200000000000001 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.3500000000000001 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.3500000000000001 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 39' ' ' GLU . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.78000000000000003 110.192 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.05 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.4700000000000002 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 32' ' ' SER . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 1.46 108.871 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 0.77000000000000002 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.29 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD13 ' A' ' 31' ' ' ILE . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.76000000000000001 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 2.6600000000000001 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.75 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.82999999999999996 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 0.78000000000000003 107.656 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.56999999999999995 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 2.8300000000000001 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 0.65000000000000002 108.514 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.5699999999999998 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 0.51000000000000001 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.3600000000000001 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 0.59999999999999998 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 1.3600000000000001 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.3799999999999999 108.898 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 0.59999999999999998 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 0.53000000000000003 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 0.98999999999999999 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.58999999999999997 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 1.8100000000000001 107.125 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 0.47999999999999998 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.57999999999999996 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.3899999999999999 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.81999999999999995 109.58 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 0.98999999999999999 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.55000000000000004 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.5899999999999999 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2000000000000002 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 1.79 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 0.64000000000000001 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.57999999999999996 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.62 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.52000000000000002 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 1.29 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 0.55000000000000004 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 1.8899999999999999 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 0.53000000000000003 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.42999999999999999 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.3500000000000001 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.1600000000000001 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 0.59999999999999998 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.28 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 0.57999999999999996 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 0.78000000000000003 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.85999999999999999 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 0.79000000000000004 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 0.70999999999999996 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.0499999999999998 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.5900000000000001 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 1.8899999999999999 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.444 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.3100000000000001 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.28 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.62 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 0.46999999999999997 109.047 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 0.56000000000000005 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 0.44 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 1.4199999999999999 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 0.60999999999999999 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 0.64000000000000001 108.457 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2000000000000002 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.81999999999999995 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 1.27 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 0.91000000000000003 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 1.73 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.04 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.03 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.26 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.8300000000000001 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.5800000000000001 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.02 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.0600000000000001 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.3900000000000001 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2000000000000002 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.0899999999999999 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 0.85999999999999999 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.3500000000000001 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.57999999999999996 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.2200000000000002 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.3200000000000001 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.5 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.44 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 2.71 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.2000000000000002 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.1299999999999999 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.54000000000000004 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 1.26 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 0.62 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.67000000000000004 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68000000000000005 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 0.77000000000000002 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.3999999999999999 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 0.87 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.726 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.3200000000000001 108.855 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.77000000000000002 109.326 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.5700000000000001 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 0.81999999999999995 108.812 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.446 HD12 HD21 ' A' ' 172' ' ' ASN . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 0.81999999999999995 109.273 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.1099999999999999 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.4099999999999999 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.56999999999999995 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 0.42999999999999999 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 0.56000000000000005 108.617 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 0.54000000000000004 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 0.62 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 0.80000000000000004 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.3399999999999999 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 0.65000000000000002 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.73999999999999999 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.59999999999999998 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.63 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.5 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.51000000000000001 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.1699999999999999 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 0.60999999999999999 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.1200000000000001 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.3400000000000001 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 1.97 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 1.8999999999999999 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 177' ' ' LEU . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 0.47999999999999998 108.8 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 176' ' ' VAL . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.3899999999999999 109.734 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.38 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.46000000000000002 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 0.58999999999999997 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 0.67000000000000004 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.2400000000000002 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.1100000000000001 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 1.6299999999999999 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.47 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.2400000000000002 109.318 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 2.9199999999999999 109.327 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 1.6000000000000001 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 0.92000000000000004 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 1.5900000000000001 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.4199999999999999 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 1.4099999999999999 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 0.85999999999999999 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 0.58999999999999997 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.0600000000000001 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.72999999999999998 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.67000000000000004 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 0.64000000000000001 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.58999999999999997 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 0.55000000000000004 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 0.63 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 0.77000000000000002 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.87 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 0.89000000000000001 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 0.93000000000000005 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.6000000000000001 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 0.75 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.83999999999999997 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 1.6100000000000001 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.2999999999999998 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.76000000000000001 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.0099999999999998 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.1899999999999999 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.3999999999999999 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.3 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.53000000000000003 109.224 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 0.59999999999999998 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 0.56999999999999995 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.2200000000000002 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 0.75 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 0.92000000000000004 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.3599999999999999 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 1.4199999999999999 108.433 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 1.97 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 0.65000000000000002 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . 0.503 ' N ' HG12 ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 0.67000000000000004 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 1.45 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.81999999999999995 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.6200000000000001 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 2.6000000000000001 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.0600000000000001 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.04 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 2.6000000000000001 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.23 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 2.6699999999999999 108.948 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 3.6600000000000001 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.1200000000000001 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.45 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92000000000000004 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.05 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 225' ' ' ASN . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 0.88 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 0.78000000000000003 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.5 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.85999999999999999 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78000000000000003 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 0.73999999999999999 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 0.45000000000000001 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.64000000000000001 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.45000000000000001 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 1.8799999999999999 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.58999999999999997 110.773 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 0.64000000000000001 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.73999999999999999 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 0.73999999999999999 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 1.8700000000000001 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.1400000000000001 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.9299999999999999 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 0.68000000000000005 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 0.83999999999999997 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 0.79000000000000004 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.3700000000000001 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 2.6200000000000001 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.3500000000000001 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.3500000000000001 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 0.78000000000000003 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.04 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.05 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.4700000000000002 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 1.46 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 0.77000000000000002 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.29 110.587 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.341 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 2.6600000000000001 109.051 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.75 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 0.82999999999999996 109.013 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 0.78000000000000003 108.236 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.56999999999999995 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 2.8300000000000001 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 0.65000000000000002 108.12 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.5699999999999998 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.51000000000000001 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.3600000000000001 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 0.59999999999999998 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 1.3600000000000001 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.3799999999999999 108.854 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.59999999999999998 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.53000000000000003 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 0.98999999999999999 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 0.58999999999999997 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 1.8100000000000001 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 0.47999999999999998 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.57999999999999996 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.3899999999999999 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 0.81999999999999995 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 0.98999999999999999 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.55000000000000004 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.5899999999999999 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2000000000000002 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 1.79 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 0.64000000000000001 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 0.57999999999999996 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.62 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.52000000000000002 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 1.29 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 0.55000000000000004 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 1.8899999999999999 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 0.53000000000000003 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 0.42999999999999999 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.3100000000000001 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.3500000000000001 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.1600000000000001 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 0.59999999999999998 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.28 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 0.57999999999999996 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 0.78000000000000003 110.358 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.85999999999999999 110.188 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 0.79000000000000004 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 0.70999999999999996 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.0499999999999998 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.5900000000000001 112.155 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 1.8899999999999999 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.3100000000000001 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.28 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.62 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.46999999999999997 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 0.56000000000000005 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 0.47999999999999998 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 0.44 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 1.4199999999999999 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 0.60999999999999999 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 0.64000000000000001 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2000000000000002 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.81999999999999995 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 1.27 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 0.91000000000000003 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 1.73 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.04 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.03 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 123' ' ' LEU . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.5800000000000001 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.7999999999999998 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.02 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 118' ' ' LEU . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.0600000000000001 109.093 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.3900000000000001 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2000000000000002 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.0899999999999999 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 0.85999999999999999 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 0.90000000000000002 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.3500000000000001 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.2200000000000002 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.3200000000000001 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 0.5 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.44 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 2.71 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.2000000000000002 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.1299999999999999 108.227 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.54000000000000004 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.3199999999999998 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 1.26 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.62 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 0.67000000000000004 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68000000000000005 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 0.77000000000000002 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.3999999999999999 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 0.87 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 0.77000000000000002 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.5700000000000001 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 0.81999999999999995 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 0.81999999999999995 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.1099999999999999 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.4099999999999999 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.56999999999999995 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 0.42999999999999999 108.104 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 0.56000000000000005 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 0.54000000000000004 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.62 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 0.80000000000000004 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.3399999999999999 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 0.65000000000000002 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.73999999999999999 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.59999999999999998 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 0.63 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 0.5 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 0.51000000000000001 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.1699999999999999 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 0.60999999999999999 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.1200000000000001 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.3400000000000001 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 1.97 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 1.8999999999999999 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 177' ' ' LEU . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 0.47999999999999998 108.91 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.515 ' N ' HG12 ' A' ' 176' ' ' VAL . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 109.637 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.38 109.623 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.46000000000000002 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 0.58999999999999997 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 0.67000000000000004 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.2400000000000002 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.1100000000000001 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 1.6299999999999999 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.484 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.47 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.2400000000000002 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.484 ' N ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 2.9199999999999999 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 1.6000000000000001 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 0.92000000000000004 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 1.5900000000000001 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.456 ' HG ' HG11 ' A' ' 203' ' ' VAL . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.4199999999999999 110.063 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 1.4099999999999999 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.85999999999999999 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 0.58999999999999997 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.72999999999999998 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.67000000000000004 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 0.64000000000000001 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.58999999999999997 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 0.55000000000000004 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 0.63 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 0.77000000000000002 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.87 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 0.89000000000000001 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 0.93000000000000005 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.6000000000000001 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 0.75 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 0.83999999999999997 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 1.6100000000000001 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.2999999999999998 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 0.76000000000000001 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.411 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.0099999999999998 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.1899999999999999 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.3999999999999999 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.3 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 0.53000000000000003 110.496 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.56999999999999995 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.2200000000000002 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 0.75 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 0.92000000000000004 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.3599999999999999 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 1.4199999999999999 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 1.97 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 0.65000000000000002 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 0.96999999999999997 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 0.67000000000000004 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 1.45 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.81999999999999995 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 1.6200000000000001 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 2.6000000000000001 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.0600000000000001 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.1399999999999999 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.04 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 2.6000000000000001 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.23 109.217 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 110.559 -178.774 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 3.6600000000000001 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.1200000000000001 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.45 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92000000000000004 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 5' ' ' ILE . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.05 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.88 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.78000000000000003 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.5 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.85999999999999999 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.696 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78000000000000003 109.712 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 0.73999999999999999 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 0.45000000000000001 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.64000000000000001 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.45000000000000001 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 1.8799999999999999 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.58999999999999997 111.003 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 0.64000000000000001 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 0.73999999999999999 110.162 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 160' ' ' ALA . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 0.73999999999999999 110.199 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 1.8700000000000001 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.5800000000000001 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.1400000000000001 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.9299999999999999 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.68000000000000005 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 0.83999999999999997 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 0.79000000000000004 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.3700000000000001 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.445 HH12 ' HB1' ' A' ' 102' ' ' ALA . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 2.6200000000000001 109.239 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.3500000000000001 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.3500000000000001 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 31' ' ' ILE . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.78000000000000003 109.962 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.04 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.05 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.4700000000000002 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.46 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.77000000000000002 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.29 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.76000000000000001 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 2.6600000000000001 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.75 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 0.82999999999999996 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 0.78000000000000003 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.56999999999999995 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 2.8300000000000001 106.251 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 0.65000000000000002 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.5699999999999998 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 0.51000000000000001 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.3600000000000001 108.431 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 0.59999999999999998 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 1.3600000000000001 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.3799999999999999 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.59999999999999998 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.482 HD13 HH12 ' A' ' 136' ' ' ARG . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.53000000000000003 109.236 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 0.98999999999999999 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 0.58999999999999997 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 1.8100000000000001 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 0.47999999999999998 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.57999999999999996 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.3899999999999999 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 0.98999999999999999 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.55000000000000004 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.5899999999999999 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2000000000000002 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 1.79 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.64000000000000001 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 0.57999999999999996 110.001 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.62 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.52000000000000002 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 1.29 109.785 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 0.55000000000000004 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 0.53000000000000003 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 0.42999999999999999 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.3100000000000001 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.1600000000000001 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 0.59999999999999998 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.28 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 0.57999999999999996 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.78000000000000003 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 0.85999999999999999 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.79000000000000004 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 0.70999999999999996 111.098 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.0499999999999998 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.5900000000000001 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 1.8899999999999999 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.3100000000000001 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.28 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 0.62 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.46999999999999997 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB1' HH12 ' A' ' 28' ' ' ARG . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 0.56000000000000005 110.483 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.47999999999999998 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.44 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 1.4199999999999999 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 0.60999999999999999 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 0.64000000000000001 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2000000000000002 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.81999999999999995 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 1.27 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 0.91000000000000003 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 1.73 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.04 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.03 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 123' ' ' LEU . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.26 108.913 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.8300000000000001 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.5800000000000001 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.7999999999999998 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.02 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 118' ' ' LEU . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.0600000000000001 109.416 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.3900000000000001 109.04 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2000000000000002 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.0899999999999999 106.344 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 0.85999999999999999 109.022 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.90000000000000002 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.3500000000000001 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 126' ' ' ARG . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.57999999999999996 108.977 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.2200000000000002 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.3200000000000001 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 0.5 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.44 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' HZ2' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 2.71 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.482 HH12 HD13 ' A' ' 57' ' ' ILE . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.2000000000000002 108.433 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1299999999999999 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.54000000000000004 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.532 HH11 ' HZ2' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.3199999999999998 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 1.26 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 0.62 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.67000000000000004 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68000000000000005 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 0.77000000000000002 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.3999999999999999 109.125 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 0.87 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.478 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.3200000000000001 109.042 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.5700000000000001 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 0.81999999999999995 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.81999999999999995 109.043 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.406 ' N ' HG22 ' A' ' 152' ' ' ILE . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 109.128 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.4099999999999999 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 0.56999999999999995 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 0.42999999999999999 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 0.56000000000000005 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 0.54000000000000004 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.62 109.697 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 0.80000000000000004 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 0.73999999999999999 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.59999999999999998 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.63 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.5 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.51000000000000001 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.1699999999999999 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 0.60999999999999999 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.1200000000000001 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.3400000000000001 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 1.97 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 1.8999999999999999 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.3899999999999999 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.38 109.272 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.46000000000000002 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.572 ' CG2' HG21 ' A' ' 205' ' ' THR . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 0.58999999999999997 106.771 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 0.67000000000000004 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.2400000000000002 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.1100000000000001 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 1.6299999999999999 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.47 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.2400000000000002 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 2.9199999999999999 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 1.6000000000000001 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.92000000000000004 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 1.5900000000000001 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.4199999999999999 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.4099999999999999 110.013 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 0.85999999999999999 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 0.58999999999999997 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.0600000000000001 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 0.72999999999999998 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.67000000000000004 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 0.64000000000000001 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.58999999999999997 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 0.55000000000000004 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 0.63 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 0.77000000000000002 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.87 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.572 HG21 ' CG2' ' A' ' 180' ' ' ILE . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 0.89000000000000001 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 0.93000000000000005 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.6000000000000001 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 0.75 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.83999999999999997 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 1.6100000000000001 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.2999999999999998 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 0.76000000000000001 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.0099999999999998 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.1899999999999999 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.3999999999999999 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.3 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 0.53000000000000003 110.551 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 219' ' ' ILE . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 0.59999999999999998 108.606 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 0.56999999999999995 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.2200000000000002 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 0.75 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 0.92000000000000004 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.3599999999999999 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 1.4199999999999999 109.424 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.414 ' OE1' ' SD ' ' A' ' 1' ' ' MET . 67.0 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 1.97 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 0.65000000000000002 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 0.96999999999999997 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.67000000000000004 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 1.45 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 1.6200000000000001 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 2.6000000000000001 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.0600000000000001 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.04 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 2.6000000000000001 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.23 110.015 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 2.6699999999999999 110.18 -179.411 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 3.6600000000000001 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.1200000000000001 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.45 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92000000000000004 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.05 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 0.88 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 0.78000000000000003 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.5 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.85999999999999999 114.455 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78000000000000003 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 0.73999999999999999 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 0.45000000000000001 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.64000000000000001 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.45000000000000001 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 1.8799999999999999 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 0.58999999999999997 110.645 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 0.64000000000000001 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 0.73999999999999999 111.071 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 0.73999999999999999 109.977 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 1.8700000000000001 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.5800000000000001 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.1400000000000001 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.9299999999999999 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.68000000000000005 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 0.83999999999999997 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 0.79000000000000004 110.02 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.3700000000000001 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 2.6200000000000001 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.3500000000000001 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.3500000000000001 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.78000000000000003 110.27 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.04 109.454 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.05 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 1.46 108.491 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 0.77000000000000002 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.29 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 0.76000000000000001 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 2.6600000000000001 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.75 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 0.82999999999999996 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 0.78000000000000003 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.56999999999999995 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 2.8300000000000001 107.506 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 0.65000000000000002 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.5699999999999998 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.51000000000000001 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.3600000000000001 108.859 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 0.59999999999999998 109.511 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.484 HE22 HD21 ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 1.3600000000000001 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.3799999999999999 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 0.59999999999999998 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.53000000000000003 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.98999999999999999 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.58999999999999997 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 1.8100000000000001 108.468 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 0.47999999999999998 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.57999999999999996 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.3899999999999999 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 0.81999999999999995 110.381 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 0.98999999999999999 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.55000000000000004 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.5899999999999999 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2000000000000002 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 1.79 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 0.64000000000000001 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.57999999999999996 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.62 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.52000000000000002 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 1.29 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 0.55000000000000004 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 1.8899999999999999 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 0.53000000000000003 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 0.42999999999999999 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.1600000000000001 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 0.59999999999999998 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.28 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 0.57999999999999996 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 0.78000000000000003 111.038 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 0.79000000000000004 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.0499999999999998 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.5900000000000001 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 1.8899999999999999 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.3100000000000001 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.28 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.62 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.46999999999999997 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 0.56000000000000005 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.47999999999999998 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 0.44 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 1.4199999999999999 109.735 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 0.60999999999999999 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 0.64000000000000001 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2000000000000002 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.81999999999999995 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 1.27 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 0.91000000000000003 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 1.73 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.04 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.03 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.26 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.8300000000000001 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.5800000000000001 109.385 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.7999999999999998 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.02 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0600000000000001 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.3900000000000001 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2000000000000002 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.0899999999999999 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 0.85999999999999999 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 0.90000000000000002 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 0.57999999999999996 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.2200000000000002 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.3200000000000001 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 0.5 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.44 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 2.71 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HG2' HH11 ' A' ' 136' ' ' ARG . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.2000000000000002 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.1299999999999999 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 0.54000000000000004 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.3199999999999998 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.484 HD21 HE22 ' A' ' 53' ' ' GLN . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 1.26 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 0.62 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.67000000000000004 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68000000000000005 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 0.77000000000000002 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.3999999999999999 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 0.87 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.3200000000000001 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 0.77000000000000002 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.5700000000000001 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 0.81999999999999995 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 172' ' ' ASN . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 0.81999999999999995 109.701 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.1099999999999999 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.4099999999999999 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 0.56999999999999995 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 0.42999999999999999 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 0.56000000000000005 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 0.54000000000000004 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 0.62 109.998 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 0.80000000000000004 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.3399999999999999 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 0.65000000000000002 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 0.73999999999999999 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.59999999999999998 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 0.63 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 0.5 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 0.51000000000000001 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.1699999999999999 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 0.60999999999999999 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.1200000000000001 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 1.97 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 1.8999999999999999 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 172' ' ' ASN . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 0.47999999999999998 108.285 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.3899999999999999 108.28 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.38 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.46000000000000002 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 0.58999999999999997 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 0.67000000000000004 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.2400000000000002 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.1100000000000001 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 1.6299999999999999 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.47 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.2400000000000002 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 2.9199999999999999 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 1.6000000000000001 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 0.92000000000000004 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 1.5900000000000001 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.4199999999999999 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 1.4099999999999999 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 0.58999999999999997 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.0600000000000001 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 0.72999999999999998 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 0.64000000000000001 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.58999999999999997 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 0.55000000000000004 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 0.63 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 0.77000000000000002 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.87 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.534 ' HB ' HG23 ' A' ' 208' ' ' VAL . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 0.89000000000000001 108.027 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 0.93000000000000005 113.387 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.6000000000000001 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 0.75 110.435 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.83999999999999997 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 1.6100000000000001 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.2999999999999998 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.76000000000000001 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.0099999999999998 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.1899999999999999 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.3999999999999999 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.3 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 0.53000000000000003 110.131 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.59999999999999998 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 0.56999999999999995 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.2200000000000002 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 9' ' ' PRO . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 0.75 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 0.92000000000000004 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.3599999999999999 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 1.4199999999999999 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 1.97 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 0.65000000000000002 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.67000000000000004 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.45 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.81999999999999995 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 233' ' ' ASN . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 1.6200000000000001 110.236 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 2.6000000000000001 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.0600000000000001 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.04 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 2.6000000000000001 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.23 110.01 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 2.6699999999999999 110.095 -178.949 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 3.6600000000000001 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.1200000000000001 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.45 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92000000000000004 109.134 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.05 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 0.88 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 0.78000000000000003 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.5 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.85999999999999999 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78000000000000003 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.73999999999999999 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 0.45000000000000001 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.64000000000000001 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.45000000000000001 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 1.8799999999999999 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 0.58999999999999997 111.146 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 0.64000000000000001 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.73999999999999999 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 158' ' ' LEU . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 0.73999999999999999 109.743 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 1.8700000000000001 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.5800000000000001 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.1400000000000001 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.9299999999999999 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 0.68000000000000005 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 0.83999999999999997 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 0.79000000000000004 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.3700000000000001 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 2.6200000000000001 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.3500000000000001 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 0.78000000000000003 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.05 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.4700000000000002 110.329 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 1.46 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.77000000000000002 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.29 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 0.76000000000000001 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 2.6600000000000001 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.75 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 0.82999999999999996 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 0.78000000000000003 108.76 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.56999999999999995 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.515 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 2.8300000000000001 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 0.65000000000000002 109.086 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.5699999999999998 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 0.51000000000000001 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.3600000000000001 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 0.59999999999999998 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 1.3600000000000001 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.3799999999999999 109.271 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 0.59999999999999998 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 0.53000000000000003 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.98999999999999999 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 0.58999999999999997 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 1.8100000000000001 107.707 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.47999999999999998 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.57999999999999996 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.3899999999999999 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.81999999999999995 110.059 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 0.98999999999999999 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.55000000000000004 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.5899999999999999 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2000000000000002 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 1.79 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 0.64000000000000001 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 0.57999999999999996 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.62 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.52000000000000002 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 1.29 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 0.55000000000000004 109.198 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 1.8899999999999999 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 0.53000000000000003 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 0.42999999999999999 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.3500000000000001 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.1600000000000001 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 0.59999999999999998 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.28 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 0.57999999999999996 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 0.78000000000000003 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.85999999999999999 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 0.79000000000000004 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.70999999999999996 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.0499999999999998 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.5900000000000001 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 1.8899999999999999 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.28 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 0.62 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 0.46999999999999997 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.56000000000000005 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 0.47999999999999998 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.44 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 1.4199999999999999 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.60999999999999999 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 0.64000000000000001 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2000000000000002 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.81999999999999995 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 1.27 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 0.91000000000000003 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 1.73 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.04 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.03 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.26 108.488 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.8300000000000001 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.5800000000000001 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.7999999999999998 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.02 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 118' ' ' LEU . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.0600000000000001 109.12 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.3900000000000001 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2000000000000002 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.0899999999999999 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 0.85999999999999999 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 0.90000000000000002 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.3500000000000001 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.57999999999999996 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.2200000000000002 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.3200000000000001 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.5 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.44 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 2.71 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.2000000000000002 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.1299999999999999 108.989 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.54000000000000004 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 1.26 109.194 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.62 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 0.67000000000000004 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68000000000000005 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 0.77000000000000002 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.3999999999999999 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 0.87 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.3200000000000001 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.77000000000000002 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.5700000000000001 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 0.81999999999999995 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.81999999999999995 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.1099999999999999 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.4099999999999999 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 0.56999999999999995 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 158' ' ' LEU . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 0.42999999999999999 107.969 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.539 ' N ' HG22 ' A' ' 157' ' ' ILE . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 0.56000000000000005 109.824 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 0.54000000000000004 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.62 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 0.80000000000000004 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.3399999999999999 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 0.65000000000000002 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 0.73999999999999999 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.59999999999999998 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 0.63 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.5 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 0.51000000000000001 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.1699999999999999 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 0.60999999999999999 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.8 m-20 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.1200000000000001 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.3400000000000001 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 1.97 109.56 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 1.8999999999999999 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 172' ' ' ASN . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.47999999999999998 108.656 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.3899999999999999 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.38 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.46000000000000002 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 0.58999999999999997 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 0.67000000000000004 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.2400000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 1.6299999999999999 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.47 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.2400000000000002 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 2.9199999999999999 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 1.6000000000000001 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 1.5900000000000001 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.4199999999999999 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 1.4099999999999999 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 0.85999999999999999 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 0.58999999999999997 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.0600000000000001 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 0.72999999999999998 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 0.67000000000000004 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 0.64000000000000001 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.58999999999999997 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 0.55000000000000004 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 220' ' ' LEU . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 0.63 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 0.77000000000000002 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.87 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 208' ' ' VAL . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 0.89000000000000001 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 0.93000000000000005 112.964 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.6000000000000001 113.194 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 0.75 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 0.83999999999999997 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 1.6100000000000001 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.2999999999999998 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 0.76000000000000001 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.0099999999999998 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.1899999999999999 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.3999999999999999 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.3 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 0.53000000000000003 111.238 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 0.59999999999999998 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 202' ' ' ILE . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.56999999999999995 109.046 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.2200000000000002 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 0.75 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 0.92000000000000004 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.3599999999999999 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 1.4199999999999999 109.248 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 1.97 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 0.96999999999999997 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 0.67000000000000004 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 1.45 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.81999999999999995 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 1.6200000000000001 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 2.6000000000000001 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.0600000000000001 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.1399999999999999 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.04 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 2.6000000000000001 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.23 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 2.6699999999999999 108.999 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 3.6600000000000001 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.1200000000000001 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.45 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92000000000000004 108.181 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.05 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.88 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 0.78000000000000003 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.5 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.85999999999999999 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78000000000000003 110.69 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 0.73999999999999999 109.725 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 0.45000000000000001 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.64000000000000001 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.45000000000000001 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 1.8799999999999999 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.58999999999999997 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 0.64000000000000001 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.73999999999999999 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 0.73999999999999999 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 1.8700000000000001 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.5800000000000001 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.9299999999999999 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 0.68000000000000005 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 0.83999999999999997 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.79000000000000004 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.3700000000000001 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 2.6200000000000001 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.3500000000000001 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.3500000000000001 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.542 HD13 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 0.78000000000000003 110.154 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.05 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.4700000000000002 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 1.46 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 0.77000000000000002 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.29 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HG3' HD13 ' A' ' 31' ' ' ILE . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 2.6600000000000001 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.75 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 0.82999999999999996 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 0.78000000000000003 107.999 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.56999999999999995 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 2.8300000000000001 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 0.65000000000000002 108.477 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.5699999999999998 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 0.51000000000000001 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.3600000000000001 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 0.59999999999999998 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 1.3600000000000001 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.3799999999999999 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.59999999999999998 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.53000000000000003 109.107 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 0.98999999999999999 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 0.58999999999999997 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 1.8100000000000001 108.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 0.47999999999999998 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.57999999999999996 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.3899999999999999 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 0.81999999999999995 110.227 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 0.98999999999999999 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.55000000000000004 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2000000000000002 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 1.79 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 0.64000000000000001 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.57999999999999996 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.62 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.52000000000000002 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 1.29 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 0.55000000000000004 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 0.53000000000000003 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 0.42999999999999999 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.3100000000000001 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 0.59999999999999998 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.28 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 0.57999999999999996 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 0.85999999999999999 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.79000000000000004 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 0.70999999999999996 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.0499999999999998 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.5900000000000001 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 1.8899999999999999 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.423 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.3100000000000001 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.28 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 0.62 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.46999999999999997 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 0.56000000000000005 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 0.47999999999999998 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 0.44 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 1.4199999999999999 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 0.60999999999999999 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 0.64000000000000001 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2000000000000002 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.81999999999999995 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 1.27 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 0.91000000000000003 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 1.73 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.04 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.03 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.26 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.8300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 110.059 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.7999999999999998 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.02 109.988 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.0600000000000001 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.3900000000000001 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2000000000000002 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.0899999999999999 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 0.85999999999999999 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 0.90000000000000002 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.57999999999999996 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.2200000000000002 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.3200000000000001 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.5 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.44 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 2.71 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 136' ' ' ARG . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.2000000000000002 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.1299999999999999 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.54000000000000004 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.3199999999999998 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.405 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 5.6 m-20 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 1.26 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.62 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.67000000000000004 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68000000000000005 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 0.77000000000000002 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.3999999999999999 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 0.87 109.127 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.3200000000000001 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.77000000000000002 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.5700000000000001 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 0.81999999999999995 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.1099999999999999 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.4099999999999999 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 0.42999999999999999 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 0.56000000000000005 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 0.54000000000000004 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.62 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 0.80000000000000004 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.3399999999999999 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 0.65000000000000002 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 0.73999999999999999 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.59999999999999998 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 0.63 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 0.5 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 0.51000000000000001 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.1699999999999999 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 176' ' ' VAL . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.60999999999999999 109.117 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.1200000000000001 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.3400000000000001 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 1.97 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 1.8999999999999999 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 0.47999999999999998 108.366 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.3899999999999999 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.38 109.245 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.46000000000000002 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 0.58999999999999997 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.67000000000000004 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.2400000000000002 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 1.6299999999999999 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.47 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.2400000000000002 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 2.9199999999999999 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 1.6000000000000001 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.92000000000000004 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.5900000000000001 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 1.4099999999999999 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 0.85999999999999999 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 0.58999999999999997 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.0600000000000001 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 0.72999999999999998 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 0.67000000000000004 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 0.64000000000000001 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.58999999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 0.55000000000000004 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 0.63 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 0.77000000000000002 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.87 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 0.89000000000000001 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 0.93000000000000005 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.6000000000000001 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 0.75 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 0.83999999999999997 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 1.6100000000000001 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.2999999999999998 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 0.76000000000000001 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.0099999999999998 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 7.1 m-80 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.1899999999999999 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.3999999999999999 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.3 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 0.53000000000000003 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 0.56999999999999995 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.2200000000000002 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 0.75 110.698 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 0.92000000000000004 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.3599999999999999 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 1.4199999999999999 109.859 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 1.97 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 0.65000000000000002 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 0.96999999999999997 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.8 t30 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 1.45 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 1.6200000000000001 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 2.6000000000000001 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.0600000000000001 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.1399999999999999 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.04 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 2.6000000000000001 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.23 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 2.6699999999999999 109.868 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 3.6600000000000001 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.1200000000000001 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.45 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92000000000000004 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 5' ' ' ILE . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.05 108.785 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 0.88 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 0.78000000000000003 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.5 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.85999999999999999 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78000000000000003 110.07 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 0.73999999999999999 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 0.45000000000000001 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.64000000000000001 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.45000000000000001 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 1.8799999999999999 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.58999999999999997 111.091 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 0.64000000000000001 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 0.73999999999999999 110.829 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 0.73999999999999999 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 1.8700000000000001 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.5800000000000001 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.1400000000000001 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.9299999999999999 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 0.68000000000000005 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 0.83999999999999997 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 0.79000000000000004 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.3700000000000001 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.3500000000000001 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.3500000000000001 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.414 HD13 ' HG3' ' A' ' 39' ' ' GLU . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 0.78000000000000003 110.52 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.04 109.015 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.05 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.4700000000000002 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 1.46 108.754 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.29 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 31' ' ' ILE . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.76000000000000001 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 2.6600000000000001 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.75 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 0.82999999999999996 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 0.78000000000000003 108.026 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.56999999999999995 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 2.8300000000000001 108.737 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 0.65000000000000002 107.996 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.5699999999999998 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.069 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.3600000000000001 107.812 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 0.59999999999999998 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 1.3600000000000001 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' LYS . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.3799999999999999 109.217 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 0.59999999999999998 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 0.53000000000000003 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' LEU . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 0.98999999999999999 110.269 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 0.58999999999999997 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 1.8100000000000001 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 0.47999999999999998 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.57999999999999996 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.3899999999999999 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.81999999999999995 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 0.98999999999999999 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.55000000000000004 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.5899999999999999 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2000000000000002 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 1.79 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.64000000000000001 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.57999999999999996 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.62 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.52000000000000002 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 1.29 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.55000000000000004 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 1.8899999999999999 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 0.53000000000000003 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 0.42999999999999999 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.3100000000000001 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.3500000000000001 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 0.59999999999999998 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.28 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 0.57999999999999996 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 0.85999999999999999 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 0.79000000000000004 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 0.70999999999999996 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.0499999999999998 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.5900000000000001 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 1.8899999999999999 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.3100000000000001 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.28 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 0.62 109.816 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.46999999999999997 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 0.56000000000000005 110.191 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.47999999999999998 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.44 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.4199999999999999 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 0.60999999999999999 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.538 HG21 ' HA3' ' A' ' 134' ' ' GLY . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 0.64000000000000001 109.636 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2000000000000002 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.81999999999999995 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 1.27 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 0.91000000000000003 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 1.73 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.04 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.03 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.26 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.8300000000000001 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.7999999999999998 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.02 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.0600000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.3900000000000001 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.0899999999999999 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 0.90000000000000002 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 0.57999999999999996 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.2200000000000002 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.3200000000000001 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 0.5 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.538 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.44 109.152 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 2.71 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.2000000000000002 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.1299999999999999 109.107 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 0.54000000000000004 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.3199999999999998 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 1.26 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.62 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 0.67000000000000004 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68000000000000005 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 0.77000000000000002 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.3999999999999999 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 146' ' ' ILE . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 0.87 109.032 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.3200000000000001 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 0.77000000000000002 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.5700000000000001 109.136 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 0.81999999999999995 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.81999999999999995 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.1099999999999999 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.4099999999999999 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.56999999999999995 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 0.56000000000000005 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 0.54000000000000004 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 0.62 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 0.80000000000000004 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.3399999999999999 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 0.65000000000000002 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.73999999999999999 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.59999999999999998 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.63 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.5 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.51000000000000001 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.1699999999999999 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.1200000000000001 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.3400000000000001 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 1.97 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 1.8999999999999999 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 178' ' ' GLY . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 110.103 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 176' ' ' VAL . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.3899999999999999 110.532 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.38 110.131 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.46000000000000002 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.512 ' CG2' HG21 ' A' ' 205' ' ' THR . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 0.58999999999999997 107.598 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 0.67000000000000004 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.2400000000000002 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.1100000000000001 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 1.6299999999999999 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.2400000000000002 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 2.9199999999999999 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 1.6000000000000001 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 0.92000000000000004 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 1.5900000000000001 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.4199999999999999 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 1.4099999999999999 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 0.85999999999999999 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.0600000000000001 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.72999999999999998 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 0.67000000000000004 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 0.64000000000000001 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.58999999999999997 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 0.55000000000000004 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 0.63 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 0.77000000000000002 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.87 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.512 HG21 ' CG2' ' A' ' 180' ' ' ILE . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 0.89000000000000001 108.551 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 0.93000000000000005 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.6000000000000001 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 0.75 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.83999999999999997 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 1.6100000000000001 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.2999999999999998 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 0.76000000000000001 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.0099999999999998 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.1899999999999999 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.3 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 0.53000000000000003 109.97 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.402 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 0.59999999999999998 108.107 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 0.56999999999999995 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.2200000000000002 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 0.75 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 0.92000000000000004 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.3599999999999999 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 1.4199999999999999 109.165 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 53.5 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 1.97 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 0.65000000000000002 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 0.96999999999999997 109.712 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.67000000000000004 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 1.45 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 111.688 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 1.6200000000000001 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 2.6000000000000001 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.0600000000000001 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.1399999999999999 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.04 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 2.6000000000000001 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.23 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 2.6699999999999999 109.565 179.91 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 3.6600000000000001 109.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.1200000000000001 109.18 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.45 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92000000000000004 108.293 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.05 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 0.88 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 0.78000000000000003 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.5 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.85999999999999999 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78000000000000003 109.92 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 0.73999999999999999 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 0.45000000000000001 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.64000000000000001 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.45000000000000001 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 1.8799999999999999 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 0.58999999999999997 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 0.64000000000000001 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 0.73999999999999999 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 0.73999999999999999 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 1.8700000000000001 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.1400000000000001 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.9299999999999999 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 0.68000000000000005 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 0.83999999999999997 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.79000000000000004 109.386 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.3700000000000001 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 2.6200000000000001 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.3500000000000001 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.3500000000000001 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.78000000000000003 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.04 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.05 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.4700000000000002 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 1.46 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.77000000000000002 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.29 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.76000000000000001 109.798 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 2.6600000000000001 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 89' ' ' ILE . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.75 109.472 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.82999999999999996 109.236 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 0.78000000000000003 108.971 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.56999999999999995 108.607 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 2.8300000000000001 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.65000000000000002 108.261 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.5699999999999998 109.249 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.51000000000000001 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.3600000000000001 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 0.59999999999999998 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.3799999999999999 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.59999999999999998 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.53000000000000003 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 0.98999999999999999 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 0.58999999999999997 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 1.8100000000000001 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 0.47999999999999998 108.396 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.57999999999999996 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.3899999999999999 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 0.81999999999999995 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 0.98999999999999999 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.55000000000000004 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.5899999999999999 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2000000000000002 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 1.79 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.64000000000000001 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 0.57999999999999996 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.62 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.52000000000000002 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 1.29 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 0.55000000000000004 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 1.8899999999999999 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 0.53000000000000003 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 0.42999999999999999 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.3100000000000001 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.3500000000000001 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.1600000000000001 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 0.59999999999999998 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.28 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 0.57999999999999996 108.196 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.85999999999999999 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.79000000000000004 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 0.70999999999999996 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.0499999999999998 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.5900000000000001 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 1.8899999999999999 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.3100000000000001 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 0.62 109.707 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.46999999999999997 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 0.56000000000000005 110.442 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.47999999999999998 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.44 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 1.4199999999999999 109.448 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 0.60999999999999999 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.64000000000000001 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2000000000000002 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.81999999999999995 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 1.27 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 0.91000000000000003 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 1.73 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.04 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.03 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.26 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.8300000000000001 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.5800000000000001 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.7999999999999998 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.02 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.0600000000000001 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.3900000000000001 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2000000000000002 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.0899999999999999 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 0.85999999999999999 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 0.90000000000000002 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.3500000000000001 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.57999999999999996 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.2200000000000002 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.3200000000000001 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.5 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.44 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 2.71 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.1299999999999999 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 0.54000000000000004 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.3199999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 1.26 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 0.62 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.67000000000000004 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68000000000000005 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 0.77000000000000002 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.87 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.3200000000000001 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.5700000000000001 109.495 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 0.81999999999999995 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.81999999999999995 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.1099999999999999 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.4099999999999999 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 0.56999999999999995 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 0.42999999999999999 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 0.56000000000000005 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.54000000000000004 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 0.62 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 0.80000000000000004 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.3399999999999999 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 0.65000000000000002 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 0.73999999999999999 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.59999999999999998 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 0.63 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.5 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.51000000000000001 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.1699999999999999 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.60999999999999999 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.1200000000000001 108.376 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.3400000000000001 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 1.97 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 1.8999999999999999 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 0.47999999999999998 108.472 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.3899999999999999 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.38 108.908 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.46000000000000002 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.481 HG23 HG21 ' A' ' 205' ' ' THR . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 0.58999999999999997 106.741 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 0.67000000000000004 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.2400000000000002 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.1100000000000001 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 1.6299999999999999 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.47 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.2400000000000002 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.9199999999999999 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 1.6000000000000001 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 0.92000000000000004 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 1.5900000000000001 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.4199999999999999 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 1.4099999999999999 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 0.85999999999999999 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 0.58999999999999997 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.0600000000000001 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.72999999999999998 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 0.67000000000000004 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 0.64000000000000001 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.58999999999999997 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 0.55000000000000004 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 0.63 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 0.77000000000000002 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.87 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.481 HG21 HG23 ' A' ' 180' ' ' ILE . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 0.89000000000000001 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 0.93000000000000005 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.6000000000000001 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 0.75 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.583 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 1.6100000000000001 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 210' ' ' SER . 39.3 mm-40 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.2999999999999998 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 0.76000000000000001 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.0099999999999998 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.3999999999999999 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.3 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 0.53000000000000003 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 0.59999999999999998 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.56999999999999995 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.2200000000000002 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 0.75 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 0.92000000000000004 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.3599999999999999 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 1.4199999999999999 109.333 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 1.97 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 0.65000000000000002 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 0.96999999999999997 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 0.67000000000000004 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 1.45 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.81999999999999995 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 1.6200000000000001 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 2.6000000000000001 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.0600000000000001 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.1399999999999999 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.04 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 2.6000000000000001 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.23 109.167 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 13.8 mmm-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 2.6699999999999999 109.648 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 3.6600000000000001 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.1200000000000001 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.45 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92000000000000004 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 5' ' ' ILE . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.05 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.88 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.5 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.85999999999999999 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78000000000000003 109.475 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 0.73999999999999999 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 0.45000000000000001 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.64000000000000001 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.45000000000000001 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 1.8799999999999999 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 0.58999999999999997 111.188 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 0.64000000000000001 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 0.73999999999999999 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 160' ' ' ALA . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 0.73999999999999999 110.588 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 1.8700000000000001 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.5800000000000001 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.1400000000000001 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.9299999999999999 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.448 ' CD1' ' HZ3' ' A' ' 135' ' ' LYS . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.68000000000000005 109.394 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 0.83999999999999997 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 0.79000000000000004 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.3700000000000001 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 2.6200000000000001 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.3500000000000001 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.3500000000000001 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 0.78000000000000003 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.04 109.53 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.05 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.4700000000000002 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 1.46 108.803 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.77000000000000002 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.29 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.76000000000000001 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 2.6600000000000001 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.75 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.82999999999999996 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 0.78000000000000003 108.266 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.56999999999999995 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 2.8300000000000001 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 0.65000000000000002 108.151 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.5699999999999998 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.51000000000000001 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.3600000000000001 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 0.59999999999999998 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.3799999999999999 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.59999999999999998 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.53000000000000003 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.98999999999999999 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 0.58999999999999997 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 1.8100000000000001 107.934 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 0.47999999999999998 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.57999999999999996 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.3899999999999999 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.81999999999999995 110.089 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 0.98999999999999999 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.55000000000000004 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.5899999999999999 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2000000000000002 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 1.79 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 0.64000000000000001 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.57999999999999996 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.62 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.52000000000000002 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 1.29 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 0.55000000000000004 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 1.8899999999999999 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 0.53000000000000003 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 0.42999999999999999 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.3100000000000001 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.3500000000000001 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.1600000000000001 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 0.59999999999999998 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.28 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 0.57999999999999996 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 0.78000000000000003 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 0.85999999999999999 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.79000000000000004 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 0.70999999999999996 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.0499999999999998 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.5900000000000001 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 1.8899999999999999 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.3100000000000001 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.28 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.62 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 0.46999999999999997 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 0.56000000000000005 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.47999999999999998 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.44 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 1.4199999999999999 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.60999999999999999 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.64000000000000001 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2000000000000002 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.81999999999999995 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 1.27 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 0.91000000000000003 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 1.73 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.04 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.03 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.26 108.555 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.8300000000000001 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.5800000000000001 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.7999999999999998 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.02 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 118' ' ' LEU . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.0600000000000001 109.184 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.3900000000000001 108.431 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2000000000000002 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.0899999999999999 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 0.85999999999999999 107.97 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 0.90000000000000002 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.57999999999999996 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.2200000000000002 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.3200000000000001 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 0.5 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.44 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 2.71 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.2000000000000002 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.1299999999999999 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.54000000000000004 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.451 ' NH2' ' NZ ' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.3199999999999998 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 1.26 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.62 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.67000000000000004 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68000000000000005 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 0.77000000000000002 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.3999999999999999 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 0.87 109.302 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.793 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.3200000000000001 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.77000000000000002 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.5700000000000001 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 0.81999999999999995 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.564 ' N ' HD12 ' A' ' 152' ' ' ILE . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 0.81999999999999995 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.1099999999999999 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.4099999999999999 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 0.56999999999999995 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 158' ' ' LEU . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 0.42999999999999999 107.464 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 0.56000000000000005 109.588 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 0.54000000000000004 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 0.62 109.615 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 0.80000000000000004 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.3399999999999999 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 0.65000000000000002 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.73999999999999999 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.59999999999999998 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.63 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.5 109.561 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 0.51000000000000001 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.1699999999999999 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 0.60999999999999999 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.1200000000000001 109.803 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.3400000000000001 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 1.8999999999999999 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 0.47999999999999998 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.3899999999999999 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.38 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.46000000000000002 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.604 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 0.58999999999999997 107.462 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 0.67000000000000004 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.2400000000000002 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.1100000000000001 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 1.6299999999999999 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.2400000000000002 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 2.9199999999999999 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 1.6000000000000001 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.424 ' CD2' HG21 ' A' ' 168' ' ' THR . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.92000000000000004 109.522 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 1.5900000000000001 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.4199999999999999 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 1.4099999999999999 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 0.85999999999999999 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 0.58999999999999997 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.0600000000000001 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 0.72999999999999998 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.67000000000000004 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 0.64000000000000001 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.58999999999999997 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 0.55000000000000004 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 0.63 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 0.77000000000000002 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.87 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.604 HG21 ' CG2' ' A' ' 180' ' ' ILE . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 0.89000000000000001 108.361 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 0.93000000000000005 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.6000000000000001 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 0.75 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.83999999999999997 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 1.6100000000000001 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.2999999999999998 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 0.76000000000000001 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.0099999999999998 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.1899999999999999 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.3999999999999999 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.3 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 0.53000000000000003 110.426 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 0.59999999999999998 107.429 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 0.56999999999999995 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.2200000000000002 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 0.75 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 0.92000000000000004 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.3599999999999999 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 1.4199999999999999 109.301 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 1.97 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 0.65000000000000002 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 0.96999999999999997 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 0.67000000000000004 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 1.45 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.465 ' HG3' HD12 ' A' ' 219' ' ' ILE . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.81999999999999995 111.495 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 1.6200000000000001 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 2.6000000000000001 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.0600000000000001 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.04 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 2.6000000000000001 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.23 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -57.53 -32.22 66.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 2.6699999999999999 109.204 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.37 -60.28 2.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 1.6599999999999999 109.572 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.7 -59.94 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 2.2000000000000002 109.722 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -45.49 -62.21 1.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 3.0 110.294 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.48 -23.99 66.27 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 1.76 110.412 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -67.77 -23.4 65.22 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.925 -1.109 . . . . 2.7799999999999998 108.01 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.16 -53.83 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.882 -0.784 . . . . 2.0600000000000001 108.882 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.58 -28.91 61.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 2.3999999999999999 108.947 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 t -77.0 -27.8 54.83 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.52 -0.738 . . . . 2.8700000000000001 109.649 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 3.4100000000000001 109.286 -179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 3.6600000000000001 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.1200000000000001 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.45 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92000000000000004 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.05 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.88 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 0.78000000000000003 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.5 108.805 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.85999999999999999 113.847 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.768 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78000000000000003 109.628 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 0.73999999999999999 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 0.45000000000000001 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.64000000000000001 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.45000000000000001 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 1.8799999999999999 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.58999999999999997 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 0.64000000000000001 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 0.73999999999999999 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 0.73999999999999999 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 1.8700000000000001 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.5800000000000001 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.1400000000000001 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.9299999999999999 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.68000000000000005 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 0.83999999999999997 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.79000000000000004 108.882 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.3700000000000001 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 2.6200000000000001 108.422 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.3500000000000001 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.3500000000000001 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 0.78000000000000003 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.04 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.05 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.4700000000000002 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 1.46 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 0.77000000000000002 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.29 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.76000000000000001 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 2.6600000000000001 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.75 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 0.82999999999999996 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 0.78000000000000003 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.56999999999999995 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 2.8300000000000001 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 0.65000000000000002 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.5699999999999998 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 0.51000000000000001 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.3600000000000001 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 0.59999999999999998 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 1.3600000000000001 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.3799999999999999 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.59999999999999998 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 0.53000000000000003 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.98999999999999999 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 0.58999999999999997 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 1.8100000000000001 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 0.47999999999999998 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.57999999999999996 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.3899999999999999 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 0.81999999999999995 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 0.98999999999999999 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.55000000000000004 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.5899999999999999 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2000000000000002 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 1.79 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 0.57999999999999996 109.758 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.62 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.52000000000000002 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 1.29 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.55000000000000004 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 1.8899999999999999 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 0.53000000000000003 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 0.42999999999999999 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.3100000000000001 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 0.59999999999999998 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.28 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 0.57999999999999996 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 0.78000000000000003 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 0.85999999999999999 110.093 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 0.79000000000000004 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 0.70999999999999996 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.0499999999999998 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.5900000000000001 112.267 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 1.8899999999999999 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.3100000000000001 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 0.62 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.46999999999999997 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 0.56000000000000005 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.47999999999999998 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.44 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 1.4199999999999999 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.60999999999999999 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 0.64000000000000001 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2000000000000002 110.312 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.81999999999999995 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 1.27 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 0.91000000000000003 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 1.73 109.651 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.04 110.079 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.03 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 123' ' ' LEU . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.26 108.339 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.8300000000000001 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.5800000000000001 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.7999999999999998 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.02 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 118' ' ' LEU . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.0600000000000001 110.077 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.3900000000000001 108.342 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2000000000000002 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.0899999999999999 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 0.85999999999999999 107.626 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 0.90000000000000002 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.3500000000000001 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 0.57999999999999996 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 131' ' ' ARG . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.2200000000000002 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.3200000000000001 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 0.5 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.44 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 2.71 109.144 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.502 ' HG2' HH11 ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.2000000000000002 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.1299999999999999 109.13 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.54000000000000004 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.3199999999999998 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 1.26 109.171 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.62 109.167 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 0.67000000000000004 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68000000000000005 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 0.77000000000000002 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.3999999999999999 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 0.87 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.3200000000000001 109.354 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.77000000000000002 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.5700000000000001 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 0.81999999999999995 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.81999999999999995 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.1099999999999999 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.4099999999999999 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.56999999999999995 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 158' ' ' LEU . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 0.42999999999999999 108.297 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 0.56000000000000005 109.489 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 0.54000000000000004 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.62 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 0.80000000000000004 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.3399999999999999 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 0.65000000000000002 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.73999999999999999 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.59999999999999998 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 0.63 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.5 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 0.51000000000000001 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.1699999999999999 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 0.60999999999999999 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.1200000000000001 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.3400000000000001 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 1.97 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 1.8999999999999999 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.47999999999999998 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.3899999999999999 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.38 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.46000000000000002 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 0.58999999999999997 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 0.67000000000000004 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.2400000000000002 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.1100000000000001 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 1.6299999999999999 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.47 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.2400000000000002 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 2.9199999999999999 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 1.6000000000000001 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.92000000000000004 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 1.5900000000000001 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.4199999999999999 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 1.4099999999999999 109.746 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 0.85999999999999999 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 0.58999999999999997 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.517 ' HG2' HH11 ' A' ' 195' ' ' ARG . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.0600000000000001 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 0.72999999999999998 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 0.67000000000000004 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 0.64000000000000001 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.58999999999999997 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 0.55000000000000004 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 0.63 107.234 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 0.77000000000000002 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.87 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 181' ' ' THR . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 0.89000000000000001 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 0.93000000000000005 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.6000000000000001 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 0.75 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 0.83999999999999997 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 1.6100000000000001 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.2999999999999998 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 0.76000000000000001 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.0099999999999998 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.1899999999999999 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.3999999999999999 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 0.53000000000000003 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 0.59999999999999998 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.56999999999999995 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.2200000000000002 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 0.75 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 0.92000000000000004 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.3599999999999999 107.484 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 1.4199999999999999 109.193 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.97 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.65000000000000002 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 0.96999999999999997 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 0.67000000000000004 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 1.45 110.128 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.81999999999999995 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 1.6200000000000001 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 2.6000000000000001 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.0600000000000001 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.1399999999999999 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.04 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 2.6000000000000001 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.23 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -57.28 -40.86 78.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 109.384 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.73 -56.3 4.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 1.6599999999999999 109.887 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.25 -56.85 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 2.2000000000000002 110.359 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -48.45 -55.21 11.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 3.0 110.241 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.57 -26.58 68.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.235 -0.915 . . . . 1.76 110.971 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -67.09 -22.64 65.81 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.483 -1.303 . . . . 2.7799999999999998 107.483 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.06 -33.6 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 109.15 -0.685 . . . . 2.0600000000000001 109.15 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.18 65.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 2.3999999999999999 109.271 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.4 p -76.07 -37.78 57.82 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.304 -0.873 . . . . 2.8700000000000001 109.509 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 3.4100000000000001 109.435 179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 3.6600000000000001 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.1200000000000001 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.45 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92000000000000004 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.05 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 0.88 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.78000000000000003 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.5 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.85999999999999999 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.817 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78000000000000003 109.091 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 0.73999999999999999 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.45000000000000001 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.51 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.64000000000000001 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.45000000000000001 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 1.8799999999999999 109.888 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.58999999999999997 110.801 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 0.64000000000000001 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.73999999999999999 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 0.73999999999999999 110.191 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 1.8700000000000001 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.5800000000000001 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.1400000000000001 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.9299999999999999 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.68000000000000005 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 0.83999999999999997 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.79000000000000004 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 2.6200000000000001 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.3500000000000001 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.3500000000000001 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 0.78000000000000003 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.04 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.05 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.4700000000000002 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 0.77000000000000002 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.29 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.76000000000000001 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 2.6600000000000001 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.75 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 0.82999999999999996 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 0.78000000000000003 107.995 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.56999999999999995 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 2.8300000000000001 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 0.65000000000000002 107.787 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.5699999999999998 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.3600000000000001 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 0.59999999999999998 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 1.3600000000000001 109.477 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.3799999999999999 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.59999999999999998 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 0.53000000000000003 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 0.98999999999999999 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.58999999999999997 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 1.8100000000000001 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 0.47999999999999998 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.57999999999999996 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.3899999999999999 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 0.81999999999999995 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.98999999999999999 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.55000000000000004 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 65' ' ' PHE . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.5899999999999999 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2000000000000002 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 1.79 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.64000000000000001 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 0.57999999999999996 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.62 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.52000000000000002 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 1.29 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 0.55000000000000004 108.263 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 1.8899999999999999 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 0.53000000000000003 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 0.42999999999999999 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.3100000000000001 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.3500000000000001 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.1600000000000001 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 0.59999999999999998 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 0.57999999999999996 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 0.78000000000000003 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.85999999999999999 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.79000000000000004 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.70999999999999996 110.12 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.0499999999999998 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.5900000000000001 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 1.8899999999999999 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.3100000000000001 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.28 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 0.62 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.46999999999999997 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 0.56000000000000005 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 0.47999999999999998 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 0.44 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 1.4199999999999999 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 107' ' ' VAL . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 0.60999999999999999 110.02 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.64000000000000001 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2000000000000002 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.81999999999999995 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 1.27 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 0.91000000000000003 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 1.73 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.04 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.03 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 123' ' ' LEU . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.26 108.534 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.8300000000000001 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.5800000000000001 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.7999999999999998 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.02 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 118' ' ' LEU . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.0600000000000001 109.517 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.3900000000000001 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2000000000000002 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.0899999999999999 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 0.85999999999999999 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 0.90000000000000002 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.3500000000000001 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 0.57999999999999996 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.2200000000000002 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.3200000000000001 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 0.5 109.432 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.44 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 2.71 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.2000000000000002 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.1299999999999999 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 0.54000000000000004 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.3199999999999998 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 80.0 m-20 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 1.26 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 0.62 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 0.67000000000000004 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68000000000000005 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 0.77000000000000002 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.442 ' N ' ' HB3' ' A' ' 139' ' ' ARG . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.3999999999999999 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 0.87 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.3200000000000001 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 0.77000000000000002 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.5700000000000001 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.81999999999999995 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.694 HD12 HD22 ' A' ' 172' ' ' ASN . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 0.81999999999999995 109.573 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.1099999999999999 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.4099999999999999 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 0.56999999999999995 109.179 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 0.42999999999999999 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 0.56000000000000005 109.983 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 0.54000000000000004 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 0.62 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 0.80000000000000004 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.3399999999999999 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.65000000000000002 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.73999999999999999 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.59999999999999998 113.158 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.63 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.5 109.367 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.51000000000000001 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.1699999999999999 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 0.60999999999999999 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.694 HD22 HD12 ' A' ' 152' ' ' ILE . 42.0 p-10 -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.1200000000000001 109.989 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.3400000000000001 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 1.97 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 1.8999999999999999 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 172' ' ' ASN . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 0.47999999999999998 109.386 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.3899999999999999 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.46000000000000002 110.218 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.486 ' CG2' HG21 ' A' ' 205' ' ' THR . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 0.58999999999999997 107.383 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 0.67000000000000004 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.2400000000000002 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.1100000000000001 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 1.6299999999999999 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.47 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.2400000000000002 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 2.9199999999999999 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 1.6000000000000001 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.92000000000000004 109.174 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 1.5900000000000001 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.4199999999999999 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 1.4099999999999999 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 0.85999999999999999 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 0.58999999999999997 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.0600000000000001 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 0.72999999999999998 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.67000000000000004 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 0.64000000000000001 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.58999999999999997 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 0.55000000000000004 111.664 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 6' ' ' LEU . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 0.63 106.92 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 0.77000000000000002 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.87 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.486 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 0.89000000000000001 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 0.93000000000000005 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.6000000000000001 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 0.75 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 0.83999999999999997 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 1.6100000000000001 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.2999999999999998 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 0.76000000000000001 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.0099999999999998 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 36.3 t-20 -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.1899999999999999 109.69 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.3999999999999999 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.3 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.582 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 0.53000000000000003 110.379 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 0.59999999999999998 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 0.56999999999999995 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.2200000000000002 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 0.75 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 0.92000000000000004 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.3599999999999999 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 1.4199999999999999 109.791 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 1.97 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 228' ' ' TYR . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 0.65000000000000002 109.096 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 227' ' ' VAL . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 0.96999999999999997 109.217 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 0.67000000000000004 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 1.45 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 236' ' ' ILE . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.81999999999999995 112.214 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 1.6200000000000001 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 2.6000000000000001 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.0600000000000001 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.1399999999999999 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 231' ' ' PRO . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.04 109.193 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 2.6000000000000001 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.23 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 -56.6 -31.93 64.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 2.6699999999999999 108.263 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.71 -60.26 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.69 -0.631 . . . . 1.6599999999999999 109.956 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.15 -53.4 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 2.2000000000000002 110.147 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.92 -57.24 9.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 3.0 109.877 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.54 -25.55 68.03 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.447 -0.783 . . . . 1.76 111.007 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -63.6 -22.03 66.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.107 -1.442 . . . . 2.7799999999999998 107.107 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.8 -41.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.106 -0.702 . . . . 2.0600000000000001 109.106 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.75 -30.06 66.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 2.3999999999999999 109.296 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 -25.21 40.19 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.926 . . . . 2.8700000000000001 109.449 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 3.4100000000000001 110.158 -179.175 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 3.6600000000000001 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.1200000000000001 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.45 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92000000000000004 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.05 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 0.88 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 0.78000000000000003 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.5 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.85999999999999999 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.838 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78000000000000003 109.218 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 0.73999999999999999 109.301 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 0.45000000000000001 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.64000000000000001 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.45000000000000001 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HZ3' ' HA ' ' A' ' 215' ' ' ASP . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 1.8799999999999999 110.039 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.58999999999999997 111.229 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 0.64000000000000001 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 0.73999999999999999 111.309 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' ALA . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 109.531 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 1.8700000000000001 109.271 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.5800000000000001 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.1400000000000001 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.9299999999999999 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.68000000000000005 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 0.83999999999999997 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 0.79000000000000004 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.3700000000000001 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 2.6200000000000001 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.3500000000000001 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.3500000000000001 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.78000000000000003 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.04 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.05 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.4700000000000002 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 1.46 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.77000000000000002 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.29 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.76000000000000001 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 2.6600000000000001 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.75 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 0.82999999999999996 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 0.78000000000000003 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.56999999999999995 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HB3' HH11 ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 2.8300000000000001 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 0.65000000000000002 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.5699999999999998 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.51000000000000001 109.371 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.3600000000000001 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 0.59999999999999998 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 1.3600000000000001 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 0.59999999999999998 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.53000000000000003 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.98999999999999999 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 0.58999999999999997 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 1.8100000000000001 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 0.47999999999999998 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.57999999999999996 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.3899999999999999 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 0.81999999999999995 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 0.98999999999999999 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.55000000000000004 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.5899999999999999 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 1.79 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 0.64000000000000001 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 0.57999999999999996 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.62 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.52000000000000002 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 1.29 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 0.55000000000000004 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 1.8899999999999999 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 0.53000000000000003 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 0.42999999999999999 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.3100000000000001 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.3500000000000001 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.1600000000000001 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 0.59999999999999998 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.28 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 0.57999999999999996 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.78000000000000003 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 0.85999999999999999 110.449 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 0.79000000000000004 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 0.70999999999999996 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.0499999999999998 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.5900000000000001 112.048 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 1.8899999999999999 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.3100000000000001 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.28 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 0.62 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.46999999999999997 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 0.56000000000000005 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 0.47999999999999998 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.44 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 1.4199999999999999 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 107' ' ' VAL . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 0.60999999999999999 109.978 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.64000000000000001 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2000000000000002 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.81999999999999995 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 1.27 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 0.91000000000000003 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 1.73 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.04 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.03 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 123' ' ' LEU . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.26 108.386 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.8300000000000001 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.5800000000000001 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.7999999999999998 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.02 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 118' ' ' LEU . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.0600000000000001 109.82 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.3900000000000001 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2000000000000002 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.0899999999999999 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 0.85999999999999999 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 0.90000000000000002 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.3500000000000001 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.57999999999999996 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.2200000000000002 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.3200000000000001 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.5 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.44 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 2.71 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.504 ' HG2' HH11 ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.2000000000000002 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.1299999999999999 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 0.54000000000000004 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.474 ' HG2' HH11 ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.3199999999999998 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 1.26 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 0.62 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 0.67000000000000004 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68000000000000005 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 0.77000000000000002 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.3999999999999999 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 0.87 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.888 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.3200000000000001 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 0.77000000000000002 109.16 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.5700000000000001 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 0.81999999999999995 109.58 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.81999999999999995 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.1099999999999999 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.4099999999999999 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 0.56999999999999995 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 0.42999999999999999 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 0.56000000000000005 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 0.54000000000000004 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.62 109.434 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 0.80000000000000004 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.3399999999999999 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 0.65000000000000002 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 0.73999999999999999 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.59999999999999998 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.63 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.5 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 0.51000000000000001 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.1699999999999999 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.60999999999999999 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.1200000000000001 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.3400000000000001 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 1.97 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 1.8999999999999999 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 0.47999999999999998 108.347 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.3899999999999999 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.38 109.081 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.46000000000000002 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 0.58999999999999997 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 0.67000000000000004 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.2400000000000002 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.1100000000000001 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 1.6299999999999999 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.47 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.2400000000000002 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 2.9199999999999999 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 1.6000000000000001 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 192' ' ' ILE . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 0.92000000000000004 110.114 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 1.5900000000000001 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.4199999999999999 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 189' ' ' HIS . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 1.4099999999999999 109.649 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 0.85999999999999999 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 0.58999999999999997 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.0600000000000001 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.72999999999999998 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.67000000000000004 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 0.64000000000000001 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.58999999999999997 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 0.55000000000000004 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 203' ' ' VAL . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 0.63 107.205 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 0.77000000000000002 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.87 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 0.89000000000000001 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 0.93000000000000005 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.6000000000000001 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 0.75 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.83999999999999997 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 1.6100000000000001 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.2999999999999998 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 0.76000000000000001 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.0099999999999998 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.1899999999999999 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.3999999999999999 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.3 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 16' ' ' ALA . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 0.53000000000000003 109.906 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 0.59999999999999998 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 0.56999999999999995 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.2200000000000002 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 0.75 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 0.92000000000000004 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.3599999999999999 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 1.4199999999999999 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.437 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 8.7 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 1.97 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 0.65000000000000002 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 0.96999999999999997 109.988 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 0.67000000000000004 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 1.45 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.81999999999999995 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 233' ' ' ASN . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 1.6200000000000001 109.26 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.437 ' H ' HG22 ' A' ' 232' ' ' THR . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 2.6000000000000001 109.949 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.0600000000000001 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.1399999999999999 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.04 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 2.6000000000000001 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.23 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 -56.62 -38.68 72.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 2.6699999999999999 109.602 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.98 -46.07 31.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 1.6599999999999999 109.541 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.89 -55.19 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 2.2000000000000002 109.661 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -52.72 6.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 3.0 110.398 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.66 -28.79 68.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.161 -0.962 . . . . 1.76 111.039 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -66.63 -24.42 66.3 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.578 -1.326 . . . . 2.7799999999999998 107.828 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.85 -43.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.733 -0.839 . . . . 2.0600000000000001 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -37.59 65.85 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.448 -0.783 . . . . 2.3999999999999999 109.48 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -78.8 -29.24 44.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 2.8700000000000001 110.206 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.067 -1.021 . . . . 3.4100000000000001 110.219 -179.312 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 3.6600000000000001 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.1200000000000001 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.45 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92000000000000004 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.05 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.88 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 0.78000000000000003 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.5 108.931 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.85999999999999999 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78000000000000003 109.971 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 0.73999999999999999 109.267 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 0.45000000000000001 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.64000000000000001 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.45000000000000001 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 1.8799999999999999 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 0.58999999999999997 111.579 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 0.64000000000000001 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 0.73999999999999999 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 0.73999999999999999 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 1.8700000000000001 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.5800000000000001 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.1400000000000001 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.9299999999999999 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.68000000000000005 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 0.83999999999999997 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 0.79000000000000004 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.3700000000000001 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 2.6200000000000001 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.3500000000000001 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.3500000000000001 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.78000000000000003 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.04 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.05 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 1.46 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.77000000000000002 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.29 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 0.76000000000000001 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 2.6600000000000001 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.75 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.82999999999999996 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 0.78000000000000003 108.451 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.56999999999999995 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 2.8300000000000001 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 0.65000000000000002 108.44 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.5699999999999998 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 0.51000000000000001 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.3600000000000001 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 0.59999999999999998 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 1.3600000000000001 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.3799999999999999 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.59999999999999998 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 HD12 HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 0.53000000000000003 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.98999999999999999 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 0.58999999999999997 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 1.8100000000000001 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 0.47999999999999998 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.57999999999999996 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.3899999999999999 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 0.81999999999999995 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 0.98999999999999999 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.55000000000000004 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.5899999999999999 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2000000000000002 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 1.79 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 0.64000000000000001 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 0.57999999999999996 109.928 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.62 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.52000000000000002 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 1.29 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 0.55000000000000004 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 1.8899999999999999 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.53000000000000003 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 0.42999999999999999 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.3100000000000001 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.3500000000000001 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.1600000000000001 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 0.59999999999999998 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.28 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 0.57999999999999996 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 0.78000000000000003 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.85999999999999999 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.79000000000000004 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 0.70999999999999996 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.0499999999999998 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.5900000000000001 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 1.8899999999999999 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.3100000000000001 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.28 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 0.62 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 0.46999999999999997 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 0.56000000000000005 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.47999999999999998 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.44 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 1.4199999999999999 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 0.60999999999999999 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.64000000000000001 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2000000000000002 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.81999999999999995 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 1.27 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.91000000000000003 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 1.73 110.201 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.04 110.244 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD21 HH21 ' A' ' 126' ' ' ARG . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.03 108.917 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.26 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.8300000000000001 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.5800000000000001 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.7999999999999998 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.02 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.3900000000000001 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2000000000000002 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.411 HH21 HD21 ' A' ' 115' ' ' LEU . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.0899999999999999 106.341 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 0.85999999999999999 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 0.90000000000000002 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.3500000000000001 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 0.57999999999999996 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.2200000000000002 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.3200000000000001 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.5 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.44 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HE2' HH11 ' A' ' 139' ' ' ARG . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 2.71 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.527 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.2000000000000002 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.1299999999999999 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.54000000000000004 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.412 HH11 ' HE2' ' A' ' 135' ' ' LYS . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.3199999999999998 110.347 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 1.26 109.155 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 0.62 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.67000000000000004 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68000000000000005 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 0.77000000000000002 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 0.87 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 147' ' ' ILE . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.3200000000000001 108.975 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 0.77000000000000002 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.5700000000000001 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.81999999999999995 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' GLN . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 0.81999999999999995 108.96 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' ILE . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.1099999999999999 109.334 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.4099999999999999 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.56999999999999995 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.42999999999999999 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 0.56000000000000005 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 0.54000000000000004 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.62 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 0.80000000000000004 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.3399999999999999 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 0.65000000000000002 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 0.73999999999999999 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.59999999999999998 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 0.63 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 0.5 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 0.51000000000000001 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.1699999999999999 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 0.60999999999999999 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.1200000000000001 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.3400000000000001 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 1.97 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 1.8999999999999999 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 178' ' ' GLY . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 0.47999999999999998 108.714 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.473 ' N ' HG12 ' A' ' 176' ' ' VAL . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.3899999999999999 109.785 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.38 109.571 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.46000000000000002 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 220' ' ' LEU . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 0.58999999999999997 108.861 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 0.67000000000000004 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.2400000000000002 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.1100000000000001 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 1.6299999999999999 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.47 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.2400000000000002 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 2.9199999999999999 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 1.6000000000000001 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.92000000000000004 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 1.5900000000000001 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.4199999999999999 110.302 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 1.4099999999999999 110.989 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 0.85999999999999999 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 0.58999999999999997 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.0600000000000001 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.72999999999999998 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 0.67000000000000004 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 0.64000000000000001 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.58999999999999997 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 0.55000000000000004 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.63 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 0.77000000000000002 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.87 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 0.89000000000000001 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 0.93000000000000005 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.6000000000000001 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 0.75 110.397 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 0.83999999999999997 110.309 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.574 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 1.6100000000000001 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.574 ' NE2' ' O ' ' A' ' 210' ' ' SER . 82.4 mm-40 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.2999999999999998 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 0.76000000000000001 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.0099999999999998 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.1899999999999999 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.3999999999999999 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.3 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 0.53000000000000003 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 0.59999999999999998 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 180' ' ' ILE . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.56999999999999995 108.612 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.2200000000000002 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 0.75 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 0.92000000000000004 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.3599999999999999 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 1.4199999999999999 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 54.7 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.97 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 0.65000000000000002 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 0.96999999999999997 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 0.67000000000000004 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 1.45 110.094 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.81999999999999995 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 1.6200000000000001 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 2.6000000000000001 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.0600000000000001 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.1399999999999999 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.04 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 2.6000000000000001 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.23 109.901 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -53.7 -40.93 66.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 2.6699999999999999 109.663 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.54 -59.8 2.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 1.6599999999999999 109.911 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.7 t -59.61 -48.44 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2000000000000002 110.264 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.423 ' CB ' ' O ' ' A' ' 239' ' ' MET . 3.1 tm0? -55.52 -61.44 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 3.0 110.198 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.24 -26.51 68.82 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.495 -0.753 . . . . 1.76 111.21 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -70.37 -20.11 62.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.672 -1.267 . . . . 2.7799999999999998 108.461 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.0 -34.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.84 -0.8 . . . . 2.0600000000000001 108.84 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.44 -38.93 68.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.444 -0.785 . . . . 2.3999999999999999 109.791 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.95 -32.92 51.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 2.8700000000000001 109.827 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.044 -1.035 . . . . 3.4100000000000001 109.253 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 3.6600000000000001 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.1200000000000001 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.45 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92000000000000004 108.709 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.05 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.88 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 0.78000000000000003 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.5 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.85999999999999999 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78000000000000003 109.801 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 0.73999999999999999 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 0.45000000000000001 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.563 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.64000000000000001 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.45000000000000001 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 1.8799999999999999 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.58999999999999997 110.949 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 0.64000000000000001 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 0.73999999999999999 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 0.73999999999999999 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 1.8700000000000001 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.5800000000000001 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.1400000000000001 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.9299999999999999 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 0.68000000000000005 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 0.83999999999999997 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.79000000000000004 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.3700000000000001 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 2.6200000000000001 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.3500000000000001 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.3500000000000001 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 0.78000000000000003 110.145 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.04 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.05 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.4700000000000002 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 1.46 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.77000000000000002 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.29 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 0.76000000000000001 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 2.6600000000000001 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.75 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 0.82999999999999996 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 0.78000000000000003 108.458 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.56999999999999995 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 2.8300000000000001 108.87 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 0.65000000000000002 108.133 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.5699999999999998 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 0.51000000000000001 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.3600000000000001 108.092 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 0.59999999999999998 109.459 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 1.3600000000000001 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.3799999999999999 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.59999999999999998 109.341 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.53000000000000003 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.98999999999999999 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 0.58999999999999997 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 1.8100000000000001 107.762 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 0.47999999999999998 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.57999999999999996 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.3899999999999999 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.81999999999999995 110.081 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 0.98999999999999999 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.55000000000000004 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.5899999999999999 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2000000000000002 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 1.79 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.64000000000000001 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 0.57999999999999996 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.62 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.52000000000000002 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 1.29 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 0.55000000000000004 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 1.8899999999999999 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 0.53000000000000003 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 0.42999999999999999 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.3100000000000001 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.3500000000000001 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.1600000000000001 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.59999999999999998 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.28 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 0.57999999999999996 107.789 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 0.78000000000000003 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.85999999999999999 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 0.79000000000000004 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.70999999999999996 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.0499999999999998 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.5900000000000001 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 1.8899999999999999 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.3100000000000001 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.28 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.62 109.848 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.46999999999999997 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 0.56000000000000005 109.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.47999999999999998 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 0.44 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 1.4199999999999999 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.60999999999999999 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 0.64000000000000001 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2000000000000002 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.81999999999999995 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 1.27 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 0.91000000000000003 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.73 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.04 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.03 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.26 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.8300000000000001 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.5800000000000001 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.7999999999999998 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.02 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.0600000000000001 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.3900000000000001 108.763 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2000000000000002 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.0899999999999999 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 0.85999999999999999 109.228 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.90000000000000002 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.3500000000000001 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.57999999999999996 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.2200000000000002 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.3200000000000001 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 0.5 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.44 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 2.71 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.449 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.2000000000000002 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.1299999999999999 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 0.54000000000000004 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.3199999999999998 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 1.26 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 0.62 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.67000000000000004 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68000000000000005 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 0.77000000000000002 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.3999999999999999 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 0.87 108.495 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.3200000000000001 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.77000000000000002 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.5700000000000001 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.81999999999999995 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.81999999999999995 108.542 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 152' ' ' ILE . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.1099999999999999 109.645 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.4099999999999999 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.56999999999999995 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 158' ' ' LEU . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 0.42999999999999999 108.164 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 0.56000000000000005 109.259 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 0.54000000000000004 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 0.62 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 0.80000000000000004 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.3399999999999999 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 0.65000000000000002 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 0.73999999999999999 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.59999999999999998 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.63 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 168' ' ' THR . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.5 110.087 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 0.51000000000000001 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.1699999999999999 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 0.60999999999999999 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.1200000000000001 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.3400000000000001 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 1.97 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 1.8999999999999999 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 172' ' ' ASN . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 0.47999999999999998 109.209 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.3899999999999999 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.38 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.46000000000000002 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 0.58999999999999997 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.67000000000000004 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.2400000000000002 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.1100000000000001 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 1.6299999999999999 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.456 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.47 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.2400000000000002 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.456 ' N ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 2.9199999999999999 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 1.6000000000000001 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.92000000000000004 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 1.5900000000000001 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.4199999999999999 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 1.4099999999999999 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 0.85999999999999999 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 0.58999999999999997 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.0600000000000001 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.72999999999999998 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.67000000000000004 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 0.64000000000000001 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.58999999999999997 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 0.55000000000000004 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 0.63 106.708 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 0.77000000000000002 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.87 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 0.89000000000000001 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 0.93000000000000005 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.6000000000000001 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 0.75 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 0.83999999999999997 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 1.6100000000000001 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.2999999999999998 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 0.76000000000000001 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.454 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.0099999999999998 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.1899999999999999 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CG ' HD22 ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.3999999999999999 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.3 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 16' ' ' ALA . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 0.53000000000000003 110.491 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 0.59999999999999998 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 0.56999999999999995 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.2200000000000002 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 0.75 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 0.92000000000000004 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.3599999999999999 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 1.97 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 0.65000000000000002 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 0.96999999999999997 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 0.67000000000000004 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 1.45 110.19 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.81999999999999995 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 1.6200000000000001 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 2.6000000000000001 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.0600000000000001 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.1399999999999999 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.04 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 2.6000000000000001 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.428 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.23 109.815 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER -55.89 -48.71 75.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 2.6699999999999999 109.74 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.85 -47.48 25.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 1.6599999999999999 110.456 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.78 -47.63 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.065 . . . . 2.2000000000000002 110.425 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 239' ' ' MET . 9.1 tm0? -53.87 -58.09 8.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 3.0 110.694 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.81 -23.11 59.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.153 -0.967 . . . . 1.76 110.002 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.99 -25.8 65.6 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.459 -1.312 . . . . 2.7799999999999998 107.459 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.53 -53.22 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.052 -0.721 . . . . 2.0600000000000001 109.052 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.32 -27.85 69.31 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.396 -0.815 . . . . 2.3999999999999999 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.8 p -77.34 -25.41 51.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.849 . . . . 2.8700000000000001 109.927 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 3.4100000000000001 110.219 -179.454 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 3.6600000000000001 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.1200000000000001 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.45 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92000000000000004 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.05 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.88 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.78000000000000003 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.5 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.85999999999999999 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78000000000000003 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 0.73999999999999999 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.45000000000000001 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.59 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.64000000000000001 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.45000000000000001 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 1.8799999999999999 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 0.58999999999999997 111.507 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 0.64000000000000001 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.73999999999999999 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 0.73999999999999999 110.154 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 1.8700000000000001 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.5800000000000001 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.1400000000000001 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.9299999999999999 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 0.68000000000000005 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 0.83999999999999997 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.79000000000000004 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.3700000000000001 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 2.6200000000000001 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.3500000000000001 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.3500000000000001 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 39' ' ' GLU . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.78000000000000003 110.192 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.05 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.4700000000000002 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 32' ' ' SER . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 1.46 108.871 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 0.77000000000000002 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.29 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD13 ' A' ' 31' ' ' ILE . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.76000000000000001 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' HG2' HH11 ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 2.6600000000000001 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.75 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.82999999999999996 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 0.78000000000000003 107.656 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.56999999999999995 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 2.8300000000000001 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 0.65000000000000002 108.514 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.5699999999999998 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 0.51000000000000001 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.3600000000000001 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 0.59999999999999998 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 1.3600000000000001 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.3799999999999999 108.898 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 0.59999999999999998 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 0.53000000000000003 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 0.98999999999999999 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.58999999999999997 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 1.8100000000000001 107.125 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 0.47999999999999998 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.57999999999999996 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.3899999999999999 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.81999999999999995 109.58 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 0.98999999999999999 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.55000000000000004 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.5899999999999999 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2000000000000002 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 1.79 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 0.64000000000000001 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.57999999999999996 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.62 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.52000000000000002 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 1.29 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 0.55000000000000004 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 1.8899999999999999 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 0.53000000000000003 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.42999999999999999 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.3100000000000001 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.3500000000000001 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.1600000000000001 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 0.59999999999999998 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.28 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 0.57999999999999996 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 0.78000000000000003 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.85999999999999999 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 0.79000000000000004 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 0.70999999999999996 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.0499999999999998 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.5900000000000001 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 1.8899999999999999 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.444 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.3100000000000001 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.28 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.62 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 0.46999999999999997 109.047 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 0.56000000000000005 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 0.44 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 61.1 t60 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 1.4199999999999999 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 0.60999999999999999 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 0.64000000000000001 108.457 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2000000000000002 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.81999999999999995 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 1.27 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 0.91000000000000003 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 1.73 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.04 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.03 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.26 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.8300000000000001 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.5800000000000001 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.02 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.0600000000000001 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.3900000000000001 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2000000000000002 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.0899999999999999 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 0.85999999999999999 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 0.90000000000000002 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.3500000000000001 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.57999999999999996 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.2200000000000002 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.3200000000000001 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.5 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.44 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 2.71 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.2000000000000002 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.1299999999999999 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.54000000000000004 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 1.26 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 0.62 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.67000000000000004 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68000000000000005 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 0.77000000000000002 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.3999999999999999 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 0.87 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.726 HD12 ' H ' ' A' ' 147' ' ' ILE . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.3200000000000001 108.855 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.77000000000000002 109.326 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.5700000000000001 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 0.81999999999999995 108.812 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.446 HD12 HD21 ' A' ' 172' ' ' ASN . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 0.81999999999999995 109.273 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.1099999999999999 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.4099999999999999 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.56999999999999995 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 0.42999999999999999 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 0.56000000000000005 108.617 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 0.54000000000000004 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 0.62 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 0.80000000000000004 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.3399999999999999 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 0.65000000000000002 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.73999999999999999 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.59999999999999998 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.63 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.5 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.51000000000000001 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.1699999999999999 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 0.60999999999999999 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.1200000000000001 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.3400000000000001 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 1.97 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 1.8999999999999999 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 177' ' ' LEU . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 0.47999999999999998 108.8 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 176' ' ' VAL . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.3899999999999999 109.734 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.38 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.46000000000000002 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 0.58999999999999997 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 0.67000000000000004 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.2400000000000002 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.1100000000000001 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 1.6299999999999999 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.47 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.2400000000000002 109.318 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 2.9199999999999999 109.327 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 1.6000000000000001 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 0.92000000000000004 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 1.5900000000000001 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.4199999999999999 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 1.4099999999999999 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 0.85999999999999999 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 0.58999999999999997 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.0600000000000001 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.72999999999999998 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.67000000000000004 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 0.64000000000000001 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.58999999999999997 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 0.55000000000000004 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 0.63 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 0.77000000000000002 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.87 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 0.89000000000000001 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 0.93000000000000005 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.6000000000000001 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 0.75 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.83999999999999997 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 1.6100000000000001 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.2999999999999998 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.76000000000000001 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.0099999999999998 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.1899999999999999 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.3999999999999999 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.3 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.53000000000000003 109.224 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 0.59999999999999998 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 0.56999999999999995 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.2200000000000002 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 0.75 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 0.92000000000000004 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.3599999999999999 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 1.4199999999999999 108.433 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 1.97 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 0.65000000000000002 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.503 ' N ' HG12 ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 0.96999999999999997 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 0.67000000000000004 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 1.45 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.81999999999999995 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.6200000000000001 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 2.6000000000000001 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.0600000000000001 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.04 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 2.6000000000000001 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.23 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -54.61 -41.3 69.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 2.6699999999999999 108.948 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.11 -35.54 59.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 1.6599999999999999 109.886 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.8 -50.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 2.2000000000000002 111.306 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -62.77 -50.79 69.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.671 -1.268 . . . . 3.0 109.619 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -62.78 -25.89 68.45 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.004 -1.06 . . . . 1.76 110.212 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.31 -23.24 63.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.865 -1.161 . . . . 2.7799999999999998 107.865 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -73.82 -41.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.345 -0.983 . . . . 2.0600000000000001 108.345 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.14 -36.92 63.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -0.86 . . . . 2.3999999999999999 108.843 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 -27.07 50.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 2.8700000000000001 109.489 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 3.4100000000000001 109.718 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 3.6600000000000001 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.1200000000000001 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.45 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92000000000000004 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.05 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 225' ' ' ASN . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 0.88 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 0.78000000000000003 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.5 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.85999999999999999 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78000000000000003 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 0.73999999999999999 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 0.45000000000000001 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.64000000000000001 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.45000000000000001 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 1.8799999999999999 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.58999999999999997 110.773 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 0.64000000000000001 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.73999999999999999 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 0.73999999999999999 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 1.8700000000000001 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.5800000000000001 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.1400000000000001 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.9299999999999999 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 0.68000000000000005 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 0.83999999999999997 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 0.79000000000000004 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.3700000000000001 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 2.6200000000000001 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.3500000000000001 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.3500000000000001 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 0.78000000000000003 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.04 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.05 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.4700000000000002 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 1.46 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 0.77000000000000002 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.29 110.587 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.76000000000000001 109.341 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 2.6600000000000001 109.051 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.75 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 0.82999999999999996 109.013 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 0.78000000000000003 108.236 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.56999999999999995 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 2.8300000000000001 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 0.65000000000000002 108.12 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.5699999999999998 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.51000000000000001 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.3600000000000001 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 0.59999999999999998 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 1.3600000000000001 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.507 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.3799999999999999 108.854 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.59999999999999998 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.53000000000000003 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 0.98999999999999999 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 0.58999999999999997 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 1.8100000000000001 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 0.47999999999999998 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.57999999999999996 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.3899999999999999 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 0.81999999999999995 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 0.98999999999999999 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.55000000000000004 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.5899999999999999 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2000000000000002 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 1.79 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 0.64000000000000001 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 0.57999999999999996 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.62 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.52000000000000002 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 1.29 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 0.55000000000000004 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 1.8899999999999999 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 0.53000000000000003 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 0.42999999999999999 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.3100000000000001 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.3500000000000001 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.1600000000000001 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 0.59999999999999998 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.28 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 0.57999999999999996 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 0.78000000000000003 110.358 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.85999999999999999 110.188 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 0.79000000000000004 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 0.70999999999999996 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.0499999999999998 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.5900000000000001 112.155 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 1.8899999999999999 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.3100000000000001 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.28 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.62 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.46999999999999997 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 0.56000000000000005 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 0.47999999999999998 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 0.44 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 1.4199999999999999 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 0.60999999999999999 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 0.64000000000000001 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2000000000000002 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.81999999999999995 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 1.27 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 0.91000000000000003 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 1.73 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.04 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.03 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 123' ' ' LEU . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.8300000000000001 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.5800000000000001 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.7999999999999998 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.02 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 118' ' ' LEU . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.0600000000000001 109.093 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.3900000000000001 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2000000000000002 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.0899999999999999 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 0.85999999999999999 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 0.90000000000000002 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.3500000000000001 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 0.57999999999999996 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.2200000000000002 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.3200000000000001 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 0.5 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.44 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 2.71 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.2000000000000002 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.1299999999999999 108.227 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.54000000000000004 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.3199999999999998 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 1.26 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.62 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 0.67000000000000004 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68000000000000005 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 0.77000000000000002 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.3999999999999999 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 0.87 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 0.77000000000000002 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.5700000000000001 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 0.81999999999999995 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 0.81999999999999995 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.1099999999999999 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.4099999999999999 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.56999999999999995 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 0.42999999999999999 108.104 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 0.56000000000000005 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 0.54000000000000004 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.62 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 0.80000000000000004 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.3399999999999999 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 0.65000000000000002 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.73999999999999999 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.59999999999999998 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 0.63 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 0.5 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 0.51000000000000001 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.1699999999999999 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 0.60999999999999999 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.1200000000000001 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.3400000000000001 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 1.97 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 1.8999999999999999 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 177' ' ' LEU . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 0.47999999999999998 108.91 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' N ' HG12 ' A' ' 176' ' ' VAL . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.3899999999999999 109.637 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.38 109.623 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.46000000000000002 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 0.58999999999999997 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 0.67000000000000004 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' O ' ' CG ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.2400000000000002 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.1100000000000001 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 1.6299999999999999 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.484 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.47 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.2400000000000002 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.484 ' N ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 2.9199999999999999 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 1.6000000000000001 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 0.92000000000000004 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 1.5900000000000001 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.456 ' HG ' HG11 ' A' ' 203' ' ' VAL . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.4199999999999999 110.063 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 1.4099999999999999 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.85999999999999999 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 0.58999999999999997 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.0600000000000001 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.72999999999999998 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.67000000000000004 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 0.64000000000000001 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.58999999999999997 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 0.55000000000000004 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 0.63 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 0.77000000000000002 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.87 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 0.89000000000000001 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 0.93000000000000005 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.6000000000000001 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 0.75 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 0.83999999999999997 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 1.6100000000000001 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.2999999999999998 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 0.76000000000000001 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.411 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.0099999999999998 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.1899999999999999 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.3999999999999999 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.3 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 0.53000000000000003 110.496 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 0.59999999999999998 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.56999999999999995 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.2200000000000002 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 0.75 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 0.92000000000000004 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.3599999999999999 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 1.4199999999999999 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 1.97 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 0.65000000000000002 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 0.96999999999999997 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 0.67000000000000004 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 1.45 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.81999999999999995 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 1.6200000000000001 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 2.6000000000000001 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.0600000000000001 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.1399999999999999 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.04 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 2.6000000000000001 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 243' ' ' GLN . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.23 109.217 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -48.27 -45.38 34.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 2.6699999999999999 110.559 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.58 -54.63 6.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.6599999999999999 110.608 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.83 -48.6 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 2.2000000000000002 110.655 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 239' ' ' MET . 8.2 tp60 -54.62 -43.46 72.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.838 -1.164 . . . . 3.0 109.726 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.91 -32.52 73.81 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.683 -1.261 . . . . 1.76 109.067 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.192 -1.003 . . . . 2.7799999999999998 108.449 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.39 -41.61 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.193 -1.04 . . . . 2.0600000000000001 108.193 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.02 92.5 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.65 -0.656 . . . . 2.3999999999999999 109.397 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -75.93 -31.56 59.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 2.8700000000000001 109.584 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.885 -1.154 . . . . 3.4100000000000001 107.885 179.137 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 3.6600000000000001 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.1200000000000001 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.45 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92000000000000004 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 5' ' ' ILE . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.05 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.88 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.78000000000000003 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.5 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.85999999999999999 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.696 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78000000000000003 109.712 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 0.73999999999999999 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 0.45000000000000001 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.64000000000000001 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.45000000000000001 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 1.8799999999999999 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.58999999999999997 111.003 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 0.64000000000000001 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 0.73999999999999999 110.162 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 160' ' ' ALA . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 0.73999999999999999 110.199 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 1.8700000000000001 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.5800000000000001 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.1400000000000001 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.9299999999999999 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.68000000000000005 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 0.83999999999999997 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 0.79000000000000004 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.3700000000000001 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.445 HH12 ' HB1' ' A' ' 102' ' ' ALA . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 2.6200000000000001 109.239 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.3500000000000001 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.3500000000000001 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 31' ' ' ILE . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.78000000000000003 109.962 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.04 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.05 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.4700000000000002 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.46 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.77000000000000002 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.29 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.76000000000000001 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 2.6600000000000001 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.75 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 0.82999999999999996 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 0.78000000000000003 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.56999999999999995 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 2.8300000000000001 106.251 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 0.65000000000000002 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.5699999999999998 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 0.51000000000000001 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.3600000000000001 108.431 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 0.59999999999999998 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 1.3600000000000001 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.3799999999999999 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.59999999999999998 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.482 HD13 HH12 ' A' ' 136' ' ' ARG . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.53000000000000003 109.236 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 0.98999999999999999 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 0.58999999999999997 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 1.8100000000000001 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 0.47999999999999998 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.57999999999999996 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.3899999999999999 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.81999999999999995 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 0.98999999999999999 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.55000000000000004 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.5899999999999999 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2000000000000002 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 1.79 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.64000000000000001 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 0.57999999999999996 110.001 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.62 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.52000000000000002 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 1.29 109.785 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 0.55000000000000004 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 0.53000000000000003 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 0.42999999999999999 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.3100000000000001 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.3500000000000001 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.1600000000000001 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 0.59999999999999998 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.28 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 0.57999999999999996 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.78000000000000003 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 0.85999999999999999 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.79000000000000004 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 0.70999999999999996 111.098 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.0499999999999998 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.5900000000000001 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 1.8899999999999999 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.3100000000000001 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.28 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 0.62 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.46999999999999997 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB1' HH12 ' A' ' 28' ' ' ARG . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 0.56000000000000005 110.483 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.47999999999999998 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.44 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 1.4199999999999999 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 0.60999999999999999 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 0.64000000000000001 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2000000000000002 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.81999999999999995 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 1.27 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 0.91000000000000003 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 1.73 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.04 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.03 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 123' ' ' LEU . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.26 108.913 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.8300000000000001 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.5800000000000001 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.62 ' H ' ' CD ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.7999999999999998 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.02 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 118' ' ' LEU . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.0600000000000001 109.416 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.3900000000000001 109.04 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2000000000000002 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.0899999999999999 106.344 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 0.85999999999999999 109.022 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.90000000000000002 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.3500000000000001 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 126' ' ' ARG . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.57999999999999996 108.977 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.2200000000000002 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.3200000000000001 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 0.5 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.44 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' HZ2' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 2.71 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.482 HH12 HD13 ' A' ' 57' ' ' ILE . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.2000000000000002 108.433 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.1299999999999999 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.54000000000000004 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.532 HH11 ' HZ2' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.3199999999999998 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 1.26 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 0.62 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.67000000000000004 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68000000000000005 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 0.77000000000000002 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.3999999999999999 109.125 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 0.87 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.478 HD12 ' H ' ' A' ' 147' ' ' ILE . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.3200000000000001 109.042 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.5700000000000001 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 0.81999999999999995 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.81999999999999995 109.043 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.406 ' N ' HG22 ' A' ' 152' ' ' ILE . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.1099999999999999 109.128 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.4099999999999999 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 0.56999999999999995 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 0.42999999999999999 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 0.56000000000000005 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 0.54000000000000004 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.62 109.697 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 0.80000000000000004 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.3399999999999999 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.65000000000000002 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 0.73999999999999999 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.59999999999999998 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.63 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.5 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.51000000000000001 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.1699999999999999 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 0.60999999999999999 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.1200000000000001 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.3400000000000001 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 1.97 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 1.8999999999999999 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 0.47999999999999998 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.3899999999999999 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.38 109.272 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.46000000000000002 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.572 ' CG2' HG21 ' A' ' 205' ' ' THR . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 0.58999999999999997 106.771 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 0.67000000000000004 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.2400000000000002 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.1100000000000001 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 1.6299999999999999 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.47 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.2400000000000002 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 2.9199999999999999 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 1.6000000000000001 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.92000000000000004 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 1.5900000000000001 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.4199999999999999 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.4099999999999999 110.013 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 0.85999999999999999 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 0.58999999999999997 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.518 HH11 ' CG ' ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.0600000000000001 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 0.72999999999999998 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.67000000000000004 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 0.64000000000000001 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.58999999999999997 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 0.55000000000000004 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 0.63 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 0.77000000000000002 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.87 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.572 HG21 ' CG2' ' A' ' 180' ' ' ILE . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 0.89000000000000001 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 0.93000000000000005 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.6000000000000001 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 0.75 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.83999999999999997 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 1.6100000000000001 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.2999999999999998 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 0.76000000000000001 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.0099999999999998 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.1899999999999999 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.3999999999999999 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.3 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 0.53000000000000003 110.551 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 219' ' ' ILE . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 0.59999999999999998 108.606 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 0.56999999999999995 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.2200000000000002 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 0.75 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 0.92000000000000004 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.3599999999999999 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 1.4199999999999999 109.424 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.414 ' OE1' ' SD ' ' A' ' 1' ' ' MET . 67.0 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 1.97 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 0.65000000000000002 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 0.96999999999999997 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.67000000000000004 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 1.45 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.81999999999999995 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 1.6200000000000001 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 2.6000000000000001 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.0600000000000001 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.1399999999999999 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.04 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 2.6000000000000001 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.421 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.23 110.015 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -57.53 -45.91 84.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 2.6699999999999999 110.18 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.57 16.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.02 . . . . 1.6599999999999999 110.578 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.8 t -69.81 -53.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 2.2000000000000002 110.547 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 239' ' ' MET . 25.0 tp60 -55.78 -50.22 71.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 3.0 109.868 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -62.63 -21.68 65.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.792 -1.193 . . . . 1.76 109.368 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -64.22 -29.4 70.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.262 -1.385 . . . . 2.7799999999999998 107.262 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.67 -49.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.211 -1.033 . . . . 2.0600000000000001 108.211 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.2 84.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.716 . . . . 2.3999999999999999 109.107 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.7 t -77.21 -18.8 57.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.368 -0.833 . . . . 2.8700000000000001 109.773 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 3.4100000000000001 109.375 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 3.6600000000000001 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.1200000000000001 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.45 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92000000000000004 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.05 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 0.88 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 0.78000000000000003 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.5 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.85999999999999999 114.455 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78000000000000003 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 0.73999999999999999 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 0.45000000000000001 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.64000000000000001 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.45000000000000001 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 1.8799999999999999 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 0.58999999999999997 110.645 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 0.64000000000000001 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 0.73999999999999999 111.071 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 0.73999999999999999 109.977 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 1.8700000000000001 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.5800000000000001 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.1400000000000001 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.9299999999999999 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.68000000000000005 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 0.83999999999999997 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 0.79000000000000004 110.02 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.3700000000000001 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 2.6200000000000001 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.3500000000000001 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.3500000000000001 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.78000000000000003 110.27 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.04 109.454 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.05 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.4700000000000002 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 1.46 108.491 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 0.77000000000000002 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.29 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 0.76000000000000001 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 2.6600000000000001 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.75 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 0.82999999999999996 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 0.78000000000000003 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.56999999999999995 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 2.8300000000000001 107.506 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 0.65000000000000002 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.5699999999999998 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.51000000000000001 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.3600000000000001 108.859 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 0.59999999999999998 109.511 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.484 HE22 HD21 ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 1.3600000000000001 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.3799999999999999 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 0.59999999999999998 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.53000000000000003 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.98999999999999999 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.58999999999999997 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 1.8100000000000001 108.468 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 0.47999999999999998 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.57999999999999996 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.3899999999999999 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 0.81999999999999995 110.381 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 0.98999999999999999 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.55000000000000004 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.5899999999999999 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2000000000000002 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 1.79 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 0.64000000000000001 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.57999999999999996 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.62 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.52000000000000002 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 1.29 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 0.55000000000000004 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 1.8899999999999999 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 0.53000000000000003 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 0.42999999999999999 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.3100000000000001 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.3500000000000001 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.1600000000000001 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 0.59999999999999998 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.28 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 0.57999999999999996 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 0.78000000000000003 111.038 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 0.85999999999999999 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 0.79000000000000004 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 0.70999999999999996 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.0499999999999998 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.5900000000000001 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 1.8899999999999999 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.3100000000000001 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.28 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.62 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.46999999999999997 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 0.56000000000000005 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.47999999999999998 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 0.44 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 1.4199999999999999 109.735 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 0.60999999999999999 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 0.64000000000000001 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2000000000000002 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.81999999999999995 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 1.27 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 0.91000000000000003 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 1.73 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.04 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.03 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.26 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.8300000000000001 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.5800000000000001 109.385 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.7999999999999998 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.02 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.0600000000000001 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.3900000000000001 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2000000000000002 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.0899999999999999 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 0.85999999999999999 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 0.90000000000000002 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 0.57999999999999996 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.2200000000000002 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.3200000000000001 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 0.5 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.44 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 2.71 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HG2' HH11 ' A' ' 136' ' ' ARG . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.2000000000000002 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.1299999999999999 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 0.54000000000000004 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.3199999999999998 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.484 HD21 HE22 ' A' ' 53' ' ' GLN . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 1.26 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 0.62 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.67000000000000004 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68000000000000005 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 0.77000000000000002 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.3999999999999999 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 0.87 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.3200000000000001 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 0.77000000000000002 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.5700000000000001 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 0.81999999999999995 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 172' ' ' ASN . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 0.81999999999999995 109.701 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.1099999999999999 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.4099999999999999 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 0.56999999999999995 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 0.42999999999999999 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 0.56000000000000005 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 0.54000000000000004 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 0.62 109.998 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 0.80000000000000004 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.3399999999999999 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 0.65000000000000002 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 0.73999999999999999 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.59999999999999998 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 0.63 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 0.5 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 0.51000000000000001 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.1699999999999999 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 0.60999999999999999 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.477 ' O ' HG23 ' A' ' 176' ' ' VAL . 0.7 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.1200000000000001 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.3400000000000001 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 1.97 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 1.8999999999999999 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 172' ' ' ASN . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 0.47999999999999998 108.285 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.3899999999999999 108.28 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.38 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.46000000000000002 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 0.58999999999999997 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 0.67000000000000004 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.2400000000000002 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.1100000000000001 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 1.6299999999999999 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.47 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.2400000000000002 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 2.9199999999999999 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 1.6000000000000001 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 0.92000000000000004 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 1.5900000000000001 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.4199999999999999 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 1.4099999999999999 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 0.85999999999999999 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 0.58999999999999997 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.0600000000000001 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 0.72999999999999998 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.67000000000000004 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 0.64000000000000001 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.58999999999999997 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 0.55000000000000004 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 0.63 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 0.77000000000000002 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.87 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.534 ' HB ' HG23 ' A' ' 208' ' ' VAL . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 0.89000000000000001 108.027 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 0.93000000000000005 113.387 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.6000000000000001 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 0.75 110.435 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.83999999999999997 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 1.6100000000000001 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.2999999999999998 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.76000000000000001 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.0099999999999998 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.1899999999999999 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.3999999999999999 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.3 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 0.53000000000000003 110.131 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.59999999999999998 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 0.56999999999999995 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.2200000000000002 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 9' ' ' PRO . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 0.75 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 0.92000000000000004 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.3599999999999999 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 1.4199999999999999 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 1.97 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 0.65000000000000002 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 0.96999999999999997 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.67000000000000004 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.45 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.81999999999999995 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 233' ' ' ASN . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 1.6200000000000001 110.236 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 2.6000000000000001 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.0600000000000001 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.1399999999999999 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.04 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 2.6000000000000001 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.23 110.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -50.41 -51.35 47.14 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 2.6699999999999999 110.095 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.24 2.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 1.6599999999999999 111.594 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.43 -50.56 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.026 -1.046 . . . . 2.2000000000000002 111.593 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 6.3 tp60 -55.57 -39.19 70.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.848 -1.158 . . . . 3.0 109.565 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -26.33 67.84 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.907 -1.121 . . . . 1.76 108.741 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -69.85 -20.86 63.4 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.289 -0.882 . . . . 2.7799999999999998 108.717 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.05 -50.53 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 2.0600000000000001 109.034 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.74 68.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.298 -0.876 . . . . 2.3999999999999999 108.967 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.5 t -77.3 -34.38 55.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 2.8700000000000001 109.512 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 3.4100000000000001 109.308 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 3.6600000000000001 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.1200000000000001 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.45 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92000000000000004 109.134 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.05 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 0.88 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 0.78000000000000003 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.5 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.85999999999999999 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78000000000000003 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.73999999999999999 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 0.45000000000000001 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.64000000000000001 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.45000000000000001 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 1.8799999999999999 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 0.58999999999999997 111.146 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 0.64000000000000001 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.73999999999999999 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 158' ' ' LEU . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 0.73999999999999999 109.743 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 1.8700000000000001 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.5800000000000001 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.1400000000000001 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.9299999999999999 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 0.68000000000000005 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 0.83999999999999997 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 0.79000000000000004 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.3700000000000001 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 2.6200000000000001 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.3500000000000001 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.3500000000000001 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 0.78000000000000003 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.05 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.4700000000000002 110.329 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 1.46 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.77000000000000002 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.29 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 0.76000000000000001 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 2.6600000000000001 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.75 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 0.82999999999999996 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 0.78000000000000003 108.76 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.56999999999999995 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.515 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 2.8300000000000001 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 0.65000000000000002 109.086 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.5699999999999998 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 0.51000000000000001 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.3600000000000001 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 0.59999999999999998 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 1.3600000000000001 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 54' ' ' LEU . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.3799999999999999 109.271 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 0.59999999999999998 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 0.53000000000000003 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.98999999999999999 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 0.58999999999999997 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 1.8100000000000001 107.707 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.47999999999999998 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.57999999999999996 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.3899999999999999 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.81999999999999995 110.059 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 0.98999999999999999 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.55000000000000004 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.5899999999999999 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2000000000000002 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 1.79 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 0.64000000000000001 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 0.57999999999999996 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.62 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.52000000000000002 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 1.29 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 0.55000000000000004 109.198 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 1.8899999999999999 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 0.53000000000000003 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 0.42999999999999999 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.3100000000000001 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.3500000000000001 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.1600000000000001 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 0.59999999999999998 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.28 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 0.57999999999999996 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 0.78000000000000003 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.85999999999999999 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 0.79000000000000004 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.70999999999999996 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.0499999999999998 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.5900000000000001 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 1.8899999999999999 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.3100000000000001 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.28 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 0.62 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 0.46999999999999997 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.56000000000000005 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 0.47999999999999998 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.44 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 1.4199999999999999 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.60999999999999999 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 0.64000000000000001 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2000000000000002 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.81999999999999995 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 1.27 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 0.91000000000000003 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 1.73 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.04 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.03 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.26 108.488 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.8300000000000001 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.5800000000000001 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.7999999999999998 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.02 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 118' ' ' LEU . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.0600000000000001 109.12 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.3900000000000001 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2000000000000002 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.0899999999999999 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 0.85999999999999999 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 0.90000000000000002 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.3500000000000001 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.57999999999999996 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.2200000000000002 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.3200000000000001 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.5 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.44 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 2.71 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.2000000000000002 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.1299999999999999 108.989 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.54000000000000004 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.3199999999999998 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 1.26 109.194 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.62 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 0.67000000000000004 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68000000000000005 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 0.77000000000000002 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.3999999999999999 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 0.87 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.3200000000000001 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.77000000000000002 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.5700000000000001 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 0.81999999999999995 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.81999999999999995 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.1099999999999999 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.4099999999999999 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 0.56999999999999995 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 158' ' ' LEU . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 0.42999999999999999 107.969 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.539 ' N ' HG22 ' A' ' 157' ' ' ILE . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 0.56000000000000005 109.824 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 0.54000000000000004 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.62 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 0.80000000000000004 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.3399999999999999 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 0.65000000000000002 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 0.73999999999999999 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.59999999999999998 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 0.63 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.5 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 0.51000000000000001 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.1699999999999999 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 0.60999999999999999 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 176' ' ' VAL . 68.8 m-20 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.1200000000000001 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.3400000000000001 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 1.97 109.56 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 1.8999999999999999 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 172' ' ' ASN . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.47999999999999998 108.656 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.3899999999999999 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.38 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.46000000000000002 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 0.58999999999999997 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 0.67000000000000004 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.2400000000000002 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.1100000000000001 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 1.6299999999999999 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.47 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.2400000000000002 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 2.9199999999999999 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 1.6000000000000001 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 0.92000000000000004 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 1.5900000000000001 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.4199999999999999 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 1.4099999999999999 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 0.85999999999999999 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 0.58999999999999997 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.0600000000000001 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 0.72999999999999998 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 0.67000000000000004 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 0.64000000000000001 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.58999999999999997 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 0.55000000000000004 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 220' ' ' LEU . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 0.63 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 0.77000000000000002 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.87 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 208' ' ' VAL . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 0.89000000000000001 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 0.93000000000000005 112.964 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.6000000000000001 113.194 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 0.75 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 0.83999999999999997 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 1.6100000000000001 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.2999999999999998 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 0.76000000000000001 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.0099999999999998 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.1899999999999999 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.3999999999999999 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.3 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 0.53000000000000003 111.238 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 0.59999999999999998 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 202' ' ' ILE . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.56999999999999995 109.046 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.2200000000000002 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 0.75 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 0.92000000000000004 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.3599999999999999 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 1.4199999999999999 109.248 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 1.97 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 0.65000000000000002 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 0.96999999999999997 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 0.67000000000000004 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 1.45 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.81999999999999995 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 1.6200000000000001 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 2.6000000000000001 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.0600000000000001 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.1399999999999999 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.04 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 2.6000000000000001 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.23 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -55.4 -34.52 64.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 2.6699999999999999 108.999 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.4 -56.97 4.26 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.859 . . . . 1.6599999999999999 109.65 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.91 -57.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 2.2000000000000002 110.008 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.471 ' NE2' ' O ' ' A' ' 243' ' ' GLN . 5.6 tp60 -50.0 -59.36 3.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 3.0 109.881 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.23 -24.32 67.82 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.475 -0.765 . . . . 1.76 110.999 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.73 -23.71 67.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.59 -1.263 . . . . 2.7799999999999998 107.59 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.84 -52.98 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.81 -0.811 . . . . 2.0600000000000001 108.81 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.83 -31.97 63.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.099 -1.074 . . . . 2.3999999999999999 108.099 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.0 p -79.38 -22.83 43.83 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.716 -0.615 . . . . 2.8700000000000001 109.58 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.857 . . . . 3.4100000000000001 108.992 -179.452 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 3.6600000000000001 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.1200000000000001 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.45 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92000000000000004 108.181 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.05 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.88 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 0.78000000000000003 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.5 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.85999999999999999 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78000000000000003 110.69 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 0.73999999999999999 109.725 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 0.45000000000000001 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.64000000000000001 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.45000000000000001 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 1.8799999999999999 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.58999999999999997 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 0.64000000000000001 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.73999999999999999 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 0.73999999999999999 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 1.8700000000000001 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.5800000000000001 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.1400000000000001 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.9299999999999999 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 0.68000000000000005 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 0.83999999999999997 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.79000000000000004 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.3700000000000001 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 2.6200000000000001 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.3500000000000001 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.3500000000000001 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.542 HD13 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 0.78000000000000003 110.154 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.05 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.4700000000000002 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 1.46 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 0.77000000000000002 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.29 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HG3' HD13 ' A' ' 31' ' ' ILE . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 0.76000000000000001 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 2.6600000000000001 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.75 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 0.82999999999999996 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 0.78000000000000003 107.999 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.56999999999999995 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 2.8300000000000001 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 0.65000000000000002 108.477 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.5699999999999998 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 0.51000000000000001 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.3600000000000001 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 0.59999999999999998 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 1.3600000000000001 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.3799999999999999 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.59999999999999998 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.53000000000000003 109.107 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 0.98999999999999999 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 0.58999999999999997 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 1.8100000000000001 108.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 0.47999999999999998 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.57999999999999996 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.3899999999999999 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 0.81999999999999995 110.227 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 0.98999999999999999 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.55000000000000004 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.5899999999999999 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2000000000000002 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 1.79 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 0.64000000000000001 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.57999999999999996 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.62 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.52000000000000002 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 1.29 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 0.55000000000000004 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 1.8899999999999999 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 0.53000000000000003 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 0.42999999999999999 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.3100000000000001 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.3500000000000001 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.1600000000000001 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 0.59999999999999998 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.28 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 0.57999999999999996 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 0.85999999999999999 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.79000000000000004 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 0.70999999999999996 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.0499999999999998 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.5900000000000001 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 1.8899999999999999 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.3100000000000001 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.28 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 0.62 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.46999999999999997 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 0.56000000000000005 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 0.47999999999999998 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 0.44 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 1.4199999999999999 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 0.60999999999999999 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 0.64000000000000001 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2000000000000002 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.81999999999999995 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 1.27 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 0.91000000000000003 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 1.73 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.04 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.03 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.26 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.8300000000000001 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.5800000000000001 110.059 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.7999999999999998 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.02 109.988 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.0600000000000001 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.3900000000000001 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2000000000000002 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.0899999999999999 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 0.85999999999999999 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 0.90000000000000002 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.3500000000000001 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.57999999999999996 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.2200000000000002 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.3200000000000001 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.5 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.44 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 2.71 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 136' ' ' ARG . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.2000000000000002 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.1299999999999999 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.54000000000000004 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.3199999999999998 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.405 ' N ' ' OD1' ' A' ' 140' ' ' ASN . 5.6 m-20 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 1.26 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.62 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.67000000000000004 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68000000000000005 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 0.77000000000000002 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.3999999999999999 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 0.87 109.127 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.3200000000000001 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.77000000000000002 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.5700000000000001 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 0.81999999999999995 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 0.81999999999999995 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.1099999999999999 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.4099999999999999 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 0.56999999999999995 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 0.42999999999999999 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 0.56000000000000005 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 0.54000000000000004 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.62 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 0.80000000000000004 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.3399999999999999 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 0.65000000000000002 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 0.73999999999999999 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.59999999999999998 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 0.63 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 0.5 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 0.51000000000000001 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.1699999999999999 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 176' ' ' VAL . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.60999999999999999 109.117 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.1200000000000001 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.3400000000000001 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 1.97 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 1.8999999999999999 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 0.47999999999999998 108.366 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.3899999999999999 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.38 109.245 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.46000000000000002 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 0.58999999999999997 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.67000000000000004 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.2400000000000002 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.1100000000000001 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 1.6299999999999999 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.47 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.2400000000000002 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 2.9199999999999999 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 1.6000000000000001 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.92000000000000004 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.5900000000000001 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.4199999999999999 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 1.4099999999999999 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 0.85999999999999999 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 0.58999999999999997 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.0600000000000001 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 0.72999999999999998 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 0.67000000000000004 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 0.64000000000000001 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.58999999999999997 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 0.55000000000000004 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 0.63 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 0.77000000000000002 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.87 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 0.89000000000000001 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 0.93000000000000005 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.6000000000000001 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 0.75 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 0.83999999999999997 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 1.6100000000000001 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.2999999999999998 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 0.76000000000000001 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.0099999999999998 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 7.1 m-80 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.1899999999999999 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.3999999999999999 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.3 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 0.53000000000000003 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 0.56999999999999995 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.2200000000000002 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 0.75 110.698 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 0.92000000000000004 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.3599999999999999 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 1.4199999999999999 109.859 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 1.97 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 0.65000000000000002 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 0.96999999999999997 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 0.67000000000000004 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.8 t30 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 1.45 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.81999999999999995 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 1.6200000000000001 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 2.6000000000000001 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.0600000000000001 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.1399999999999999 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.04 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 2.6000000000000001 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.23 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.87 -32.89 69.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 2.6699999999999999 109.868 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.4 -52.95 8.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 1.6599999999999999 110.73 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.38 -56.78 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.001 -1.062 . . . . 2.2000000000000002 110.404 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.2 tp60 -50.46 -57.48 7.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.271 -0.893 . . . . 3.0 110.135 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.93 -23.2 67.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.439 -0.788 . . . . 1.76 110.942 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.34 -25.78 67.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.304 -1.369 . . . . 2.7799999999999998 107.304 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.32 -47.3 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.967 -1.123 . . . . 2.0600000000000001 107.967 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.98 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.259 -1.015 . . . . 2.3999999999999999 108.259 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.8 t -75.17 -22.73 57.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.873 -0.788 . . . . 2.8700000000000001 108.873 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.465 -0.772 . . . . 3.4100000000000001 109.155 179.768 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 3.6600000000000001 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.1200000000000001 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.45 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92000000000000004 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 5' ' ' ILE . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.05 108.785 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 0.88 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 0.78000000000000003 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.5 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.85999999999999999 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78000000000000003 110.07 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 0.73999999999999999 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 0.45000000000000001 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.64000000000000001 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.45000000000000001 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 1.8799999999999999 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.58999999999999997 111.091 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 0.64000000000000001 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 0.73999999999999999 110.829 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 0.73999999999999999 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 1.8700000000000001 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.5800000000000001 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.1400000000000001 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.9299999999999999 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 0.68000000000000005 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 0.83999999999999997 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 0.79000000000000004 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.3700000000000001 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.507 ' HG2' HH11 ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 2.6200000000000001 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.3500000000000001 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.3500000000000001 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.414 HD13 ' HG3' ' A' ' 39' ' ' GLU . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 0.78000000000000003 110.52 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.04 109.015 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.05 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.4700000000000002 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 1.46 108.754 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.29 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 31' ' ' ILE . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.76000000000000001 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 2.6600000000000001 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.75 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 0.82999999999999996 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 0.78000000000000003 108.026 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.56999999999999995 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 2.8300000000000001 108.737 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 0.65000000000000002 107.996 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.5699999999999998 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.069 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.3600000000000001 107.812 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 0.59999999999999998 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 1.3600000000000001 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' LYS . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.3799999999999999 109.217 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 0.59999999999999998 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 0.53000000000000003 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' LEU . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 0.98999999999999999 110.269 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 0.58999999999999997 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 1.8100000000000001 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 0.47999999999999998 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.57999999999999996 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.3899999999999999 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.81999999999999995 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 0.98999999999999999 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.55000000000000004 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.5899999999999999 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2000000000000002 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 1.79 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.64000000000000001 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.57999999999999996 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.62 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.52000000000000002 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 1.29 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.55000000000000004 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 1.8899999999999999 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 0.53000000000000003 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 0.42999999999999999 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.3100000000000001 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.3500000000000001 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.1600000000000001 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 0.59999999999999998 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.28 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 0.57999999999999996 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 0.78000000000000003 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 0.85999999999999999 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 0.79000000000000004 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 0.70999999999999996 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.0499999999999998 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.5900000000000001 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 1.8899999999999999 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.3100000000000001 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.28 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 0.62 109.816 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.46999999999999997 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 0.56000000000000005 110.191 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.47999999999999998 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.44 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.4199999999999999 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 0.60999999999999999 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.538 HG21 ' HA3' ' A' ' 134' ' ' GLY . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 0.64000000000000001 109.636 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2000000000000002 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.81999999999999995 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 1.27 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 0.91000000000000003 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 1.73 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.04 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.03 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.26 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.8300000000000001 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.5800000000000001 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.7999999999999998 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.02 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.0600000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.3900000000000001 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2000000000000002 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.0899999999999999 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 0.85999999999999999 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 0.90000000000000002 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.3500000000000001 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 0.57999999999999996 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.2200000000000002 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.3200000000000001 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 0.5 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.538 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.44 109.152 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 2.71 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.2000000000000002 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.1299999999999999 109.107 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 0.54000000000000004 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.3199999999999998 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 1.26 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.62 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 0.67000000000000004 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68000000000000005 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 0.77000000000000002 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.3999999999999999 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 146' ' ' ILE . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 0.87 109.032 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.3200000000000001 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 0.77000000000000002 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.5700000000000001 109.136 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 0.81999999999999995 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.81999999999999995 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.1099999999999999 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.4099999999999999 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.56999999999999995 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 0.42999999999999999 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 0.56000000000000005 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 0.54000000000000004 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 0.62 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 0.80000000000000004 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.3399999999999999 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 0.65000000000000002 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.73999999999999999 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.59999999999999998 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.63 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.5 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.51000000000000001 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.1699999999999999 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 0.60999999999999999 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.1200000000000001 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.3400000000000001 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 1.97 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 1.8999999999999999 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 178' ' ' GLY . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.47999999999999998 110.103 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 176' ' ' VAL . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.3899999999999999 110.532 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.38 110.131 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.46000000000000002 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.512 ' CG2' HG21 ' A' ' 205' ' ' THR . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 0.58999999999999997 107.598 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 0.67000000000000004 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.2400000000000002 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.1100000000000001 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 1.6299999999999999 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.2400000000000002 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 2.9199999999999999 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 1.6000000000000001 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 0.92000000000000004 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 1.5900000000000001 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.4199999999999999 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 1.4099999999999999 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 0.85999999999999999 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.0600000000000001 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.72999999999999998 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 0.67000000000000004 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 0.64000000000000001 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.58999999999999997 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 0.55000000000000004 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 0.63 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 0.77000000000000002 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.87 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.512 HG21 ' CG2' ' A' ' 180' ' ' ILE . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 0.89000000000000001 108.551 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 0.93000000000000005 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.6000000000000001 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 0.75 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.83999999999999997 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 1.6100000000000001 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.2999999999999998 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 0.76000000000000001 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.0099999999999998 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.1899999999999999 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.3999999999999999 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.3 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 0.53000000000000003 109.97 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.402 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 0.59999999999999998 108.107 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 0.56999999999999995 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.2200000000000002 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 0.75 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 0.92000000000000004 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.3599999999999999 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 1.4199999999999999 109.165 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 53.5 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 1.97 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 0.65000000000000002 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 0.96999999999999997 109.712 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.67000000000000004 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 1.45 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.81999999999999995 111.688 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 1.6200000000000001 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 2.6000000000000001 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.0600000000000001 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.1399999999999999 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.04 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 2.6000000000000001 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.23 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -58.09 -25.72 61.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 2.6699999999999999 109.565 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.07 -62.05 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 1.6599999999999999 109.864 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.5 t -62.7 -51.05 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.095 -1.003 . . . . 2.2000000000000002 109.833 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -48.42 -59.01 3.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 3.0 109.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -63.62 -23.38 67.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 1.76 110.551 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -66.31 -25.03 66.65 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.832 -1.168 . . . . 2.7799999999999998 107.973 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.78 -53.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.713 -0.847 . . . . 2.0600000000000001 108.713 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.49 72.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.836 -0.802 . . . . 2.3999999999999999 108.836 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.2 p -74.45 -21.45 59.59 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.47 -0.769 . . . . 2.8700000000000001 109.158 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.49 -0.756 . . . . 3.4100000000000001 108.998 -179.702 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 3.6600000000000001 109.593 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.1200000000000001 109.18 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.45 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92000000000000004 108.293 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.05 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 0.88 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 0.78000000000000003 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.5 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.85999999999999999 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78000000000000003 109.92 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 0.73999999999999999 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 0.45000000000000001 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.64000000000000001 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.45000000000000001 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 1.8799999999999999 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 0.58999999999999997 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 0.64000000000000001 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 0.73999999999999999 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 0.73999999999999999 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' CB ' ' NZ ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 1.8700000000000001 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.5800000000000001 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.1400000000000001 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.9299999999999999 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 0.68000000000000005 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 0.83999999999999997 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.79000000000000004 109.386 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.3700000000000001 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 2.6200000000000001 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.3500000000000001 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.3500000000000001 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.78000000000000003 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.04 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.05 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.4700000000000002 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 1.46 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.77000000000000002 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.29 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.76000000000000001 109.798 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 2.6600000000000001 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 89' ' ' ILE . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.75 109.472 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.82999999999999996 109.236 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 0.78000000000000003 108.971 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.56999999999999995 108.607 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 2.8300000000000001 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.65000000000000002 108.261 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.5699999999999998 109.249 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.51000000000000001 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.3600000000000001 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 0.59999999999999998 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 1.3600000000000001 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.3799999999999999 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.59999999999999998 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.53000000000000003 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 0.98999999999999999 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 0.58999999999999997 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 1.8100000000000001 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 0.47999999999999998 108.396 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.57999999999999996 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.3899999999999999 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 0.81999999999999995 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 0.98999999999999999 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.55000000000000004 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.5899999999999999 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2000000000000002 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 1.79 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.64000000000000001 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 0.57999999999999996 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.62 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.52000000000000002 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 1.29 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 0.55000000000000004 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 1.8899999999999999 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 0.53000000000000003 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 0.42999999999999999 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.3100000000000001 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.3500000000000001 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.1600000000000001 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 0.59999999999999998 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.28 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 0.57999999999999996 108.196 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.85999999999999999 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.79000000000000004 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 0.70999999999999996 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.0499999999999998 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.5900000000000001 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 1.8899999999999999 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.3100000000000001 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 0.62 109.707 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.46999999999999997 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 0.56000000000000005 110.442 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.47999999999999998 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.44 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 1.4199999999999999 109.448 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 0.60999999999999999 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.64000000000000001 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2000000000000002 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.81999999999999995 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 1.27 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 0.91000000000000003 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 1.73 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.04 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.03 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.26 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.8300000000000001 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.5800000000000001 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.7999999999999998 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.02 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.0600000000000001 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.3900000000000001 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2000000000000002 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.0899999999999999 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 0.85999999999999999 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 0.90000000000000002 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.3500000000000001 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.57999999999999996 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.2200000000000002 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.3200000000000001 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.5 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.44 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 2.71 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.2000000000000002 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.1299999999999999 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 0.54000000000000004 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.3199999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 1.26 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 0.62 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.67000000000000004 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68000000000000005 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 0.77000000000000002 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.3999999999999999 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.87 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.3200000000000001 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.5700000000000001 109.495 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 0.81999999999999995 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.81999999999999995 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.1099999999999999 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.4099999999999999 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 0.56999999999999995 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 0.42999999999999999 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 0.56000000000000005 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.54000000000000004 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 0.62 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 0.80000000000000004 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.3399999999999999 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 0.65000000000000002 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 0.73999999999999999 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.59999999999999998 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 0.63 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.5 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.51000000000000001 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.1699999999999999 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.60999999999999999 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.1200000000000001 108.376 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.3400000000000001 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 1.97 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 1.8999999999999999 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 0.47999999999999998 108.472 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.3899999999999999 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.38 108.908 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.46000000000000002 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.481 HG23 HG21 ' A' ' 205' ' ' THR . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 0.58999999999999997 106.741 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 0.67000000000000004 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.2400000000000002 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.1100000000000001 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 1.6299999999999999 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.47 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.2400000000000002 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.9199999999999999 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 1.6000000000000001 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 0.92000000000000004 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 1.5900000000000001 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.4199999999999999 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 1.4099999999999999 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 0.85999999999999999 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 0.58999999999999997 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.0600000000000001 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.72999999999999998 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 0.67000000000000004 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 0.64000000000000001 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.58999999999999997 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 0.55000000000000004 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 0.63 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 0.77000000000000002 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.87 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.481 HG21 HG23 ' A' ' 180' ' ' ILE . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 0.89000000000000001 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 0.93000000000000005 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.6000000000000001 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 0.75 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.83999999999999997 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.583 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 1.6100000000000001 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 210' ' ' SER . 39.3 mm-40 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.2999999999999998 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 0.76000000000000001 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.0099999999999998 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.3999999999999999 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.3 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 0.53000000000000003 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 0.59999999999999998 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.56999999999999995 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.2200000000000002 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 0.75 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 0.92000000000000004 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.3599999999999999 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 1.4199999999999999 109.333 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 1.97 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 0.65000000000000002 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 0.96999999999999997 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 0.67000000000000004 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 1.45 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.81999999999999995 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 1.6200000000000001 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 2.6000000000000001 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.0600000000000001 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.1399999999999999 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.04 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 2.6000000000000001 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.23 109.167 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.41 ' HG3' ' NH1' ' A' ' 240' ' ' ARG . 13.8 mmm-85 -51.03 -41.73 60.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 2.6699999999999999 109.648 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.93 -61.67 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 1.6599999999999999 110.808 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.6 t -67.96 -49.19 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.038 -1.039 . . . . 2.2000000000000002 110.942 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.3 tt0 -54.14 -44.35 71.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.822 -1.174 . . . . 3.0 110.406 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.24 -29.76 71.03 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.866 -1.146 . . . . 1.76 109.926 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -68.59 -19.81 64.48 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.95 -1.093 . . . . 2.7799999999999998 108.702 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.45 -43.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 2.0600000000000001 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.76 69.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 2.3999999999999999 109.301 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.2 t -75.66 -24.88 56.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.317 -0.864 . . . . 2.8700000000000001 109.659 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 3.4100000000000001 110.302 -179.618 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 3.66 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.12 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.45 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 5' ' ' ILE . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.05 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.88 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.78 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.5 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.86 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78 109.475 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 0.74 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 0.45 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.64 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.45 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 1.88 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 0.59 111.188 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 0.64 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 0.74 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 160' ' ' ALA . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 0.74 110.588 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 1.87 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.58 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.14 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.93 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.448 ' CD1' ' HZ3' ' A' ' 135' ' ' LYS . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.68 109.394 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 0.84 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 0.79 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.37 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 2.62 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.35 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.35 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 0.78 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.04 109.53 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.05 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.47 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 1.46 108.803 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.77 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.29 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.76 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 2.66 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.75 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.83 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 0.78 108.266 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.57 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 2.83 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 0.65 108.151 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.57 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.51 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.36 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 0.6 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 1.36 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.38 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.6 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.53 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.99 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 0.59 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 1.81 107.934 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 0.48 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.58 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.39 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.82 110.089 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 0.99 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.55 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.59 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 1.79 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 0.64 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.58 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.62 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.52 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 1.29 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 0.55 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 1.89 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 0.53 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 0.43 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.31 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.35 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.16 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 0.6 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.28 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 0.58 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 0.78 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 0.86 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.79 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 0.71 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.05 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.59 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 1.89 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.31 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.28 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.62 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 0.47 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 0.56 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.48 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.44 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 1.42 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.61 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.64 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.82 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 1.27 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 0.91 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 1.73 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.04 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.03 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.26 108.555 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.83 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.58 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.8 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.02 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 118' ' ' LEU . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.06 109.184 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.39 108.431 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.09 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 0.86 107.97 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 0.9 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.35 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.58 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.22 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.32 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 0.5 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.44 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 2.71 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.2 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.13 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.54 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.451 ' NH2' ' NZ ' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.32 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 1.26 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.62 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.67 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 0.77 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.4 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 0.87 109.302 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.793 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.32 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.77 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.57 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 0.82 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 0.82 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.11 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.41 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 0.57 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 158' ' ' LEU . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 0.43 107.464 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 0.56 109.588 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 0.54 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 0.62 109.615 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 0.8 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.34 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 0.65 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.74 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.6 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.63 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.5 109.561 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 0.51 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.17 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 0.61 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.12 109.803 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.34 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 1.9 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 0.48 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.39 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.38 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.46 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.604 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 0.59 107.462 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 0.67 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.24 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.11 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 1.63 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.24 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 2.92 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 1.6 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.424 ' CD2' HG21 ' A' ' 168' ' ' THR . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.92 109.522 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 1.59 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.42 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 1.41 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 0.86 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 0.59 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.06 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 0.73 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.67 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 0.64 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.59 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 0.55 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 0.63 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 0.77 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.87 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.604 HG21 ' CG2' ' A' ' 180' ' ' ILE . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 0.89 108.361 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 0.93 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.6 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 0.75 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.84 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 1.61 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.3 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 0.76 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.01 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.19 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.4 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.3 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 0.53 110.426 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 0.6 107.429 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 0.57 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.22 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 0.75 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 0.92 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.36 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 1.42 109.301 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 1.97 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 0.65 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 0.97 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 0.67 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 1.45 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.465 ' HG3' HD12 ' A' ' 219' ' ' ILE . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.82 111.495 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 1.62 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 2.6 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.06 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.14 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.04 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 2.6 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.23 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 2.67 109.204 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 3.66 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.12 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.45 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.05 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.88 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 0.78 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.5 108.805 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.86 113.847 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.768 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78 109.628 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 0.74 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 0.45 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.64 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.45 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 1.88 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.59 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 0.64 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 0.74 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 0.74 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 1.87 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.58 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.14 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.93 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.68 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 0.84 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.79 108.882 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.37 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 2.62 108.422 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.35 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.35 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 0.78 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.04 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.05 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.47 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 1.46 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 0.77 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.29 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.76 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 2.66 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.75 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 0.83 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 0.78 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.57 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 2.83 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 0.65 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.57 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 0.51 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.36 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 0.6 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 1.36 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.38 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.6 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 0.53 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.99 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 0.59 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 1.81 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 0.48 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.58 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.39 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 0.82 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 0.99 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.55 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.59 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 1.79 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.64 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 0.58 109.758 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.62 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.52 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 19.3 m170 -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 1.29 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.55 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 1.89 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 0.53 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 0.43 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.31 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.35 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.16 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 0.6 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.28 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 0.58 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 0.78 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 0.86 110.093 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 0.79 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 0.71 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.05 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.59 112.267 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 1.89 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.31 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 0.62 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.47 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 0.56 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.48 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.44 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 1.42 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.61 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 0.64 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2 110.312 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.82 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 1.27 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 0.91 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 1.73 109.651 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.04 110.079 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.03 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 123' ' ' LEU . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.26 108.339 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.83 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.58 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.8 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.02 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 118' ' ' LEU . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.06 110.077 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.39 108.342 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.09 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 0.86 107.626 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 0.9 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.35 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 0.58 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 131' ' ' ARG . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.22 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.32 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 0.5 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.44 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 2.71 109.144 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.2 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.13 109.13 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.54 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.32 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.6 m120 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 1.26 109.171 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.62 109.167 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 0.67 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 0.77 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.4 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 0.87 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.32 109.354 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.77 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.57 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 0.82 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.82 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.11 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.41 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.57 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 158' ' ' LEU . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 0.43 108.297 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 0.56 109.489 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 0.54 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.62 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 0.8 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.34 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 0.65 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.74 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.6 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 0.63 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.5 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 0.51 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.17 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 0.61 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.12 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.34 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 1.97 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 1.9 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.48 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.39 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.38 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.46 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 0.59 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 0.67 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.24 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.11 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 1.63 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.47 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.24 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 2.92 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 1.6 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.92 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 1.59 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.42 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 1.41 109.746 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 0.86 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 0.59 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 195' ' ' ARG . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.06 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 0.73 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 0.67 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 0.64 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.59 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 0.55 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 0.63 107.234 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 0.77 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.87 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 181' ' ' THR . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 0.89 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 0.93 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.6 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 0.75 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 0.84 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 1.61 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.3 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 0.76 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.01 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.19 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.4 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 0.53 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 0.6 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.57 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.22 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 0.75 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 0.92 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 224' ' ' ASN . 2.2 t-20 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.36 107.484 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 1.42 109.193 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.97 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.65 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 0.97 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 0.67 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.439 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.2 OUTLIER 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 1.45 110.128 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.82 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 1.62 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 2.6 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.06 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.14 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.04 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 2.6 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.23 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 2.67 109.384 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 3.66 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.12 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.45 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.05 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 0.88 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.78 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.5 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.86 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.817 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78 109.091 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 0.74 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.45 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.64 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.45 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 1.88 109.888 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.59 110.801 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 0.64 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.74 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 0.74 110.191 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 1.87 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.58 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.93 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.68 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 0.84 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.79 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.37 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 2.62 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.35 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.35 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 0.78 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.04 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.05 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.47 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 0.77 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.29 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.76 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 2.66 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.75 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 0.83 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 0.78 107.995 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.57 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 2.83 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 0.65 107.787 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.57 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.51 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.36 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 0.6 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.724 HE22 ' ND2' ' A' ' 140' ' ' ASN . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 1.36 109.477 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.38 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.6 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 0.53 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 0.99 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.59 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 1.81 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 0.48 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.58 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.39 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 0.82 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.99 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.55 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 65' ' ' PHE . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.59 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 1.79 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.64 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 0.58 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.62 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.52 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 1.29 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 0.55 108.263 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 1.89 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 0.53 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 0.43 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.31 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.35 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.16 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 0.6 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 0.58 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 0.78 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.86 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.79 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.71 110.12 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.05 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.59 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 1.89 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.31 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.28 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 0.62 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.47 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 0.56 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 0.48 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 0.44 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 1.42 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 107' ' ' VAL . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 0.61 110.02 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.64 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.82 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 1.27 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 0.91 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 1.73 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.04 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.03 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 123' ' ' LEU . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.26 108.534 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.83 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.58 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.8 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.02 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 118' ' ' LEU . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.06 109.517 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.39 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.09 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 0.9 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.35 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 0.58 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.22 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.32 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 0.5 109.432 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.44 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 2.71 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.2 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.13 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 0.54 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.32 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.724 ' ND2' HE22 ' A' ' 53' ' ' GLN . 13.5 m120 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 1.26 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 0.62 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 0.67 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 0.77 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.515 ' CB ' ' ND2' ' A' ' 140' ' ' ASN . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.4 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 0.87 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.32 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 0.77 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.57 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.82 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 0.82 109.573 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.11 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.41 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 0.57 109.179 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 0.43 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 0.56 109.983 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 0.54 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 0.62 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 0.8 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.34 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.65 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.74 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.6 113.158 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.63 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.5 109.367 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.51 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.17 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 0.61 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.691 HD22 ' N ' ' A' ' 172' ' ' ASN . 0.0 OUTLIER -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.12 109.989 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.34 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 1.97 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 1.9 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 172' ' ' ASN . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 0.48 109.386 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.39 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.46 110.218 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.486 ' CG2' HG21 ' A' ' 205' ' ' THR . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 0.59 107.383 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 0.67 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.24 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.11 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 1.63 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.47 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.24 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 2.92 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 1.6 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.92 109.174 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 1.59 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.42 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 1.41 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 0.86 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 0.59 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.06 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 0.73 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.67 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 0.64 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.59 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 0.55 111.664 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 6' ' ' LEU . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 0.63 106.92 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 0.77 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.87 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.486 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 0.89 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 0.93 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.6 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 0.75 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 0.84 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 1.61 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.3 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 0.76 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.01 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 215' ' ' ASP . 0.4 OUTLIER -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.19 109.69 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.635 ' H ' HD22 ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.4 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.3 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.582 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 0.53 110.379 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 0.6 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 0.57 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.22 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 0.75 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 0.92 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.36 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 1.42 109.791 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 1.97 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 228' ' ' TYR . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 0.65 109.096 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 227' ' ' VAL . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 0.97 109.217 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 0.67 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 1.45 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 236' ' ' ILE . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.82 112.214 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 1.62 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 2.6 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.06 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.14 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 231' ' ' PRO . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.04 109.193 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 2.6 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.23 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 2.67 108.263 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 3.66 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.12 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.45 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.05 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 0.88 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 0.78 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.5 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.86 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.838 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78 109.218 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 0.74 109.301 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 0.45 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.64 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.45 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HZ3' ' HA ' ' A' ' 215' ' ' ASP . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 1.88 110.039 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.59 111.229 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 0.64 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 0.74 111.309 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' ALA . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 0.74 109.531 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 1.87 109.271 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.58 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.14 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.93 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.68 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 0.84 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 0.79 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.37 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 2.62 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.35 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.35 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.78 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.04 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.05 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.47 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 1.46 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.77 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.29 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.76 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 2.66 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.75 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 0.83 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.57 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.434 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 2.83 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 0.65 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.57 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.51 109.371 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.36 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 0.6 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 1.36 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.38 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 0.6 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.53 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.99 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 0.59 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 1.81 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 0.48 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.58 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.39 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 0.82 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 0.99 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.55 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.59 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 1.79 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 0.64 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 0.58 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.62 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.52 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 1.29 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 0.55 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 1.89 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 0.53 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 0.43 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.31 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.16 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 0.6 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.28 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.78 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 0.86 110.449 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 0.79 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 0.71 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.05 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.59 112.048 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 1.89 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.31 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.28 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 0.62 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.47 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 0.56 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 0.48 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.44 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 1.42 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 107' ' ' VAL . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 0.61 109.978 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.64 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.82 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 1.27 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 0.91 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 1.73 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.04 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.03 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 123' ' ' LEU . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.26 108.386 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.83 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.58 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.8 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.02 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 118' ' ' LEU . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.06 109.82 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.39 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.09 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 0.86 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 0.9 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.35 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.58 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.22 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.32 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.5 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.44 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 2.71 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.2 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.13 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 0.54 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.32 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 1.26 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 0.62 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 0.67 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 0.77 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.4 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 0.87 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.888 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.32 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 0.77 109.16 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.57 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 0.82 109.58 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.82 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.11 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.41 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 0.57 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 0.43 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 0.56 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 0.54 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.62 109.434 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 0.8 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.34 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 0.65 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 0.74 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.6 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.63 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.5 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 0.51 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.17 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.61 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.12 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.34 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 1.97 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 1.9 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.39 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.38 109.081 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.46 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 0.59 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 0.67 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.24 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.11 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 1.63 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.47 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.24 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 2.92 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 1.6 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 192' ' ' ILE . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 0.92 110.114 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 1.59 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.42 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 189' ' ' HIS . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 1.41 109.649 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 0.86 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 0.59 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.06 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.73 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.67 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 0.64 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.59 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 0.55 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 203' ' ' VAL . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 0.63 107.205 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 0.77 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.87 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 0.89 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 0.93 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.6 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 0.75 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.84 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 1.61 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.3 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 0.76 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.01 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.19 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.4 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.3 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 16' ' ' ALA . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 0.53 109.906 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 0.6 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 0.57 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.22 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 0.75 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 0.92 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.36 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 1.42 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 228' ' ' TYR . 52.5 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 1.97 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 0.65 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 226' ' ' GLN . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 0.97 109.988 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 0.67 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 1.45 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.82 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 233' ' ' ASN . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 1.62 109.26 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.437 ' H ' HG22 ' A' ' 232' ' ' THR . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 2.6 109.949 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.06 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.14 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.04 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 2.6 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.23 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 2.67 109.602 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 3.66 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.12 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.45 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.05 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.88 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 0.78 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.5 108.931 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.86 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78 109.971 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 0.74 109.267 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 0.45 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.64 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.45 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 1.88 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 0.59 111.579 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 0.64 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 0.74 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 0.74 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 1.87 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.58 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.14 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.93 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.68 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 0.84 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 0.79 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.37 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 2.62 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.35 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.35 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.78 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.04 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.05 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.47 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 1.46 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.77 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.29 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 0.76 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 2.66 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.75 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.83 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 0.78 108.451 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.57 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 2.83 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 0.65 108.44 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.57 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 0.51 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.36 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 0.6 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 1.36 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.38 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.6 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.527 HD12 HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 0.53 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.99 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 0.59 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 1.81 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 0.48 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.58 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.39 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 0.82 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 0.99 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.55 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.59 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 1.79 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 0.64 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 0.58 109.928 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.62 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.52 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 17.0 m170 -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 1.29 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 0.55 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 1.89 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.53 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 0.43 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.31 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.35 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.16 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 0.6 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.28 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 0.58 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 0.78 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.86 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.79 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 0.71 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.05 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.59 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 1.89 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.31 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.28 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 0.62 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 0.47 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 0.56 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.48 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.44 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 1.42 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 0.61 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.64 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.82 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 1.27 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.91 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 1.73 110.201 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.04 110.244 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.411 HD21 HH21 ' A' ' 126' ' ' ARG . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.03 108.917 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.26 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.83 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.58 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.8 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.02 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.06 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.39 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.411 HH21 HD21 ' A' ' 115' ' ' LEU . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.09 106.341 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 0.86 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 0.9 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.35 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 0.58 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.22 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.32 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.5 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.44 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HE2' HH11 ' A' ' 139' ' ' ARG . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 2.71 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.527 HH12 HD12 ' A' ' 57' ' ' ILE . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.2 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.13 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.412 HH11 ' HE2' ' A' ' 135' ' ' LYS . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.32 110.347 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 4.8 m120 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 1.26 109.155 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 0.62 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.67 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 0.77 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.4 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 0.87 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 147' ' ' ILE . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.32 108.975 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 0.77 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.57 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.82 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' GLN . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 0.82 108.96 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' ILE . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.11 109.334 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.41 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.57 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.43 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 0.56 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.62 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 0.8 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.34 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 0.65 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 0.74 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.6 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 0.63 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 0.5 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 0.51 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.17 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 0.61 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.12 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.34 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 1.97 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 1.9 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 178' ' ' GLY . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 0.48 108.714 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.473 ' N ' HG12 ' A' ' 176' ' ' VAL . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.39 109.785 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.38 109.571 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.46 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 220' ' ' LEU . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 0.59 108.861 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 0.67 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.24 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.11 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 1.63 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.47 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.24 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 2.92 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 1.6 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.92 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 1.59 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.42 110.302 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 1.41 110.989 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 0.86 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 0.59 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.06 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.73 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 0.67 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 0.64 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.59 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 0.55 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.63 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 0.77 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.87 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 0.89 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 0.93 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.6 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 0.75 110.397 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 0.84 110.309 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 1.61 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 210' ' ' SER . 26.9 mm100 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.3 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 0.76 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.01 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.19 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.4 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.3 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 0.53 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 0.6 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 180' ' ' ILE . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.57 108.612 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.22 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 0.75 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 0.92 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.36 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 1.42 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 6.9 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.97 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 0.65 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 0.97 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 0.67 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 1.45 110.094 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.82 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 1.62 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 2.6 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.06 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.14 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.04 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 2.6 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.23 109.901 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 2.67 109.663 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 3.66 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.12 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.45 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92 108.709 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.05 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.88 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 0.78 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.5 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.86 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78 109.801 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 0.74 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 0.45 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.64 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.45 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 1.88 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.59 110.949 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 0.64 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 0.74 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 0.74 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 1.87 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.58 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.14 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.93 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 0.68 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 0.84 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.79 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.37 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 2.62 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.35 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.35 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 0.78 110.145 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.04 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.05 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.47 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 1.46 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.77 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.29 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 0.76 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 2.66 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.75 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 0.83 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 0.78 108.458 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.57 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 2.83 108.87 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 0.65 108.133 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.57 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 0.51 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.36 108.092 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 0.6 109.459 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 1.36 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.38 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.6 109.341 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.53 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.99 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 0.59 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 1.81 107.762 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 0.48 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.58 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.39 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.82 110.081 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.497 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 0.99 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.55 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.59 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 1.79 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.64 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 0.58 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.62 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.52 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 1.29 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 0.55 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 1.89 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 0.53 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 0.43 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.31 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.35 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.16 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.6 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.28 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 0.58 107.789 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 0.78 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.86 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 0.79 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.71 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.05 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.59 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 1.89 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.31 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.28 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.62 109.848 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.47 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 0.56 109.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.48 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 0.44 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 1.42 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.61 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 0.64 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.82 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 1.27 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 0.91 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.73 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.04 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.03 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.26 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.83 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.58 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.8 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.02 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.06 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.39 108.763 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.09 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 0.86 109.228 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.9 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.35 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.58 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.22 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.32 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 0.5 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.44 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 2.71 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.449 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.2 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.13 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 0.54 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.32 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 1.26 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 0.62 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.67 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 0.77 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.4 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 0.87 108.495 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.32 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.77 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.57 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.82 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.82 108.542 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 152' ' ' ILE . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.11 109.645 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.41 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.57 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 158' ' ' LEU . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 0.43 108.164 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 0.56 109.259 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 0.54 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 0.62 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 0.8 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.34 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 0.65 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 0.74 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.6 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.63 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 168' ' ' THR . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.5 110.087 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 0.51 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.17 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 0.61 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.12 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.34 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 1.97 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 1.9 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 172' ' ' ASN . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 0.48 109.209 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.39 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.38 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.46 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 0.59 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.67 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.24 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.11 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 1.63 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.456 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.47 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.24 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.456 ' N ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 2.92 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 1.6 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.92 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 1.59 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.42 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 1.41 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 0.86 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 0.59 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.06 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.73 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.67 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 0.64 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.59 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 0.55 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 0.63 106.708 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 0.77 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.87 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 0.89 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 0.93 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.6 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 0.75 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 0.84 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 1.61 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.3 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 0.76 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.454 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.01 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.19 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CG ' HD22 ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.4 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.3 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 16' ' ' ALA . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 0.53 110.491 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 0.6 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 0.57 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.22 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 0.75 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 0.92 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.36 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.421 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 1.42 109.359 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 1.97 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 0.65 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 0.97 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 0.67 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.415 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 1.45 110.19 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.82 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 1.62 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 2.6 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.06 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.14 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.04 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 2.6 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.23 109.815 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 2.67 109.74 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 3.66 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.12 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.45 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.05 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.88 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.78 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.5 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.86 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 0.74 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.45 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.59 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.64 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.45 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 1.88 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 0.59 111.507 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 0.64 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.74 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 0.74 110.154 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 1.87 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.58 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.14 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.93 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 0.68 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 0.84 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.79 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.37 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 2.62 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.35 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.35 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 39' ' ' GLU . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.78 110.192 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.05 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.47 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 32' ' ' SER . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 1.46 108.871 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 0.77 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.29 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD13 ' A' ' 31' ' ' ILE . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.76 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 2.66 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.75 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.83 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 0.78 107.656 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.57 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 2.83 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 0.65 108.514 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.57 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 0.51 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.36 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 0.6 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 1.36 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.38 108.898 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 0.6 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 0.53 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 0.99 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.59 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 1.81 107.125 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.58 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.39 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.82 109.58 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 0.99 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.55 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.59 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 1.79 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 0.64 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.58 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.62 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.52 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 1.29 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 0.55 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 1.89 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 0.53 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.43 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.31 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.35 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.16 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 0.6 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.28 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 0.58 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 0.78 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.86 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 0.79 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 0.71 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.05 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.59 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 1.89 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.31 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.28 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.62 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 0.47 109.047 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 0.56 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.48 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 0.44 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 1.42 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 0.61 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 0.64 108.457 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.82 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 1.27 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 0.91 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 1.73 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.04 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.03 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.26 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.83 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.58 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.8 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.02 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.06 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.39 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.09 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 0.86 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 0.9 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.35 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.58 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.22 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.32 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.5 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.44 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 2.71 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.2 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.13 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.54 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.32 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 1.26 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 0.62 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.67 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 0.77 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.4 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 0.87 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.32 108.855 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.77 109.326 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.57 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 0.82 108.812 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.446 HD12 HD21 ' A' ' 172' ' ' ASN . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 0.82 109.273 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.11 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.41 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.57 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 0.43 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 0.56 108.617 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 0.54 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 0.62 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 0.8 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.34 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 0.65 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.74 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.6 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.63 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.5 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.51 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.17 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 0.61 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.12 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.34 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 1.97 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 1.9 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 177' ' ' LEU . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 0.48 108.8 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 176' ' ' VAL . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.39 109.734 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.38 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.46 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 0.59 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 0.67 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.24 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.11 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 1.63 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.47 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.24 109.318 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 2.92 109.327 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 1.6 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 0.92 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 1.59 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.42 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 1.41 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 0.86 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 0.59 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.06 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.73 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.67 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 0.64 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.59 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 0.55 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 0.63 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 0.77 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.87 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 0.89 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 0.93 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.6 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 0.75 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.84 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 1.61 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.3 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.76 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.01 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.19 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.4 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.3 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.53 109.224 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 0.6 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 0.57 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.22 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 0.75 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 0.92 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.36 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 1.42 108.433 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 1.97 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 0.65 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.503 ' N ' HG12 ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 0.97 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 0.67 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 1.45 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.82 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.62 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 2.6 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.06 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.14 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.04 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 2.6 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.23 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 2.67 108.948 -179.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 3.66 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.12 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.45 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.05 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 225' ' ' ASN . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 0.88 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 0.78 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.5 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.86 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 0.74 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 0.45 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.64 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.45 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 1.88 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.59 110.773 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 0.64 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.74 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 0.74 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 1.87 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.58 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.14 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.93 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 0.68 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 0.84 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 0.79 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.37 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 2.62 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.35 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.35 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 0.78 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.04 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.05 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.47 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 1.46 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 0.77 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.438 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 13.5 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.29 110.587 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.76 109.341 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' NH2' ' NE2' ' A' ' 38' ' ' GLN . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 2.66 109.051 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.75 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 0.83 109.013 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 0.78 108.236 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.57 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 2.83 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 0.65 108.12 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.57 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.51 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.36 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 0.6 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 1.36 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.38 108.854 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.6 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.53 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 0.99 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 0.59 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 1.81 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 0.48 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.58 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.39 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 0.82 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 0.99 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.55 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.59 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 1.79 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 0.64 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 0.58 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.62 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.52 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 1.29 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 0.55 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 1.89 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 0.53 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 0.43 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.31 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.35 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.16 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 0.6 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.28 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 0.58 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 0.78 110.358 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.86 110.188 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 0.79 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 0.71 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.05 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.59 112.155 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 1.89 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.31 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.28 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.62 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.47 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 0.56 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 0.48 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 0.44 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 1.42 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 0.61 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 0.64 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.82 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 1.27 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 0.91 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 1.73 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.04 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.03 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 123' ' ' LEU . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.83 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.58 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.8 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.02 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 118' ' ' LEU . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.06 109.093 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.39 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.09 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 0.86 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 0.9 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.35 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 0.58 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.22 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.32 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 0.5 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.44 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 2.71 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.2 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.13 108.227 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.54 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.32 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 1.26 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.62 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 0.67 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 0.77 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.4 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 0.87 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.32 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 0.77 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.57 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 0.82 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 0.82 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.11 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.57 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 0.43 108.104 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 0.56 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 0.54 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.62 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 0.8 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.34 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 0.65 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.74 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.6 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 0.63 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 0.5 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 0.51 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.17 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 0.61 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.12 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.34 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 1.97 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 1.9 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 177' ' ' LEU . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 0.48 108.91 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.515 ' N ' HG12 ' A' ' 176' ' ' VAL . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.39 109.637 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.38 109.623 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.46 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 0.59 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 0.67 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.24 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.11 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 1.63 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.484 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.47 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.24 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.484 ' N ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 2.92 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 1.6 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 0.92 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 1.59 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.456 ' HG ' HG11 ' A' ' 203' ' ' VAL . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.42 110.063 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 1.41 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.86 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 0.59 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.06 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.73 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.67 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 0.64 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.59 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 0.55 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 0.63 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 0.77 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.87 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 0.89 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 0.93 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.6 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 0.75 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 0.84 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 1.61 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.3 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 0.76 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.411 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.01 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.19 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.4 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.3 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 0.53 110.496 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 0.6 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.57 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.22 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 0.75 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 0.92 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.36 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 1.42 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 1.97 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 0.65 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 0.97 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 0.67 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 1.45 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.82 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 1.62 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 2.6 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.06 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.14 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.04 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 2.6 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.23 109.217 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 2.67 110.559 -178.774 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.562 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 3.66 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.12 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.45 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 5' ' ' ILE . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.05 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.88 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.78 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.5 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.86 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.696 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78 109.712 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 0.74 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 0.45 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.64 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.45 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 1.88 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.59 111.003 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 0.64 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 0.74 110.162 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 160' ' ' ALA . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 0.74 110.199 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 1.87 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.58 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.14 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.93 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.68 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 0.84 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 0.79 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.37 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.445 HH12 ' HB1' ' A' ' 102' ' ' ALA . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 2.62 109.239 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.35 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.35 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 31' ' ' ILE . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.78 109.962 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.04 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.05 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.47 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.46 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.77 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.29 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.76 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.75 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 0.83 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 0.78 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.57 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 2.83 106.251 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 0.65 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.57 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 0.51 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.36 108.431 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 0.6 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 1.36 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.38 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.6 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.482 HD13 HH12 ' A' ' 136' ' ' ARG . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.53 109.236 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 0.99 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 0.59 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 1.81 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 0.48 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.58 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.39 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.82 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.513 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 0.99 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.55 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.59 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 1.79 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.64 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 0.58 110.001 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.62 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.52 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 29.9 m170 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 1.29 109.785 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 0.55 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 1.89 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 0.53 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 0.43 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.31 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.35 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.16 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 0.6 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.28 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.78 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 0.86 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.79 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 0.71 111.098 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.05 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.59 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 1.89 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.31 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.28 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 0.62 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.47 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB1' HH12 ' A' ' 28' ' ' ARG . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 0.56 110.483 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.48 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.44 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 1.42 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 0.61 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 0.64 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.82 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 1.27 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 0.91 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 1.73 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.04 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.03 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 123' ' ' LEU . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.26 108.913 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.83 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.58 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.8 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.02 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 118' ' ' LEU . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.06 109.416 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.39 109.04 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.09 106.344 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.9 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.35 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 126' ' ' ARG . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.58 108.977 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.22 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.32 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 0.5 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.44 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.532 ' HZ2' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 2.71 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.482 HH12 HD13 ' A' ' 57' ' ' ILE . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.2 108.433 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.13 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.54 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.532 HH11 ' HZ2' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.32 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 1.26 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 0.62 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.67 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 0.77 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.4 109.125 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 0.87 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.32 109.042 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.77 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.57 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 0.82 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.82 109.043 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.406 ' N ' HG22 ' A' ' 152' ' ' ILE . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.11 109.128 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.41 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 0.57 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 0.43 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 0.56 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 0.54 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.62 109.697 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 0.8 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.34 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.65 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 0.74 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.6 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.63 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.5 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.51 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.17 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 0.61 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.12 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.34 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 1.97 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 1.9 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.39 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.38 109.272 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.46 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.572 ' CG2' HG21 ' A' ' 205' ' ' THR . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 0.59 106.771 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 0.67 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.24 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.11 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 1.63 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.47 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.24 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 2.92 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 1.6 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.92 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 1.59 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.42 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.41 110.013 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 0.86 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 0.59 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.518 ' CG ' HH11 ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.06 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 0.73 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.67 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 0.64 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.59 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 0.55 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 0.63 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 0.77 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.87 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.572 HG21 ' CG2' ' A' ' 180' ' ' ILE . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 0.89 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 0.93 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.6 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 0.75 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.84 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 1.61 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.3 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 0.76 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.01 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.19 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.4 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.3 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 0.53 110.551 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 219' ' ' ILE . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 0.6 108.606 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 0.57 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.22 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 0.75 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 0.92 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.36 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 1.42 109.424 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.562 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 22.2 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 1.97 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 0.65 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 0.97 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.67 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 1.45 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.82 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 1.62 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 2.6 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.06 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.14 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.04 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 2.6 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.23 110.015 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 2.67 110.18 -179.411 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 3.66 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.12 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.45 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.05 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 0.88 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 0.78 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.5 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.86 114.455 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 0.74 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 0.45 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.64 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.45 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 1.88 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 0.59 110.645 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 0.64 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 0.74 111.071 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 0.74 109.977 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 1.87 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.58 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.14 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.93 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.68 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 0.84 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 0.79 110.02 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.37 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 2.62 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.35 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.35 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.78 110.27 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.458 ' H ' HE21 ' A' ' 35' ' ' GLN . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.04 109.454 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.05 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.47 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.458 HE21 ' H ' ' A' ' 32' ' ' SER . 7.5 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 1.46 108.491 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 0.77 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.29 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 0.76 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 2.66 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.75 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 0.83 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 0.78 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.57 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 2.83 107.506 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 0.65 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.57 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.51 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.36 108.859 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 0.6 109.511 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.484 HE22 HD21 ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 1.36 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.38 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 0.6 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.53 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.99 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.59 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 1.81 108.468 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 0.48 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.58 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.39 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 0.82 110.381 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 0.99 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.55 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.59 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 1.79 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 0.64 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.58 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.62 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.52 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 1.29 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 0.55 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 1.89 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 0.53 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 0.43 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.31 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.35 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.16 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 0.6 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.28 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 0.58 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 0.78 111.038 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 0.86 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 0.79 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 0.71 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.05 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.59 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 1.89 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.31 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.28 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.62 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.47 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 0.56 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.48 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 0.44 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 16.0 t60 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 1.42 109.735 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 0.61 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 0.64 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.82 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 1.27 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 0.91 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 1.73 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.04 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.03 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.26 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.83 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.58 109.385 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.8 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.02 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.06 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.39 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.09 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 0.86 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 0.9 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.35 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 0.58 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.22 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.32 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 0.5 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.44 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 2.71 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.2 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.13 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 0.54 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.32 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.484 HD21 HE22 ' A' ' 53' ' ' GLN . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 1.26 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 0.62 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.67 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 0.77 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.4 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 0.87 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.32 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 0.77 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.57 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 0.82 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.502 HD12 HD21 ' A' ' 172' ' ' ASN . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 0.82 109.701 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.11 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.41 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 0.57 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 0.43 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 0.56 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 0.54 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 0.62 109.998 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 0.8 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.34 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 0.65 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 0.74 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.6 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 0.63 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 0.5 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 0.51 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.17 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 0.61 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.813 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.12 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.34 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 1.97 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 1.9 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 172' ' ' ASN . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 0.48 108.285 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.39 108.28 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.38 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.46 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 0.59 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 0.67 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.24 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.11 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 1.63 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.47 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.24 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 2.92 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 1.6 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 0.92 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 1.59 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.42 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 1.41 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 0.86 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 0.59 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.06 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 0.73 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.67 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 0.64 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.59 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 0.55 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 0.63 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 0.77 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.87 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.534 ' HB ' HG23 ' A' ' 208' ' ' VAL . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 0.89 108.027 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 0.93 113.387 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.6 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 0.75 110.435 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.84 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 1.61 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.3 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.76 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.01 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.19 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.4 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.3 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 0.53 110.131 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.6 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 0.57 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.22 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 9' ' ' PRO . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 0.75 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 0.92 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.36 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 1.42 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 1.97 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 0.65 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 0.97 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.67 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.45 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.82 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 233' ' ' ASN . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 1.62 110.236 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 2.6 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.06 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.14 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.04 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 2.6 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.23 110.01 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 . . . . . 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 2.67 110.095 -178.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 3.66 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.12 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.45 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.519 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92 109.134 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.05 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 0.88 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 0.78 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.5 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.86 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.74 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 0.45 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.64 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.45 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 1.88 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 0.59 111.146 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 0.64 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.74 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 158' ' ' LEU . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 0.74 109.743 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 1.87 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.58 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.14 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.93 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 0.68 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 0.84 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 0.79 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.37 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 2.62 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.35 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.35 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 0.78 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.05 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.47 110.329 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 1.46 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.77 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.29 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 0.76 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 2.66 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.75 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 0.83 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 0.78 108.76 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.57 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.515 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 2.83 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 0.65 109.086 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.57 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 0.51 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.36 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 0.6 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 1.36 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.38 109.271 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 0.6 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 0.53 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.99 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 0.59 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 1.81 107.707 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.48 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.58 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.39 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.82 110.059 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 0.99 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.55 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.59 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 1.79 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 0.64 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 0.58 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.62 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.52 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 1.29 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 0.55 109.198 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 1.89 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 0.53 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 0.43 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.31 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.35 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.16 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 0.6 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.28 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 0.58 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 0.78 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.86 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 0.79 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.71 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.05 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.59 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 1.89 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.31 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.28 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 0.62 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 0.47 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.56 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 0.48 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.44 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 1.42 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.61 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 0.64 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.82 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 1.27 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 0.91 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 1.73 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.04 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.03 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.26 108.488 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.83 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.58 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.8 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.02 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 118' ' ' LEU . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.06 109.12 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.39 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.09 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 0.86 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 0.9 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.35 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.58 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.22 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.32 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.5 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.44 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 2.71 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.2 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.13 108.989 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.54 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.32 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.0 m-20 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 1.26 109.194 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.62 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 0.67 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 0.77 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.4 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 0.87 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.32 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.77 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.57 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 0.82 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.82 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.11 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.41 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 0.57 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 158' ' ' LEU . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 0.43 107.969 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.539 ' N ' HG22 ' A' ' 157' ' ' ILE . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 0.56 109.824 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 0.54 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.62 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 0.8 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.34 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 0.65 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 0.74 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.6 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 0.63 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.5 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 0.51 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.17 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 0.61 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 176' ' ' VAL . 4.6 m120 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.12 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.34 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 1.97 109.56 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 1.9 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 172' ' ' ASN . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.48 108.656 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.39 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.38 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.46 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 0.59 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 0.67 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.24 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.11 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 1.63 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.47 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.24 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 2.92 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 1.6 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 0.92 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 1.59 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.42 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 1.41 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 0.86 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 0.59 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.06 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 0.73 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 0.67 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 0.64 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.59 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 0.55 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 220' ' ' LEU . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 0.63 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 0.77 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.87 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 208' ' ' VAL . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 0.89 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 0.93 112.964 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.6 113.194 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 0.75 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 0.84 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 1.61 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.3 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 0.76 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.01 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.19 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.4 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.3 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 0.53 111.238 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 0.6 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 202' ' ' ILE . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.57 109.046 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.22 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 0.75 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 0.92 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.36 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.3 OUTLIER 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 1.42 109.248 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 1.97 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 0.65 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 0.97 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 0.67 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 1.45 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.82 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 1.62 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 2.6 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.06 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.14 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.04 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 2.6 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.23 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 2.67 108.999 179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 3.66 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.12 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.45 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.408 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92 108.181 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.05 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.88 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 0.78 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.5 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.86 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78 110.69 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 0.74 109.725 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 0.45 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.64 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.45 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 1.88 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.59 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 0.64 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.679 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.74 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 0.74 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 1.87 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.58 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.14 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.93 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 0.68 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 0.84 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.79 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.37 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 2.62 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.35 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.35 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.542 HD13 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 0.78 110.154 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.05 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.47 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 1.46 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 0.77 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.29 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HG3' HD13 ' A' ' 31' ' ' ILE . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 0.76 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 2.66 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.75 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 0.83 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 0.78 107.999 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.57 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 2.83 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 0.65 108.477 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.57 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 0.51 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.36 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 0.6 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 1.36 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.38 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.6 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.53 109.107 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 0.99 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 0.59 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 1.81 108.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 0.48 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.58 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.39 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 0.82 110.227 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 0.99 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.55 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.59 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 1.79 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 0.64 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.58 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.62 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.52 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 1.29 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 0.55 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 1.89 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 0.53 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 0.43 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.31 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.35 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.16 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 0.6 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.28 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 0.58 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.78 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 0.86 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.79 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 0.71 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.05 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.59 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 1.89 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.31 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.28 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 0.62 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.47 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 0.56 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 0.48 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 0.44 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 1.42 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 0.61 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 0.64 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.82 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 1.27 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 0.91 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 1.73 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.04 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.03 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.26 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.83 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.58 110.059 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.8 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.02 109.988 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.06 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.39 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.09 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 0.86 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 0.9 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.35 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.58 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.22 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.32 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.5 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.44 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 2.71 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 136' ' ' ARG . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.2 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.13 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.54 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.32 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 1.26 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.62 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.67 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 0.77 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.4 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 0.87 109.127 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.32 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.77 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.57 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 0.82 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 0.82 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.11 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.41 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 0.57 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 0.43 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 0.56 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 0.54 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.62 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 0.8 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.34 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 0.65 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 0.74 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.6 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 0.63 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 0.5 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 0.51 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.17 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 176' ' ' VAL . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.61 109.117 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.12 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.34 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 1.97 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 1.9 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 0.48 108.366 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.39 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.38 109.245 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.46 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 0.59 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.67 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.24 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.11 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 1.63 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.47 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.24 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 2.92 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 1.6 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.92 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.59 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.42 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 1.41 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 0.86 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 0.59 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.06 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 0.73 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 0.67 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 0.64 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.59 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 0.55 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 0.63 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 0.77 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.87 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 0.89 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 0.93 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.6 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 0.75 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 0.84 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 1.61 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.3 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 0.76 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.01 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 9.1 m120 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.19 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.4 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.3 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 0.53 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 0.6 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 0.57 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.22 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 0.75 110.698 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 0.92 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.36 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.434 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.4 OUTLIER 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 1.42 109.859 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 1.97 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 0.65 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 0.97 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 0.67 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 1.45 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.82 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 1.62 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 2.6 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.06 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.14 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.04 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 2.6 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.23 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 2.67 109.868 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 3.66 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.12 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.45 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 5' ' ' ILE . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.05 108.785 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 0.88 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 0.78 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.5 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.86 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78 110.07 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 0.74 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 0.45 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.64 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.45 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 1.88 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.59 111.091 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 0.64 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 0.74 110.829 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 0.74 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 1.87 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.58 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.14 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.93 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 0.68 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 0.84 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 0.79 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.37 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 2.62 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.35 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.35 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.414 HD13 ' HG3' ' A' ' 39' ' ' GLU . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 0.78 110.52 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.415 ' H ' HE21 ' A' ' 35' ' ' GLN . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.04 109.015 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.05 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.47 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.415 HE21 ' H ' ' A' ' 32' ' ' SER . 8.7 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 1.46 108.754 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.77 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.29 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 31' ' ' ILE . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.76 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 2.66 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.75 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 0.83 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 0.78 108.026 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.57 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 2.83 108.737 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 0.65 107.996 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.57 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 0.51 109.069 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.36 107.812 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 0.6 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 1.36 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' LYS . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.38 109.217 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 0.6 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 0.53 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' LEU . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 0.99 110.269 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 0.59 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 1.81 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 0.48 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.58 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.39 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.82 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 0.99 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.55 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.59 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 1.79 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.64 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.58 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.62 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.52 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 1.29 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.55 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 1.89 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 0.53 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 0.43 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.31 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.35 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.16 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 0.6 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.28 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 0.58 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 0.78 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 0.86 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 0.79 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 0.71 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.05 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.59 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 1.89 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.31 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.28 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 0.62 109.816 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.47 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 0.56 110.191 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.48 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.44 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.42 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 0.61 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.538 HG21 ' HA3' ' A' ' 134' ' ' GLY . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 0.64 109.636 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.82 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 1.27 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 0.91 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 1.73 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.04 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.03 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.26 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.83 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.58 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.8 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.02 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.06 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.39 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.09 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 0.86 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 0.9 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.35 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 0.58 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.22 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.32 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 0.5 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.538 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.44 109.152 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 2.71 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.2 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.13 109.107 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 0.54 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.32 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 1.26 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.62 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 0.67 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 0.77 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.4 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 146' ' ' ILE . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 0.87 109.032 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.32 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 0.77 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.57 109.136 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 0.82 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.82 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.11 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.41 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.57 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 0.43 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 0.56 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 0.54 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 0.62 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 0.8 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.34 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 0.65 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.74 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.6 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.63 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.5 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.51 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.17 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 0.61 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.12 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.34 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 1.97 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 1.9 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 178' ' ' GLY . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.48 110.103 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 176' ' ' VAL . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.39 110.532 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.38 110.131 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.46 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.512 ' CG2' HG21 ' A' ' 205' ' ' THR . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 0.59 107.598 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 0.67 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.24 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.11 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 1.63 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.24 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 2.92 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 1.6 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 0.92 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 1.59 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.42 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 1.41 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 0.86 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 0.59 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.06 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.73 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 0.67 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 0.64 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.59 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 0.55 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 0.63 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 0.77 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.87 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.512 HG21 ' CG2' ' A' ' 180' ' ' ILE . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 0.89 108.551 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 0.93 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.6 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 0.75 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.84 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 1.61 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.3 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 0.76 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.01 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.19 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.4 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.3 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 0.53 109.97 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.402 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 0.6 108.107 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 0.57 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.22 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 0.75 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 0.92 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.36 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.515 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.2 OUTLIER 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 1.42 109.165 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 6.8 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 1.97 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 0.65 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 0.97 109.712 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.67 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 1.45 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.82 111.688 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 1.62 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 2.6 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.06 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.14 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.04 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 2.6 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.23 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 2.67 109.565 179.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 3.66 109.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.12 109.18 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.45 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.808 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92 108.293 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.05 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 0.88 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 0.78 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.5 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.86 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78 109.92 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 0.74 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 0.45 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.64 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.45 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 1.88 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 0.59 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 0.64 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 0.74 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 0.74 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 1.87 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.58 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.14 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.93 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 0.68 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 0.84 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.79 109.386 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.37 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 2.62 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.35 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.35 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.78 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.04 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.05 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.47 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 1.46 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.77 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.29 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.76 109.798 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 2.66 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 89' ' ' ILE . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.75 109.472 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.83 109.236 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 0.78 108.971 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.57 108.607 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 2.83 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.65 108.261 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.57 109.249 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.51 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.36 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 0.6 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 1.36 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.38 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.6 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.53 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 0.99 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 0.59 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 1.81 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 0.48 108.396 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.58 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.39 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 0.82 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 0.99 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.55 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.59 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 1.79 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.64 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 0.58 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.62 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.52 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 1.29 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 0.55 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 1.89 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 0.53 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 0.43 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.31 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.35 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.16 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 0.6 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.28 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 0.58 108.196 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 0.78 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.86 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.79 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 0.71 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.05 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.59 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 1.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.31 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 0.62 109.707 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.47 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 0.56 110.442 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.48 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.44 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.42 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 32.4 t60 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 1.42 109.448 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 0.61 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.64 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.82 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 1.27 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 0.91 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 1.73 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.04 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.03 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.26 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.83 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.58 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.8 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.02 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.06 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.39 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.09 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 0.86 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 0.9 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.35 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.58 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.22 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.32 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.5 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.44 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 2.71 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.2 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.13 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 0.54 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.32 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 1.26 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 0.62 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.67 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 0.77 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.4 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.87 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.32 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.77 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.57 109.495 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 0.82 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.82 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.11 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.41 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 0.57 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 0.43 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 0.56 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.54 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 0.62 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 0.8 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.34 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 0.65 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 0.74 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.6 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 0.63 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.5 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.51 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.17 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.61 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.12 108.376 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.34 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 1.97 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 1.9 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 0.48 108.472 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.39 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.38 108.908 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.46 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.481 HG23 HG21 ' A' ' 205' ' ' THR . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 0.59 106.741 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 0.67 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.24 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.11 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 1.63 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.47 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.24 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.92 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 1.6 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 0.92 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 1.59 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.42 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 1.41 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 0.86 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 0.59 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.06 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.73 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 0.67 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 0.64 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.59 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 0.55 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 0.63 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 0.77 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.87 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.481 HG21 HG23 ' A' ' 180' ' ' ILE . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 0.89 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 0.93 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.6 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 0.75 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.84 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 1.61 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 210' ' ' SER . 15.3 mm100 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.3 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 0.76 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.01 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.19 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.4 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.3 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 0.53 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 0.6 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.57 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.22 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 0.75 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 0.92 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.36 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.808 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 1.42 109.333 -179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 1.97 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 0.65 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 0.97 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 0.67 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 1.45 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.82 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 1.62 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 2.6 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.06 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.14 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.04 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 2.6 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.23 109.167 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 13.8 mmm-85 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 2.67 109.648 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.24 -0.652 . . . . 3.66 109.24 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 73.6 mt -90.17 99.09 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.169 -0.957 . . . . 1.12 109.531 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -97.22 120.6 37.87 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.298 -0.876 . . . . 1.45 109.81 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.18 -159.26 11.77 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 108.563 -1.815 . . . . 0.92 108.563 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' O ' HG22 ' A' ' 5' ' ' ILE . 79.7 mt -94.85 -10.47 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.063 -1.257 . . . . 1.05 109.068 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 5' ' ' ILE . 5.2 tp 58.6 108.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.88 109.13 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.46 4.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.159 -0.963 . . . . 0.78 108.623 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.18 151.09 40.03 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.397 -0.815 . . . . 1.5 108.927 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.42 151.53 22.85 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.388 2.059 . . . . 0.86 113.639 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.766 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.98 173.31 25.24 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.475 -1.45 . . . . 0.78 109.475 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.0 mt -136.17 129.7 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.234 -1.156 . . . . 0.74 108.984 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.15 157.95 45.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.393 -0.817 . . . . 0.45 109.779 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.607 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -129.92 140.68 50.9 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.239 -1.023 . . . . 0.64 108.239 179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.41 165.45 30.26 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.783 -1.675 . . . . 0.45 111.173 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -78.59 149.93 32.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.56 -0.965 . . . . 1.88 109.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.15 125.35 29.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.344 -0.848 . . . . 0.59 111.188 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -104.73 93.39 4.72 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.833 -1.173 . . . . 0.64 107.833 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.52 130.93 35.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.02 -1.05 . . . . 0.74 109.866 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 HD12 ' HB2' ' A' ' 160' ' ' ALA . 13.9 mt -94.76 90.67 6.16 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.504 0.669 . . . . 0.74 110.588 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -94.26 160.8 14.52 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.39 -0.966 . . . . 1.87 108.39 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.41 135.66 50.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.267 -0.895 . . . . 2.58 109.387 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.86 134.87 36.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.192 -0.942 . . . . 2.14 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.03 136.76 55.77 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.484 -0.76 . . . . 1.93 109.802 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.448 ' CD1' ' HZ3' ' A' ' 135' ' ' LYS . 62.6 mt -92.11 134.61 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.288 -0.883 . . . . 0.68 109.394 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -106.64 111.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.365 -0.834 . . . . 0.84 109.248 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.3 mt -88.21 139.45 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 0.79 109.654 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -90.57 123.23 34.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.321 -0.862 . . . . 1.37 109.527 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -97.22 26.21 4.96 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.252 -0.905 . . . . 2.62 109.061 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -76.04 144.51 40.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 2.35 109.948 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -86.94 128.44 35.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.203 -1.036 . . . . 2.35 108.203 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.07 175.01 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.146 -0.971 . . . . 0.78 110.762 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.2 p -105.95 160.22 15.44 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.53 -0.545 . . . . 1.04 109.53 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.35 -17.08 4.2 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 1.05 109.615 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -82.73 -14.5 54.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 2.47 109.296 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -109.54 -12.07 14.72 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.803 -0.814 . . . . 1.46 108.803 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.2 t -68.4 -48.86 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.77 109.283 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -56.08 -38.25 70.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.425 -0.797 . . . . 1.46 109.363 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -69.13 -34.76 75.55 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.419 -0.8 . . . . 2.29 110.362 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -66.29 -37.69 86.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.952 -1.093 . . . . 1.3 109.8 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.14 -45.1 96.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.225 -0.922 . . . . 0.76 109.217 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.52 -45.18 84.52 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 1.5 108.688 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -64.71 -29.1 70.08 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 2.66 108.787 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' CZ ' ' NH2' ' A' ' 47' ' ' ARG . 44.9 t80 -86.03 -47.53 9.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.433 -0.792 . . . . 0.75 108.983 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.34 -56.17 10.83 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.311 -0.868 . . . . 0.83 109.266 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.24 -33.45 75.84 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.266 -1.013 . . . . 0.78 108.266 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -53.62 -53.85 33.56 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 107.665 -2.174 . . . . 0.57 107.665 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' NH2' ' CZ ' ' A' ' 43' ' ' PHE . 26.7 ttm-85 -47.03 -32.78 4.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.636 -0.92 . . . . 2.83 108.714 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.56 -33.44 66.15 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.151 -1.055 . . . . 0.65 108.151 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 46' ' ' GLY . 20.7 mtpp -81.17 -61.07 2.06 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.056 -0.658 . . . . 2.57 109.547 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.45 -33.18 43.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.51 109.735 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.464 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 20.5 m -64.86 -40.25 94.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.071 -1.018 . . . . 1.36 108.587 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.55 62.83 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.884 -0.51 . . . . 0.6 109.867 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -73.83 -64.51 0.99 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 1.36 109.682 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 54' ' ' LEU . 3.5 mm? -52.97 -36.22 59.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.924 . . . . 1.38 109.105 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' CG ' ' O ' ' A' ' 51' ' ' SER . 11.0 mm-40 -58.97 -49.64 77.1 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 1.27 108.682 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.3 m -59.86 -36.13 76.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.6 109.493 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.47 -27.53 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.53 109.018 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -62.18 -47.19 85.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.99 109.847 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -69.21 -28.45 66.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.21 -0.931 . . . . 0.59 109.912 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -71.1 -21.54 62.2 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.761 -1.175 . . . . 1.81 107.934 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.88 -32.74 46.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.28 -1.008 . . . . 0.48 108.28 178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.26 -29.64 24.53 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 110.348 -1.101 . . . . 0.58 110.348 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -86.05 -15.83 40.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.33 . . . . 1.39 109.142 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.1 m -94.72 -49.01 5.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.82 110.089 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -107.22 -22.51 12.59 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.312 -0.867 . . . . 0.99 110.761 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.78 148.61 8.04 Favored Glycine 0 N--CA 1.504 3.183 0 N-CA-C 109.76 -1.336 . . . . 0.55 109.76 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -50.32 -8.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.399 -1.059 . . . . 2.59 110.528 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 66' ' ' GLY . 50.2 mt-10 -64.5 -30.6 71.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.967 -1.083 . . . . 2.2 109.968 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -92.49 -10.15 38.85 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.111 -0.993 . . . . 1.79 110.568 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.82 -24.81 67.9 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.915 -1.115 . . . . 1.54 110.651 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.36 -32.12 73.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.952 -1.092 . . . . 0.64 109.816 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -72.61 -43.18 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.295 -0.878 . . . . 0.58 109.932 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -78.73 -23.73 45.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.62 109.752 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -63.46 -40.13 96.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.146 -0.971 . . . . 1.23 108.774 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.3 -29.27 62.42 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.856 -1.698 . . . . 0.52 108.856 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -61.43 -24.07 66.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -1.161 . . . . 1.29 109.863 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.5 mt -85.5 -40.87 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.903 -1.123 . . . . 0.55 109.143 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.1 ttm -57.21 -37.54 72.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 1.89 109.004 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.1 tp -69.13 -41.36 77.45 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.289 -0.882 . . . . 0.53 109.022 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.64 -47.11 70.51 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.452 -0.78 . . . . 0.43 109.228 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -84.75 8.26 17.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.479 -0.763 . . . . 1.24 110.15 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -47.67 122.63 5.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.994 -1.066 . . . . 1.31 109.445 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -67.55 -24.98 65.59 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.464 -0.772 . . . . 1.35 109.253 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -78.68 -45.31 21.65 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.235 -0.915 . . . . 2.16 109.988 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.0 mt -64.76 -21.18 66.71 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.835 -1.166 . . . . 0.6 109.448 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.67 -43.23 48.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 1.28 109.87 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -63.47 -31.67 72.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.243 -0.91 . . . . 1.28 109.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.4 -44.8 57.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 1.29 109.346 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.04 -54.94 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.446 -0.946 . . . . 0.58 108.446 178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 71.4 mt -46.79 -59.79 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.731 -0.606 . . . . 0.78 110.219 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -43.82 -59.11 2.39 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.375 -0.828 . . . . 0.86 110.336 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.6 mt -49.65 -53.85 21.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.79 109.404 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.04 -41.72 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.033 -1.042 . . . . 0.71 110.068 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -85.85 -36.61 19.9 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.17 -0.956 . . . . 2.05 111.684 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -83.52 -40.68 18.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.84 -1.163 . . . . 1.59 112.061 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -104.69 16.88 25.17 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 120.806 -1.184 . . . . 1.89 110.052 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.9 m80 45.49 48.28 10.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.134 -0.979 . . . . 1.31 109.424 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.5 mtt -98.41 151.78 20.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.28 109.607 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -78.07 144.38 36.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.354 -0.841 . . . . 0.62 109.459 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.53 -26.79 2.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.167 -0.958 . . . . 0.47 109.125 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.47 -45.11 32.57 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.825 -0.806 . . . . 2.0 108.825 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.58 -55.15 9.52 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.735 -0.603 . . . . 0.56 110.538 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.72 -52.81 61.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.48 109.899 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.34 -32.1 55.99 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.44 109.726 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -70.1 -28.56 65.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.123 -0.986 . . . . 1.42 109.781 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -66.27 -54.09 29.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 1.26 110.174 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.0 t -59.24 -45.05 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.997 -1.064 . . . . 0.61 109.584 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.7 mm -63.84 -19.56 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.406 -0.809 . . . . 0.64 109.415 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -75.17 -35.43 61.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.04 -1.037 . . . . 2.2 109.605 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.56 -20.75 53.54 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.365 -1.398 . . . . 0.82 111.666 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -68.53 -52.8 28.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.45 . . . . 1.27 108.53 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.93 -48.56 70.97 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.319 0.58 . . . . 0.91 109.453 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.7 t -61.84 -47.25 85.9 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 1.73 110.083 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.22 71.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.181 -0.949 . . . . 1.04 110.476 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.5 mt -70.01 -27.13 64.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 1.03 109.069 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -72.51 -20.72 61.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.05 -1.031 . . . . 1.95 109.132 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -83.16 -2.44 55.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 1.71 109.691 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -83.29 152.55 25.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 1.26 108.555 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.72 57.02 1.54 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.304 -0.873 . . . . 2.83 109.244 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -150.38 115.03 5.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 1.58 109.636 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.7 -14.68 15.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 2.8 109.316 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -79.5 -65.07 1.05 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.02 109.372 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.534 HD13 HD13 ' A' ' 118' ' ' LEU . 13.0 mt -53.9 -21.85 8.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 1.06 109.184 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 16.5 ttmt -68.82 -51.55 39.57 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.959 -1.088 . . . . 2.39 108.431 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -59.73 -20.95 59.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 2.2 108.732 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -73.12 -25.5 60.88 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.462 -1.681 . . . . 2.09 106.462 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.09 -43.44 91.84 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 107.97 -1.122 . . . . 0.86 107.97 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.32 85.5 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.429 -0.795 . . . . 0.9 109.033 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.1 m-20 -69.35 -23.74 63.8 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.38 -0.825 . . . . 1.35 109.369 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 10.0 t -78.81 -48.6 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.58 108.558 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -51.35 -40.04 58.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.015 -1.053 . . . . 3.22 108.481 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -61.69 -37.37 83.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 1.32 109.679 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.11 -31.28 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.056 . . . . 0.5 109.291 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.69 -49.5 7.14 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.158 -1.577 . . . . 0.44 109.158 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' ' NH2' ' A' ' 139' ' ' ARG . 39.2 tttm -53.19 -42.73 66.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.451 -1.029 . . . . 2.71 109.201 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 136' ' ' ARG . 13.3 mtt-85 -65.62 -43.19 90.3 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.603 -0.888 . . . . 2.2 108.603 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.3 tp -56.88 -38.55 72.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.502 -0.749 . . . . 1.13 108.982 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.97 -61.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.54 109.513 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.451 ' NH2' ' NZ ' ' A' ' 135' ' ' LYS . 86.1 mtt180 -49.52 -16.92 0.24 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.864 . . . . 2.32 110.331 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -84.75 -34.17 22.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.017 -1.052 . . . . 1.26 109.244 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.6 mt -72.99 -37.97 54.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.62 109.226 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.1 mt -89.81 -3.38 58.16 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.67 108.658 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 57.44 30.02 61.28 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.597 -1.801 . . . . 0.68 108.597 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.78 154.51 25.53 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.528 -0.984 . . . . 0.77 109.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -67.39 139.24 57.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 2.4 109.775 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.72 151.19 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.552 -0.717 . . . . 0.87 109.302 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.793 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.9 mp -77.65 132.48 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 1.32 109.179 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.36 80.53 2.42 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.318 -0.864 . . . . 1.54 109.75 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 33.2 mt -81.16 -2.0 46.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.77 108.59 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.8 m -85.66 -13.81 47.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.329 -0.857 . . . . 1.57 109.651 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.65 63.22 1.64 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.359 -0.838 . . . . 0.82 111.03 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.564 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.9 mp -69.99 163.78 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.004 -1.11 . . . . 0.82 108.004 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 152' ' ' ILE . 56.1 mt-30 -129.99 -8.38 4.4 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.298 -0.876 . . . . 2.11 109.59 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -128.67 127.0 41.3 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.494 -0.753 . . . . 1.41 109.445 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -64.71 125.32 24.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.913 . . . . 1.3 108.648 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.9 m -151.6 178.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.0 . . . . 0.57 110.135 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 158' ' ' LEU . 69.7 mt -90.35 158.49 2.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.464 -1.31 . . . . 0.43 107.464 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.404 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.0 tp -111.64 121.49 45.26 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.635 0.731 . . . . 0.56 109.588 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.5 t -125.7 133.26 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.483 -0.932 . . . . 0.54 108.483 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.88 151.03 13.95 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.299 -0.876 . . . . 0.62 109.615 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.87 -36.34 72.23 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.69 -1.226 . . . . 0.8 107.69 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -172.87 156.4 3.39 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.836 -0.802 . . . . 2.34 108.836 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 24.6 mt -123.41 131.6 53.7 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.443 -0.786 . . . . 0.65 109.352 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 44.6 p -92.96 150.51 39.46 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.74 109.26 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -35.67 -39.68 0.3 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 122.395 2.064 . . . . 0.6 112.257 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 8.1 m -61.81 -55.28 31.6 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.63 108.775 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -55.05 -39.96 69.77 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.426 -0.796 . . . . 1.25 109.146 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.424 HG21 ' CD2' ' A' ' 189' ' ' HIS . 23.8 p -74.83 -27.03 60.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.447 -0.783 . . . . 0.5 109.561 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.41 -23.93 46.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.26 -0.9 . . . . 0.51 110.211 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -103.96 -12.01 17.09 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.251 -0.906 . . . . 1.17 109.41 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 tp -57.87 140.09 52.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.981 -1.118 . . . . 0.61 107.981 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.27 100.66 11.5 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.177 -0.952 . . . . 2.12 109.803 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 44.4 mt -78.0 41.55 0.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.368 -0.833 . . . . 1.34 109.253 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -111.58 -22.56 11.17 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.812 -0.81 . . . . 1.97 108.812 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.6 mtmt -131.28 7.13 4.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.607 -0.683 . . . . 1.9 109.712 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.7 t -80.79 157.08 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.155 -0.966 . . . . 0.48 109.704 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 19.2 tp -118.7 -25.55 6.35 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.667 -0.646 . . . . 1.39 109.992 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -178.02 176.7 48.15 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.795 -1.322 . . . . 0.38 109.795 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.89 130.45 35.94 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.299 -1.118 . . . . 0.46 110.201 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.604 ' CG2' HG21 ' A' ' 205' ' ' THR . 8.6 mt -127.88 124.93 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 107.462 -1.31 . . . . 0.59 107.462 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 16.5 p -139.52 150.27 44.91 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.156 -0.965 . . . . 0.67 112.232 -178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -79.29 37.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 115.964 -0.562 . . . . 2.24 110.771 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -103.71 106.15 16.57 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.92 -1.113 . . . . 1.11 111.002 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.11 43.98 3.08 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 109.545 -1.422 . . . . 1.63 109.545 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 187' ' ' THR . . . -102.93 116.67 5.54 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -57.19 -7.03 0.46 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.085 -1.244 . . . . 5.24 108.359 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 185' ' ' GLY . 71.2 p -134.8 44.29 2.65 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.967 -0.753 . . . . 2.92 108.967 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.6 t -81.54 140.19 34.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 1.6 109.436 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.424 ' CD2' HG21 ' A' ' 168' ' ' THR . 4.8 t60 -47.85 -42.94 27.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.92 109.522 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.1 m -52.24 -50.42 62.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.352 -0.842 . . . . 1.59 109.492 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 m -57.32 -47.79 80.64 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 1.42 109.663 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 35.3 mm -50.84 -37.19 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.263 -0.898 . . . . 1.41 109.785 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 49.6 mtp -72.93 -60.25 2.32 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.575 -1.268 . . . . 0.86 107.575 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.48 11.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.781 -0.645 . . . . 0.59 109.647 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.76 -48.83 10.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 3.06 110.027 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 21.4 m -69.27 -35.38 76.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.873 -1.142 . . . . 0.73 110.102 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 199' ' ' LEU . 27.7 mt -83.91 -0.84 53.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.065 -1.022 . . . . 0.67 108.956 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 57.49 -0.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.647 -0.658 . . . . 1.49 111.268 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.441 ' H ' ' C ' ' A' ' 197' ' ' LEU . 11.6 mt -65.19 162.27 41.41 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 120.623 -1.298 . . . . 0.64 108.385 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.46 140.81 8.61 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 C-N-CA 121.627 1.551 . . . . 0.59 110.57 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.27 -177.23 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.496 -1.377 . . . . 0.55 111.346 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.67 156.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.692 -1.595 . . . . 0.63 106.692 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 13.4 m -140.0 -27.91 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 120.925 -1.11 . . . . 0.77 110.554 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.15 35.38 3.14 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.953 -1.259 . . . . 0.87 109.953 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.604 HG21 ' CG2' ' A' ' 180' ' ' ILE . 9.1 p -64.33 -28.21 69.55 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 120.854 -1.38 . . . . 0.89 108.361 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 76.03 -98.75 1.23 Allowed Glycine 0 N--CA 1.483 1.79 0 C-N-CA 119.778 -1.201 . . . . 0.93 110.509 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 210' ' ' SER . 14.3 t -114.7 46.43 1.4 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.282 -1.128 . . . . 1.6 112.577 -176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 7.8 t -74.91 -24.1 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.47 -1.307 . . . . 0.75 107.47 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -71.73 -11.53 60.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.84 109.603 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.434 ' HG ' ' HG ' ' A' ' 207' ' ' SER . 13.0 p -101.65 7.39 42.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.334 -0.854 . . . . 1.61 108.901 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.9 mm100 -132.81 -9.44 3.11 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.613 -0.68 . . . . 2.3 109.298 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 12.1 t -115.76 161.89 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.089 -0.708 . . . . 0.76 109.089 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.1 mmmt -134.13 173.25 11.8 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 107.044 -1.465 . . . . 2.01 107.044 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 3.4 p-10 -75.07 146.17 41.72 Favored 'General case' 0 C--N 1.296 -1.752 0 O-C-N 120.905 -1.122 . . . . 2.19 109.696 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 t70 80.13 -12.22 1.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.775 -0.578 . . . . 2.4 110.079 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 20.4 t0 -56.9 144.71 32.5 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.019 -1.05 . . . . 1.99 108.54 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.521 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.1 t80 -87.71 123.74 32.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.139 -0.976 . . . . 1.3 108.643 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 39.6 mt -126.09 165.11 19.45 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.078 0.942 . . . . 0.53 110.426 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.465 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.9 mt -141.44 111.07 2.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.429 -1.323 . . . . 0.6 107.429 178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.26 126.89 34.06 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.911 -0.774 . . . . 0.57 108.911 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 35.2 p-10 -98.31 -32.24 11.64 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.254 -0.904 . . . . 2.22 109.882 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.766 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.64 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.72 -0.613 . . . . 0.75 110.416 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.3 t -117.49 -45.27 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 N-CA-C 106.885 -1.524 . . . . 0.92 106.885 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -105.98 5.51 30.47 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.366 -1.346 . . . . 2.36 107.366 178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 63.68 61.91 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.301 -0.629 . . . . 1.42 109.301 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.455 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 59.6 mt-30 -155.58 143.4 19.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.967 . . . . 1.97 110.63 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 40.8 t -105.06 130.83 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.174 -1.047 . . . . 0.65 108.174 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -105.45 126.39 52.06 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.261 -0.9 . . . . 0.97 109.689 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 29.7 t -102.61 116.35 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.411 -0.806 . . . . 0.67 109.591 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.59 71.05 1.72 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 1.45 110.246 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.465 ' HG3' HD12 ' A' ' 219' ' ' ILE . 88.8 Cg_endo -83.02 168.05 13.86 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.779 2.319 . . . . 0.82 111.495 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.6 m -75.41 157.02 34.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.002 -1.061 . . . . 1.62 109.629 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 233' ' ' ASN . 1.4 p-10 -62.76 -17.45 61.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 2.6 108.729 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -71.64 -36.42 70.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.595 -0.691 . . . . 3.06 110.067 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.06 -37.82 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.123 -0.986 . . . . 1.14 109.186 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 42.4 mt -62.97 -55.9 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.42 -0.8 . . . . 1.04 109.352 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -54.86 -40.38 69.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 2.54 109.793 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -67.35 -37.32 83.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.895 . . . . 2.6 109.991 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 63.5 mtp -80.99 -34.8 32.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.128 -0.982 . . . . 1.23 109.744 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -57.53 -32.22 66.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 2.67 109.204 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.37 -60.28 2.37 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.315 -0.866 . . . . 1.66 109.572 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.7 -59.94 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.171 -0.956 . . . . 2.2 109.722 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -45.49 -62.21 1.37 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.346 -0.846 . . . . 3.0 110.294 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.48 -23.99 66.27 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.372 -0.83 . . . . 1.76 110.412 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -67.77 -23.4 65.22 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.925 -1.109 . . . . 2.78 108.01 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.3 t -75.16 -53.83 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.882 -0.784 . . . . 2.06 108.882 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.58 -28.91 61.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 2.4 108.947 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.5 t -77.0 -27.8 54.83 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.52 -0.738 . . . . 2.87 109.649 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 3.41 109.286 -179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mmm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.308 -0.627 . . . . 3.66 109.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -91.04 90.52 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 1.12 108.738 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -96.18 116.42 28.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.419 -0.801 . . . . 1.45 109.785 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.46 -163.92 22.65 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 108.323 -1.911 . . . . 0.92 108.323 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 5' ' ' ILE . 42.0 mt -98.55 -6.17 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.161 -1.199 . . . . 1.05 109.258 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp 62.32 104.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.312 -0.868 . . . . 0.88 109.296 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.72 -51.64 6.31 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.192 -1.04 . . . . 0.78 108.192 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.87 149.84 31.32 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.383 -0.823 . . . . 1.5 108.805 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.01 148.79 25.12 Favored 'Trans proline' 0 N--CA 1.5 1.861 0 C-N-CA 122.709 2.273 . . . . 0.86 113.847 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.768 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.73 174.13 28.03 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.628 -1.389 . . . . 0.78 109.628 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.3 mt -135.07 134.71 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.275 -1.132 . . . . 0.74 109.032 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.49 159.6 41.88 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.234 -0.916 . . . . 0.45 110.139 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.2 m-85 -130.31 135.74 48.4 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.275 -1.009 . . . . 0.64 108.275 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.95 161.51 26.73 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.935 -1.602 . . . . 0.45 110.826 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -78.19 150.99 33.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.53 -0.982 . . . . 1.88 109.324 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.64 119.66 18.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.59 110.414 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -99.02 92.0 5.29 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.508 -1.293 . . . . 0.64 107.508 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.5 tp -81.97 127.13 32.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.022 . . . . 0.74 110.589 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 39.0 mt -96.78 91.84 5.88 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.357 0.599 . . . . 0.74 110.048 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -94.37 158.16 15.7 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.693 -0.854 . . . . 1.87 108.693 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -130.65 139.37 50.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.269 -0.894 . . . . 2.58 109.093 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -79.48 134.33 36.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.249 -0.907 . . . . 2.14 109.022 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -63.64 131.12 46.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 1.93 108.938 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.3 mt -89.65 138.61 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.68 109.543 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 t -107.76 114.76 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.604 -0.685 . . . . 0.84 109.514 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -89.62 133.56 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.161 -0.962 . . . . 0.79 108.882 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -92.09 112.74 24.8 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 1.37 110.108 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.2 mmm-85 -96.48 27.2 3.93 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.422 -0.955 . . . . 2.62 108.422 179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -82.91 152.21 25.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.5 -0.75 . . . . 2.35 109.494 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -85.24 122.48 29.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 2.35 109.087 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 pt -88.35 175.42 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 0.78 109.612 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.406 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 19.7 p -96.02 172.49 7.96 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.358 -0.838 . . . . 1.04 109.776 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.03 -17.71 64.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.329 -0.857 . . . . 1.05 110.112 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 1.5 p30 -81.45 -15.59 54.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.089 -1.007 . . . . 2.47 108.933 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -101.66 -10.82 19.68 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.235 -0.654 . . . . 1.46 109.235 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.71 -49.86 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.081 -1.012 . . . . 0.77 109.416 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -54.8 -36.98 65.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -0.935 . . . . 1.46 109.42 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 62.8 mm-40 -68.94 -35.65 77.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.383 -0.823 . . . . 2.29 110.122 -179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' CD ' ' H ' ' A' ' 100' ' ' ALA . 45.0 mm-40 -63.11 -38.82 92.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.016 -1.053 . . . . 1.3 109.803 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.2 t -60.96 -45.25 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.76 109.289 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -62.89 -33.57 75.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -0.908 . . . . 1.5 108.777 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 42' ' ' ARG . 2.3 mtt-85 -66.08 -33.35 75.58 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.751 -0.833 . . . . 2.66 108.751 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -85.72 -53.24 5.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.75 108.787 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.89 -62.0 1.99 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.282 -0.886 . . . . 0.83 108.867 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 t -65.24 -23.02 66.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.436 -0.79 . . . . 0.78 109.024 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.01 -51.76 7.41 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 106.931 -2.467 . . . . 0.57 106.931 178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 51' ' ' SER . 42.5 ttt180 -51.9 -31.22 27.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.365 -0.976 . . . . 2.83 108.365 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.19 86.8 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.664 -1.235 . . . . 0.65 107.664 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -80.62 -58.17 3.23 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.559 -0.904 . . . . 2.57 108.559 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.93 56.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.11 -0.994 . . . . 0.51 109.457 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 47' ' ' ARG . 75.7 m -61.85 -34.05 75.29 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.678 -1.23 . . . . 1.36 107.678 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.73 62.98 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.481 -0.562 . . . . 0.6 109.481 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -72.45 -68.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 1.36 109.555 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.6 -34.29 11.33 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.38 108.921 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 51' ' ' SER . 15.0 mm-40 -65.87 -50.87 62.99 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.602 -0.888 . . . . 1.27 108.602 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.0 m -61.76 -39.55 92.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.6 108.948 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.0 mt -62.85 -29.18 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.374 -0.829 . . . . 0.53 109.17 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -65.41 -37.85 88.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.99 109.454 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.92 -33.37 70.47 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.279 -0.888 . . . . 0.59 109.383 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 64' ' ' THR . 80.6 mttt -70.59 -37.05 73.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.175 -1.417 . . . . 1.81 107.175 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.11 -30.93 71.98 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.931 -1.137 . . . . 0.48 107.931 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.66 -31.35 21.66 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.394 -1.483 . . . . 0.58 109.394 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -86.38 -15.31 40.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.818 -1.401 . . . . 1.39 108.469 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 60' ' ' LYS . 78.4 m -92.05 -52.34 4.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.427 -0.796 . . . . 0.82 109.652 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' C ' ' H ' ' A' ' 67' ' ' GLU . 60.5 m-85 -107.41 -36.41 6.5 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.274 -0.891 . . . . 0.99 110.029 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.63 -32.51 0.59 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.652 -1.379 . . . . 0.55 109.652 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' LYS . 50.3 mt-10 -50.44 179.93 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -1.132 . . . . 2.59 109.718 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.91 39.03 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.397 -0.815 . . . . 2.2 109.891 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.4 mmtp -87.69 -16.84 33.21 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.529 -0.732 . . . . 1.79 109.11 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -68.27 -29.27 68.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 1.54 109.964 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.97 -26.84 67.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.64 110.342 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.528 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 89.2 mt -73.06 -38.71 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.062 -1.024 . . . . 0.58 109.758 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -77.14 -27.85 54.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.62 109.733 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -63.81 -40.6 97.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.952 -1.093 . . . . 1.23 108.799 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.08 -33.73 74.77 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.612 -1.795 . . . . 0.52 108.612 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 19.3 m170 -61.02 -20.24 62.28 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -1.068 . . . . 1.29 109.163 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -86.04 -39.69 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.079 -1.082 . . . . 0.55 108.079 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 32.5 ttm -58.01 -28.09 64.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.382 -0.97 . . . . 1.89 108.382 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -76.97 -40.97 44.89 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.619 -0.882 . . . . 0.53 108.619 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.53 -38.4 68.05 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.354 -0.841 . . . . 0.43 109.421 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -86.13 6.26 30.04 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 1.24 109.831 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -49.41 125.38 11.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.048 -1.032 . . . . 1.31 109.427 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -66.62 -23.89 66.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.309 -0.869 . . . . 1.35 108.693 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -79.82 -52.16 8.25 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.49 -0.756 . . . . 2.16 109.919 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.59 -15.26 57.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.977 -1.077 . . . . 0.6 109.427 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -81.24 -52.51 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -0.957 . . . . 1.28 109.892 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -62.34 -27.45 69.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.314 -0.867 . . . . 1.28 109.516 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -74.27 -48.63 27.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 1.29 109.085 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.91 -60.28 2.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.062 -1.088 . . . . 0.58 108.062 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.6 mt -45.72 -58.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-O 121.281 0.563 . . . . 0.78 110.186 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.51 -58.06 4.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.2 -0.937 . . . . 0.86 110.093 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.1 mt -51.61 -55.13 21.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.885 . . . . 0.79 109.119 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.9 mt -48.05 -43.99 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 0.71 109.845 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -85.79 -32.59 21.72 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.171 -0.956 . . . . 2.05 111.875 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 91' ' ' ALA . 30.3 t70 -82.81 -39.49 21.65 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.687 -1.258 . . . . 1.59 112.267 -176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -107.25 23.72 13.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.715 -1.24 . . . . 1.89 110.278 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.6 m80 43.35 42.83 3.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.289 -0.882 . . . . 1.31 109.569 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 28.7 mtt -94.1 146.7 23.78 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.876 -0.787 . . . . 1.28 108.876 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.9 p -76.18 146.16 39.35 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.444 -0.785 . . . . 0.62 109.183 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' H ' ' CD ' ' A' ' 39' ' ' GLU . . . -46.83 -30.81 2.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.198 -0.939 . . . . 0.47 109.478 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.9 -39.89 49.34 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.428 -0.795 . . . . 2.0 108.875 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.09 -59.32 2.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.6 -0.688 . . . . 0.56 110.512 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.99 76.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.48 109.532 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.6 -31.67 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.428 -0.795 . . . . 0.44 109.853 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -49.33 54.3 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 1.42 109.992 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -46.39 -64.06 0.85 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 1.26 110.37 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 t -48.04 -50.62 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 0.61 109.738 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.6 mm -64.51 -17.7 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.373 -0.829 . . . . 0.64 109.29 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -73.81 -36.73 65.02 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.323 -0.86 . . . . 2.2 110.312 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.04 -22.23 46.31 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.49 -1.338 . . . . 0.82 112.207 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -68.12 -45.06 74.68 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.663 -1.493 . . . . 1.27 108.693 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.81 42.19 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.842 -0.799 . . . . 0.91 108.842 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.2 p -61.25 -37.63 83.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 1.73 109.651 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.28 88.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.029 -1.045 . . . . 1.04 110.079 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.36 -26.32 63.68 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.963 -1.086 . . . . 1.03 109.173 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -67.94 -18.11 64.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.969 -1.082 . . . . 1.95 109.387 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -81.16 -7.68 59.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.302 -0.873 . . . . 1.71 109.171 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 123' ' ' LEU . 2.8 mt -87.18 148.24 25.26 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.339 -0.985 . . . . 1.26 108.339 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -100.59 59.65 0.97 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.374 -0.829 . . . . 2.83 109.51 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -149.08 115.4 5.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.201 -0.937 . . . . 1.58 109.891 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -55.39 -12.11 0.99 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.545 -0.722 . . . . 2.8 109.387 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -79.74 -62.53 1.66 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 1.02 109.919 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.51 HD13 HD13 ' A' ' 118' ' ' LEU . 22.8 mt -66.01 -25.49 67.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 1.06 110.077 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -67.76 -50.01 59.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.849 -1.157 . . . . 2.39 108.342 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -59.01 -20.64 54.94 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.367 -0.975 . . . . 2.2 108.367 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 126' ' ' ARG . 2.1 ttt-85 -71.92 -27.48 62.85 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.415 -1.698 . . . . 2.09 106.415 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.43 -41.15 79.87 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.626 -1.25 . . . . 0.86 107.626 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.54 -37.0 82.09 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.68 -0.859 . . . . 0.9 108.68 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.26 -32.8 70.79 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 1.35 109.656 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.8 t -76.58 -40.18 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.236 -1.024 . . . . 0.58 108.236 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.405 ' NH1' ' HG2' ' A' ' 131' ' ' ARG . 35.8 ttt-85 -58.67 -37.84 76.89 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.081 -1.081 . . . . 3.22 108.081 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -61.95 -35.25 77.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.569 -0.707 . . . . 1.32 109.916 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.08 -30.38 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.106 -0.996 . . . . 0.5 109.251 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.2 -40.25 11.67 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.648 -1.781 . . . . 0.44 108.648 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -55.78 -43.92 77.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.577 -0.955 . . . . 2.71 109.144 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.0 mtt-85 -64.66 -49.82 69.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 2.2 108.455 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -49.64 -42.79 46.07 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.13 -0.693 . . . . 1.13 109.13 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.13 -66.64 0.49 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 0.54 109.712 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -48.83 -16.57 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.851 . . . . 2.32 110.582 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.414 ' N ' ' ND2' ' A' ' 140' ' ' ASN . 3.6 m120 -84.43 -37.75 21.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.912 -1.118 . . . . 1.26 109.171 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.5 -35.14 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.224 -0.923 . . . . 0.62 109.167 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 38.7 mt -92.59 -9.0 42.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.921 . . . . 0.67 108.956 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 60.33 22.64 58.93 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.413 -1.875 . . . . 0.68 108.413 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 145' ' ' LYS . 11.3 tp -54.78 169.16 0.23 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.588 -0.948 . . . . 0.77 109.457 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' H ' ' HG ' ' A' ' 144' ' ' LEU . 19.3 tptm -65.93 138.99 58.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 2.4 109.84 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 91.2 mt -111.96 146.94 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.534 -0.729 . . . . 0.87 109.153 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.9 mm -76.54 113.65 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.968 . . . . 1.32 109.354 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -98.74 87.15 3.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.854 . . . . 1.54 109.652 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.5 mt -81.24 -21.32 39.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.21 -0.931 . . . . 0.77 108.793 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.9 t -82.13 32.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 1.57 109.363 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.07 23.59 2.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.214 -0.929 . . . . 0.82 109.733 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 70.4 mt -73.3 148.75 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.82 109.319 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -132.4 -16.97 2.67 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.426 -0.796 . . . . 2.11 109.376 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -114.23 137.24 52.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.461 -0.774 . . . . 1.41 109.027 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.79 124.26 21.96 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.362 -0.836 . . . . 1.3 109.5 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.7 m -150.01 172.04 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.25 -0.906 . . . . 0.57 109.388 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.447 HG22 ' N ' ' A' ' 158' ' ' LEU . 87.6 mt -90.96 158.95 2.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.297 -1.001 . . . . 0.43 108.297 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.8 tp -105.98 121.57 44.38 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.535 0.683 . . . . 0.56 109.489 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.5 t -122.65 129.27 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.112 -0.699 . . . . 0.54 109.112 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.03 149.01 12.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 0.62 109.746 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.01 -37.69 72.07 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.578 -1.326 . . . . 0.8 108.093 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -173.36 155.17 2.8 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.436 -0.79 . . . . 2.34 109.087 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 31.2 mt -129.59 132.12 46.7 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.44 -0.788 . . . . 0.65 109.738 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 166' ' ' SER . 2.3 p -93.13 151.39 40.44 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.394 -0.816 . . . . 0.74 108.953 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.427 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.8 Cg_exo -34.57 -33.3 0.08 OUTLIER 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 122.597 2.198 . . . . 0.6 112.488 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 164' ' ' THR . 69.9 m -62.79 -62.99 1.35 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.268 -0.895 . . . . 0.63 108.999 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -51.98 -33.59 38.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.293 -0.879 . . . . 1.25 109.311 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 p -79.43 -30.43 42.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -0.938 . . . . 0.5 109.476 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.71 -21.97 60.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.916 . . . . 0.51 109.798 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -106.31 -15.69 14.77 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.245 -0.909 . . . . 1.17 109.506 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.2 tp -56.55 136.1 54.43 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.007 -1.109 . . . . 0.61 108.007 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -100.64 110.02 22.12 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.26 -0.9 . . . . 2.12 109.713 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 10.8 mt -80.41 48.52 1.04 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.461 -0.774 . . . . 1.34 109.13 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -110.92 -24.06 10.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.103 -1.073 . . . . 1.97 108.103 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -131.04 7.2 4.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 109.121 -0.696 . . . . 1.9 109.121 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.5 148.19 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.48 109.158 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 8.1 tp -121.11 -4.14 9.54 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.641 -0.662 . . . . 1.39 109.908 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 163.03 176.32 34.96 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.637 -1.385 . . . . 0.38 109.637 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -131.99 127.14 35.64 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.359 -1.083 . . . . 0.46 110.053 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.9 mt -124.79 115.23 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.156 -1.424 . . . . 0.59 107.156 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 17.6 p -141.41 153.81 45.24 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.116 -0.99 . . . . 0.67 112.647 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 43.9 t0 -81.67 43.02 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.054 -0.721 . . . . 2.24 109.054 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.11 -171.66 3.6 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.668 -1.27 . . . . 1.11 110.136 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -93.27 -90.94 1.56 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.294 -1.523 . . . . 1.63 109.294 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 152.88 -19.54 0.76 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.754 -1.738 . . . . 1.47 108.754 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -72.75 91.21 1.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.457 -1.025 . . . . 5.24 109.269 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.3 p 52.07 44.95 29.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -0.758 . . . . 2.92 109.736 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -84.97 135.5 34.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.206 -0.934 . . . . 1.6 109.288 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -47.83 -54.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.149 -0.969 . . . . 0.92 109.778 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 60.3 p -48.54 -40.6 27.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 1.59 109.496 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.512 ' OG ' ' NE ' ' A' ' 195' ' ' ARG . 8.7 t -63.53 -47.77 80.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.842 . . . . 1.42 109.782 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.4 mm -46.24 -30.82 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 1.41 109.746 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 73.3 mtp -72.25 -56.84 4.85 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.886 -1.153 . . . . 0.86 107.886 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.12 -38.82 84.19 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.689 -0.687 . . . . 0.59 110.63 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 195' ' ' ARG . 6.9 mtt-85 -77.11 -49.33 15.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.051 -1.03 . . . . 3.06 110.6 -178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 11.1 m -68.56 -35.83 77.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.879 -1.138 . . . . 0.73 110.35 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 199' ' ' LEU . 15.9 mt -86.12 -0.92 56.81 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.041 -1.037 . . . . 0.67 109.348 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 57.39 0.53 0.09 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.449 -0.782 . . . . 1.49 111.561 178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.403 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.2 mt -65.01 170.11 4.62 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.531 -1.356 . . . . 0.64 108.308 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.72 141.98 3.26 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 122.251 1.967 . . . . 0.59 111.439 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.24 -177.96 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 118.335 -1.346 . . . . 0.55 111.433 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 203' ' ' VAL . 68.3 mt -148.29 157.94 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.234 -1.395 . . . . 0.63 107.234 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.3 m -137.69 -34.22 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 O-C-N 120.813 -1.179 . . . . 0.77 110.704 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -76.28 39.95 1.47 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.53 -1.428 . . . . 0.87 109.53 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 181' ' ' THR . 15.4 p -66.94 -18.89 65.59 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.15 -1.206 . . . . 0.89 108.709 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.415 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 59.13 -101.87 0.26 Allowed Glycine 0 N--CA 1.484 1.871 0 C-N-CA 119.778 -1.201 . . . . 0.93 110.256 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.4 m -113.92 47.91 1.14 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.389 -1.065 . . . . 1.6 112.275 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.83 -25.26 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.62 -1.252 . . . . 0.75 107.62 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 43.0 p -71.3 -14.24 62.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.491 -0.756 . . . . 0.84 109.941 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.9 t -108.17 15.16 24.43 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.687 -0.857 . . . . 1.61 108.687 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.2 mm-40 -125.71 -27.8 3.33 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.671 -0.643 . . . . 2.3 109.751 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 213' ' ' LYS . 39.6 t -116.32 163.14 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.513 -0.742 . . . . 0.76 109.333 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 212' ' ' VAL . 30.1 mmtt -122.35 -178.06 3.79 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.485 -1.302 . . . . 2.01 107.485 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 2.8 p-10 -77.55 146.92 36.0 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.894 -1.128 . . . . 2.19 109.866 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 80.87 -11.33 1.14 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.985 -0.447 . . . . 2.4 110.411 179.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -56.62 147.93 21.18 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.765 -1.198 . . . . 1.99 107.765 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -85.93 121.83 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.738 -1.226 . . . . 1.3 108.871 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 81.1 mt -124.34 159.76 29.6 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.962 0.887 . . . . 0.53 110.231 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.48 115.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.216 -1.401 . . . . 0.6 107.216 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.1 tp -83.92 128.82 34.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.57 109.294 -178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.532 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -96.98 -37.08 10.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.284 -0.885 . . . . 2.22 109.031 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.768 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.34 24.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.433 0.635 . . . . 0.75 109.888 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.0 t -118.37 -48.27 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 106.782 -1.562 . . . . 0.92 106.782 178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 224' ' ' ASN . 2.2 t-20 -105.04 13.21 31.24 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.484 -1.302 . . . . 2.36 107.484 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.65 57.26 4.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.193 -0.669 . . . . 1.42 109.193 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -155.13 143.4 20.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.247 -0.908 . . . . 1.97 110.556 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 17.9 t -106.33 147.71 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.65 108.435 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -113.37 121.56 44.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.344 -0.847 . . . . 0.97 109.313 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.65 118.06 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.517 -0.739 . . . . 0.67 109.798 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.439 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.2 OUTLIER 57.71 64.44 4.03 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.356 -0.84 . . . . 1.45 110.128 179.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.0 155.85 23.22 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.776 2.317 . . . . 0.82 111.885 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 9.2 m -72.96 161.19 31.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 1.62 109.668 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -68.48 -28.97 67.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 2.6 109.074 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.09 -35.99 82.1 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.414 -0.804 . . . . 3.06 109.616 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.6 t -79.36 -35.27 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 1.14 109.125 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.1 mt -67.75 -57.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.467 -0.77 . . . . 1.04 109.651 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -53.16 -42.48 66.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 2.54 109.818 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.69 -39.3 84.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 2.6 110.003 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 56.5 mtp -80.55 -30.77 37.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.963 . . . . 1.23 109.615 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -57.28 -40.86 78.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 2.67 109.384 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.73 -56.3 4.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 1.66 109.887 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.25 -56.85 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.259 -0.901 . . . . 2.2 110.359 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -48.45 -55.21 11.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.964 -1.085 . . . . 3.0 110.241 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -64.57 -26.58 68.47 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.235 -0.915 . . . . 1.76 110.971 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -67.09 -22.64 65.81 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.483 -1.303 . . . . 2.78 107.483 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -81.06 -33.6 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 109.15 -0.685 . . . . 2.06 109.15 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.18 65.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 2.4 109.271 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.4 p -76.07 -37.78 57.82 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.304 -0.873 . . . . 2.87 109.509 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.282 -0.886 . . . . 3.41 109.435 179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 3' ' ' SER . 53.9 mtt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.609 0.719 . . . . 3.66 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -48.09 97.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.517 -0.739 . . . . 1.12 109.688 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.403 ' N ' ' O ' ' A' ' 1' ' ' MET . 68.1 m -95.7 121.8 37.8 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.074 -1.016 . . . . 1.45 109.622 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.72 -156.98 10.0 Favored Glycine 0 N--CA 1.5 2.911 0 N-CA-C 108.873 -1.691 . . . . 0.92 108.873 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 6' ' ' LEU . 36.9 mt -101.62 -11.83 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.282 -1.128 . . . . 1.05 108.638 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' ILE . 47.9 tp 56.1 114.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.536 0.684 . . . . 0.88 109.786 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.91 -54.75 4.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.044 -1.035 . . . . 0.78 109.534 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.48 150.38 54.31 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.257 -0.902 . . . . 1.5 109.27 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.48 151.07 25.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.429 2.086 . . . . 0.86 114.847 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.817 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 156.74 170.62 21.98 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.091 -1.604 . . . . 0.78 109.091 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 98.1 mt -133.49 132.22 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.199 -1.177 . . . . 0.74 109.221 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.37 164.47 29.76 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.484 -0.76 . . . . 0.45 109.995 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.51 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -130.54 133.61 46.37 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.629 -0.878 . . . . 0.64 108.629 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.96 164.13 31.19 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 118.785 -1.674 . . . . 0.45 111.293 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HZ3' HG12 ' A' ' 156' ' ' VAL . 19.2 mtmm -80.77 153.32 27.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.617 -0.931 . . . . 1.88 109.888 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.582 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.23 127.69 33.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.59 110.801 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.1 tp -102.86 93.18 4.92 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 107.236 -1.394 . . . . 0.64 107.236 177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.1 tp -81.33 121.83 26.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.068 -1.02 . . . . 0.74 109.785 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 95.3 mt -99.07 92.25 5.4 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.308 0.575 . . . . 0.74 110.191 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.4 mtpm? -92.8 159.87 15.2 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.968 -1.123 . . . . 1.87 107.968 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.5 mp0 -128.02 132.77 49.1 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.183 -0.948 . . . . 2.58 109.131 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -79.39 134.62 36.57 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.31 -0.869 . . . . 2.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -61.2 145.19 52.03 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.93 108.996 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.95 135.15 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.68 109.001 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.59 107.83 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.951 -0.759 . . . . 0.84 108.951 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 58.8 mt -87.44 125.31 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.218 -0.926 . . . . 0.79 109.012 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -90.19 119.47 30.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.309 -0.87 . . . . 1.37 110.405 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.49 18.61 13.69 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.272 -0.893 . . . . 2.62 109.818 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -63.65 153.04 37.3 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.011 -1.056 . . . . 2.35 110.062 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -89.28 127.06 35.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 2.35 108.996 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 pt -94.39 175.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.07 -1.019 . . . . 0.78 110.178 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -99.79 149.91 22.88 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.555 -0.716 . . . . 1.04 109.674 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -50.53 -20.36 1.14 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.16 -0.963 . . . . 1.05 109.785 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.05 -14.71 53.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.168 -0.957 . . . . 2.47 108.841 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -101.75 -15.27 17.01 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.24 -43.52 95.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.564 -0.71 . . . . 0.77 109.523 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 3.9 m-20 -52.49 -37.6 57.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 1.46 109.027 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -67.02 -33.16 74.94 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.473 -0.767 . . . . 2.29 109.641 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -62.47 -44.88 95.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.987 -1.07 . . . . 1.3 109.836 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.94 -46.62 93.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.76 109.605 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.48 -37.95 86.23 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.001 -1.062 . . . . 1.5 108.91 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -62.97 -36.23 82.8 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.564 -0.902 . . . . 2.66 108.564 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -85.8 -54.15 4.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.75 108.672 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -50.13 -60.59 2.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.996 -1.112 . . . . 0.83 107.996 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.7 t -63.45 -30.23 71.39 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.995 -1.113 . . . . 0.78 107.995 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -61.53 -53.18 46.0 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 107.018 -2.433 . . . . 0.57 107.018 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' NH1' ' OE2' ' A' ' 86' ' ' GLU . 55.6 ttt180 -48.42 -28.33 3.19 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.801 -0.823 . . . . 2.83 108.804 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -66.74 -30.38 70.59 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.787 -1.19 . . . . 0.65 107.787 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 46' ' ' GLY . 27.4 mttp -82.92 -60.65 2.09 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.328 -0.619 . . . . 2.57 109.328 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.98 -41.21 61.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.127 -0.983 . . . . 0.51 109.564 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 89.3 p -61.85 -38.64 89.01 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.018 -1.104 . . . . 1.36 108.018 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.83 -36.32 67.47 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.281 0.563 . . . . 0.6 109.826 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.724 HE22 ' ND2' ' A' ' 140' ' ' ASN . 35.7 mt-30 -71.25 -51.51 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 1.36 109.477 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.54 -29.51 70.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.966 -1.083 . . . . 1.38 108.985 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 51' ' ' SER . 13.9 mm-40 -72.13 -51.25 22.24 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.262 -0.899 . . . . 1.27 109.408 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -59.53 -33.67 71.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.007 . . . . 0.6 109.268 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.3 mt -67.81 -32.62 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.048 -1.033 . . . . 0.53 108.564 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -63.67 -40.97 98.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.555 -0.716 . . . . 0.99 109.454 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -73.02 -30.9 64.1 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.355 -0.84 . . . . 0.59 109.275 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 64' ' ' THR . 29.4 mttm -71.29 -29.96 65.68 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.199 -1.408 . . . . 1.81 107.199 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.45 -33.93 75.06 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.11 -1.07 . . . . 0.48 108.11 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.21 -30.37 34.46 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.051 -1.619 . . . . 0.58 109.051 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -86.63 -18.34 31.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.978 -1.307 . . . . 1.39 108.77 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' O ' ' A' ' 60' ' ' LYS . 51.5 m -95.65 -46.46 6.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.29 -0.881 . . . . 0.82 109.746 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.514 ' C ' ' H ' ' A' ' 67' ' ' GLU . 42.1 m-85 -106.94 -39.56 5.73 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.335 -0.853 . . . . 0.99 109.644 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.18 -33.87 0.53 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.52 -1.432 . . . . 0.55 109.52 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 65' ' ' PHE . 18.7 tt0 -50.73 176.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.137 -1.213 . . . . 2.59 109.24 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 67' ' ' GLU . 23.2 tt0 -68.64 36.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.2 109.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 67' ' ' GLU . 36.4 mmtm -85.49 -14.7 45.2 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.312 -0.868 . . . . 1.79 108.993 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -67.55 -34.95 78.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.54 110.672 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -25.36 67.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.64 110.716 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -72.42 -43.16 64.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.873 -1.142 . . . . 0.58 109.685 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -73.94 -23.45 59.51 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.053 -1.029 . . . . 0.62 109.347 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -65.0 -47.6 76.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.302 -0.873 . . . . 1.23 108.993 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.94 -35.5 91.97 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.714 -1.754 . . . . 0.52 108.714 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -62.36 -19.06 62.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.393 -1.063 . . . . 1.29 109.789 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.2 mt -82.84 -37.24 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.99 -1.069 . . . . 0.55 108.263 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 82' ' ' ASP . 25.4 ttt -58.8 -48.82 79.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.358 -0.978 . . . . 1.89 108.358 179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.0 tp -55.4 -44.96 76.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.358 -0.978 . . . . 0.53 108.358 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 tp -71.61 -42.82 67.21 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.512 -0.742 . . . . 0.43 109.182 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -85.24 8.77 17.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.143 -0.973 . . . . 1.24 109.577 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.496 ' N ' ' O ' ' A' ' 78' ' ' MET . 28.1 t0 -48.66 122.64 5.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.255 -0.903 . . . . 1.31 110.058 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -67.19 -25.19 66.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.707 -0.849 . . . . 1.35 108.707 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.91 -48.91 22.23 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.413 -0.805 . . . . 2.16 109.945 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.4 mt -67.01 -14.98 63.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.962 -1.086 . . . . 0.6 110.18 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.513 ' OE2' ' NH1' ' A' ' 47' ' ' ARG . 26.9 tt0 -79.43 -41.65 27.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.849 -1.157 . . . . 1.28 109.844 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -65.35 -36.35 83.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.26 -0.9 . . . . 1.28 109.983 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.84 -45.18 64.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 1.29 109.637 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.2 mt -56.94 -52.77 51.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.132 -1.062 . . . . 0.58 108.132 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.2 mt -50.68 -61.19 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.649 -0.657 . . . . 0.78 110.135 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -46.86 -57.41 4.96 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.299 -0.876 . . . . 0.86 110.687 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.6 mt -48.95 -57.56 6.27 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.081 -1.012 . . . . 0.79 109.31 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.3 mt -49.08 -45.01 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.71 110.12 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -83.3 -36.24 24.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.047 -1.033 . . . . 2.05 112.151 -178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -83.48 -35.37 24.95 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.695 -1.253 . . . . 1.59 111.97 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -107.92 13.54 26.14 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.674 -1.266 . . . . 1.89 109.742 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.4 m80 45.85 50.44 11.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.31 109.88 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 40.3 mtp -103.31 154.75 19.04 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.015 -0.735 . . . . 1.28 109.015 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.0 p -77.63 144.16 37.66 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.368 -0.833 . . . . 0.62 110.039 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -47.26 -28.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.47 109.559 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -75.46 -44.6 43.33 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.316 -0.994 . . . . 2.0 108.316 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.16 -55.32 11.01 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.663 -0.648 . . . . 0.56 110.175 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.1 -52.73 63.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.061 -1.025 . . . . 0.48 109.462 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.96 -30.81 36.99 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.437 -0.789 . . . . 0.44 109.734 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -71.79 -49.21 40.74 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -0.946 . . . . 1.42 110.181 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -45.84 -57.91 3.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.153 -0.967 . . . . 1.26 110.055 -179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 107' ' ' VAL . 3.6 t -50.99 -51.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.439 -0.788 . . . . 0.61 110.02 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.0 mm -62.72 -20.35 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.521 -0.737 . . . . 0.64 109.824 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -72.33 -38.29 68.68 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.982 -1.074 . . . . 2.2 110.047 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -85.93 -19.37 57.85 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.38 -1.391 . . . . 0.82 111.873 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -70.29 -43.32 70.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.504 -1.586 . . . . 1.27 109.275 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.68 -44.91 18.02 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.592 -0.693 . . . . 0.91 109.252 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 31.5 t -64.51 -41.6 96.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.227 -0.921 . . . . 1.73 109.953 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -62.64 -37.28 85.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.716 -1.24 . . . . 1.04 109.962 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.13 -26.04 66.48 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.236 -0.986 . . . . 1.03 109.591 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.68 -17.02 62.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.014 . . . . 1.95 108.598 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -82.29 -6.74 59.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.529 -0.732 . . . . 1.71 109.606 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 123' ' ' LEU . 3.2 mt -85.96 153.42 22.19 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.224 -0.922 . . . . 1.26 108.534 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.19 57.38 0.8 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.341 -0.849 . . . . 2.83 109.75 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' TYR . 28.8 t0 -149.76 110.03 4.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.048 -1.033 . . . . 1.58 109.311 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -52.99 -9.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.507 -0.746 . . . . 2.8 109.547 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.455 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.3 t80 -80.81 -59.77 2.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 1.02 109.222 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.527 HD13 HD13 ' A' ' 118' ' ' LEU . 22.1 mt -65.17 -26.1 68.01 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.52 -0.737 . . . . 1.06 109.517 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -69.13 -45.15 70.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.139 -0.976 . . . . 2.39 108.665 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -62.6 -21.95 66.02 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.145 -0.972 . . . . 2.2 108.685 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.5 HH11 ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -73.66 -25.88 60.48 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.846 -1.538 . . . . 2.09 106.846 178.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.07 -43.35 99.01 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.988 -0.745 . . . . 0.86 108.988 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.48 -38.65 87.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.535 -0.866 . . . . 0.9 109.187 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.14 -30.25 67.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.398 -0.814 . . . . 1.35 109.612 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.89 -48.15 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.918 -1.142 . . . . 0.58 107.918 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.3 ttp180 -56.98 -37.36 71.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.962 -1.095 . . . . 3.22 108.064 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' O ' ' NH1' ' A' ' 136' ' ' ARG . 47.2 t0 -56.79 -38.74 72.94 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.433 -0.792 . . . . 1.32 109.229 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.33 -19.37 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.417 -0.802 . . . . 0.5 109.432 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -82.29 -55.36 3.09 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.187 -1.165 . . . . 0.44 110.187 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -42.14 66.08 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.798 -1.413 . . . . 2.71 108.967 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' A' ' 132' ' ' ASP . 46.6 mtm-85 -64.75 -35.07 79.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.942 -1.099 . . . . 2.2 108.489 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.9 tp -70.61 -49.21 50.06 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.125 -1.065 . . . . 1.13 108.125 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 13.0 mt -55.25 -52.97 61.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.291 -1.003 . . . . 0.54 108.291 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.477 ' O ' ' N ' ' A' ' 144' ' ' LEU . 97.5 mtt180 -56.82 -19.05 15.2 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.706 -0.621 . . . . 2.32 110.462 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.724 ' ND2' HE22 ' A' ' 53' ' ' GLN . 13.5 m120 -79.83 -40.13 29.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.681 -1.262 . . . . 1.26 108.45 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.83 -30.99 23.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.813 -1.18 . . . . 0.62 107.813 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.84 -16.02 17.41 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.762 -0.829 . . . . 0.67 108.762 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 78.45 19.86 73.08 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.106 -1.598 . . . . 0.68 109.106 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 139' ' ' ARG . 28.3 tp -90.85 4.02 52.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.621 -0.929 . . . . 0.77 109.382 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.515 ' CB ' ' ND2' ' A' ' 140' ' ' ASN . 12.9 tmtt? -73.62 -14.4 61.17 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.29 -0.881 . . . . 2.4 111.116 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.1 mt -111.87 93.3 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.459 -0.776 . . . . 0.87 110.265 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.7 mm -78.06 -129.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.778 -1.193 . . . . 1.32 107.778 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.92 50.87 1.23 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.849 -1.167 . . . . 1.54 107.849 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 151' ' ' ALA . 19.8 mt -80.71 -75.04 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.672 -0.642 . . . . 0.77 109.857 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.0 p -75.64 12.69 0.96 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 1.57 109.365 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -99.26 18.92 16.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.82 109.171 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 26.1 mt -73.29 152.08 7.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.395 -0.816 . . . . 0.82 109.573 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -130.02 -30.92 1.96 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.558 -0.904 . . . . 2.11 108.558 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -110.48 154.84 23.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.224 -1.028 . . . . 1.41 108.224 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -76.49 136.52 39.37 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.165 -0.959 . . . . 1.3 109.566 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.409 HG12 ' HZ3' ' A' ' 15' ' ' LYS . 20.1 m -149.25 178.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.492 -0.755 . . . . 0.57 109.179 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 24.9 mt -91.82 151.59 3.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.262 -1.384 . . . . 0.43 107.262 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 14.8 tp -106.94 119.33 39.08 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.824 0.821 . . . . 0.56 109.983 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 17.5 t -124.47 135.24 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 108.799 -0.815 . . . . 0.54 108.799 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.38 150.59 10.85 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.433 -0.792 . . . . 0.62 109.307 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.09 -41.91 75.93 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.698 -1.251 . . . . 0.8 108.026 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -176.32 144.97 0.57 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.914 -0.773 . . . . 2.34 108.914 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -117.54 137.75 52.37 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.65 109.387 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.2 p -91.55 149.64 39.73 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.506 -0.746 . . . . 0.74 109.349 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -32.29 -54.76 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.876 2.384 . . . . 0.6 113.158 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.2 m -46.87 -63.23 1.08 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.63 109.653 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -50.13 -33.33 18.47 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.298 -0.876 . . . . 1.25 109.741 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 21.9 p -79.72 -23.99 41.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.16 -0.963 . . . . 0.5 109.367 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.23 -20.49 51.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.223 -0.923 . . . . 0.51 109.755 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -113.98 -4.7 13.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.767 . . . . 1.17 109.588 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.4 tp -53.8 149.8 8.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.869 -1.144 . . . . 0.61 108.041 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.691 HD22 ' N ' ' A' ' 172' ' ' ASN . 0.0 OUTLIER -94.23 83.19 4.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.104 -0.997 . . . . 2.12 109.989 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 40.4 mt -71.39 35.38 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.188 -0.945 . . . . 1.34 108.809 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.6 mtmm -104.14 -27.26 12.18 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.477 -0.764 . . . . 1.97 109.021 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -132.67 18.51 4.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.544 -0.722 . . . . 1.9 110.044 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 172' ' ' ASN . 73.4 t -81.28 151.78 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.865 -1.147 . . . . 0.48 109.386 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.2 tp -112.46 -18.37 12.45 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.676 -0.64 . . . . 1.39 109.917 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.51 173.69 39.27 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.28 -1.528 . . . . 0.38 109.28 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 1.6 m-85 -127.03 124.19 38.76 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.34 -1.094 . . . . 0.46 110.218 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.486 ' CG2' HG21 ' A' ' 205' ' ' THR . 15.0 mt -125.1 119.73 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.383 -1.34 . . . . 0.59 107.383 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.562 ' O ' ' O ' ' A' ' 203' ' ' VAL . 13.2 p -140.43 150.79 44.29 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.254 -0.904 . . . . 0.67 112.219 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.49 43.44 1.02 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.792 -0.568 . . . . 2.24 111.345 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 185' ' ' GLY . . . -114.46 124.62 52.37 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.062 -1.023 . . . . 1.11 109.27 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 183' ' ' ALA . . . -37.17 -24.93 0.01 OUTLIER Glycine 0 N--CA 1.499 2.883 0 O-C-N 121.441 -0.787 . . . . 1.63 111.135 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 183' ' ' ALA . . . 94.7 -13.04 67.94 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 120.965 -1.315 . . . . 1.47 109.833 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.418 ' O ' ' O ' ' A' ' 185' ' ' GLY . 47.5 mtp180 -52.76 -100.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -1.043 . . . . 5.24 109.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.6 p -82.55 34.09 0.43 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.318 -0.864 . . . . 2.92 109.091 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 1.8 m -85.15 125.99 33.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 1.6 109.784 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -65.36 -37.07 85.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.068 -1.02 . . . . 0.92 109.174 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 31.1 p -56.17 -44.27 79.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 1.59 109.35 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 t -56.02 -31.1 62.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 1.42 109.253 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.7 mt -69.4 -28.97 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.885 . . . . 1.41 109.985 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 53.9 mtp -71.79 -58.45 3.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.753 -1.203 . . . . 0.86 107.753 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.75 -30.1 21.34 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.476 -0.784 . . . . 0.59 110.387 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -81.6 -50.28 9.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.972 -1.08 . . . . 3.06 110.247 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.6 m -68.78 -35.97 77.72 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.039 -1.038 . . . . 0.73 110.267 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 27.6 mt -88.01 -1.06 57.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.017 -1.052 . . . . 0.67 109.691 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 51.41 10.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.282 -0.886 . . . . 1.49 111.513 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 11.3 mt -67.72 164.67 37.46 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.519 -1.363 . . . . 0.64 108.276 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -84.09 132.17 5.29 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 121.51 1.473 . . . . 0.59 111.325 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -162.1 -178.85 6.66 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.877 -1.129 . . . . 0.55 111.664 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.434 HG23 ' H ' ' A' ' 6' ' ' LEU . 23.8 mt -144.41 160.92 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 106.92 -1.511 . . . . 0.63 106.92 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.562 ' O ' ' O ' ' A' ' 181' ' ' THR . 30.1 m -143.47 -35.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 120.637 -1.289 . . . . 0.77 110.948 -178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.33 34.84 1.53 Allowed Glycine 0 C--N 1.288 -2.084 0 N-CA-C 109.313 -1.515 . . . . 0.87 109.313 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.486 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.9 p -65.37 -31.7 72.95 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.034 -1.274 . . . . 0.89 108.577 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 64.35 -91.33 0.1 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 120.284 -0.96 . . . . 0.93 111.335 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 73.2 p -111.0 45.11 1.19 Allowed 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.016 -1.285 . . . . 1.6 113.027 -175.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.6 t -78.11 -28.44 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 106.959 -1.497 . . . . 0.75 106.959 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 9.4 p -63.73 -10.73 21.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.494 -0.753 . . . . 0.84 109.128 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 m -103.65 11.21 36.34 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.127 -0.694 . . . . 1.61 109.127 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -138.51 -5.28 1.58 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.356 -0.84 . . . . 2.3 110.064 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 25.4 t -118.9 150.42 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.328 -0.858 . . . . 0.76 109.146 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -123.6 163.76 20.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 106.913 -1.514 . . . . 2.01 106.913 177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.635 HD22 ' H ' ' A' ' 215' ' ' ASP . 0.4 OUTLIER -65.11 141.05 58.84 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.984 -1.073 . . . . 2.19 109.69 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.635 ' H ' HD22 ' A' ' 214' ' ' ASN . 1.6 m-20 79.19 -4.51 2.06 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.683 -0.636 . . . . 2.4 111.363 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -56.9 146.15 27.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.467 -1.396 . . . . 1.99 108.49 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -87.63 105.81 17.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.953 -1.092 . . . . 1.3 108.904 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.582 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 12.9 mt -120.33 156.23 31.73 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-O 121.681 0.753 . . . . 0.53 110.379 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.74 127.28 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 107.569 -1.271 . . . . 0.6 107.569 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.1 tp -88.47 125.84 34.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.944 -1.098 . . . . 0.57 108.834 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 16.5 t70 -95.19 -37.0 11.24 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.138 -0.976 . . . . 2.22 108.82 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.817 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.6 23.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.461 0.648 . . . . 0.75 109.887 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.9 t -117.12 -62.02 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.328 -1.73 . . . . 0.92 106.328 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -84.72 15.65 3.74 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.175 -1.417 . . . . 2.36 107.175 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 55.15 53.33 10.29 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.174 0.511 . . . . 1.42 109.791 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -156.85 157.07 34.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.157 -0.965 . . . . 1.97 110.666 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 228' ' ' TYR . 49.7 t -104.98 165.62 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.096 -0.705 . . . . 0.65 109.096 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.543 ' N ' HG12 ' A' ' 227' ' ' VAL . 37.2 m-85 -125.5 113.04 16.95 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.58 -0.7 . . . . 0.97 109.217 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 66.0 t -101.2 110.82 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.357 -0.839 . . . . 0.67 109.725 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 58.93 62.47 4.24 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.515 -0.74 . . . . 1.45 110.145 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 236' ' ' ILE . 72.6 Cg_endo -77.98 152.23 28.05 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.655 2.236 . . . . 0.82 112.214 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.2 p -75.6 146.56 40.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 1.62 109.527 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -56.44 -18.1 10.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 2.6 109.872 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -68.21 -43.4 78.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 3.06 109.496 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.7 -45.97 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 1.14 109.009 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.478 HD11 ' HG2' ' A' ' 231' ' ' PRO . 63.4 mt -51.43 -57.74 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.281 -0.887 . . . . 1.04 109.193 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -53.17 -34.56 57.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.839 . . . . 2.54 109.84 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -68.09 -42.96 79.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 2.6 110.424 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 9.9 mtm -80.02 -31.73 39.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.944 -1.097 . . . . 1.23 109.718 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 13.4 mmm-85 -56.6 -31.93 64.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.905 -1.122 . . . . 2.67 108.263 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.71 -60.26 2.39 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.69 -0.631 . . . . 1.66 109.956 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.15 -53.4 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 2.2 110.147 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.92 -57.24 9.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 3.0 109.877 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.54 -25.55 68.03 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.447 -0.783 . . . . 1.76 111.007 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.6 -22.03 66.68 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.107 -1.442 . . . . 2.78 107.107 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 47.2 t -81.8 -41.4 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 109.106 -0.702 . . . . 2.06 109.106 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -70.75 -30.06 66.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 2.4 109.296 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 -25.21 40.19 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.219 -0.926 . . . . 2.87 109.449 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.949 . . . . 3.41 110.158 -179.175 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.412 -0.588 . . . . 3.66 109.412 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.5 mt 50.41 82.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.338 -0.851 . . . . 1.12 109.755 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.5 m -94.18 114.32 26.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.182 -0.949 . . . . 1.45 109.405 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.69 -165.66 24.33 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.803 -1.319 . . . . 0.92 109.803 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 5' ' ' ILE . 59.5 mt -93.96 -6.9 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.275 -1.132 . . . . 1.05 108.288 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 57.62 108.34 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.46 -0.775 . . . . 0.88 109.543 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -86.73 -55.75 3.72 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.405 -0.961 . . . . 0.78 108.405 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.58 154.87 52.97 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.434 -0.792 . . . . 1.5 108.88 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.17 151.63 18.15 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.569 2.179 . . . . 0.86 114.681 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.838 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.74 170.59 23.51 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.218 -1.553 . . . . 0.78 109.218 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.37 126.6 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.206 -1.173 . . . . 0.74 109.301 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.94 145.9 36.65 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.91 . . . . 0.45 110.416 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -114.42 142.43 46.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 107.695 -1.224 . . . . 0.64 107.695 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.62 164.38 31.45 Favored Glycine 0 N--CA 1.497 2.743 0 C-N-CA 118.197 -1.954 . . . . 0.45 111.675 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' HZ3' ' HA ' ' A' ' 215' ' ' ASP . 8.2 mtpm? -79.76 149.02 31.25 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.72 -0.87 . . . . 1.88 110.039 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -77.73 128.2 33.67 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.59 111.229 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.6 tp -111.96 91.83 3.8 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 107.194 -1.41 . . . . 0.64 107.194 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.2 tp -83.78 132.7 34.81 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.992 -1.068 . . . . 0.74 111.309 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 160' ' ' ALA . 20.4 mt -95.29 94.95 8.17 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.792 -0.64 . . . . 0.74 109.531 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -94.99 142.46 27.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 1.87 109.271 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -124.36 144.49 49.99 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.952 -0.759 . . . . 2.58 108.952 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -80.15 133.82 36.09 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.212 -0.93 . . . . 2.14 109.328 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.7 tp10 -67.33 129.61 40.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.826 -0.805 . . . . 1.93 108.826 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 95.0 mt -91.02 132.01 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.68 109.893 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 t -104.46 122.73 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.578 -0.897 . . . . 0.84 108.578 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.1 mt -90.02 123.66 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.08 -1.013 . . . . 0.79 109.728 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.6 124.8 36.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.24 -0.912 . . . . 1.37 109.395 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -98.81 28.44 4.31 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.246 -0.909 . . . . 2.62 109.722 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mtpm? -79.15 151.36 31.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.11 -0.993 . . . . 2.35 109.638 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -90.16 120.96 31.77 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.461 -0.94 . . . . 2.35 108.461 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.4 pt -84.34 177.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.129 -0.982 . . . . 0.78 110.255 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.476 ' C ' ' H ' ' A' ' 34' ' ' ASP . 21.6 p -102.05 153.12 20.2 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 1.04 108.725 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.27 -7.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 1.05 109.703 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 32' ' ' SER . 6.8 m-20 -83.34 -8.89 59.35 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 2.47 109.92 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -120.69 -10.71 9.14 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.388 -0.82 . . . . 1.46 109.465 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.9 t -60.64 -43.21 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.11 -0.994 . . . . 0.77 108.963 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 1.6 m-20 -54.88 -34.57 63.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.342 -0.849 . . . . 1.46 108.943 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -70.51 -40.9 73.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.485 -0.76 . . . . 2.29 110.338 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.71 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.202 -0.936 . . . . 1.3 109.923 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.22 -47.4 93.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.76 110.04 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.36 -40.8 94.02 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.06 -1.025 . . . . 1.5 108.906 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 42' ' ' ARG . 4.2 mtt-85 -65.21 -32.41 74.08 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.682 -0.859 . . . . 2.66 108.682 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -85.71 -53.38 5.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.75 108.806 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.01 -58.58 7.57 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.577 -0.898 . . . . 0.83 108.577 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 t -64.46 -22.35 66.94 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.605 -0.887 . . . . 0.78 108.605 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.15 -52.58 26.77 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.046 -2.422 . . . . 0.57 107.046 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.434 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -52.73 -30.83 34.67 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.793 -0.827 . . . . 2.83 108.974 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.31 -32.94 74.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.532 -1.284 . . . . 0.65 107.532 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -82.85 -59.17 2.58 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.569 -0.9 . . . . 2.57 108.569 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -51.92 -38.35 55.99 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 0.51 109.371 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.6 p -64.77 -36.35 84.04 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.129 -1.063 . . . . 1.36 108.129 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.11 -23.75 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.243 -0.651 . . . . 0.6 109.243 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -71.37 -72.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 1.36 109.426 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 58' ' ' LYS . 9.3 mp -47.57 -41.63 21.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.22 -0.925 . . . . 1.38 109.197 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.22 -56.39 16.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.389 -0.819 . . . . 1.27 109.029 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 m -61.42 -39.02 89.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.383 -0.823 . . . . 0.6 109.653 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.4 mt -72.17 -27.46 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.53 109.245 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 54' ' ' LEU . 7.8 ttpt -62.07 -46.09 90.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.99 110.241 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -70.56 -27.69 64.34 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.095 -1.003 . . . . 0.59 109.586 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp -70.67 -28.89 65.12 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.823 -1.177 . . . . 1.81 107.823 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.2 -31.13 62.52 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.534 -0.913 . . . . 0.48 108.534 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.52 -27.45 32.6 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.012 -1.235 . . . . 0.58 110.012 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -86.01 -18.11 33.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.928 -1.336 . . . . 1.39 109.003 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.7 m -96.3 -48.0 5.78 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.21 -0.931 . . . . 0.82 111.049 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -106.29 -14.49 15.1 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.035 -1.04 . . . . 0.99 110.665 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' GLU . . . 118.99 140.6 6.32 Favored Glycine 0 N--CA 1.501 3.018 0 N-CA-C 109.826 -1.31 . . . . 0.55 109.826 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -48.81 -8.5 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -1.014 . . . . 2.59 110.546 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' GLY . 60.7 mt-10 -64.82 -25.13 67.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.882 -1.136 . . . . 2.2 110.287 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -90.52 -10.19 44.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.997 -1.065 . . . . 1.79 110.445 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -64.68 -27.55 69.0 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.983 -1.073 . . . . 1.54 110.522 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.63 -35.69 81.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.052 -1.03 . . . . 0.64 110.485 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.7 mt -73.1 -43.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.064 -1.023 . . . . 0.58 110.042 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -77.32 -24.22 50.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.079 -1.013 . . . . 0.62 109.477 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -63.56 -40.17 96.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.116 -0.99 . . . . 1.23 108.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.06 -33.6 65.2 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.867 -1.693 . . . . 0.52 108.867 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -59.35 -22.85 61.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.384 -1.068 . . . . 1.29 109.629 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -84.25 -38.82 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.919 -1.113 . . . . 0.55 108.89 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.9 ttt -58.06 -46.46 85.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.312 -0.868 . . . . 1.89 108.818 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.49 -40.06 85.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.448 -0.782 . . . . 0.53 109.414 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.0 tp -68.21 -45.78 72.4 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.242 -0.911 . . . . 0.43 109.41 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -85.31 9.06 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 1.24 110.078 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -47.78 122.37 4.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 1.31 109.544 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -66.93 -24.41 66.08 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.723 -0.843 . . . . 1.35 108.723 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -75.12 -48.91 21.43 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.46 -0.775 . . . . 2.16 109.278 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 69.0 mt -65.3 -17.84 64.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.01 -1.056 . . . . 0.6 109.266 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -77.24 -46.58 22.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 1.28 109.743 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -64.01 -34.39 77.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.234 -0.916 . . . . 1.28 109.587 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -72.94 -46.62 51.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.226 -0.921 . . . . 1.29 109.357 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 64.3 mt -58.22 -61.42 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.328 -0.99 . . . . 0.58 108.328 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.4 mt -44.04 -59.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.613 -0.679 . . . . 0.78 110.144 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.68 -60.93 1.93 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.191 -0.943 . . . . 0.86 110.449 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.33 -53.98 24.88 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.068 -1.02 . . . . 0.79 109.551 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.51 -47.05 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.025 -1.047 . . . . 0.71 110.382 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -85.65 -34.07 21.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.871 -1.143 . . . . 2.05 111.485 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -85.75 -34.08 21.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.753 -1.217 . . . . 1.59 112.048 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' HIS . 33.1 mmtm -107.8 19.07 20.57 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.748 -1.22 . . . . 1.89 109.982 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' A' ' 96' ' ' LYS . 17.3 m80 44.49 42.1 5.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.31 109.812 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.1 mtt -94.74 146.53 24.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.404 -0.81 . . . . 1.28 108.909 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 p -76.53 145.84 38.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.302 -0.873 . . . . 0.62 109.385 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.28 -27.06 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.47 109.151 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -75.66 -44.94 39.89 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.579 -0.897 . . . . 2.0 108.579 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.86 5.6 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.716 -0.615 . . . . 0.56 110.53 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.8 -51.37 67.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -0.98 . . . . 0.48 109.332 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.44 -37.23 69.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.44 109.382 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -68.19 -37.0 80.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 1.42 109.578 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -52.43 -64.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 1.26 110.404 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' H ' HG23 ' A' ' 107' ' ' VAL . 6.6 t -52.35 -46.39 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.048 -1.032 . . . . 0.61 109.978 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -63.04 -20.76 26.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.209 -0.932 . . . . 0.64 109.182 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -76.92 -37.85 54.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.209 -0.932 . . . . 2.2 109.554 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.06 -24.04 39.0 Favored Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.578 -1.296 . . . . 0.82 111.859 178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -68.05 -47.79 67.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.744 -1.445 . . . . 1.27 108.743 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.81 -50.31 30.88 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.697 -0.627 . . . . 0.91 109.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.2 m -60.19 -42.51 95.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.339 -0.851 . . . . 1.73 110.076 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.49 -34.19 77.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.053 -1.03 . . . . 1.04 110.752 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 25.8 mt -68.17 -27.58 66.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.705 -1.247 . . . . 1.03 109.639 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -70.33 -17.21 63.06 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.986 . . . . 1.95 109.294 179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -81.78 -9.27 59.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.39 -0.819 . . . . 1.71 109.159 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 123' ' ' LEU . 1.7 mt -87.48 140.59 29.37 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.386 -0.968 . . . . 1.26 108.386 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.24 62.78 1.8 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 2.83 109.211 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -146.95 117.99 7.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.316 -0.865 . . . . 1.58 109.589 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -56.35 -18.26 10.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.45 -0.781 . . . . 2.8 109.807 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -78.43 -59.11 2.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.292 -0.88 . . . . 1.02 109.3 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.408 HD13 HD13 ' A' ' 118' ' ' LEU . 17.8 mt -69.17 -30.52 68.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.99 . . . . 1.06 109.82 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.1 ttpt -66.46 -54.89 18.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.956 -1.09 . . . . 2.39 108.603 179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -56.98 -19.35 17.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.521 -0.918 . . . . 2.2 108.521 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -73.9 -26.35 60.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.487 -1.672 . . . . 2.09 106.487 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.88 -44.5 94.16 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.388 -0.967 . . . . 0.86 108.388 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.64 -38.74 84.27 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.749 -0.781 . . . . 0.9 109.253 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.6 -29.34 66.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.368 -0.832 . . . . 1.35 109.59 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.2 t -77.31 -41.74 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.58 108.427 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 131' ' ' ARG . 0.1 OUTLIER -54.61 -41.57 70.11 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.419 -0.956 . . . . 3.22 108.419 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.49 -36.57 80.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.509 -0.744 . . . . 1.32 109.81 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.9 mt -69.3 -29.65 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.5 109.3 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.95 -53.11 5.94 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.516 -1.434 . . . . 0.44 109.516 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -50.81 -44.71 59.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.227 -1.161 . . . . 2.71 109.186 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.504 HH11 ' HG2' ' A' ' 136' ' ' ARG . 8.8 mtt-85 -65.43 -44.73 86.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.924 . . . . 2.2 108.579 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 39.6 tp -55.41 -38.14 68.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 1.13 109.653 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.6 mt -69.29 -55.32 10.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.952 . . . . 0.54 109.804 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.474 HH11 ' HG2' ' A' ' 139' ' ' ARG . 25.1 mtt-85 -49.2 -20.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 2.32 110.614 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -84.8 -38.64 19.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.069 -1.02 . . . . 1.26 109.106 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.37 -44.03 97.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.232 -0.918 . . . . 0.62 109.109 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 15.8 mt -90.04 4.81 49.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.435 -0.791 . . . . 0.67 109.588 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.74 28.2 37.92 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.443 -1.863 . . . . 0.68 108.443 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -50.78 164.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.547 -0.972 . . . . 0.77 109.253 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -67.55 139.2 56.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 2.4 109.61 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.43 138.83 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.819 -0.808 . . . . 0.87 108.819 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.888 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.4 mp -78.39 124.99 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 1.32 109.214 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.16 82.04 2.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.315 -0.865 . . . . 1.54 109.758 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.9 mt -84.4 -26.4 28.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.104 -0.998 . . . . 0.77 109.16 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.5 t -80.5 22.03 0.59 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.845 . . . . 1.57 109.171 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.37 34.89 1.87 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.324 -0.86 . . . . 0.82 109.58 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.23 145.87 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.156 -0.965 . . . . 0.82 109.37 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -122.38 -18.01 6.88 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.082 -0.71 . . . . 2.11 109.082 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.03 128.2 49.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.875 -0.787 . . . . 1.41 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.15 127.93 33.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.916 . . . . 1.3 109.699 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.6 m -149.64 177.18 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.29 -0.881 . . . . 0.57 109.038 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.5 mt -88.46 151.32 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.375 -0.972 . . . . 0.43 108.375 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.3 tp -104.94 119.06 38.11 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.621 -0.674 . . . . 0.56 109.517 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 9.6 t -123.22 131.86 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.841 -0.8 . . . . 0.54 108.841 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.424 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -162.95 148.9 12.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.45 -0.781 . . . . 0.62 109.434 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -57.35 -40.09 77.32 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.753 -1.217 . . . . 0.8 107.978 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 41.9 t0 -173.05 145.78 1.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 109.336 -0.616 . . . . 2.34 109.336 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 48.4 mt -118.27 135.82 54.05 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.944 -0.761 . . . . 0.65 108.944 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.0 p -91.51 152.29 43.4 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.213 -0.929 . . . . 0.74 109.295 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -34.59 -47.6 0.61 Allowed 'Trans proline' 0 N--CA 1.49 1.276 0 C-N-CA 122.724 2.282 . . . . 0.6 112.696 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.7 m -50.84 -55.79 15.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.63 109.407 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -58.9 -42.42 89.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.345 -0.847 . . . . 1.25 109.765 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.6 p -71.04 -17.86 62.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.5 109.925 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.25 -30.22 27.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.152 -0.967 . . . . 0.51 110.494 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -100.29 -11.08 20.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.005 -1.059 . . . . 1.17 109.644 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.0 tp -60.76 147.82 41.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.61 109.01 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -96.98 143.76 27.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.126 -0.984 . . . . 2.12 108.796 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.61 -38.41 14.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.088 -1.007 . . . . 1.34 111.128 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -81.46 -15.14 55.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.722 -1.236 . . . . 1.97 111.814 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -97.87 -7.33 30.53 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.597 -1.314 . . . . 1.9 109.273 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.0 t -99.46 155.65 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 13.3 tp -107.22 -21.81 12.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.279 -0.888 . . . . 1.39 109.743 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 178.8 171.34 41.94 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.081 -1.608 . . . . 0.38 109.081 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -124.41 124.49 42.45 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.418 -1.048 . . . . 0.46 109.643 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.0 mt -128.65 119.59 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.893 -1.151 . . . . 0.59 107.893 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.509 ' O ' ' O ' ' A' ' 203' ' ' VAL . 21.3 p -140.56 154.52 46.55 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 122.064 0.935 . . . . 0.67 112.209 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 8.4 m-20 -85.46 37.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.966 -0.561 . . . . 2.24 111.012 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.82 99.17 10.22 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.761 -1.212 . . . . 1.11 110.588 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.42 47.59 2.4 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.833 -1.307 . . . . 1.63 109.833 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.463 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -98.81 112.9 4.58 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.886 -1.286 . . . . 1.47 109.886 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -50.19 -17.09 0.38 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -1.179 . . . . 5.24 108.473 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.463 ' N ' ' C ' ' A' ' 185' ' ' GLY . 25.5 p -143.13 61.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.644 -0.873 . . . . 2.92 108.644 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 t -79.39 143.33 35.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 1.6 109.51 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.408 ' HA ' HD12 ' A' ' 192' ' ' ILE . 64.0 t60 -50.02 -54.01 22.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 0.92 110.114 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.3 t -51.14 -31.96 21.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 1.59 109.481 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.0 p -72.61 -42.97 63.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 1.42 109.341 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 189' ' ' HIS . 95.4 mt -50.32 -30.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.346 -0.846 . . . . 1.41 109.649 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 17.6 mtm -72.21 -55.91 6.44 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.906 -1.146 . . . . 0.86 107.906 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.16 -39.07 55.51 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.305 0.574 . . . . 0.59 109.495 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.578 ' CG ' HH11 ' A' ' 195' ' ' ARG . 3.7 mtt-85 -70.01 -45.53 67.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.13 -0.981 . . . . 3.06 109.326 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.1 m -71.01 -36.19 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.73 109.594 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 31.6 mt -90.23 -3.26 57.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.233 -0.917 . . . . 0.67 109.341 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 57.28 3.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.392 -0.818 . . . . 1.49 111.983 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.93 169.26 5.68 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.364 -1.46 . . . . 0.64 108.034 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -88.45 139.23 4.09 Favored 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.031 1.821 . . . . 0.59 110.916 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.75 176.81 9.2 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.416 -1.313 . . . . 0.55 111.29 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.444 HG22 ' N ' ' A' ' 203' ' ' VAL . 62.5 mt -147.88 159.3 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 107.205 -1.406 . . . . 0.63 107.205 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.509 ' O ' ' O ' ' A' ' 181' ' ' THR . 11.2 m -143.09 -34.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 120.837 -1.164 . . . . 0.77 111.642 -178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.79 41.86 2.76 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.404 -1.435 . . . . 0.87 110.4 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.428 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 31.1 p -70.09 0.8 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.887 -1.361 . . . . 0.89 110.065 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 59.41 -101.78 0.26 Allowed Glycine 0 N--CA 1.484 1.868 0 C-N-CA 119.61 -1.281 . . . . 0.93 110.083 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.8 m -124.97 55.52 1.36 Allowed 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.28 -1.13 . . . . 1.6 112.082 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -72.06 -23.11 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.433 -1.321 . . . . 0.75 107.433 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 45.7 p -67.02 -14.24 62.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.84 108.907 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.6 t -103.04 14.06 32.78 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.802 -0.814 . . . . 1.61 108.802 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -134.82 -20.57 1.74 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.58 -0.7 . . . . 2.3 109.958 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 23.6 t -115.66 163.62 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.374 -0.828 . . . . 0.76 109.343 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 20.3 mmmt -133.21 -176.06 4.01 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.811 -1.551 . . . . 2.01 106.811 178.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.9 p30 -80.27 146.59 31.58 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.723 -1.235 . . . . 2.19 110.211 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.0 t0 80.72 -13.46 0.93 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.729 -0.607 . . . . 2.4 110.422 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.427 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.1 m-20 -58.05 141.9 48.52 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.019 -1.051 . . . . 1.99 108.839 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -87.93 121.75 30.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 1.3 109.05 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 16' ' ' ALA . 5.8 mt -121.21 169.35 10.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.917 0.865 . . . . 0.53 109.906 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.6 mt -138.78 115.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.944 -1.132 . . . . 0.6 107.944 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 27.0 tp -90.12 122.97 33.57 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.477 -0.934 . . . . 0.57 108.477 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 21.9 p-10 -98.05 -29.63 13.15 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.247 -0.908 . . . . 2.22 108.874 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.838 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.25 24.97 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.164 0.507 . . . . 0.75 110.271 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.3 t -119.72 -64.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.186 -1.413 . . . . 0.92 107.186 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -90.04 14.91 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 107.917 -1.142 . . . . 2.36 107.917 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 57.14 65.68 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.772 -0.58 . . . . 1.42 109.668 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 228' ' ' TYR . 52.5 tt0 -156.82 139.43 15.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.026 -1.046 . . . . 1.97 110.715 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.36 124.9 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.198 -1.038 . . . . 0.65 108.198 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.54 ' CE2' ' NE2' ' A' ' 226' ' ' GLN . 85.0 m-85 -98.49 126.32 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.118 -0.989 . . . . 0.97 109.988 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 12.6 t -106.52 137.01 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.681 -0.637 . . . . 0.67 109.325 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 54.09 62.65 8.55 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.274 -0.891 . . . . 1.45 109.301 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -81.72 150.51 16.58 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.018 2.479 . . . . 0.82 112.369 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 233' ' ' ASN . 2.2 m -74.62 171.12 14.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.405 -0.809 . . . . 1.62 109.26 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.437 ' H ' HG22 ' A' ' 232' ' ' THR . 74.3 m-20 -75.86 -27.2 57.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 2.6 109.949 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -71.68 -29.73 64.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -0.896 . . . . 3.06 109.769 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.25 -31.56 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.005 -1.059 . . . . 1.14 109.041 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 62.5 mt -69.98 -64.02 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.835 . . . . 1.04 109.638 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -51.62 -37.14 48.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 2.54 110.19 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -67.46 -37.77 83.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.029 . . . . 2.6 110.012 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 60.9 mtp -82.87 -35.87 25.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -0.972 . . . . 1.23 110.209 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 240' ' ' ARG . 17.9 mmm-85 -56.62 -38.68 72.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.006 -1.059 . . . . 2.67 109.602 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.98 -46.07 31.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 1.66 109.541 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.89 -55.19 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 2.2 109.661 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -43.82 -52.72 6.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 3.0 110.398 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.66 -28.79 68.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.161 -0.962 . . . . 1.76 111.039 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -66.63 -24.42 66.3 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.578 -1.326 . . . . 2.78 107.828 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 58.9 t -71.85 -43.19 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.733 -0.839 . . . . 2.06 108.733 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -37.59 65.85 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.448 -0.783 . . . . 2.4 109.48 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.4 t -78.8 -29.24 44.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.206 -0.934 . . . . 2.87 110.206 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.067 -1.021 . . . . 3.41 110.219 -179.312 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.273 0.559 . . . . 3.66 109.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.9 mt -91.54 99.58 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 1.12 110.003 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 m -94.92 120.86 35.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.207 -0.933 . . . . 1.45 109.305 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -105.53 -164.73 23.54 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.269 -1.533 . . . . 0.92 109.269 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 5' ' ' ILE . 73.6 mt -95.5 -7.22 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.308 . . . . 1.05 109.083 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.4 tp 54.51 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.546 -0.721 . . . . 0.88 110.032 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.69 8.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.077 -1.014 . . . . 0.78 108.602 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.73 152.7 35.23 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.369 -0.832 . . . . 1.5 108.931 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.5 148.27 20.57 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.842 2.361 . . . . 0.86 114.683 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.869 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.29 170.09 26.58 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.971 -1.251 . . . . 0.78 109.971 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.2 mt -136.35 119.85 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.332 -1.099 . . . . 0.74 109.267 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.06 154.47 50.52 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.446 -0.784 . . . . 0.45 109.46 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -122.55 137.6 54.84 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.276 -1.009 . . . . 0.64 108.276 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.53 162.75 30.2 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 118.267 -1.921 . . . . 0.45 111.56 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm -80.05 145.42 32.48 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.75 -0.853 . . . . 1.88 109.319 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.28 141.09 45.33 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.403 -0.811 . . . . 0.59 111.579 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.6 tp -118.32 96.59 5.38 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.125 -1.435 . . . . 0.64 107.125 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.42 121.4 27.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.09 -1.006 . . . . 0.74 110.71 -177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.6 mt -95.42 105.55 17.53 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.514 0.673 . . . . 0.74 109.521 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -95.56 159.82 14.81 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.446 -0.784 . . . . 1.87 108.896 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 135' ' ' LYS . 34.6 mt-10 -125.56 130.05 50.92 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.166 -0.959 . . . . 2.58 109.838 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -80.95 130.01 34.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.414 -0.804 . . . . 2.14 109.213 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.82 145.24 56.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.868 . . . . 1.93 109.396 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.5 mt -91.49 132.36 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.68 109.702 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.4 t -105.0 103.73 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.949 -0.76 . . . . 0.84 108.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 52.5 mt -88.36 132.69 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.183 -0.948 . . . . 0.79 109.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -89.54 118.47 29.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.218 -0.926 . . . . 1.37 109.542 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.542 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.1 OUTLIER -96.51 24.83 5.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 2.62 108.936 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -78.41 149.7 33.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.353 -0.842 . . . . 2.35 109.442 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -86.27 122.59 30.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 2.35 108.592 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -86.53 171.32 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.388 -0.82 . . . . 0.78 110.081 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.2 p -100.48 160.26 14.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.532 -0.73 . . . . 1.04 109.06 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.99 -12.08 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 1.05 109.639 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -83.75 -14.32 51.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.068 -1.02 . . . . 2.47 109.4 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -111.35 -12.37 14.05 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.909 -0.774 . . . . 1.46 108.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.45 -46.2 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.77 109.256 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -55.59 -33.51 63.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.865 . . . . 1.46 109.266 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -69.14 -36.35 77.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.411 -0.806 . . . . 2.29 109.978 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.19 -40.09 92.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.981 -1.074 . . . . 1.3 109.669 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.5 t -59.95 -43.18 91.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.204 -0.935 . . . . 0.76 109.124 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -64.49 -49.88 69.64 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.234 -0.916 . . . . 1.5 109.619 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' NH2' ' OD2' ' A' ' 101' ' ' ASP . 13.9 mtm180 -63.18 -24.04 67.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 2.66 108.894 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -86.11 -61.4 1.76 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.597 -0.89 . . . . 0.75 108.597 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.67 -53.39 52.69 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.631 -0.877 . . . . 0.83 108.631 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 4.7 t -64.87 -39.06 92.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.181 -0.95 . . . . 0.78 108.451 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.53 -12.29 45.61 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.79 -1.724 . . . . 0.57 108.79 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -83.81 -26.56 29.47 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 106.297 -1.742 . . . . 2.83 106.297 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.74 -36.26 80.46 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.44 -0.948 . . . . 0.65 108.44 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -84.53 -57.07 3.29 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 109.075 -0.713 . . . . 2.57 109.075 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.41 -43.66 62.03 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.297 -0.877 . . . . 0.51 109.55 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CG ' ' A' ' 55' ' ' GLU . 33.3 t -63.65 -35.87 81.97 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.337 -0.986 . . . . 1.36 108.337 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 56' ' ' THR . . . -74.32 -42.86 58.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.813 -0.554 . . . . 0.6 109.823 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -54.86 -73.26 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 1.36 109.676 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 54' ' ' LEU . 4.0 mm? -45.67 -41.91 10.93 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.38 109.458 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 51' ' ' SER . 29.0 mm-40 -64.65 -49.06 72.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 1.27 110.211 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 52' ' ' ALA . 4.5 m -60.84 -34.08 74.02 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.208 -0.933 . . . . 0.6 110.336 -178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 HD12 HH12 ' A' ' 136' ' ' ARG . 85.8 mt -73.5 -36.17 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.997 -1.064 . . . . 0.53 108.601 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpt -51.87 -42.61 62.77 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.406 -0.809 . . . . 0.99 109.429 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -74.52 -30.87 61.96 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.213 -0.929 . . . . 0.59 109.977 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -73.05 -31.62 64.54 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.558 -1.275 . . . . 1.81 107.558 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.23 -31.77 70.56 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.896 -1.149 . . . . 0.48 107.896 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.92 -29.31 26.37 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.636 -1.386 . . . . 0.58 109.636 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -86.44 -18.96 30.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.414 . . . . 1.39 108.841 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.9 m -94.99 -47.82 6.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.363 -0.835 . . . . 0.82 110.28 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 67' ' ' GLU . 51.6 m-85 -106.66 -35.61 6.97 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.265 -0.897 . . . . 0.99 109.859 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 68.86 -30.0 0.29 Allowed Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.883 -1.287 . . . . 0.55 109.883 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' A' ' 65' ' ' PHE . 47.1 mt-10 -49.64 178.64 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.238 -1.154 . . . . 2.59 109.636 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -68.91 38.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.423 -0.798 . . . . 2.2 109.347 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.533 ' H ' ' C ' ' A' ' 67' ' ' GLU . 26.8 mmtp -84.19 -11.94 55.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.651 -0.87 . . . . 1.79 108.651 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -68.75 -36.98 79.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.48 -0.762 . . . . 1.54 110.379 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.69 -23.73 66.84 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.265 -0.897 . . . . 0.64 110.852 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.421 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 9.9 mt -73.72 -44.04 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.923 -1.111 . . . . 0.58 109.928 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -77.4 -27.4 52.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.131 -0.981 . . . . 0.62 109.793 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -62.5 -54.82 34.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.088 -1.008 . . . . 1.23 109.278 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.21 87.98 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.637 -1.385 . . . . 0.52 109.637 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.421 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 17.0 m170 -62.17 -18.07 59.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.182 -1.187 . . . . 1.29 110.409 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.5 mt -84.48 -36.82 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.666 -1.271 . . . . 0.55 108.4 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 19.1 ttt -58.43 -45.57 88.22 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.978 -0.749 . . . . 1.89 108.978 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.79 -39.63 92.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -0.825 . . . . 0.53 109.145 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.7 tp -67.42 -45.12 77.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.163 -0.961 . . . . 0.43 109.164 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -86.32 8.59 20.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.379 -0.826 . . . . 1.24 110.742 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 22.3 t0 -46.56 124.42 5.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.824 -1.172 . . . . 1.31 109.528 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -64.43 -26.05 68.28 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.881 -0.785 . . . . 1.35 108.881 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.494 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 46.0 mm-40 -77.99 -52.93 8.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.506 -0.746 . . . . 2.16 109.908 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.8 mt -65.13 -16.41 63.46 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.11 -1.036 . . . . 0.6 109.558 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -83.31 -42.52 17.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.333 -0.854 . . . . 1.28 110.15 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -63.09 -32.51 73.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.098 -1.001 . . . . 1.28 109.464 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -72.51 -42.56 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.988 . . . . 1.29 108.777 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.7 mt -59.15 -59.15 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.657 -1.238 . . . . 0.58 107.657 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 76.1 mt -48.54 -54.34 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.664 . . . . 0.78 109.576 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.31 -62.9 1.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.86 110.915 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.2 mt -44.8 -49.84 10.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.399 -0.813 . . . . 0.79 110.184 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -54.23 -44.1 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.098 -1.001 . . . . 0.71 110.145 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -84.94 -39.05 18.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.219 -0.925 . . . . 2.05 111.318 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -84.57 -26.02 28.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.777 -1.202 . . . . 1.59 112.551 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -114.03 20.1 15.96 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.69 -1.256 . . . . 1.89 110.701 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 69.2 m80 44.18 38.92 2.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.192 -0.942 . . . . 1.31 110.009 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 mtt -97.88 150.23 21.53 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.249 -0.907 . . . . 1.28 109.417 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.3 p -77.94 145.29 36.19 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.43 -0.794 . . . . 0.62 109.238 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.8 -28.97 4.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.036 . . . . 0.47 108.934 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.448 ' OD2' ' NH2' ' A' ' 42' ' ' ARG . 58.1 m-20 -74.46 -44.71 50.42 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.168 -1.049 . . . . 2.0 108.168 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.84 -54.22 12.38 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.695 -0.628 . . . . 0.56 109.989 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.3 73.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.375 -0.828 . . . . 0.48 109.96 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.61 66.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.19 -0.944 . . . . 0.44 109.92 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -70.42 -29.55 66.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.931 -1.106 . . . . 1.42 109.601 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.95 -58.11 9.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.189 -0.944 . . . . 1.26 109.886 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 55.0 t -55.66 -47.19 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.959 -1.088 . . . . 0.61 109.366 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.8 mm -65.99 -20.19 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.64 109.448 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -70.59 -38.16 74.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.925 -1.109 . . . . 2.2 109.252 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.32 -23.25 41.06 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.587 -1.292 . . . . 0.82 112.676 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -68.52 -44.22 75.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.319 -1.695 . . . . 1.27 109.131 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.8 -52.27 11.87 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.91 110.015 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 96.4 p -60.98 -44.05 97.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 1.73 110.201 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.74 -32.86 74.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.924 -1.11 . . . . 1.04 110.244 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD21 HH21 ' A' ' 126' ' ' ARG . 27.8 mt -66.97 -28.16 68.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.912 -1.117 . . . . 1.03 108.917 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -72.58 -17.9 61.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.138 -0.976 . . . . 1.95 109.164 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -82.65 -5.66 58.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.489 -0.757 . . . . 1.71 109.363 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.79 143.68 28.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -0.875 . . . . 1.26 108.86 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.73 59.27 2.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.263 -0.898 . . . . 2.83 108.865 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -150.54 111.27 4.27 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.968 -0.753 . . . . 1.58 108.968 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.8 -14.92 6.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.441 -0.787 . . . . 2.8 109.995 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -77.33 -64.43 1.14 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 1.02 108.845 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.5 mt -57.98 -28.59 64.52 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.315 -0.866 . . . . 1.06 109.063 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 127' ' ' ALA . 33.0 ttmt -66.22 -47.0 75.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.063 -1.023 . . . . 2.39 108.362 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -57.55 -22.57 45.4 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.259 -1.015 . . . . 2.2 108.259 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.411 HH21 HD21 ' A' ' 115' ' ' LEU . 32.0 ttp180 -72.34 -25.42 61.54 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.341 -1.725 . . . . 2.09 106.341 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -58.6 -47.1 85.46 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.01 -1.107 . . . . 0.86 108.01 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.56 81.73 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.58 -0.896 . . . . 0.9 108.58 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -69.1 -27.41 65.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 1.35 109.223 179.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.16 -45.71 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.186 -1.042 . . . . 0.58 108.186 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -51.2 -39.87 57.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.087 -1.008 . . . . 3.22 108.624 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.58 -41.58 97.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 1.32 109.483 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 79.5 mt -70.16 -33.99 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.5 109.325 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -80.05 -46.64 7.54 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.628 -1.389 . . . . 0.44 109.628 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HE2' HH11 ' A' ' 139' ' ' ARG . 78.7 tttt -49.61 -55.54 13.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.509 -0.994 . . . . 2.71 109.879 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.527 HH12 HD12 ' A' ' 57' ' ' ILE . 32.5 mtm180 -63.53 -44.82 93.11 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.114 -1.034 . . . . 2.2 108.446 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 52.0 tp -48.62 -39.42 23.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 1.13 109.179 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.59 -56.6 7.71 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 0.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.412 HH11 ' HE2' ' A' ' 135' ' ' LYS . 29.8 mtp180 -57.33 -13.0 2.83 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.493 -0.754 . . . . 2.32 110.347 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 4.8 m120 -83.72 -44.32 14.58 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.028 -1.045 . . . . 1.26 109.155 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.06 -33.87 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 0.62 108.996 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 24.0 mt -87.53 0.16 55.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.67 109.029 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 52.39 23.14 12.26 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 107.846 -2.102 . . . . 0.68 107.846 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.6 tp -50.67 160.11 0.46 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.726 -0.867 . . . . 0.77 109.189 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -66.61 129.41 39.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 2.4 109.669 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.3 133.91 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.689 -0.856 . . . . 0.87 108.689 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 147' ' ' ILE . 1.8 mp -76.07 115.62 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.044 -1.035 . . . . 1.32 108.975 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -96.57 87.97 4.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 1.54 109.382 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.0 mt -80.17 -10.34 59.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.429 -0.794 . . . . 0.77 109.125 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.5 t -80.87 13.34 2.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.365 -0.834 . . . . 1.57 109.565 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.75 40.75 2.01 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.252 -0.905 . . . . 0.82 109.79 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.491 HG22 ' N ' ' A' ' 153' ' ' GLN . 45.3 mt -72.96 161.77 4.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.312 -0.867 . . . . 0.82 108.96 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.491 ' N ' HG22 ' A' ' 152' ' ' ILE . 20.6 mt-30 -141.12 -2.65 1.27 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.963 . . . . 2.11 109.334 -179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -119.08 128.37 54.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.554 -0.716 . . . . 1.41 109.359 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -67.17 114.56 6.01 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.489 -0.93 . . . . 1.3 108.489 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.6 m -147.49 174.2 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.106 -0.996 . . . . 0.57 109.924 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 15.7 mt -90.68 152.63 3.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.241 -1.022 . . . . 0.43 108.241 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.2 tp -103.02 119.9 39.67 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.69 . . . . 0.56 109.228 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.0 t -122.84 129.51 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.265 -0.643 . . . . 0.54 109.265 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.74 145.1 10.64 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.62 109.37 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.13 -37.26 69.21 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.348 -1.47 . . . . 0.8 107.649 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -173.43 154.18 2.54 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.895 -0.78 . . . . 2.34 108.895 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.7 mt -126.98 140.17 52.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.492 -0.755 . . . . 0.65 109.332 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -93.31 151.15 40.09 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.344 -0.847 . . . . 0.74 109.734 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.451 ' O ' ' N ' ' A' ' 169' ' ' ALA . 81.1 Cg_exo -35.05 -47.85 0.7 Allowed 'Trans proline' 0 N--CA 1.49 1.277 0 C-N-CA 122.681 2.254 . . . . 0.6 113.009 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.527 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 58.3 m -49.28 -64.66 0.74 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.122 -0.986 . . . . 0.63 109.838 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -53.59 -38.28 63.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.091 -1.006 . . . . 1.25 110.113 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 17.2 p -73.69 -29.46 62.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.079 -1.013 . . . . 0.5 109.833 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -72.29 -27.61 62.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.126 -0.984 . . . . 0.51 110.256 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -102.98 -8.32 20.73 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.143 -0.973 . . . . 1.17 109.89 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 53.4 tp -60.92 152.92 26.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.025 -1.047 . . . . 0.61 109.232 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -100.21 151.14 21.79 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.962 . . . . 2.12 109.148 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 173' ' ' LEU . 8.5 mp -94.56 -42.65 8.71 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.246 -0.909 . . . . 1.34 110.186 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -81.18 -15.18 56.49 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.054 -1.029 . . . . 1.97 112.527 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -96.13 -9.13 31.45 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.468 -1.395 . . . . 1.9 109.419 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 178' ' ' GLY . 36.6 t -101.73 163.85 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.714 -0.847 . . . . 0.48 108.714 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.473 ' N ' HG12 ' A' ' 176' ' ' VAL . 5.2 tp -114.13 -23.02 9.72 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.428 -0.795 . . . . 1.39 109.785 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.481 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -178.87 173.66 45.89 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.571 -1.412 . . . . 0.38 109.571 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -127.34 124.06 37.76 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.461 -1.023 . . . . 0.46 109.393 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.518 HD11 HD13 ' A' ' 220' ' ' LEU . 9.5 mt -133.32 128.58 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.861 -0.792 . . . . 0.59 108.861 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.2 p -141.97 149.63 40.32 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.443 -0.786 . . . . 0.67 111.38 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.47 ' HA ' ' H ' ' A' ' 206' ' ' GLY . 36.4 m-20 -86.21 41.26 0.92 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 2.24 109.337 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.02 117.93 35.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.415 -0.803 . . . . 1.11 109.773 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.22 87.94 1.49 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.675 -1.37 . . . . 1.63 109.675 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -143.77 103.19 0.3 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.166 -1.574 . . . . 1.47 109.166 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 186' ' ' ARG . 5.7 mtt-85 -47.53 -20.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.194 -1.18 . . . . 5.24 108.607 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.453 ' N ' ' C ' ' A' ' 185' ' ' GLY . 5.4 p -121.05 47.61 1.79 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.11 -1.07 . . . . 2.92 108.11 178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 65.5 m -77.64 130.02 36.32 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.412 -0.805 . . . . 1.6 109.04 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -45.32 -47.25 13.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.277 -0.89 . . . . 0.92 110.163 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 84.6 m -52.52 -36.98 56.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 1.59 109.78 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.3 p -72.7 -46.46 53.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.277 -0.89 . . . . 1.42 110.302 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 30.1 mm -46.73 -40.29 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.288 -0.882 . . . . 1.41 110.989 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 10.0 mtm -69.78 -49.25 54.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.631 -1.293 . . . . 0.86 107.647 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.9 -29.88 56.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.368 0.604 . . . . 0.59 109.48 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtp180 -78.0 -52.0 9.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.344 -0.847 . . . . 3.06 110.094 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 14.7 m -67.08 -32.98 74.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.948 . . . . 0.73 109.506 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 199' ' ' LEU . 16.8 mt -89.16 0.49 56.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.147 -0.971 . . . . 0.67 109.275 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 56.82 -1.94 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.778 . . . . 1.49 111.196 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 197' ' ' LEU . 15.5 mt -63.32 167.9 5.95 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.491 -1.381 . . . . 0.64 107.979 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -90.41 142.15 3.5 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 C-N-CA 122.143 1.896 . . . . 0.59 111.292 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.52 176.05 10.12 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 118.779 -1.168 . . . . 0.55 111.196 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.0 mt -150.3 159.59 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 107.584 -1.265 . . . . 0.63 107.584 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.479 ' O ' ' O ' ' A' ' 181' ' ' THR . 8.0 m -145.21 -28.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 O-C-N 120.755 -1.216 . . . . 0.77 111.572 -178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -85.79 28.3 5.01 Favored Glycine 0 N--CA 1.492 2.429 0 O-C-N 120.789 -1.194 . . . . 0.87 110.179 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.533 ' O ' ' N ' ' A' ' 207' ' ' SER . 2.9 p -59.06 -36.68 75.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.415 . . . . 0.89 108.687 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 59.6 -33.15 0.03 OUTLIER Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.647 -0.658 . . . . 0.93 113.513 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 205' ' ' THR . 12.5 m -120.9 -6.23 9.58 Favored 'General case' 0 N--CA 1.514 2.746 0 CA-C-N 119.736 1.768 . . . . 1.6 113.128 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.8 t -52.8 -51.32 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 120.11 -1.619 . . . . 0.75 110.397 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.0 p -57.57 -16.61 10.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.604 -1.31 . . . . 0.84 110.309 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.424 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.9 p -108.03 11.11 28.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.351 -0.843 . . . . 1.61 109.001 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 210' ' ' SER . 26.9 mm100 -139.16 -6.7 1.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.383 -0.823 . . . . 2.3 110.346 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' A' ' 213' ' ' LYS . 27.2 t -120.05 157.35 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.274 -0.891 . . . . 0.76 110.261 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.405 ' N ' ' CG1' ' A' ' 212' ' ' VAL . 2.8 mptt -132.36 166.88 20.95 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 106.863 -1.532 . . . . 2.01 106.863 177.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.422 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 7.8 p-10 -69.77 142.12 53.26 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.805 -1.184 . . . . 2.19 109.991 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.422 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.3 m-20 76.34 -3.27 2.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.869 -0.519 . . . . 2.4 110.733 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.817 -1.177 . . . . 1.99 108.62 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -89.03 103.09 15.73 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.009 -1.057 . . . . 1.3 108.684 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 44.3 mt -111.77 171.66 7.36 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.082 0.944 . . . . 0.53 110.708 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.6 119.09 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.326 -0.99 . . . . 0.6 108.326 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.518 HD13 HD11 ' A' ' 180' ' ' ILE . 19.5 tp -89.55 124.05 34.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.57 108.612 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 223' ' ' VAL . 31.3 p-10 -93.57 -30.58 14.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.22 108.879 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.869 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.23 22.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.304 0.574 . . . . 0.75 110.147 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.7 t -117.49 -47.27 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 106.879 -1.526 . . . . 0.92 106.879 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -103.64 12.98 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.579 -1.267 . . . . 2.36 107.579 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 50.3 t-20 54.91 63.43 2.13 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.995 -0.743 . . . . 1.42 108.995 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.447 ' O ' ' OD1' ' A' ' 221' ' ' ASP . 6.9 tt0 -156.34 143.05 18.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.97 110.658 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.8 t -104.56 130.73 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.37 -0.974 . . . . 0.65 108.37 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -105.9 132.78 51.59 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.245 -0.909 . . . . 0.97 110.148 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.7 t -104.8 111.27 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.439 -0.788 . . . . 0.67 109.303 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 46.79 58.92 16.73 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 1.45 110.094 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.93 166.54 20.26 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.194 1.929 . . . . 0.82 111.398 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 81.6 p -73.93 159.76 32.32 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.171 -0.956 . . . . 1.62 109.529 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 237' ' ' ASP . 41.5 t30 -64.91 -18.1 64.91 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.286 -0.884 . . . . 2.6 108.698 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.03 -40.49 91.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.648 -0.657 . . . . 3.06 109.485 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.3 t -79.2 -47.37 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.905 . . . . 1.14 109.323 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 79.8 mt -55.97 -56.22 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.411 -0.805 . . . . 1.04 109.93 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 233' ' ' ASN . 2.6 m-20 -52.49 -38.22 58.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 2.54 110.151 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -64.95 -42.26 94.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.138 -0.976 . . . . 2.6 110.182 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.423 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 28.7 mtm -79.36 -31.02 42.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.23 109.901 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -53.7 -40.93 66.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.143 -0.973 . . . . 2.67 109.663 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.54 -59.8 2.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 1.66 109.911 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.7 t -59.61 -48.44 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.038 -1.039 . . . . 2.2 110.264 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.423 ' CB ' ' O ' ' A' ' 239' ' ' MET . 3.1 tm0? -55.52 -61.44 2.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 3.0 110.198 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.24 -26.51 68.82 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.495 -0.753 . . . . 1.76 111.21 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -70.37 -20.11 62.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.672 -1.267 . . . . 2.78 108.461 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.9 t -84.0 -34.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.84 -0.8 . . . . 2.06 108.84 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -72.44 -38.93 68.18 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.444 -0.785 . . . . 2.4 109.791 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.95 -32.92 51.77 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 2.87 109.827 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.044 -1.035 . . . . 3.41 109.253 179.783 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.7 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.324 -0.621 . . . . 3.66 109.324 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.7 mt -70.37 105.88 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.172 -0.955 . . . . 1.12 109.353 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 m -94.24 121.88 36.2 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.202 -0.936 . . . . 1.45 109.816 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.17 -161.39 15.89 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 108.709 -1.756 . . . . 0.92 108.709 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 56.9 mt -94.25 -5.27 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.032 -1.276 . . . . 1.05 108.866 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.0 tp 56.04 105.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.88 109.559 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.0 -52.44 5.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.89 . . . . 0.78 108.616 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.11 150.91 39.8 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.297 -0.877 . . . . 1.5 108.92 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -79.95 149.66 20.36 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.604 2.203 . . . . 0.86 113.749 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.546 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 149.92 136.94 2.67 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.801 -1.32 . . . . 0.78 109.801 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -98.98 133.77 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.999 -1.294 . . . . 0.74 110.087 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.37 158.47 43.97 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 0.45 109.948 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -130.46 149.46 52.12 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.453 -0.943 . . . . 0.64 108.453 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.74 166.03 25.13 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.711 -1.709 . . . . 0.45 111.097 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -78.72 150.37 32.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.951 . . . . 1.88 110.079 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' HD11 ' A' ' 218' ' ' LEU . . . -78.27 125.02 28.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -0.856 . . . . 0.59 110.949 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.0 tp -101.43 86.26 2.94 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.057 -1.46 . . . . 0.64 107.057 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 25.3 tp -81.32 131.73 35.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.113 0.958 . . . . 0.74 110.783 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mt -96.02 92.52 6.5 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 115.707 -0.679 . . . . 0.74 109.95 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.06 151.27 19.98 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.721 -0.844 . . . . 1.87 108.721 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -130.08 139.71 50.92 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.449 -0.945 . . . . 2.58 108.449 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -77.53 139.76 39.63 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.157 -0.965 . . . . 2.14 109.17 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -63.82 128.16 34.57 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.383 -0.823 . . . . 1.93 109.321 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.3 mt -91.24 133.91 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.364 -0.835 . . . . 0.68 109.569 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.4 t -107.19 118.89 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.629 -0.669 . . . . 0.84 109.403 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.67 120.46 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.206 -0.934 . . . . 0.79 109.23 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -89.46 121.8 32.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.068 -1.02 . . . . 1.37 109.388 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CG ' HH11 ' A' ' 28' ' ' ARG . 0.2 OUTLIER -97.93 25.49 5.96 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.289 -0.882 . . . . 2.62 109.437 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -80.23 148.35 30.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 2.35 109.332 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -85.3 133.94 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.209 -0.932 . . . . 2.35 109.607 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.0 pt -94.79 175.61 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.421 -0.8 . . . . 0.78 110.145 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 77.8 p -97.68 177.88 5.34 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.504 -0.747 . . . . 1.04 109.423 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.44 -18.48 62.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.089 -1.007 . . . . 1.05 109.949 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.04 0.06 33.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.111 -0.993 . . . . 2.47 109.154 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.09 -15.51 8.72 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.637 -0.664 . . . . 1.46 109.242 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.8 t -67.15 -46.53 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.77 109.55 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -57.01 -33.47 67.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.136 -0.977 . . . . 1.46 108.606 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.4 mp0 -71.84 -40.29 69.16 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.074 -0.512 . . . . 2.29 110.287 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -63.32 -41.84 98.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 1.3 110.082 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 44' ' ' LEU . 90.8 t -60.09 -44.17 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.131 -0.981 . . . . 0.76 109.326 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -64.74 -43.7 92.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.084 -1.01 . . . . 1.5 109.093 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtm180 -65.01 -31.53 72.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.871 -0.788 . . . . 2.66 108.871 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -86.4 -58.32 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.75 108.8 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 40' ' ' VAL . 30.5 tp -51.79 -62.99 1.28 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.544 -0.722 . . . . 0.83 109.146 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.563 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.7 t -63.5 -31.86 73.14 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.458 -0.942 . . . . 0.78 108.458 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -58.69 -53.5 45.59 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 107.23 -2.348 . . . . 0.57 107.23 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -48.77 -29.88 5.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.646 -0.914 . . . . 2.83 108.87 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -64.19 -33.62 76.2 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.133 -1.062 . . . . 0.65 108.133 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 46' ' ' GLY . 26.8 ttpt -82.55 -59.78 2.41 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.856 -0.794 . . . . 2.57 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.75 -37.13 49.85 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.935 -1.103 . . . . 0.51 109.127 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.7 m -63.44 -37.77 88.57 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.092 -1.077 . . . . 1.36 108.092 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.26 -22.5 60.37 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.459 -0.571 . . . . 0.6 109.459 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -75.22 -65.87 0.83 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.077 -1.014 . . . . 1.36 109.462 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.7 mt -54.09 -34.12 59.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.074 -1.016 . . . . 1.38 109.303 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.42 -53.24 51.48 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 1.27 109.135 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 m -60.81 -35.59 76.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.297 -0.877 . . . . 0.6 109.341 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' CD1' HH21 ' A' ' 136' ' ' ARG . 97.5 mt -70.77 -27.15 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.53 108.804 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -62.14 -42.88 99.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.471 -0.768 . . . . 0.99 109.775 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -71.37 -28.71 64.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.327 -0.858 . . . . 0.59 109.497 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.7 mttp -72.02 -26.7 62.32 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.762 -1.199 . . . . 1.81 107.762 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.14 -34.06 65.88 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.341 -0.985 . . . . 0.48 108.341 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.57 -27.97 31.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.405 -1.478 . . . . 0.58 109.405 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -86.61 -17.96 32.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.894 -1.356 . . . . 1.39 108.89 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -94.27 -48.89 5.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.282 -0.886 . . . . 0.82 110.081 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.497 ' C ' ' H ' ' A' ' 67' ' ' GLU . 61.1 m-85 -107.05 -36.62 6.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.196 -0.94 . . . . 0.99 110.092 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 72.02 -26.39 0.66 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.92 -1.272 . . . . 0.55 109.92 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 69' ' ' LYS . 43.5 mt-10 -51.15 -179.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.087 -1.243 . . . . 2.59 109.631 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -68.76 41.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 2.2 108.946 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 67' ' ' GLU . 15.0 mmmt -86.1 -13.99 45.58 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.577 -0.702 . . . . 1.79 109.401 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.11 -37.07 78.17 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.011 . . . . 1.54 110.566 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.99 -23.67 65.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.18 -0.95 . . . . 0.64 111.021 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 ' O ' ' ND1' ' A' ' 76' ' ' HIS . 23.1 mt -73.09 -47.09 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.83 -1.168 . . . . 0.58 110.11 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -76.75 -21.23 55.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.16 -0.962 . . . . 0.62 109.79 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.21 -51.46 60.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 1.23 109.671 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.35 -33.61 85.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.494 -1.442 . . . . 0.52 109.494 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.495 ' ND1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -62.43 -22.35 66.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 1.29 110.291 -179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 94.7 mt -83.36 -35.77 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.646 -1.284 . . . . 0.55 108.26 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ttt -58.55 -36.28 73.64 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.269 -1.012 . . . . 1.89 108.269 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 tp -65.89 -40.91 91.98 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.385 -0.968 . . . . 0.53 108.385 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.08 -48.22 66.13 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.539 -0.726 . . . . 0.43 110.027 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.68 8.97 17.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.109 -0.994 . . . . 1.24 110.824 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -48.7 128.17 14.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.833 -1.167 . . . . 1.31 109.516 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -66.08 -23.85 66.6 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.511 -0.922 . . . . 1.35 108.511 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -77.68 -55.53 5.27 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.424 -0.797 . . . . 2.16 108.958 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 mt -65.26 -24.66 67.38 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 119.393 -0.923 . . . . 0.6 109.265 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -75.7 -54.34 7.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.228 -0.92 . . . . 1.28 110.191 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -62.28 -28.4 69.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.213 -0.929 . . . . 1.28 109.726 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -73.74 -43.87 57.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.061 -1.025 . . . . 1.29 108.532 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.6 mt -58.61 -58.58 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.789 -1.189 . . . . 0.58 107.789 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 92.9 mt -47.7 -60.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.803 -0.561 . . . . 0.78 110.13 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.45 -59.18 2.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.192 -0.943 . . . . 0.86 110.158 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.9 mt -47.17 -52.04 16.68 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.371 -0.83 . . . . 0.79 109.664 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.9 mt -55.98 -45.93 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.237 -0.914 . . . . 0.71 110.769 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -85.58 -39.34 17.47 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.956 -1.09 . . . . 2.05 111.849 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -85.14 -31.06 23.49 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.683 -1.261 . . . . 1.59 111.922 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -109.63 14.46 23.4 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.895 -1.128 . . . . 1.89 109.621 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.3 m80 44.72 47.0 8.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 1.31 110.258 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.5 mtt -99.49 148.44 24.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.304 -0.873 . . . . 1.28 108.816 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.3 p -75.79 143.29 42.0 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.62 109.848 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.41 -30.02 7.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.47 108.972 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -74.29 -45.32 48.38 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.182 -1.044 . . . . 2.0 108.182 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.6 -54.94 10.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.306 0.574 . . . . 0.56 109.889 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.12 -54.74 39.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.358 -0.839 . . . . 0.48 109.483 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.12 58.83 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.319 -0.863 . . . . 0.44 109.414 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.517 ' O ' ' N ' ' A' ' 109' ' ' GLU . 17.7 t-80 -69.81 -49.14 55.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.216 -0.927 . . . . 1.42 109.813 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -47.5 -61.63 1.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -0.91 . . . . 1.26 110.016 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 78.0 t -48.97 -51.22 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.61 109.079 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.03 -19.09 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.545 -0.722 . . . . 0.64 109.211 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 105' ' ' HIS . 48.9 tt0 -72.37 -37.95 68.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 2.2 109.795 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.89 -20.96 52.27 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.489 -1.338 . . . . 0.82 112.036 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -68.51 -48.81 63.4 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.643 -1.504 . . . . 1.27 108.762 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.08 -48.87 21.75 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.233 0.54 . . . . 0.91 109.813 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.9 t -59.88 -44.97 93.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.73 110.065 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.39 -36.28 83.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.04 110.343 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -68.58 -29.61 68.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.869 -1.144 . . . . 1.03 109.516 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.31 -17.49 64.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.151 -0.968 . . . . 1.95 109.496 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -80.22 -5.07 55.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 1.71 108.894 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 66.5 mt -84.56 165.24 18.19 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 1.26 108.822 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -116.33 50.83 1.01 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.562 -0.711 . . . . 2.83 109.324 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -148.74 121.12 8.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.962 -1.086 . . . . 1.58 110.058 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -59.38 -9.73 2.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.482 -0.761 . . . . 2.8 109.61 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.49 -61.48 1.99 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.255 -0.903 . . . . 1.02 108.988 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.7 mt -69.89 -30.88 68.42 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.368 -0.833 . . . . 1.06 109.335 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 52.5 tttm -67.21 -47.15 71.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.006 . . . . 2.39 108.763 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.53 -21.42 62.47 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.502 -0.925 . . . . 2.2 108.502 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -72.85 -26.94 61.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.644 -1.613 . . . . 2.09 106.644 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -61.2 -45.65 93.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.228 -0.656 . . . . 0.86 109.228 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.0 -37.76 86.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.256 -0.902 . . . . 0.9 108.968 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -70.34 -32.18 69.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 1.35 109.334 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.01 -43.93 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.122 -0.986 . . . . 0.58 108.889 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -59.62 -35.84 75.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.18 -0.95 . . . . 3.22 108.517 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -60.25 -37.96 81.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 1.32 109.891 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -67.23 -26.39 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 0.5 108.986 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -77.44 -48.13 8.36 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.195 -1.562 . . . . 0.44 109.195 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.58 -35.86 63.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -1.076 . . . . 2.71 109.489 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.449 HH21 ' CD1' ' A' ' 57' ' ' ILE . 7.8 mtp180 -64.21 -45.02 90.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 2.2 108.982 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 tp -62.81 -49.06 76.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.366 -0.834 . . . . 1.13 109.825 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt -49.12 -63.89 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.038 -1.039 . . . . 0.54 109.514 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -45.99 -26.12 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 2.32 110.255 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -84.13 -44.09 14.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.968 -1.082 . . . . 1.26 109.79 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.6 mt -56.47 -44.98 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.066 -1.021 . . . . 0.62 109.397 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -87.88 10.64 17.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.67 109.495 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.11 28.02 7.66 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.672 -1.771 . . . . 0.68 108.672 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 tp -51.62 153.47 2.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.565 -0.962 . . . . 0.77 109.33 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -66.96 121.85 16.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 2.4 109.521 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.69 131.44 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.495 -0.928 . . . . 0.87 108.495 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 147' ' ' ILE . 2.9 mp -77.96 137.5 22.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.178 -0.951 . . . . 1.32 109.767 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.04 85.96 4.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.389 -0.82 . . . . 1.54 109.275 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 12.5 mt -82.08 -14.1 56.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.363 -0.836 . . . . 0.77 109.874 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.0 p -82.17 -22.51 36.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.09 . . . . 1.57 109.373 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -102.07 56.57 0.8 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.82 110.141 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.448 HG22 ' N ' ' A' ' 153' ' ' GLN . 26.5 mm -71.05 159.48 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.987 -1.071 . . . . 0.82 108.542 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.448 ' N ' HG22 ' A' ' 152' ' ' ILE . 4.6 pt20 -133.21 -25.55 1.76 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.457 -0.777 . . . . 2.11 109.645 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -115.86 138.0 51.57 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.505 -0.747 . . . . 1.41 109.445 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -67.81 121.69 16.52 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.325 -0.86 . . . . 1.3 108.935 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -149.64 177.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.183 -0.948 . . . . 0.57 109.808 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 158' ' ' LEU . 78.2 mt -91.52 158.72 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.164 -1.05 . . . . 0.43 108.164 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 ' N ' HG22 ' A' ' 157' ' ' ILE . 17.2 tp -107.11 120.47 42.2 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.596 0.712 . . . . 0.56 109.259 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -122.06 129.78 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.862 -0.792 . . . . 0.54 108.862 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.9 144.33 13.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.154 -0.967 . . . . 0.62 109.703 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -56.55 -30.98 63.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.697 -1.223 . . . . 0.8 107.697 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -173.27 156.8 3.23 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.021 -0.733 . . . . 2.34 109.021 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 20.6 mt -127.77 122.25 32.31 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.459 -0.776 . . . . 0.65 109.759 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 166' ' ' SER . 4.4 p -92.65 153.08 42.38 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 108.452 -0.944 . . . . 0.74 108.452 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -35.11 -30.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.452 2.101 . . . . 0.6 112.66 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 164' ' ' THR . 14.6 m -61.88 -53.05 61.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 0.63 109.22 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.88 -45.3 82.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.357 -0.84 . . . . 1.25 109.958 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 168' ' ' THR . 6.7 p -67.29 -25.01 65.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.225 -0.922 . . . . 0.5 110.087 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.3 -32.53 43.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.008 -1.058 . . . . 0.51 110.169 -179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -105.82 3.24 28.51 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.275 -0.891 . . . . 1.17 109.993 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -57.17 155.26 8.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.866 -1.146 . . . . 0.61 108.407 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.525 ' O ' HG23 ' A' ' 176' ' ' VAL . 23.8 t-20 -100.85 80.97 2.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.13 -0.981 . . . . 2.12 110.265 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 15.7 mt -71.2 33.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.166 -0.959 . . . . 1.34 109.483 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 172' ' ' ASN . 52.5 mttp -110.85 -25.39 9.89 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.424 -0.798 . . . . 1.97 109.403 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -132.92 8.47 4.1 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.495 -0.753 . . . . 1.9 109.732 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 172' ' ' ASN . 54.0 t -79.03 155.06 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.075 -1.016 . . . . 0.48 109.209 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 15.6 tp -117.23 -13.56 10.47 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.634 -0.666 . . . . 1.39 110.269 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.07 175.72 39.77 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.588 -1.292 . . . . 0.38 109.938 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.89 125.96 36.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.48 -1.012 . . . . 0.46 110.018 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.3 mt -127.76 128.31 69.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 107.856 -1.165 . . . . 0.59 107.856 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.513 ' O ' ' O ' ' A' ' 203' ' ' VAL . 24.0 p -138.79 144.42 39.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.316 -0.865 . . . . 0.67 110.766 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.446 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -84.33 37.74 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.379 -0.826 . . . . 2.24 110.319 -178.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -107.33 119.98 40.9 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.933 -1.104 . . . . 1.11 109.939 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.38 58.74 3.45 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.921 -1.272 . . . . 1.63 109.921 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.456 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -97.21 113.07 4.61 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.788 -1.325 . . . . 1.47 109.788 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 186' ' ' ARG . 0.1 OUTLIER -50.1 -15.91 0.26 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -1.187 . . . . 5.24 108.536 179.351 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.456 ' N ' ' C ' ' A' ' 185' ' ' GLY . 81.9 p -148.09 64.08 1.1 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.335 -0.987 . . . . 2.92 108.335 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.1 p -81.4 144.17 31.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.805 . . . . 1.6 109.723 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -51.73 -31.26 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.92 109.083 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 13.8 m -60.06 -32.79 71.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.432 -0.792 . . . . 1.59 109.434 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.8 t -75.53 -40.7 56.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 1.42 110.096 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.8 mt -53.35 -36.82 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.068 -1.02 . . . . 1.41 109.791 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 54.6 mtp -70.68 -48.52 54.39 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.451 -1.315 . . . . 0.86 107.451 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.95 -38.1 64.58 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.56 -0.746 . . . . 0.59 109.89 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -69.32 -47.77 63.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.229 -0.919 . . . . 3.06 109.97 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.7 m -68.57 -37.69 80.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.119 -0.988 . . . . 0.73 109.733 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.524 ' O ' ' N ' ' A' ' 199' ' ' LEU . 17.1 mt -88.68 -0.5 57.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.175 -0.953 . . . . 0.67 108.949 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 48.49 5.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.469 -0.769 . . . . 1.49 111.465 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' A' ' 197' ' ' LEU . 10.7 mt -67.1 169.51 8.24 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.653 -1.279 . . . . 0.64 108.368 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -90.32 142.45 3.63 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 122.152 1.901 . . . . 0.59 111.354 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.47 -178.86 6.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.688 -1.257 . . . . 0.55 111.32 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 16.3 mt -151.49 159.99 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 106.708 -1.59 . . . . 0.63 106.708 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.7 m -140.21 -31.69 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.89 -1.131 . . . . 0.77 111.06 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -85.47 41.54 3.08 Favored Glycine 0 N--CA 1.495 2.625 0 O-C-N 120.635 -1.29 . . . . 0.87 111.122 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 4.9 p -77.17 36.95 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.605 -1.527 . . . . 0.89 109.163 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 43.04 -99.04 0.01 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 110.362 -1.095 . . . . 0.93 110.362 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.436 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 31.4 p -135.0 42.1 2.8 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.624 -0.927 . . . . 1.6 110.498 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 15.8 t -51.9 -21.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.644 -1.285 . . . . 0.75 109.043 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.6 p -71.23 -18.17 62.46 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.061 -1.024 . . . . 0.84 109.118 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.53 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 23.3 m -101.31 13.44 35.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.388 -0.82 . . . . 1.61 109.115 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 210' ' ' SER . 15.3 mp0 -131.72 -24.34 2.21 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.405 -0.81 . . . . 2.3 109.513 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.454 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.0 t -113.39 158.2 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.255 -0.903 . . . . 0.76 109.763 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.454 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.6 mppt? -118.08 -174.84 2.73 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.718 -1.216 . . . . 2.01 107.718 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 18' ' ' LEU . 6.7 t30 -79.84 144.79 33.18 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.174 -0.954 . . . . 2.19 110.223 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CG ' HD22 ' A' ' 214' ' ' ASN . 2.2 m-20 80.83 -10.29 1.25 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.988 -0.445 . . . . 2.4 110.8 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.54 146.38 13.03 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.904 -1.122 . . . . 1.99 108.794 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -86.84 121.75 29.75 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 1.3 108.619 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 16' ' ' ALA . 40.4 mt -123.37 167.48 13.76 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 122.112 0.958 . . . . 0.53 110.491 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.0 mt -141.8 109.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.744 -1.206 . . . . 0.6 107.744 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 18.5 tp -85.36 124.74 32.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.106 -1.072 . . . . 0.57 108.106 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.438 ' O ' ' N ' ' A' ' 223' ' ' VAL . 5.0 m-20 -98.18 -34.69 10.64 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.242 -0.911 . . . . 2.22 110.251 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 40.12 28.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.568 -0.708 . . . . 0.75 110.195 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 221' ' ' ASP . 15.8 t -121.43 -52.64 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 106.56 -1.645 . . . . 0.92 106.56 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -98.47 10.33 41.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.202 -1.407 . . . . 2.36 107.202 177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.421 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.32 55.58 4.19 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.359 -0.608 . . . . 1.42 109.359 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -153.67 147.23 25.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.287 -0.883 . . . . 1.97 110.181 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 78.3 t -115.96 127.54 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.379 -0.971 . . . . 0.65 108.379 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -98.64 134.44 41.57 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.137 -0.977 . . . . 0.97 109.847 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.1 t -108.81 129.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.773 -0.58 . . . . 0.67 109.706 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.415 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 19.4 t-20 46.25 55.18 15.4 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.237 -0.914 . . . . 1.45 110.19 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 36.3 Cg_endo -67.16 159.88 50.08 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.611 2.207 . . . . 0.82 112.084 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.404 ' C ' ' N ' ' A' ' 234' ' ' GLU . 5.0 p -74.75 137.79 42.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.402 -0.811 . . . . 1.62 109.85 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -48.9 -18.79 0.31 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.862 . . . . 2.6 109.312 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 232' ' ' THR . 54.5 tt0 -69.42 -44.58 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.342 -0.849 . . . . 3.06 108.969 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.5 t -75.08 -28.78 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 1.14 109.201 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 33.8 mt -77.53 -60.47 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 1.04 109.842 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -54.58 -45.6 73.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.353 -0.842 . . . . 2.54 110.775 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -62.7 -43.98 97.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.315 -0.865 . . . . 2.6 110.331 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.428 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 88.1 mtp -80.24 -22.89 41.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.014 -1.054 . . . . 1.23 109.815 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 240' ' ' ARG . 0.7 OUTLIER -55.89 -48.71 75.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.082 -1.011 . . . . 2.67 109.74 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.85 -47.48 25.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.935 . . . . 1.66 110.456 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.78 -47.63 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.065 . . . . 2.2 110.425 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 239' ' ' MET . 9.1 tm0? -53.87 -58.09 8.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 3.0 110.694 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -58.81 -23.11 59.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.153 -0.967 . . . . 1.76 110.002 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -67.99 -25.8 65.6 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.459 -1.312 . . . . 2.78 107.459 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.53 -53.22 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.052 -0.721 . . . . 2.06 109.052 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.32 -27.85 69.31 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.396 -0.815 . . . . 2.4 109.519 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.8 p -77.34 -25.41 51.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.341 -0.849 . . . . 2.87 109.927 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 3.41 110.219 -179.454 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.165 -0.68 . . . . 3.66 109.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.8 mt 50.71 84.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.484 -0.76 . . . . 1.12 109.515 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -97.95 117.18 31.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 1.45 108.728 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.77 -161.04 17.54 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.684 -1.766 . . . . 0.92 108.684 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 63.2 mt -98.22 -8.61 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 1.05 108.973 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 23.2 tp 54.47 104.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.661 -0.866 . . . . 0.88 108.661 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.19 13.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.086 -1.009 . . . . 0.78 109.22 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.79 148.35 27.43 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.246 -0.909 . . . . 1.5 108.692 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.19 151.59 15.93 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.422 2.081 . . . . 0.86 113.548 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.3 -177.78 38.34 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.384 -1.486 . . . . 0.78 109.384 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 55.7 mt -141.9 133.64 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.108 -1.231 . . . . 0.74 108.721 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.2 158.68 43.59 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.332 -0.855 . . . . 0.45 109.458 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.59 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -131.01 130.64 43.58 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.362 -0.977 . . . . 0.64 108.362 179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.23 163.97 33.61 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 118.397 -1.858 . . . . 0.45 111.528 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -79.36 148.68 31.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.651 -0.911 . . . . 1.88 109.275 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -74.03 132.45 42.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 0.59 111.507 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.9 tp -111.01 93.52 4.53 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 107.104 -1.443 . . . . 0.64 107.104 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 8.2 tp -81.41 124.69 29.62 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.74 110.079 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 158' ' ' LEU . 16.3 mt -97.38 98.23 9.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.71 0.767 . . . . 0.74 110.154 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.83 156.64 16.49 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.91 -0.774 . . . . 1.87 108.91 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -131.65 133.09 44.54 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.244 -0.91 . . . . 2.58 109.733 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.04 134.97 37.68 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.209 -0.932 . . . . 2.14 108.666 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.4 150.22 48.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 1.93 109.813 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.24 132.95 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.352 -0.843 . . . . 0.68 109.101 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -107.11 124.03 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.441 -0.787 . . . . 0.84 109.364 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -89.63 137.98 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.55 -0.719 . . . . 0.79 109.335 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.55 120.62 31.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.229 -0.92 . . . . 1.37 109.733 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.1 mmt-85 -93.57 32.19 1.43 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.316 -0.865 . . . . 2.62 109.145 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -87.44 142.96 27.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.409 -0.807 . . . . 2.35 109.723 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -87.59 132.33 34.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.176 -0.952 . . . . 2.35 108.85 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.494 HD13 ' HG3' ' A' ' 39' ' ' GLU . 17.6 pt -86.86 170.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.78 110.192 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.41 ' H ' ' HB2' ' A' ' 35' ' ' GLN . 80.5 p -105.17 166.2 10.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.94 -0.763 . . . . 1.04 108.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.35 -20.24 64.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.07 -1.019 . . . . 1.05 109.461 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -83.03 -13.8 55.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.119 -1.067 . . . . 2.47 108.119 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 32' ' ' SER . 21.5 mt-30 -102.65 -10.67 19.04 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.871 -0.789 . . . . 1.46 108.871 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.35 -46.75 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.023 -1.103 . . . . 0.77 108.023 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -56.51 -39.72 73.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 1.46 109.614 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -70.69 -39.4 73.5 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.487 -0.758 . . . . 2.29 110.919 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' HD13 ' A' ' 31' ' ' ILE . 33.6 mm-40 -61.04 -41.9 97.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.885 -1.134 . . . . 1.3 108.685 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' LEU . 57.7 t -62.99 -44.8 99.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.426 -0.796 . . . . 0.76 109.242 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.6 tp10 -66.57 -46.34 76.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -0.91 . . . . 1.5 108.834 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.4 mtt-85 -60.57 -31.01 70.15 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.227 -1.027 . . . . 2.66 108.227 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -86.43 -58.05 2.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.376 -0.827 . . . . 0.75 108.778 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 40' ' ' VAL . 6.7 tp -52.01 -60.53 3.09 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.303 -0.873 . . . . 0.83 109.159 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 8.0 t -63.91 -31.27 72.4 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.656 -1.239 . . . . 0.78 107.656 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.24 -52.35 50.16 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 106.856 -2.498 . . . . 0.57 106.856 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -48.56 -30.86 5.74 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.7 -0.882 . . . . 2.83 108.88 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.44 -35.91 76.96 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.514 -0.921 . . . . 0.65 108.514 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -81.44 -58.48 3.01 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.826 -0.805 . . . . 2.57 108.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.55 29.88 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.973 -1.079 . . . . 0.51 109.772 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -65.55 -36.58 84.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 1.36 108.406 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.67 -20.33 61.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.82 -0.55 . . . . 0.6 109.611 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' ND2' ' A' ' 140' ' ' ASN . 46.6 mt-30 -77.86 -63.71 1.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.247 -0.908 . . . . 1.36 109.351 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.6 mp -52.77 -40.2 62.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.153 -0.967 . . . . 1.38 108.898 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -52.88 -50.91 62.92 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.808 -0.812 . . . . 1.27 108.808 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m -62.93 -39.99 96.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -0.8 . . . . 0.6 109.639 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.3 mt -72.85 -20.19 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.419 -0.801 . . . . 0.53 109.042 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -71.35 -49.93 37.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.423 -0.798 . . . . 0.99 110.368 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -70.74 -23.66 62.48 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.59 109.253 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -69.82 -37.41 76.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.125 -1.435 . . . . 1.81 107.125 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.13 -28.22 69.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.63 -32.16 19.57 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.673 -1.371 . . . . 0.58 109.673 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -86.22 -17.15 35.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.067 -1.255 . . . . 1.39 108.312 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.6 m -93.35 -50.57 5.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.443 -0.785 . . . . 0.82 109.58 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 67' ' ' GLU . 47.1 m-85 -106.95 -39.34 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.368 -0.833 . . . . 0.99 109.936 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.73 -29.12 0.62 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.851 -1.3 . . . . 0.55 109.851 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' A' ' 69' ' ' LYS . 66.5 mt-10 -52.66 -173.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -1.204 . . . . 2.59 109.793 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -71.05 31.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.594 -0.692 . . . . 2.2 109.704 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 67' ' ' GLU . 10.9 mmmt -83.72 -13.71 53.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.038 -1.039 . . . . 1.79 108.875 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -66.85 -37.26 84.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.268 -0.895 . . . . 1.54 110.196 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.03 -20.49 65.86 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.254 -0.904 . . . . 0.64 110.761 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 91.5 mt -75.03 -46.73 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.822 -1.174 . . . . 0.58 109.881 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.92 -28.34 49.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.62 110.307 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -64.4 -49.97 69.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 1.23 109.735 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.31 -37.19 93.65 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.209 -1.556 . . . . 0.52 109.209 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -57.28 -20.75 30.02 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.38 -1.071 . . . . 1.29 109.247 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 53.6 mt -82.42 -36.85 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.079 -1.082 . . . . 0.55 108.079 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.7 ttp -58.44 -48.72 79.78 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.692 -0.855 . . . . 1.89 108.692 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.4 tp -54.5 -41.57 69.77 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.422 -0.955 . . . . 0.53 108.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.2 tp -66.23 -45.42 80.75 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.546 -0.721 . . . . 0.43 109.45 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -84.57 11.5 8.69 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.272 -0.892 . . . . 1.24 110.24 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -53.57 127.56 25.77 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.102 -0.999 . . . . 1.31 110.346 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.21 -22.83 65.7 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.563 -0.903 . . . . 1.35 108.563 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -77.51 -52.43 9.09 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.464 -0.772 . . . . 2.16 109.259 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.9 mt -64.82 -14.53 59.59 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.105 -0.997 . . . . 0.6 109.606 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -80.08 -52.32 7.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.112 -0.993 . . . . 1.28 110.165 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.58 -29.35 69.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 1.28 109.755 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -72.14 -46.79 55.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.131 -0.98 . . . . 1.29 108.66 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 52.4 mt -56.6 -42.25 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.374 -0.973 . . . . 0.58 108.374 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 98.5 mt -67.4 -62.3 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.591 -0.693 . . . . 0.78 110.084 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.04 -32.15 8.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.123 -0.986 . . . . 0.86 109.89 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.65 -58.77 4.93 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.125 -1.03 . . . . 0.79 108.288 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -47.91 -46.68 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.618 -0.677 . . . . 0.71 110.362 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -80.41 -33.95 36.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.94 . . . . 2.05 111.478 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -79.78 -47.07 15.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.696 -1.252 . . . . 1.59 111.283 -177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -104.36 17.64 23.72 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.807 -1.183 . . . . 1.89 110.989 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.444 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 4.1 m80 44.75 50.13 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.04 -1.037 . . . . 1.31 109.845 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.2 mtm -107.58 152.31 24.44 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.99 -0.744 . . . . 1.28 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 p -77.06 152.03 35.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.513 -0.742 . . . . 0.62 109.321 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.36 -30.9 13.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.134 -0.979 . . . . 0.47 109.047 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.5 -43.48 60.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.315 -0.995 . . . . 2.0 108.315 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.5 -57.33 4.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.79 -0.568 . . . . 0.56 110.44 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.99 65.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.48 109.529 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.91 -31.69 29.58 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.139 -0.976 . . . . 0.44 109.147 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -68.08 -30.77 70.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.933 -1.104 . . . . 1.42 109.652 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -69.19 -49.73 53.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.051 -1.031 . . . . 1.26 109.516 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -58.86 -46.09 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.029 -1.044 . . . . 0.61 109.259 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -63.3 -17.81 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.457 -0.942 . . . . 0.64 108.457 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -76.37 -38.61 55.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.266 -0.896 . . . . 2.2 110.347 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.81 -26.49 31.84 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.255 -1.45 . . . . 0.82 111.928 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.27 -46.82 78.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.677 -1.484 . . . . 1.27 108.278 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.39 -51.0 18.88 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.889 -0.507 . . . . 0.91 110.078 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.0 m -60.64 -40.66 92.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.099 -1.0 . . . . 1.73 110.12 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -37.82 88.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.924 -1.11 . . . . 1.04 111.041 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.97 -27.35 66.51 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.692 -1.255 . . . . 1.03 109.511 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -69.52 -17.74 63.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.113 -0.992 . . . . 1.95 109.684 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.75 -7.03 59.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 1.71 109.433 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.61 146.69 25.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.241 -0.912 . . . . 1.26 109.266 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -100.48 62.33 1.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.343 -0.848 . . . . 2.83 109.152 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -147.99 124.7 11.15 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.123 -0.986 . . . . 1.58 109.737 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -63.8 -12.93 39.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.196 -0.94 . . . . 2.8 109.673 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -58.06 3.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 1.02 108.813 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.52 -26.56 61.81 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.417 -0.802 . . . . 1.06 109.866 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 23.0 ttpp -70.81 -53.94 13.49 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.035 -1.041 . . . . 2.39 108.628 179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.402 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 54.2 mm-40 -57.43 -20.53 30.73 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.942 -1.132 . . . . 2.2 107.942 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -73.6 -27.78 61.48 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.575 -1.639 . . . . 2.09 106.575 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.37 -44.59 92.71 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.838 -0.801 . . . . 0.86 108.838 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.04 -41.35 82.24 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.433 -0.792 . . . . 0.9 109.526 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -68.48 -27.69 66.37 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.173 -0.955 . . . . 1.35 109.737 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.59 -42.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.11 -0.994 . . . . 0.58 109.48 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -59.82 -33.94 72.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.03 -1.044 . . . . 3.22 108.379 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -62.09 -38.09 87.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.49 -0.756 . . . . 1.32 109.691 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.8 mt -66.48 -28.55 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 0.5 108.892 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.73 26.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 108.201 -1.96 . . . . 0.44 108.201 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -54.66 -46.05 73.95 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.526 -0.985 . . . . 2.71 109.307 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 84.2 mtt180 -65.36 -44.16 88.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.001 -1.062 . . . . 2.2 108.358 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 25.8 tp -56.68 -43.66 80.65 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.56 -0.713 . . . . 1.13 109.556 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.405 ' O ' ' N ' ' A' ' 140' ' ' ASN . 13.6 mt -62.71 -58.63 6.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.16 -0.962 . . . . 0.54 109.87 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -46.58 -19.58 0.09 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 2.32 110.432 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.423 ' ND2' ' OE1' ' A' ' 53' ' ' GLN . 2.3 m120 -85.1 -39.53 17.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.01 -1.056 . . . . 1.26 110.104 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 58.0 mt -68.87 -37.84 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.872 -1.142 . . . . 0.62 109.803 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.9 mt -87.26 -1.22 57.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.121 -0.987 . . . . 0.67 108.742 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.46 25.93 43.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.417 -1.873 . . . . 0.68 108.417 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.53 156.35 1.86 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.638 -0.919 . . . . 0.77 109.116 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -67.3 143.48 56.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 2.4 109.369 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 68.0 mt -104.25 148.83 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.311 -0.868 . . . . 0.87 108.673 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.726 ' H ' HD12 ' A' ' 147' ' ' ILE . 4.2 mp -81.25 128.77 38.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 1.32 108.855 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -92.48 85.55 5.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.349 -0.844 . . . . 1.54 109.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.7 mt -82.51 -37.73 24.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.243 -0.911 . . . . 0.77 109.326 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 p -80.53 38.35 0.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 1.57 109.036 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.54 21.86 2.72 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.812 -0.81 . . . . 0.82 108.812 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.446 HD12 HD21 ' A' ' 172' ' ' ASN . 58.7 mt -71.48 144.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.623 -0.673 . . . . 0.82 109.273 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -133.77 -2.54 2.97 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.788 -0.819 . . . . 2.11 108.788 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -122.38 144.1 49.24 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.873 -0.788 . . . . 1.41 108.873 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -74.76 121.45 21.76 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.361 -0.837 . . . . 1.3 108.99 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.74 173.76 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.57 109.33 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 31.6 mt -89.71 151.51 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.076 -1.083 . . . . 0.43 108.076 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD11 HD11 ' A' ' 19' ' ' LEU . 15.5 tp -105.81 117.8 34.95 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.617 -0.883 . . . . 0.56 108.617 179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.5 t -124.59 136.86 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 109.04 -0.726 . . . . 0.54 109.04 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -164.97 152.05 10.9 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.821 -0.752 . . . . 0.62 109.568 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.19 78.31 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.641 -1.287 . . . . 0.8 107.663 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -173.26 149.9 1.83 Allowed 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.186 -0.672 . . . . 2.34 109.186 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.8 mt -115.75 139.11 50.48 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.36 -0.837 . . . . 0.65 110.088 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 73.7 p -98.02 149.92 36.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.255 -0.903 . . . . 0.74 109.455 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -33.53 -51.19 0.5 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.859 2.372 . . . . 0.6 112.598 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.413 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 19.7 m -53.47 -53.73 47.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.367 -0.833 . . . . 0.63 108.965 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -58.1 -43.4 87.12 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.469 -0.77 . . . . 1.25 109.595 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.5 p -70.86 -31.73 68.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.5 109.638 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.39 -24.52 59.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.51 110.222 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -103.03 -7.24 21.55 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.169 -0.957 . . . . 1.17 109.187 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -56.28 144.04 31.68 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.326 -0.99 . . . . 0.61 108.326 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 174' ' ' LYS . 4.8 p30 -98.87 92.03 5.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.301 -0.874 . . . . 2.12 109.856 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 34.7 mt -72.0 39.54 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.253 -1.018 . . . . 1.34 108.253 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.534 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.2 mtpp -110.53 -28.1 8.67 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.669 -0.644 . . . . 1.97 109.843 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -131.61 7.65 4.49 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.509 -0.744 . . . . 1.9 109.598 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 177' ' ' LEU . 96.0 t -79.22 154.93 4.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.941 -1.099 . . . . 0.48 108.8 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.409 ' N ' HG12 ' A' ' 176' ' ' VAL . 20.0 tp -113.26 -25.36 8.9 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.796 -0.565 . . . . 1.39 109.734 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.38 177.44 48.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.618 -1.393 . . . . 0.38 109.618 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -129.68 124.81 34.5 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.603 -0.939 . . . . 0.46 109.687 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 5.7 mt -124.48 120.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 107.189 -1.411 . . . . 0.59 107.189 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.503 ' O ' ' O ' ' A' ' 203' ' ' VAL . 30.7 p -140.56 151.69 44.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.982 0.896 . . . . 0.67 112.084 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -95.79 45.55 1.08 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.629 -0.669 . . . . 2.24 109.843 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.03 -151.72 0.28 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.989 -1.069 . . . . 1.11 110.631 -178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.42 -94.81 1.11 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.842 -1.303 . . . . 1.63 109.842 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 150.41 -41.94 0.78 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.252 -1.539 . . . . 1.47 109.252 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.6 mtm180 -62.19 101.27 0.21 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -1.114 . . . . 5.24 109.318 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 27.5 p 51.85 39.73 26.38 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.303 -0.873 . . . . 2.92 109.327 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 189' ' ' HIS . 18.9 p -83.29 130.55 35.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 1.6 108.919 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.433 ' C ' ' O ' ' A' ' 188' ' ' SER . 17.0 t60 -37.14 -56.25 0.93 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-O 121.328 0.585 . . . . 0.92 110.407 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 91.7 m -45.54 -56.23 5.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.465 -0.772 . . . . 1.59 109.846 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 9.6 m -52.85 -44.41 66.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 1.42 110.324 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 23.4 mm -49.91 -33.55 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.948 -1.095 . . . . 1.41 109.752 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 42.5 mtp -73.3 -57.94 3.66 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.449 -1.315 . . . . 0.86 107.449 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.17 -36.6 73.27 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.774 -0.648 . . . . 0.59 109.835 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.31 -52.37 19.2 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 3.06 110.675 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 13.7 m -69.84 -35.74 75.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.902 . . . . 0.73 110.488 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 199' ' ' LEU . 19.9 mt -86.87 0.2 55.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.67 109.278 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 51.99 5.9 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.54 -0.725 . . . . 1.49 111.62 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 197' ' ' LEU . 22.1 mt -66.39 167.09 13.8 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.458 -1.401 . . . . 0.64 107.655 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -85.5 138.57 6.4 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.872 1.715 . . . . 0.59 110.95 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.5 -177.6 6.06 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.471 -1.292 . . . . 0.55 111.63 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 12.8 mt -149.52 162.1 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.646 -1.613 . . . . 0.63 106.646 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 181' ' ' THR . 14.3 m -144.18 -36.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 120.507 -1.371 . . . . 0.77 111.673 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -86.06 39.42 3.04 Favored Glycine 0 N--CA 1.492 2.393 0 O-C-N 120.719 -1.238 . . . . 0.87 110.489 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 p -66.31 -30.44 70.85 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 120.951 -1.323 . . . . 0.89 108.511 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 72.87 -93.71 0.66 Allowed Glycine 0 N--CA 1.49 2.261 0 C-N-CA 120.116 -1.04 . . . . 0.93 111.758 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.42 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 5.0 t -113.77 42.43 2.01 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.286 -1.126 . . . . 1.6 112.49 -176.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.4 t -71.98 -27.27 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.438 -1.414 . . . . 0.75 107.464 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 78.7 p -65.79 -8.31 20.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.26 -0.9 . . . . 0.84 109.206 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.415 ' O ' ' NE2' ' A' ' 211' ' ' GLN . 14.8 m -104.34 5.58 34.59 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 108.417 -0.957 . . . . 1.61 108.417 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 207' ' ' SER . 14.8 mp0 -131.22 -7.29 3.82 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.911 -0.774 . . . . 2.3 108.911 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.85 150.84 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.703 . . . . 0.76 109.179 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -126.88 166.11 18.09 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.407 -1.701 . . . . 2.01 106.407 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.436 ' O ' ' OD2' ' A' ' 215' ' ' ASP . 43.0 t-20 -70.11 143.31 52.43 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.942 -1.099 . . . . 2.19 110.695 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.436 ' OD2' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 78.8 -12.08 1.13 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.87 -0.519 . . . . 2.4 111.515 178.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -58.03 147.14 30.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.494 -1.379 . . . . 1.99 108.882 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.97 117.52 25.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.0 -1.062 . . . . 1.3 108.847 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 9.2 mt -133.46 139.24 46.58 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.641 -0.662 . . . . 0.53 109.224 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 97.2 mt -109.38 129.77 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.115 -1.069 . . . . 0.6 108.115 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 11.2 tp -91.81 124.44 35.94 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.839 -1.171 . . . . 0.57 107.839 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' O ' ' N ' ' A' ' 223' ' ' VAL . 0.9 OUTLIER -95.53 -34.44 12.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.27 -0.894 . . . . 2.22 109.472 -179.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 41.03 21.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.355 0.598 . . . . 0.75 109.976 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 221' ' ' ASP . 13.1 t -113.08 -66.91 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 106.806 -1.554 . . . . 0.92 106.806 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -83.79 16.97 2.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.183 -1.414 . . . . 2.36 107.183 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.7 t30 53.96 57.11 6.29 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.433 -0.951 . . . . 1.42 108.433 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -155.77 150.16 25.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 1.97 110.958 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . 0.503 HG12 ' N ' ' A' ' 228' ' ' TYR . 73.9 t -107.35 162.26 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.312 -0.995 . . . . 0.65 108.312 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.503 ' N ' HG12 ' A' ' 227' ' ' VAL . 25.2 m-85 -126.5 118.16 24.36 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.405 -0.809 . . . . 0.97 109.233 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.0 t -100.5 114.9 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.375 -0.828 . . . . 0.67 109.883 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 44.7 t30 73.05 72.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.78 0 CA-C-O 121.417 0.627 . . . . 1.45 109.618 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -90.93 145.97 3.69 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.453 2.769 . . . . 0.82 112.231 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.4 m -74.68 161.64 29.48 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.62 109.473 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.59 -21.47 61.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 2.6 108.786 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.53 -30.85 66.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.5 -0.75 . . . . 3.06 110.139 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.34 -38.02 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.14 -0.975 . . . . 1.14 109.04 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.1 mt -63.61 -54.98 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.639 -0.663 . . . . 1.04 109.683 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 1.2 m-20 -54.78 -38.46 67.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.197 -0.939 . . . . 2.54 110.415 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.07 -46.15 75.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.34 -0.85 . . . . 2.6 110.924 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 40.5 mtm -78.53 -29.18 46.31 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.909 -1.119 . . . . 1.23 109.791 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm-85 -54.61 -41.3 69.8 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.182 -0.949 . . . . 2.67 108.948 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.11 -35.54 59.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 1.66 109.886 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 46.1 t -77.8 -50.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.03 -1.044 . . . . 2.2 111.306 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -62.77 -50.79 69.63 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.671 -1.268 . . . . 3.0 109.619 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -62.78 -25.89 68.45 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.004 -1.06 . . . . 1.76 110.212 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -69.31 -23.24 63.77 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.865 -1.161 . . . . 2.78 107.865 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.4 t -73.82 -41.88 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.345 -0.983 . . . . 2.06 108.345 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.14 -36.92 63.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -0.86 . . . . 2.4 108.843 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 -27.07 50.95 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 2.87 109.489 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 3.41 109.718 -179.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.628 -0.508 . . . . 3.66 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.5 mt -94.85 98.17 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.291 -0.881 . . . . 1.12 109.327 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.3 m -94.63 114.06 25.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.231 -0.918 . . . . 1.45 108.938 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.448 ' O ' ' ND2' ' A' ' 225' ' ' ASN . . . -103.78 -166.09 25.2 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.176 -1.569 . . . . 0.92 109.176 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 6' ' ' LEU . 66.5 mt -94.32 -10.25 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 1.05 108.083 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 225' ' ' ASN . 11.9 tp 57.81 110.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.489 -0.757 . . . . 0.88 109.805 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.98 -45.96 9.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.058 . . . . 0.78 108.676 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -148.92 151.15 34.25 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.354 -0.841 . . . . 1.5 108.934 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.64 149.54 18.58 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.505 2.137 . . . . 0.86 114.242 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.723 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.4 -175.48 38.83 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.666 -1.374 . . . . 0.78 109.666 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 15.1 mt -147.9 128.69 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.119 -1.224 . . . . 0.74 109.202 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.85 160.12 40.48 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.273 -0.892 . . . . 0.45 110.174 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 10.9 m-85 -129.91 129.48 43.94 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.119 -1.067 . . . . 0.64 108.119 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.89 166.77 37.2 Favored Glycine 0 N--CA 1.496 2.647 0 C-N-CA 118.208 -1.949 . . . . 0.45 111.609 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -79.6 149.56 31.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.735 -0.862 . . . . 1.88 109.984 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -76.82 123.08 25.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.59 110.773 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.01 93.83 5.23 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 107.852 -1.166 . . . . 0.64 107.852 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.06 127.52 33.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.022 -1.049 . . . . 0.74 110.599 -178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.1 mt -95.22 94.92 8.18 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.399 0.619 . . . . 0.74 110.28 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -95.46 142.71 27.5 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.251 -1.018 . . . . 1.87 108.251 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -130.72 142.09 50.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.285 -0.884 . . . . 2.58 108.91 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -78.4 135.6 37.46 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.194 -0.941 . . . . 2.14 109.103 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -63.99 151.22 43.4 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.316 -0.865 . . . . 1.93 109.277 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -88.67 128.59 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.17 -0.957 . . . . 0.68 109.527 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 t -102.9 115.14 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.809 -0.812 . . . . 0.84 108.809 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.7 mt -88.61 137.72 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.128 -0.983 . . . . 0.79 109.731 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -90.03 120.56 31.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.181 -0.949 . . . . 1.37 109.278 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -99.71 26.46 6.2 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.486 -0.759 . . . . 2.62 109.283 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -85.03 148.65 26.06 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.115 -0.99 . . . . 2.35 110.527 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -87.73 121.72 30.51 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.385 -0.969 . . . . 2.35 108.385 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.2 pt -82.53 174.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.025 -1.047 . . . . 0.78 110.565 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASP . 78.1 p -97.27 153.64 17.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.612 -0.885 . . . . 1.04 108.612 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -55.07 -8.13 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 1.05 109.811 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' SER . 67.8 m-20 -83.11 -12.39 57.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.113 -0.992 . . . . 2.47 110.193 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -114.75 -3.62 12.8 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.334 -0.854 . . . . 1.46 109.716 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 64.9 t -66.11 -47.26 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.907 -1.121 . . . . 0.77 109.257 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.46 -36.31 63.95 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 1.46 109.091 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.438 ' NE2' ' NH2' ' A' ' 42' ' ' ARG . 13.5 mt-30 -69.78 -35.21 74.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.496 -0.752 . . . . 2.29 110.587 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -62.96 -40.15 96.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.847 -1.158 . . . . 1.3 109.21 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -62.06 -46.11 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.37 -0.831 . . . . 0.76 109.341 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -66.8 -44.47 81.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.14 -0.975 . . . . 1.5 108.986 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' NH2' ' NE2' ' A' ' 38' ' ' GLN . 72.3 mtt180 -64.79 -32.01 73.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.404 -0.81 . . . . 2.66 109.051 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.93 -50.23 7.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.75 108.664 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.9 tp -59.87 -59.43 5.44 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.422 -0.799 . . . . 0.83 109.013 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.579 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 7.1 t -65.8 -29.23 69.68 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.236 -1.024 . . . . 0.78 108.236 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.01 -54.08 41.09 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 107.768 -2.133 . . . . 0.57 107.768 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.1 ttp180 -49.83 -30.22 9.4 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.496 -1.003 . . . . 2.83 108.822 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.48 -39.46 80.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.12 -1.067 . . . . 0.65 108.12 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' ALA . 22.1 mtmm -81.23 -60.5 2.26 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.002 -0.74 . . . . 2.57 109.002 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.57 -39.55 16.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.069 -1.019 . . . . 0.51 109.506 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -64.06 -35.81 81.94 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.026 -1.101 . . . . 1.36 108.026 178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -73.59 -24.84 60.12 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.145 0.497 . . . . 0.6 109.794 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -75.8 -64.69 1.03 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.133 -0.98 . . . . 1.36 109.57 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.1 mp -52.95 -35.0 58.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 1.38 108.854 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -60.77 -47.92 84.13 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.823 -0.806 . . . . 1.27 108.823 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.7 m -63.55 -38.92 92.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.355 -0.841 . . . . 0.6 109.857 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.1 mt -69.93 -25.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.155 -0.965 . . . . 0.53 108.808 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -66.16 -42.74 88.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.398 -0.814 . . . . 0.99 109.784 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -74.09 -25.42 59.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.335 -0.853 . . . . 0.59 109.981 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 64' ' ' THR . 79.2 mttt -72.95 -38.59 66.72 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.752 -1.203 . . . . 1.81 107.752 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.36 70.42 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.36 -0.978 . . . . 0.48 108.36 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.48 -33.85 15.56 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.348 -1.501 . . . . 0.58 109.348 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -86.57 -15.29 40.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.328 . . . . 1.39 108.691 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 60' ' ' LYS . 86.3 m -92.77 -49.65 5.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.355 -0.841 . . . . 0.82 109.911 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' C ' ' H ' ' A' ' 67' ' ' GLU . 62.9 m-85 -107.19 -34.96 6.97 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.212 -0.93 . . . . 0.99 110.156 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 66.83 -34.27 0.18 Allowed Glycine 0 N--CA 1.496 2.638 0 N-CA-C 110.294 -1.122 . . . . 0.55 110.294 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' A' ' 69' ' ' LYS . 8.6 tt0 -52.45 -173.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -1.219 . . . . 2.59 109.159 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -67.93 35.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.019 -1.051 . . . . 2.2 110.256 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 67' ' ' GLU . 24.1 mmtm -92.42 -18.24 23.52 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.581 -0.7 . . . . 1.79 109.325 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.62 -38.67 67.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.117 -0.99 . . . . 1.54 111.001 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.88 -18.98 65.71 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.225 -0.922 . . . . 0.64 111.296 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.01 -41.39 68.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.91 -1.119 . . . . 0.58 109.983 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -80.23 -24.67 40.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.109 -0.994 . . . . 0.62 110.069 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.67 -48.53 78.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.997 -1.065 . . . . 1.23 109.571 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.44 -39.16 94.03 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.461 -1.456 . . . . 0.52 109.461 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -15.68 40.73 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -1.133 . . . . 1.29 110.415 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 74.9 mt -85.6 -43.28 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.433 -1.417 . . . . 0.55 108.954 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.4 ttp -57.19 -41.21 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 1.89 108.948 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -62.81 -38.34 90.34 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.754 -0.832 . . . . 0.53 108.754 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.8 tp -68.63 -41.11 79.9 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.601 -0.888 . . . . 0.43 108.601 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -85.83 6.8 26.51 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 1.24 110.162 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -48.42 122.25 5.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.846 -1.159 . . . . 1.31 109.656 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -67.23 -25.23 66.0 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.815 -0.809 . . . . 1.35 108.815 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.85 -48.77 17.46 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.699 -0.8 . . . . 2.16 109.668 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.95 -17.26 63.09 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.605 -1.238 . . . . 0.6 108.593 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -78.99 -40.36 31.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.491 -0.756 . . . . 1.28 110.13 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -66.1 -34.82 78.93 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 1.28 110.535 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -71.42 -40.25 70.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.071 . . . . 1.29 109.323 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.5 mt -60.69 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.419 -0.956 . . . . 0.58 108.419 178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 70.1 mt -43.12 -60.14 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.806 -0.559 . . . . 0.78 110.358 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.91 -49.83 62.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.159 -0.963 . . . . 0.86 110.188 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.5 mt -52.7 -56.15 17.53 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.102 -0.999 . . . . 0.79 109.13 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.1 mt -53.07 -46.56 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.368 -0.833 . . . . 0.71 111.08 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -85.15 -36.98 20.73 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.003 -1.061 . . . . 2.05 111.76 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -83.66 -32.52 25.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.816 -1.177 . . . . 1.59 112.155 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -107.57 15.18 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.703 -1.248 . . . . 1.89 110.237 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.2 OUTLIER 46.36 41.26 8.95 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.078 -1.014 . . . . 1.31 109.739 179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 27.6 mtp -100.09 152.17 20.54 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.778 -0.823 . . . . 1.28 108.778 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.4 p -76.74 146.69 37.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.211 -0.93 . . . . 0.62 109.266 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -49.78 -26.95 4.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.165 -0.959 . . . . 0.47 108.893 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.441 ' OD1' ' CD2' ' A' ' 138' ' ' LEU . 21.8 t0 -76.31 -47.06 24.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.061 -0.718 . . . . 2.0 109.061 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.55 -53.13 20.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.731 -0.606 . . . . 0.56 110.472 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.83 -53.82 52.11 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.246 -0.909 . . . . 0.48 109.717 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.43 -31.24 33.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.454 -0.779 . . . . 0.44 109.697 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -68.79 -27.86 66.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.955 -1.091 . . . . 1.42 109.716 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -69.5 -55.55 9.91 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.275 -0.89 . . . . 1.26 109.933 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 40.9 t -53.07 -46.04 54.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.931 -1.106 . . . . 0.61 109.273 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.18 -17.75 21.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.443 -0.786 . . . . 0.64 108.951 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -73.77 -37.87 64.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 2.2 109.732 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.07 -22.98 42.87 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.466 -1.35 . . . . 0.82 111.996 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -66.42 -42.04 88.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.695 -1.474 . . . . 1.27 108.261 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.67 -50.18 16.18 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.579 -0.7 . . . . 0.91 109.133 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 t -60.47 -43.91 96.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.361 -0.837 . . . . 1.73 109.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.45 -34.39 78.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.192 -0.942 . . . . 1.04 111.288 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.48 -28.11 67.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.621 -1.3 . . . . 1.03 109.13 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.41 -17.81 63.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 1.95 109.269 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -83.01 -5.03 58.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.352 -0.842 . . . . 1.71 109.961 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 123' ' ' LEU . 2.6 mt -82.19 147.65 28.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.244 -1.021 . . . . 1.26 108.244 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -92.88 54.57 2.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 2.83 109.154 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 122' ' ' TYR . 16.7 t0 -148.98 106.91 3.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.58 109.069 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -53.42 -9.68 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.479 -0.763 . . . . 2.8 109.138 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.469 ' H ' ' C ' ' A' ' 120' ' ' ASP . 1.6 t80 -79.8 -64.47 1.18 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.77 . . . . 1.02 109.272 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.55 HD13 HD13 ' A' ' 118' ' ' LEU . 24.1 mt -58.28 -20.73 44.98 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.407 -0.808 . . . . 1.06 109.093 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.455 ' O ' ' N ' ' A' ' 127' ' ' ALA . 15.7 ttpp -67.61 -52.5 37.64 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.517 -0.919 . . . . 2.39 108.517 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -56.79 -21.25 27.34 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.114 -1.069 . . . . 2.2 108.114 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -72.23 -27.12 62.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 106.765 -1.569 . . . . 2.09 106.765 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.57 -42.72 97.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.656 -0.868 . . . . 0.86 108.656 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.85 -42.52 81.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.437 -0.79 . . . . 0.9 109.221 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.05 -26.79 65.14 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.302 -0.874 . . . . 1.35 109.619 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.94 -45.13 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.073 -1.017 . . . . 0.58 108.469 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -53.96 -37.49 63.97 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.829 -1.174 . . . . 3.22 107.829 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -63.03 -32.62 74.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.649 . . . . 1.32 109.782 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.7 mt -69.01 -25.47 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.067 -1.021 . . . . 0.5 109.778 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.7 -45.03 9.76 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.09 -1.604 . . . . 0.44 109.09 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -50.31 -50.39 50.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 2.71 109.602 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 136' ' ' ARG . 3.5 mtt-85 -64.18 -38.76 92.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.942 -1.099 . . . . 2.2 108.476 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.559 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.4 tt -56.32 -39.29 72.54 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.227 -1.027 . . . . 1.13 108.227 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' A' ' 140' ' ' ASN . 10.3 mt -69.4 -57.97 4.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.829 . . . . 0.54 109.486 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -47.75 -16.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.303 -0.873 . . . . 2.32 110.241 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 138' ' ' LEU . 5.4 m120 -85.05 -50.69 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.962 -1.086 . . . . 1.26 109.207 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 60.2 mt -54.33 -39.78 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.62 109.331 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 31.7 mt -90.05 5.08 48.23 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.233 -0.917 . . . . 0.67 109.043 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 49.71 31.45 15.78 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.347 -1.901 . . . . 0.68 108.347 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -58.77 142.92 48.77 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.693 -0.887 . . . . 0.77 110.041 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -69.68 143.79 53.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.756 . . . . 2.4 109.384 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.51 HG22 ' N ' ' A' ' 147' ' ' ILE . 97.3 mt -104.62 161.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.542 -0.91 . . . . 0.87 108.542 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.51 ' N ' HG22 ' A' ' 146' ' ' ILE . 9.2 mm -78.16 131.25 34.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.188 -0.945 . . . . 1.32 109.676 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -94.36 86.14 4.8 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.634 -0.876 . . . . 1.54 108.634 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.1 mt -81.75 -31.66 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 0.77 109.542 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.8 p -82.69 38.5 0.57 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 1.57 109.217 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -139.84 23.29 2.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.38 -0.825 . . . . 0.82 109.081 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 69.4 mt -71.08 150.87 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.467 -0.77 . . . . 0.82 109.649 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.99 -29.87 5.51 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.842 -0.799 . . . . 2.11 108.842 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -115.52 135.26 54.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.815 -0.809 . . . . 1.41 108.815 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.88 135.66 56.74 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.371 -0.831 . . . . 1.3 109.632 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.3 m -148.95 176.88 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.394 -0.816 . . . . 0.57 108.879 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 45.5 mt -89.21 151.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.104 -1.073 . . . . 0.43 108.104 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.42 119.91 40.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.605 0.717 . . . . 0.56 109.354 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.3 t -123.05 128.34 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 108.727 -0.842 . . . . 0.54 108.727 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.24 149.32 13.74 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.203 -0.936 . . . . 0.62 110.067 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.01 -42.43 90.13 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.733 -1.229 . . . . 0.8 108.11 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -174.67 144.83 0.87 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.335 -0.853 . . . . 2.34 109.501 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -114.89 141.96 47.23 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.102 -0.703 . . . . 0.65 109.102 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.1 p -92.11 150.55 40.61 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.194 -0.941 . . . . 0.74 109.589 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -36.94 -35.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.487 2.125 . . . . 0.6 112.596 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.2 m -64.97 -62.6 1.46 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 0.63 109.406 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -53.73 -28.71 35.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.177 -0.952 . . . . 1.25 109.731 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.3 p -78.81 -23.7 44.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.092 -1.005 . . . . 0.5 109.406 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.19 -24.33 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.957 . . . . 0.51 110.196 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -101.82 -14.3 17.34 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.102 -0.999 . . . . 1.17 109.287 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.76 146.01 43.1 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.138 -0.976 . . . . 0.61 108.701 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -97.31 131.26 44.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 2.12 108.484 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 43.9 mt -79.02 -41.21 29.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 1.34 111.171 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -80.6 -12.0 59.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.665 -1.272 . . . . 1.97 111.827 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -96.77 -8.54 30.94 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.568 -1.332 . . . . 1.9 109.145 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 177' ' ' LEU . 82.9 t -99.84 162.37 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.366 -0.834 . . . . 0.48 108.91 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' N ' HG12 ' A' ' 176' ' ' VAL . 51.2 tp -109.42 -23.47 11.52 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.378 -0.826 . . . . 1.39 109.637 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.499 ' H ' HG12 ' A' ' 176' ' ' VAL . . . -179.96 173.13 44.73 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 109.623 -1.391 . . . . 0.38 109.623 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -124.75 123.35 39.8 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.439 -1.036 . . . . 0.46 109.736 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 14.4 mt -130.44 129.08 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.941 -1.133 . . . . 0.59 107.941 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 203' ' ' VAL . 19.7 p -140.55 147.72 39.91 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.15 -0.969 . . . . 0.67 111.324 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -87.27 36.34 0.73 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 2.24 109.938 -178.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -105.42 118.99 37.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.957 -1.089 . . . . 1.11 109.798 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -90.42 64.15 2.93 Favored Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.837 -1.305 . . . . 1.63 109.837 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.484 ' C ' ' N ' ' A' ' 187' ' ' THR . . . -106.39 108.4 2.91 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.748 -1.341 . . . . 1.47 109.748 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.411 ' NH1' ' HG2' ' A' ' 186' ' ' ARG . 7.3 ptt-85 -51.23 -13.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.09 -1.241 . . . . 5.24 108.497 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.484 ' N ' ' C ' ' A' ' 185' ' ' GLY . 23.7 p -141.45 59.08 1.51 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.323 -0.991 . . . . 2.92 108.323 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 9.5 p -80.59 137.66 36.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.359 -0.838 . . . . 1.6 109.522 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -48.03 -55.52 9.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 0.92 110.506 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 p -44.25 -52.92 7.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.349 -0.844 . . . . 1.59 110.461 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.456 ' HG ' HG11 ' A' ' 203' ' ' VAL . 67.3 m -53.27 -45.09 68.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.938 . . . . 1.42 110.063 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.18 -37.92 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.057 -1.027 . . . . 1.41 109.89 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 13.8 mtm -69.86 -51.55 32.41 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.558 -1.275 . . . . 0.86 107.558 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.88 -36.66 49.35 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 109.449 -0.574 . . . . 0.59 109.449 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -72.77 -45.66 57.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.906 . . . . 3.06 109.985 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.5 m -69.26 -35.48 76.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 0.73 109.371 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 199' ' ' LEU . 20.2 mt -87.96 -0.16 56.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -0.919 . . . . 0.67 108.944 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 57.39 2.53 0.14 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.426 -0.796 . . . . 1.49 111.229 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 197' ' ' LEU . 46.1 mt -67.04 169.97 7.23 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.649 -1.282 . . . . 0.64 108.685 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -91.48 144.89 3.23 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 122.37 2.047 . . . . 0.59 111.487 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.68 176.15 10.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.697 -1.252 . . . . 0.55 111.17 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.1 mt -150.66 158.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 106.157 -1.794 . . . . 0.63 106.157 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.486 ' O ' ' O ' ' A' ' 181' ' ' THR . 16.5 m -144.69 -30.31 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 120.763 -1.211 . . . . 0.77 111.304 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 206' ' ' GLY . . . -84.95 37.25 2.99 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.912 -1.118 . . . . 0.87 110.77 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 206' ' ' GLY . 5.9 p -73.43 39.37 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.658 -1.495 . . . . 0.89 109.015 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.528 ' H ' ' C ' ' A' ' 204' ' ' GLY . . . 40.78 -100.04 0.01 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.215 -1.154 . . . . 0.93 110.215 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.2 p -132.38 41.48 3.21 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.794 -0.827 . . . . 1.6 110.718 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 10.5 t -52.42 -29.09 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.479 -1.388 . . . . 0.75 108.455 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 37.6 p -63.97 -18.97 64.8 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.237 -0.914 . . . . 0.84 109.36 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 16.1 t -103.98 18.97 20.91 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.446 -0.783 . . . . 1.61 109.24 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -136.41 -27.56 1.06 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.314 -0.866 . . . . 2.3 110.669 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 213' ' ' LYS . 34.2 t -114.23 158.51 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.132 0 O-C-N 121.238 -0.914 . . . . 0.76 109.613 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.411 ' N ' HG12 ' A' ' 212' ' ' VAL . 13.0 mmtm -117.31 -171.67 2.08 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.563 -1.273 . . . . 2.01 107.563 178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 0.5 OUTLIER -81.95 148.3 28.79 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 120.982 -1.074 . . . . 2.19 110.047 179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.1 t70 82.41 -9.18 1.18 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 122.083 -0.385 . . . . 2.4 111.663 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -58.56 146.1 36.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.295 -1.503 . . . . 1.99 108.182 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.81 115.23 24.1 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.833 -1.167 . . . . 1.3 109.504 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.501 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 35.6 mt -120.79 164.37 16.71 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.016 0.912 . . . . 0.53 110.496 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 26.6 mt -136.94 118.56 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 107.555 -1.276 . . . . 0.6 107.555 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -89.73 124.13 34.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.57 109.853 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.7 m-20 -100.6 -29.32 12.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.425 -0.797 . . . . 2.22 108.912 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.723 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.97 24.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.779 -0.575 . . . . 0.75 110.311 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 221' ' ' ASP . 12.0 t -115.79 -65.59 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 106.804 -1.554 . . . . 0.92 106.804 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.34 15.12 4.58 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.576 -1.268 . . . . 2.36 107.576 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 4' ' ' GLY . 57.5 t-20 57.39 59.58 3.27 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.441 -0.577 . . . . 1.42 109.441 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -156.76 147.49 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.064 -1.023 . . . . 1.97 111.036 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.7 t -116.22 147.32 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 107.979 -1.119 . . . . 0.65 107.979 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -106.4 124.63 49.89 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.15 -0.969 . . . . 0.97 109.606 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.06 125.73 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.697 -0.627 . . . . 0.67 109.342 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.3 t30 60.31 66.84 1.79 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 1.45 110.607 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -86.85 146.31 7.91 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.698 2.265 . . . . 0.82 112.206 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -75.1 158.3 33.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.175 -0.953 . . . . 1.62 109.833 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -61.26 -23.18 65.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.237 -0.914 . . . . 2.6 108.552 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -77.51 -30.92 53.17 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.551 -0.907 . . . . 3.06 108.551 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.7 t -75.43 -31.78 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 108.701 -0.852 . . . . 1.14 108.701 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.2 mt -73.17 -58.74 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 1.04 109.466 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -55.91 -41.99 75.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.8 . . . . 2.54 109.962 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -65.96 -28.92 69.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.06 -1.025 . . . . 2.6 109.46 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 243' ' ' GLN . 46.2 mtp -80.75 -43.35 20.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 1.23 109.217 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -48.27 -45.38 34.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.105 -0.997 . . . . 2.67 110.559 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.58 -54.63 6.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.996 . . . . 1.66 110.608 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -72.83 -48.6 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 2.2 110.655 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 239' ' ' MET . 0.4 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.838 -1.164 . . . . 3.0 109.726 -179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -62.91 -32.52 73.81 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.683 -1.261 . . . . 1.76 109.067 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.2 -19.27 63.97 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.192 -1.003 . . . . 2.78 108.449 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.8 t -68.39 -41.61 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 108.193 -1.04 . . . . 2.06 108.193 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -45.02 92.5 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.65 -0.656 . . . . 2.4 109.397 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.2 t -75.93 -31.56 59.17 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.321 -0.862 . . . . 2.87 109.584 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 107.885 -1.154 . . . . 3.41 107.885 179.137 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' SD ' ' NE2' ' A' ' 226' ' ' GLN . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.532 -0.544 . . . . 3.66 109.532 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.63 102.97 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.297 -0.877 . . . . 1.12 109.534 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.0 m -98.6 117.33 32.8 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.221 -0.924 . . . . 1.45 109.906 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -112.8 -160.03 14.37 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.211 -1.956 . . . . 0.92 108.211 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 5' ' ' ILE . 44.7 mt -95.62 -7.81 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.267 . . . . 1.05 108.889 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 4.2 tp 60.51 110.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.88 109.081 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.43 -51.5 5.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.78 108.489 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.78 148.63 28.35 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 108.583 -0.895 . . . . 1.5 108.583 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.65 147.57 22.2 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.388 2.059 . . . . 0.86 114.166 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.696 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.69 -177.3 37.15 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.712 -1.355 . . . . 0.78 109.712 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.6 mt -146.72 129.47 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.067 -1.255 . . . . 0.74 109.332 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.01 140.32 32.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.283 -0.886 . . . . 0.45 109.88 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 12.5 m-85 -108.21 139.44 42.89 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.918 -1.141 . . . . 0.64 107.918 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.37 162.94 30.05 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 118.229 -1.938 . . . . 0.45 111.266 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -78.19 149.23 33.75 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.78 -0.835 . . . . 1.88 109.287 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -77.09 128.58 34.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.59 111.003 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.4 tp -107.48 90.59 3.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 106.991 -1.485 . . . . 0.64 106.991 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 18' ' ' LEU . 11.6 tp -80.58 129.0 34.25 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.962 . . . . 0.74 110.162 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.443 HD12 ' HB2' ' A' ' 160' ' ' ALA . 16.8 mt -92.68 91.37 7.49 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.459 0.647 . . . . 0.74 110.199 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -97.24 146.43 25.11 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.793 -0.817 . . . . 1.87 108.793 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.9 137.91 51.67 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.941 -0.763 . . . . 2.58 108.941 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.26 129.13 34.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.264 -0.897 . . . . 2.14 108.923 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tt0 -63.67 131.8 49.08 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.381 -0.824 . . . . 1.93 109.526 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.49 134.92 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.68 108.945 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.2 t -102.74 118.83 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.453 -0.779 . . . . 0.84 109.47 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -86.88 136.36 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.902 -0.777 . . . . 0.79 108.902 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -90.35 125.16 35.44 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.238 -0.914 . . . . 1.37 109.763 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.445 HH12 ' HB1' ' A' ' 102' ' ' ALA . 18.7 mmm180 -95.26 23.03 6.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 2.62 109.239 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -81.97 140.01 34.24 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 2.35 109.435 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.0 mttp -84.76 127.83 34.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 2.35 108.697 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 31' ' ' ILE . 21.7 pt -85.53 173.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.071 -1.018 . . . . 0.78 109.962 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 42.5 p -99.18 179.78 4.49 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.407 -0.808 . . . . 1.04 109.565 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.22 -23.44 60.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.918 . . . . 1.05 109.635 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -80.08 5.7 13.52 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.41 -0.959 . . . . 2.47 108.41 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -120.55 -17.48 8.07 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.899 -0.778 . . . . 1.46 108.899 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -65.47 -47.42 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 0.77 109.477 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -56.39 -36.91 69.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.312 -0.868 . . . . 1.46 109.663 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -70.25 -38.93 75.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 2.29 110.819 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -65.03 -38.92 92.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.963 -1.085 . . . . 1.3 110.373 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.41 -47.15 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.138 -0.976 . . . . 0.76 110.115 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -64.86 -40.86 95.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.026 -1.046 . . . . 1.5 108.621 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -65.81 -28.65 69.16 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.727 -0.842 . . . . 2.66 108.727 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -85.87 -57.07 3.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.509 -0.923 . . . . 0.75 108.509 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 tp -53.77 -56.21 19.5 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.56 -0.904 . . . . 0.83 108.56 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 t -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.223 -1.029 . . . . 0.78 108.223 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.21 -9.39 57.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.344 -1.902 . . . . 0.57 108.344 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.7 ttm-85 -86.6 -28.32 23.33 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 106.251 -1.759 . . . . 2.83 106.251 176.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.92 -35.01 78.69 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.53 -0.915 . . . . 0.65 108.53 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -84.38 -60.8 1.97 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.588 -0.695 . . . . 2.57 109.406 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.9 -43.07 59.71 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.122 -0.987 . . . . 0.51 109.82 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.0 p -63.24 -37.63 87.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 1.36 108.431 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.58 -39.15 64.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.861 -0.524 . . . . 0.6 109.737 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -64.22 -63.64 1.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.217 -0.927 . . . . 1.36 109.728 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 67.0 mt -51.63 -32.73 30.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 1.38 109.406 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.14 -45.75 83.74 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.584 -0.895 . . . . 1.27 108.584 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -61.31 -38.96 88.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.351 -0.843 . . . . 0.6 109.368 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.482 HD13 HH12 ' A' ' 136' ' ' ARG . 84.8 mt -71.93 -37.04 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.53 109.236 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -52.6 -49.3 65.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.352 -0.843 . . . . 0.99 109.981 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -70.47 -25.03 62.98 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.278 -0.889 . . . . 0.59 109.862 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 64' ' ' THR . 55.5 mttm -70.82 -34.02 71.28 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.62 -1.252 . . . . 1.81 107.62 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.04 -32.1 73.65 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.331 -0.988 . . . . 0.48 108.331 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -30.72 23.46 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.445 -1.462 . . . . 0.58 109.445 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -86.7 -16.86 35.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.951 -1.323 . . . . 1.39 108.416 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 60' ' ' LYS . 88.3 m -93.29 -52.1 4.69 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.389 -0.819 . . . . 0.82 109.942 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.513 ' C ' ' H ' ' A' ' 67' ' ' GLU . 52.2 m-85 -107.3 -34.9 6.96 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.32 -0.863 . . . . 0.99 110.043 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 67' ' ' GLU . . . 71.93 -25.54 0.66 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.714 -1.355 . . . . 0.55 109.714 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 65' ' ' PHE . 26.3 mt-10 -52.29 -175.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -1.141 . . . . 2.59 109.945 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -70.27 36.98 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.412 -0.805 . . . . 2.2 109.444 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 67' ' ' GLU . 27.9 mmtp -85.56 -9.8 56.84 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.314 -0.866 . . . . 1.79 109.582 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.9 -39.47 72.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.096 -1.002 . . . . 1.54 110.696 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.13 -26.97 67.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.27 -0.894 . . . . 0.64 111.148 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 76' ' ' HIS . 56.6 mt -72.2 -42.78 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.759 -1.213 . . . . 0.58 110.001 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -78.95 -24.97 43.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.128 -0.983 . . . . 0.62 109.615 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.2 -36.58 84.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.101 -0.999 . . . . 1.23 109.001 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.76 -31.37 56.2 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 108.795 -1.722 . . . . 0.52 108.795 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.487 ' CD2' ' O ' ' A' ' 72' ' ' ILE . 29.9 m170 -61.25 -22.49 64.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -1.061 . . . . 1.29 109.785 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -85.77 -38.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.803 -1.186 . . . . 0.55 108.767 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 11.3 ttt -59.22 -35.13 73.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.423 -0.798 . . . . 1.89 109.267 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.79 -37.67 70.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.405 -0.809 . . . . 0.53 109.007 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.0 tp -70.19 -43.97 69.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.642 -0.823 . . . . 0.43 109.705 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -85.89 6.63 27.5 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.163 -0.961 . . . . 1.24 110.974 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -52.34 119.77 4.8 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.682 -1.261 . . . . 1.31 109.424 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.64 -21.76 65.36 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.339 -0.851 . . . . 1.35 108.821 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 84' ' ' GLU . 1.4 mp0 -76.67 -51.09 12.16 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.368 -0.832 . . . . 2.16 108.856 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.4 mt -64.94 -15.66 62.41 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.266 -0.974 . . . . 0.6 108.807 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.3 -48.41 20.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 1.28 109.986 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -61.63 -26.83 68.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.278 -0.889 . . . . 1.28 109.421 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -73.49 -48.54 32.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 1.29 109.123 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -58.97 -58.87 4.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 77.8 mt -44.01 -67.59 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.518 -0.739 . . . . 0.78 110.341 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -44.37 -47.42 9.69 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.275 -0.89 . . . . 0.86 110.489 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.5 mt -56.34 -56.02 26.22 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.983 -1.073 . . . . 0.79 108.876 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.5 mt -51.72 -47.89 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -0.893 . . . . 0.71 111.098 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -85.77 -33.54 21.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.844 -1.16 . . . . 2.05 111.888 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 91' ' ' ALA . 46.9 t0 -84.66 -36.76 21.73 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.734 -1.229 . . . . 1.59 111.834 -176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -105.1 17.52 23.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.725 -1.235 . . . . 1.89 109.725 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m80 44.32 42.46 5.27 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.311 -0.868 . . . . 1.31 109.932 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.3 mtt -98.31 151.59 20.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.388 -0.82 . . . . 1.28 108.884 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 47.4 p -76.79 145.6 38.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.947 . . . . 0.62 109.651 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.31 -29.56 4.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.47 108.981 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -75.16 -41.01 59.09 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.302 -0.999 . . . . 2.0 108.302 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.445 ' HB1' HH12 ' A' ' 28' ' ' ARG . . . -71.49 -58.2 3.72 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.785 -0.572 . . . . 0.56 110.483 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.0 -47.27 78.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.211 -0.931 . . . . 0.48 109.535 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.04 65.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.44 109.581 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.505 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.1 t60 -71.54 -41.34 69.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.003 . . . . 1.42 109.797 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -53.66 -64.22 0.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.306 -0.871 . . . . 1.26 110.35 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 39.4 t -48.08 -48.49 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.031 -1.043 . . . . 0.61 109.564 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.3 mm -65.37 -17.43 22.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.446 -0.784 . . . . 0.64 109.658 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.505 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 22.2 tp10 -71.28 -34.82 71.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.091 . . . . 2.2 109.733 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.68 -27.16 27.68 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.436 -1.364 . . . . 0.82 112.168 178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -68.05 -39.64 82.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.648 -1.501 . . . . 1.27 109.23 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -81.9 -52.95 6.57 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.648 -0.658 . . . . 0.91 109.24 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t -57.32 -42.58 82.1 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.332 -0.855 . . . . 1.73 110.214 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.42 83.5 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.16 -0.963 . . . . 1.04 111.17 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 64.7 mt -67.79 -29.9 69.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.647 -1.283 . . . . 1.03 109.823 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.52 -17.08 64.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 1.95 109.872 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -80.93 -8.86 59.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.196 -0.94 . . . . 1.71 109.162 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 123' ' ' LEU . 4.2 mt -87.01 143.56 27.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.322 -0.861 . . . . 1.26 108.913 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 5.1 p-10 -99.45 62.27 1.22 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 2.83 109.044 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -147.41 118.46 7.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.141 -0.974 . . . . 1.58 109.686 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.62 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 6.1 mp0 -56.92 -14.28 3.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.457 -0.777 . . . . 2.8 109.533 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -79.91 -60.64 2.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 1.02 108.907 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.491 HD13 HD13 ' A' ' 118' ' ' LEU . 74.8 mt -72.73 -28.06 62.42 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.175 -0.953 . . . . 1.06 109.416 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 127' ' ' ALA . 2.4 ttmp? -69.13 -50.34 48.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.049 -1.032 . . . . 2.39 109.04 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -59.32 -23.25 62.32 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.186 -0.946 . . . . 2.2 108.67 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 55.7 ttt180 -72.08 -26.7 62.26 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.344 -1.724 . . . . 2.09 106.344 178.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 124' ' ' LYS . . . -59.49 -48.64 80.86 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.022 -0.733 . . . . 0.86 109.022 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.91 -38.91 87.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.362 -0.836 . . . . 0.9 109.273 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -68.47 -25.46 65.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.467 -0.771 . . . . 1.35 109.466 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 126' ' ' ARG . 20.2 t -79.48 -49.84 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.58 108.977 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -53.21 -40.59 64.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.996 -1.065 . . . . 3.22 108.528 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -60.66 -37.27 81.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.485 -0.759 . . . . 1.32 109.891 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.2 mt -67.96 -28.64 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.964 -1.085 . . . . 0.5 108.846 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.71 -47.07 6.47 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.791 -1.724 . . . . 0.44 108.791 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.532 ' HZ2' HH11 ' A' ' 139' ' ' ARG . 25.2 ttpp -57.09 -50.93 71.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.579 -0.953 . . . . 2.71 109.772 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.482 HH12 HD13 ' A' ' 57' ' ' ILE . 56.9 mtt180 -62.52 -40.88 98.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.2 108.433 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.34 -47.92 82.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.475 -0.766 . . . . 1.13 109.282 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 25.5 mt -56.86 -57.98 10.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.54 109.599 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.532 HH11 ' HZ2' ' A' ' 135' ' ' LYS . 13.3 mtp180 -48.61 -20.28 0.43 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -0.856 . . . . 2.32 110.213 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -84.19 -30.42 25.8 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.076 -1.015 . . . . 1.26 109.446 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -72.5 -36.99 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.122 -0.986 . . . . 0.62 109.394 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 33.3 mt -91.77 -10.95 38.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.179 -0.951 . . . . 0.67 109.436 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 144' ' ' LEU . . . 63.21 21.69 64.36 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.087 -2.005 . . . . 0.68 108.087 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' A' ' 143' ' ' GLY . 2.8 tp -49.52 177.86 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.767 -0.843 . . . . 0.77 109.243 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -65.63 133.41 51.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 2.4 109.125 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.68 123.77 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.328 -0.857 . . . . 0.87 109.462 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.478 ' H ' HD12 ' A' ' 147' ' ' ILE . 3.6 mp -77.83 111.4 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 1.32 109.042 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -96.79 89.0 4.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.345 -0.847 . . . . 1.54 109.708 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.7 mt -80.94 -20.85 41.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.77 109.082 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -80.57 12.69 2.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 1.57 109.168 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.95 29.28 3.78 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.018 -0.734 . . . . 0.82 109.018 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.406 HG22 ' N ' ' A' ' 153' ' ' GLN . 57.7 mt -72.14 156.31 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.438 -0.789 . . . . 0.82 109.043 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.406 ' N ' HG22 ' A' ' 152' ' ' ILE . 79.2 mt-30 -145.76 13.44 1.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.189 -0.944 . . . . 2.11 109.128 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -124.54 120.61 32.46 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.928 -0.768 . . . . 1.41 108.928 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -62.98 113.97 3.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.333 -0.854 . . . . 1.3 109.5 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 m -148.18 174.48 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.091 -1.006 . . . . 0.57 109.591 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 54.0 mt -90.75 153.34 3.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.275 -1.009 . . . . 0.43 108.275 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 15.8 tp -108.59 120.73 43.31 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.535 0.683 . . . . 0.56 109.753 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.05 131.82 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.008 -0.738 . . . . 0.54 109.008 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.97 145.59 12.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.62 109.697 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.58 73.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.547 -1.346 . . . . 0.8 108.011 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -173.96 148.83 1.43 Allowed 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.586 -0.696 . . . . 2.34 109.184 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.9 mt -118.26 136.97 53.36 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.519 -0.738 . . . . 0.65 109.888 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.2 p -94.05 151.41 39.66 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.36 -0.837 . . . . 0.74 108.869 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.505 ' O ' ' N ' ' A' ' 169' ' ' ALA . 71.3 Cg_exo -37.14 -42.92 0.97 Allowed 'Trans proline' 0 N--CA 1.489 1.237 0 C-N-CA 122.255 1.97 . . . . 0.6 112.386 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -52.57 -52.85 53.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.63 108.848 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -61.77 -48.57 80.09 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.415 -0.803 . . . . 1.25 109.578 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.4 p -66.49 -26.42 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.5 109.892 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -76.16 -26.05 55.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.162 -0.961 . . . . 0.51 110.197 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -106.17 -15.47 14.85 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.257 -0.902 . . . . 1.17 109.728 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 15.3 tp -63.05 148.19 48.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.035 -1.041 . . . . 0.61 109.002 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -97.94 143.5 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.122 -1.066 . . . . 2.12 108.122 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -90.88 -40.25 11.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 1.34 110.41 -178.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -82.81 -9.52 59.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.933 -1.105 . . . . 1.97 111.52 -177.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -100.66 -12.07 19.48 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.795 -1.191 . . . . 1.9 108.965 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 178' ' ' GLY . 54.8 t -94.93 163.8 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.176 -1.046 . . . . 0.48 108.176 178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.497 ' N ' HG12 ' A' ' 176' ' ' VAL . 10.6 tp -106.61 -23.03 12.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.107 -0.996 . . . . 1.39 109.888 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.537 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.5 175.38 43.79 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.272 -1.531 . . . . 0.38 109.272 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -127.36 125.08 40.09 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.42 -1.047 . . . . 0.46 109.818 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.572 ' CG2' HG21 ' A' ' 205' ' ' THR . 4.6 mt -125.49 115.92 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.771 -1.566 . . . . 0.59 106.771 178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.496 ' O ' ' O ' ' A' ' 203' ' ' VAL . 20.7 p -140.59 154.1 46.34 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.21 1.005 . . . . 0.67 112.866 -177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 37.1 t0 -84.13 39.22 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.571 -0.74 . . . . 2.24 109.383 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -86.86 -171.03 3.33 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.343 -1.473 . . . . 1.11 110.14 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.11 -100.53 1.36 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.554 -1.418 . . . . 1.63 109.554 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.07 -19.98 0.16 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.057 -1.617 . . . . 1.47 109.057 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 186' ' ' ARG . 5.5 mtt-85 -71.78 90.93 1.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -1.119 . . . . 5.24 109.159 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 2.7 p 52.95 43.58 31.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.305 -0.872 . . . . 2.92 109.997 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.7 p -84.05 148.55 26.78 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.175 -0.953 . . . . 1.6 109.017 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -59.48 -58.48 8.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.153 -0.967 . . . . 0.92 109.677 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.9 t -46.75 -37.54 8.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.423 -0.798 . . . . 1.59 110.068 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 29.6 t -68.97 -40.02 79.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.12 -0.987 . . . . 1.42 110.382 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 84.7 mt -59.32 -27.97 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 1.41 110.013 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 62.3 mtp -70.14 -53.01 19.13 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.506 -1.294 . . . . 0.86 107.506 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.27 -37.56 72.57 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.635 -0.712 . . . . 0.59 110.034 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.518 ' CG ' HH11 ' A' ' 195' ' ' ARG . 4.7 mtt-85 -79.9 -46.52 16.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 3.06 110.433 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.1 m -67.53 -36.45 81.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.778 -1.201 . . . . 0.73 109.575 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 199' ' ' LEU . 19.8 mt -87.42 -1.2 57.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 0.67 109.053 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 55.16 0.41 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.423 -0.798 . . . . 1.49 111.789 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.439 ' H ' ' C ' ' A' ' 197' ' ' LEU . 43.6 mt -65.42 170.7 4.21 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.455 -1.403 . . . . 0.64 108.068 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -90.92 141.29 3.01 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.324 2.016 . . . . 0.59 111.514 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.48 -174.95 3.66 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 118.541 -1.264 . . . . 0.55 111.193 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 14.6 mt -150.59 155.45 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.16 -1.422 . . . . 0.63 107.16 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.496 ' O ' ' O ' ' A' ' 181' ' ' THR . 7.5 m -132.96 -37.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 O-C-N 120.98 -1.075 . . . . 0.77 110.409 -178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.94 39.9 1.84 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.182 -1.567 . . . . 0.87 109.182 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.572 HG21 ' CG2' ' A' ' 180' ' ' ILE . 22.0 p -67.16 -18.47 65.29 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.242 -1.152 . . . . 0.89 108.627 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.408 ' O ' ' CG ' ' A' ' 182' ' ' ASP . . . 62.81 -99.64 0.27 Allowed Glycine 0 N--CA 1.484 1.837 0 C-N-CA 120.211 -0.995 . . . . 0.93 111.235 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 91.5 p -114.31 44.76 1.64 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.459 -1.024 . . . . 1.6 112.499 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -75.96 -26.38 17.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.563 -1.336 . . . . 0.75 107.7 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 40.5 p -67.51 -13.49 62.1 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.84 109.43 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.2 p -104.6 12.17 33.36 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.566 -0.901 . . . . 1.61 108.566 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -135.12 4.91 3.25 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.121 -0.696 . . . . 2.3 109.121 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.9 t -124.46 160.75 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.639 -0.663 . . . . 0.76 109.67 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 212' ' ' VAL . 1.5 mptp? -134.1 168.69 18.36 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 106.719 -1.585 . . . . 2.01 106.719 177.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.9 t30 -72.34 141.24 48.79 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.835 -1.166 . . . . 2.19 110.095 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 76.99 -4.91 2.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.855 -0.528 . . . . 2.4 110.339 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -57.68 144.95 35.98 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.996 -1.065 . . . . 1.99 109.066 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -88.07 116.12 26.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.125 -0.984 . . . . 1.3 108.905 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.414 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 50.3 mt -124.63 165.14 18.42 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.014 0.911 . . . . 0.53 110.551 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 219' ' ' ILE . 17.1 mt -136.17 116.68 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.606 -0.887 . . . . 0.6 108.606 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.7 tp -90.08 122.99 33.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.01 -1.107 . . . . 0.57 108.01 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 223' ' ' VAL . 2.9 m-20 -97.03 -30.18 13.21 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.095 -1.003 . . . . 2.22 109.378 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.69 22.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.398 0.618 . . . . 0.75 109.819 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 221' ' ' ASP . 18.1 t -120.12 -65.29 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 107.083 -1.451 . . . . 0.92 107.083 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -82.64 9.55 9.29 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.401 -1.333 . . . . 2.36 107.401 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.424 -0.584 . . . . 1.42 109.424 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.562 ' NE2' ' SD ' ' A' ' 1' ' ' MET . 22.2 mt-30 -155.03 146.31 22.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.915 . . . . 1.97 110.298 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 64.3 t -116.44 132.96 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.349 -0.982 . . . . 0.65 108.349 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -98.23 129.25 44.97 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.018 -1.051 . . . . 0.97 109.709 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.9 t -105.69 129.51 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.67 109.531 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 55.6 t30 47.65 67.83 4.1 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.877 . . . . 1.45 109.958 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -86.04 152.79 9.69 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.7 2.267 . . . . 0.82 111.615 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.5 m -72.86 163.55 27.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.091 -1.006 . . . . 1.62 109.888 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -65.51 -30.53 71.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.888 . . . . 2.6 109.382 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -62.4 -38.78 90.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 3.06 109.483 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.32 -30.48 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 1.14 109.061 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.3 mt -76.97 -60.71 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.845 . . . . 1.04 109.498 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -55.55 -42.95 75.36 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 2.54 110.686 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt -65.91 -38.81 89.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.042 -1.036 . . . . 2.6 110.123 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.421 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 90.6 mtp -82.59 -29.48 30.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 1.23 110.015 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -57.53 -45.91 84.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.098 -1.001 . . . . 2.67 110.18 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -76.53 -49.57 16.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.02 . . . . 1.66 110.578 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.8 t -69.81 -53.07 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 2.2 110.547 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 239' ' ' MET . 4.9 tp-100 -55.78 -50.22 71.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.845 -1.16 . . . . 3.0 109.868 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -62.63 -21.68 65.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.792 -1.193 . . . . 1.76 109.368 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -64.22 -29.4 70.51 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.262 -1.385 . . . . 2.78 107.262 178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.67 -49.71 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.211 -1.033 . . . . 2.06 108.211 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.78 -37.2 84.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.555 -0.716 . . . . 2.4 109.107 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.7 t -77.21 -18.8 57.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.368 -0.833 . . . . 2.87 109.773 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.145 -0.972 . . . . 3.41 109.375 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mtp . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.273 0.559 . . . . 3.66 109.839 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.7 mt -92.52 93.3 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.202 -0.936 . . . . 1.12 109.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -95.5 108.98 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.186 -0.946 . . . . 1.45 109.016 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.0 -165.04 23.13 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.533 -1.427 . . . . 0.92 109.533 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 53.6 mt -94.99 -8.39 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.406 -1.056 . . . . 1.05 108.768 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 9.2 tp 55.81 107.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.582 -0.698 . . . . 0.88 109.582 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -87.41 -49.53 7.16 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.405 -0.961 . . . . 0.78 108.405 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.41 141.89 15.83 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.293 -1.002 . . . . 1.5 108.293 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HA ' ' HB1' ' A' ' 222' ' ' ALA . 72.8 Cg_endo -80.85 159.9 21.31 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.819 1.679 . . . . 0.86 114.455 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 156.07 -173.65 34.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 108.953 -1.659 . . . . 0.78 108.953 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 23.0 mt -148.34 128.73 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.639 -1.506 . . . . 0.74 109.911 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.64 164.24 30.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.216 -0.928 . . . . 0.45 109.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.9 m-85 -129.97 136.98 50.06 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 107.792 -1.188 . . . . 0.64 107.792 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.12 165.76 36.99 Favored Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.37 -1.871 . . . . 0.45 111.772 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -77.98 147.11 35.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.656 -0.908 . . . . 1.88 109.45 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.04 118.9 20.76 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.449 -0.782 . . . . 0.59 110.645 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.8 tp -101.65 90.5 4.06 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.544 -1.65 . . . . 0.64 106.544 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 18' ' ' LEU . 12.1 tp -80.06 127.96 32.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.476 1.131 . . . . 0.74 111.071 -177.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.432 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -95.89 86.06 4.24 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.151 -0.932 . . . . 0.74 109.977 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -89.95 139.08 30.95 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.268 -1.382 . . . . 1.87 107.268 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -118.93 139.11 52.2 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.105 -0.997 . . . . 2.58 109.869 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -82.12 128.73 34.42 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.358 -0.839 . . . . 2.14 108.903 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.26 144.89 56.55 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.123 -0.986 . . . . 1.93 108.796 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.5 mt -88.82 131.07 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.68 109.269 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.79 113.9 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.339 -0.851 . . . . 0.84 109.194 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.432 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 99.3 mt -88.0 145.36 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.023 -1.048 . . . . 0.79 110.02 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -95.48 121.53 37.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.614 -0.679 . . . . 1.37 109.267 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -96.14 23.58 6.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.202 -0.937 . . . . 2.62 109.594 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -83.02 144.44 29.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.181 -0.949 . . . . 2.35 109.57 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -85.93 131.23 34.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.071 -1.018 . . . . 2.35 108.698 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 31' ' ' ILE . 9.4 pt -92.5 177.91 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -0.972 . . . . 0.78 110.27 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.458 ' H ' HE21 ' A' ' 35' ' ' GLN . 68.7 p -101.97 170.63 8.0 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.354 0.597 . . . . 1.04 109.454 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.45 -20.19 65.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 1.05 109.795 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.68 -1.99 48.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.068 -1.02 . . . . 2.47 109.39 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.458 HE21 ' H ' ' A' ' 32' ' ' SER . 7.5 mt-30 -114.65 -14.61 12.04 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.491 -0.929 . . . . 1.46 108.491 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.6 t -66.7 -44.07 89.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.182 -0.949 . . . . 0.77 108.983 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.41 -37.44 56.61 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.446 -0.946 . . . . 1.46 108.446 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -69.36 -36.79 77.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.778 -0.576 . . . . 2.29 109.724 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -62.55 -39.53 93.92 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 1.3 109.803 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' LEU . 86.4 t -61.27 -44.87 99.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.977 -1.077 . . . . 0.76 109.186 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.18 -36.03 80.64 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.115 -1.068 . . . . 1.5 108.115 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -66.3 -36.65 83.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.568 -0.901 . . . . 2.66 108.568 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -83.72 -57.9 3.03 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.759 -0.83 . . . . 0.75 108.759 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' VAL . 57.0 tp -49.13 -66.2 0.44 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.421 -0.799 . . . . 0.83 109.117 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 t -61.68 -28.87 69.7 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.448 -0.945 . . . . 0.78 108.448 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.2 -11.53 61.6 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.224 -2.35 . . . . 0.57 107.224 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -86.17 -28.01 24.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.506 -1.294 . . . . 2.83 107.506 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.86 -32.33 72.76 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.272 -1.011 . . . . 0.65 108.272 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -84.48 -57.21 3.24 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.421 -0.955 . . . . 2.57 108.421 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.4 -49.95 60.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.51 110.413 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.1 p -63.12 -34.31 77.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.003 -1.061 . . . . 1.36 108.859 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.13 -25.29 59.68 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.729 -0.607 . . . . 0.6 109.511 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.484 HE22 HD21 ' A' ' 140' ' ' ASN . 35.9 mt-30 -78.95 -53.91 6.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.25 -0.906 . . . . 1.36 109.662 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.37 -28.69 70.17 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.108 -0.995 . . . . 1.38 108.721 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -71.23 -55.35 8.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.319 -0.863 . . . . 1.27 109.473 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.5 m -60.19 -32.2 70.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 0.6 109.597 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.6 mt -73.93 -32.85 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.041 -1.037 . . . . 0.53 108.609 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -54.75 -45.59 74.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.457 -0.777 . . . . 0.99 109.934 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.2 m -70.04 -32.35 70.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.305 -0.872 . . . . 0.59 110.084 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -72.28 -23.8 61.25 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.86 -1.136 . . . . 1.81 108.468 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.89 -34.34 62.19 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.697 -1.223 . . . . 0.48 107.697 178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.77 -28.95 27.74 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.307 -1.117 . . . . 0.58 110.307 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -85.73 -10.5 55.51 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.81 -1.406 . . . . 1.39 108.86 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.8 m -99.31 -49.6 4.4 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.39 -0.819 . . . . 0.82 110.381 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -106.67 -21.59 13.0 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.283 -0.885 . . . . 0.99 110.104 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.49 145.98 7.3 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.269 -1.533 . . . . 0.55 109.269 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -50.7 -6.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.684 -0.892 . . . . 2.59 111.09 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 22.6 mt-10 -67.1 -27.92 67.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.814 -1.179 . . . . 2.2 110.218 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -91.76 -7.34 49.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.773 -1.204 . . . . 1.79 110.204 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -62.3 -21.92 65.63 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.786 -1.196 . . . . 1.54 109.766 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.18 79.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.986 -1.071 . . . . 0.64 109.757 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.49 -42.46 78.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.58 108.853 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -74.36 -25.01 59.25 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.103 -0.998 . . . . 0.62 109.135 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.44 -36.04 82.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.085 -1.009 . . . . 1.23 109.219 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.69 -32.02 54.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.524 -1.431 . . . . 0.52 109.524 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -63.33 -23.71 67.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 1.29 110.08 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.92 -36.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.744 -1.223 . . . . 0.55 108.15 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 12.0 ttt -57.5 -32.38 66.95 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.603 -0.888 . . . . 1.89 108.603 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 tp -79.42 -37.64 36.63 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.525 -0.734 . . . . 0.53 109.074 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.1 tp -66.37 -53.56 34.56 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.479 -0.763 . . . . 0.43 109.567 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -80.07 12.67 2.66 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 1.24 109.76 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -50.57 122.29 6.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.23 -0.919 . . . . 1.31 108.818 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -67.71 -22.38 65.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.175 -0.953 . . . . 1.35 108.929 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -77.57 -47.3 19.77 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.454 -0.779 . . . . 2.16 109.376 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 71.6 mt -66.07 -18.51 65.39 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.83 -1.169 . . . . 0.6 109.121 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -74.35 -56.91 4.34 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.536 0.684 . . . . 1.28 109.819 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -62.46 -30.72 71.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 1.28 110.411 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.18 -45.77 54.52 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.956 -1.09 . . . . 1.29 109.064 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 27.1 mt -57.65 -56.74 13.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 107.73 -1.211 . . . . 0.58 107.73 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 94.1 mt -48.71 -45.07 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.808 -0.557 . . . . 0.78 111.038 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -64.21 -38.45 91.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.842 -1.161 . . . . 0.86 110.036 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.2 mt -59.45 -57.38 13.21 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.213 -0.929 . . . . 0.79 108.546 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.8 mt -49.6 -46.92 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.468 -0.77 . . . . 0.71 109.795 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -81.09 -34.62 32.52 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.305 -0.872 . . . . 2.05 112.016 -178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.0 t70 -82.74 -44.4 15.66 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.436 -1.415 . . . . 1.59 112.315 -176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -105.42 14.62 28.46 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 120.519 -1.363 . . . . 1.89 109.589 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.3 m170 47.46 51.68 13.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.194 -0.941 . . . . 1.31 108.772 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.7 mtt -100.19 148.84 24.17 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.573 0.701 . . . . 1.28 109.448 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 p -77.26 145.28 37.6 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.609 -0.682 . . . . 0.62 109.329 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.46 -28.12 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.156 -0.965 . . . . 0.47 108.827 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -75.49 -44.7 42.53 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.192 -1.04 . . . . 2.0 108.192 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.57 -55.82 7.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.612 -0.68 . . . . 0.56 110.267 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -54.88 -57.38 11.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.316 -0.865 . . . . 0.48 109.758 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.78 -35.16 56.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.807 . . . . 0.44 110.081 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.432 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 16.0 t60 -69.67 -30.96 68.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 1.42 109.735 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 109' ' ' GLU . 30.8 tt0 -66.19 -61.05 2.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.14 -0.975 . . . . 1.26 109.615 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.2 t -47.06 -48.23 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.97 -1.081 . . . . 0.61 109.535 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mm -65.57 -13.92 16.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.86 -0.793 . . . . 0.64 108.86 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' N ' ' O ' ' A' ' 106' ' ' GLU . 13.0 tm-20 -77.05 -32.59 57.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 2.2 109.791 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -86.38 -29.0 25.92 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.227 -1.464 . . . . 0.82 111.869 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -66.47 -45.48 79.54 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.508 -1.584 . . . . 1.27 108.092 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.36 -55.13 8.59 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.156 -0.683 . . . . 0.91 109.156 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 27.7 t -58.87 -38.21 78.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 1.73 110.106 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -67.34 -32.57 73.61 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 1.04 110.53 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.0 mt -69.04 -28.33 66.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.82 -1.175 . . . . 1.03 108.789 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -68.7 -16.15 63.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.895 . . . . 1.95 109.246 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -83.64 -7.42 59.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.71 109.66 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 mt -85.81 146.86 26.57 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.426 -0.953 . . . . 1.26 108.426 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -96.7 60.0 1.79 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.18 -0.95 . . . . 2.83 110.073 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -151.13 108.35 3.59 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.263 -0.898 . . . . 1.58 109.385 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.03 -11.73 0.49 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.483 -0.76 . . . . 2.8 109.596 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' OH ' ' NH2' ' A' ' 126' ' ' ARG . 7.2 t80 -79.64 -63.67 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.84 . . . . 1.02 109.64 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 9.9 mt -60.7 -23.41 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.148 -0.97 . . . . 1.06 108.997 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 127' ' ' ALA . 68.3 tttt -68.94 -46.33 68.49 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.069 -1.019 . . . . 2.39 108.274 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.43 -23.49 49.83 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.227 -1.027 . . . . 2.2 108.227 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.524 ' NH2' ' OH ' ' A' ' 122' ' ' TYR . 30.3 ttm-85 -73.38 -26.19 60.89 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.573 -1.64 . . . . 2.09 106.573 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -56.81 -41.23 77.42 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.414 -1.328 . . . . 0.86 107.414 178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.96 91.82 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.26 -1.015 . . . . 0.9 108.26 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.59 -30.83 69.66 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.774 -0.824 . . . . 1.35 108.774 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.3 t -77.25 -52.11 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.77 -0.826 . . . . 0.58 108.77 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -52.01 -38.07 55.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 3.22 108.703 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -61.9 -34.96 77.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.339 -0.85 . . . . 1.32 110.376 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.9 mt -66.04 -29.59 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.984 -1.073 . . . . 0.5 109.439 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.55 -47.27 6.44 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.386 -1.486 . . . . 0.44 109.386 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm -50.5 -47.43 57.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.36 . . . . 2.71 108.936 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 136' ' ' ARG . 10.3 mtt-85 -63.21 -34.62 78.05 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.51 -0.922 . . . . 2.2 108.51 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.9 tp -65.03 -34.45 78.46 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.764 -0.828 . . . . 1.13 108.764 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.9 mt -75.44 -50.88 14.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.533 -0.729 . . . . 0.54 110.291 -179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -52.69 -23.18 6.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.92 -1.112 . . . . 2.32 110.2 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.484 HD21 HE22 ' A' ' 53' ' ' GLN . 85.8 m-20 -85.16 -42.87 14.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.944 -1.098 . . . . 1.26 109.849 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.86 -38.91 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.771 -1.206 . . . . 0.62 108.872 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.57 -1.17 57.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.255 -0.903 . . . . 0.67 109.393 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 58.53 29.38 63.69 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 108.382 -1.887 . . . . 0.68 108.382 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.65 153.44 23.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.586 -0.949 . . . . 0.77 109.798 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -68.1 134.92 51.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 2.4 109.075 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 13.0 mt -106.77 130.81 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.3 -0.875 . . . . 0.87 109.442 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 147' ' ' ILE . 1.9 mp -77.69 109.25 12.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.424 -0.798 . . . . 1.32 109.074 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -92.8 96.71 10.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.508 -0.745 . . . . 1.54 109.475 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.14 -14.51 59.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.491 -0.756 . . . . 0.77 109.145 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 p -85.65 27.79 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 1.57 109.543 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -140.02 30.17 2.03 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.242 -0.911 . . . . 0.82 109.747 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.502 HD12 HD21 ' A' ' 172' ' ' ASN . 53.7 mt -70.48 155.16 7.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.312 -0.868 . . . . 0.82 109.701 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -130.88 -12.77 3.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.583 -0.698 . . . . 2.11 109.215 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -127.69 137.03 52.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.418 -0.801 . . . . 1.41 109.028 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -67.96 128.06 35.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.958 . . . . 1.3 109.579 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.1 m -151.24 176.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.623 -0.88 . . . . 0.57 108.623 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.1 mt -88.33 159.69 2.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 107.776 -1.194 . . . . 0.43 107.776 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 11.4 tp -117.16 119.97 36.84 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 109.281 -0.637 . . . . 0.56 109.281 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.75 134.83 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 CA-C-O 121.305 0.574 . . . . 0.54 109.71 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.432 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.4 149.63 11.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.342 -0.849 . . . . 0.62 109.998 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.86 87.26 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.392 -1.442 . . . . 0.8 107.882 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -175.18 146.38 0.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.049 -0.723 . . . . 2.34 109.049 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 17.8 mt -118.54 142.7 47.35 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.381 -0.824 . . . . 0.65 109.446 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.6 p -95.58 148.94 35.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.349 -0.845 . . . . 0.74 108.89 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 169' ' ' ALA . 29.5 Cg_exo -34.64 -40.45 0.22 Allowed 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.665 2.243 . . . . 0.6 112.867 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.2 m -53.32 -65.22 0.6 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.261 -0.899 . . . . 0.63 108.836 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -52.06 -37.11 52.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.685 -0.634 . . . . 1.25 109.891 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 8.6 p -74.75 -30.1 61.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.869 -1.145 . . . . 0.5 109.255 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -68.5 -28.12 66.73 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.391 -0.818 . . . . 0.51 109.806 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.87 -9.05 18.27 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.326 -0.859 . . . . 1.17 109.899 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.83 152.23 16.29 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.013 . . . . 0.61 108.895 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.813 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -101.43 130.82 47.73 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.755 -1.202 . . . . 2.12 107.755 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.35 -46.5 13.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 1.34 111.233 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -77.89 -8.32 57.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.788 -1.195 . . . . 1.97 112.366 -175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -100.91 -13.04 18.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.832 -1.167 . . . . 1.9 108.335 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 172' ' ' ASN . 53.8 t -91.8 160.61 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.285 -1.006 . . . . 0.48 108.285 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER -111.75 -30.08 7.45 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.28 -1.007 . . . . 1.39 108.28 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -174.95 177.28 47.05 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.225 -1.55 . . . . 0.38 109.225 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -132.52 129.96 39.79 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.289 -1.124 . . . . 0.46 109.628 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.1 mt -130.41 127.64 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 107.572 -1.27 . . . . 0.59 107.572 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.482 ' O ' ' O ' ' A' ' 203' ' ' VAL . 26.9 p -140.59 147.28 39.16 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.539 -0.726 . . . . 0.67 111.218 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.452 ' OD2' ' CG2' ' A' ' 209' ' ' THR . 9.3 p30 -101.48 42.83 1.1 Allowed 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.336 -0.852 . . . . 2.24 110.674 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -134.15 30.53 3.61 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.126 -0.984 . . . . 1.11 110.964 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -41.76 151.8 0.2 Allowed Glycine 0 N--CA 1.496 2.688 0 O-C-N 120.96 -1.087 . . . . 1.63 111.819 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.68 155.85 27.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.828 -1.309 . . . . 1.47 109.828 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -52.62 -28.42 21.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -1.184 . . . . 5.24 109.696 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 57.4 p -140.03 54.56 1.65 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.309 -0.869 . . . . 2.92 109.916 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.5 t -79.63 132.33 36.22 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.235 -0.915 . . . . 1.6 109.195 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -60.47 -46.93 88.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.507 -0.745 . . . . 0.92 110.332 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -44.58 -36.64 3.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.236 -0.915 . . . . 1.59 110.035 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.5 t -70.3 -36.5 74.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 1.42 109.807 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 72.5 mt -56.2 -32.39 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.232 . . . . 1.41 109.837 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 40.1 mtp -74.34 -63.12 1.3 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.158 -1.052 . . . . 0.86 108.158 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.85 -24.88 6.75 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.475 -0.565 . . . . 0.59 109.475 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 44.0 mtp180 -81.37 -48.05 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 3.06 109.615 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 8.3 m -71.65 -35.42 70.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.259 -0.901 . . . . 0.73 110.036 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 199' ' ' LEU . 31.0 mt -85.51 -0.83 56.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.196 -0.94 . . . . 0.67 108.95 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 53.77 2.76 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.495 -0.753 . . . . 1.49 111.694 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.426 ' H ' ' C ' ' A' ' 197' ' ' LEU . 92.4 mt -66.22 165.81 20.54 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.595 -1.316 . . . . 0.64 108.568 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -85.29 136.62 5.72 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.869 1.712 . . . . 0.59 111.599 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.58 5.81 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.85 -1.156 . . . . 0.55 110.887 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.4 mt -150.29 162.93 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.882 -1.525 . . . . 0.63 106.882 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.482 ' O ' ' O ' ' A' ' 181' ' ' THR . 31.4 m -146.19 -32.01 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.676 -1.265 . . . . 0.77 111.792 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.4 7.38 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.934 -1.104 . . . . 0.87 110.715 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.534 ' HB ' HG23 ' A' ' 208' ' ' VAL . 49.6 p -55.1 -38.1 67.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.704 -1.468 . . . . 0.89 108.027 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 71.3 -34.26 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.923 -0.656 . . . . 0.93 113.387 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 39.5 m -127.62 -0.95 6.14 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 119.883 1.841 . . . . 1.6 113.547 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.534 HG23 ' HB ' ' A' ' 205' ' ' THR . 4.5 t -52.84 -49.64 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.029 -1.669 . . . . 0.75 110.435 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.452 ' CG2' ' OD2' ' A' ' 182' ' ' ASP . 10.7 p -53.67 -13.28 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.806 -1.184 . . . . 0.84 110.351 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.44 ' O ' ' OG ' ' A' ' 210' ' ' SER . 2.2 t -111.77 15.76 20.78 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.241 -0.912 . . . . 1.61 108.902 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -142.31 -3.62 1.05 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.231 -0.918 . . . . 2.3 110.829 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.35 149.86 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.174 -0.954 . . . . 0.76 108.773 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -129.49 155.37 45.85 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.02 -1.474 . . . . 2.01 107.02 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.423 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 60.4 t-20 -61.96 142.68 57.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.886 -1.133 . . . . 2.19 110.998 -178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.8 t70 75.48 -12.49 0.97 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.658 -0.651 . . . . 2.4 111.028 178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -58.36 150.32 22.46 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.792 -1.192 . . . . 1.99 108.998 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.29 121.3 33.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.984 -1.073 . . . . 1.3 108.724 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.426 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 15.4 mt -126.86 164.38 21.54 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.383 -0.823 . . . . 0.53 110.131 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 27.5 mt -138.07 117.85 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 108.257 -1.016 . . . . 0.6 108.257 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.0 tp -88.56 128.34 35.57 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.68 -0.859 . . . . 0.57 108.68 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 223' ' ' VAL . 44.8 t0 -101.35 -32.38 10.49 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.622 -0.881 . . . . 2.22 108.622 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' A' ' 9' ' ' PRO . . . 38.9 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.532 0.682 . . . . 0.75 110.494 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 221' ' ' ASP . 7.2 t -114.46 -59.9 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 105.739 -1.949 . . . . 0.92 105.739 178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -88.71 18.24 4.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.32 -1.363 . . . . 2.36 107.32 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 16.1 t30 52.18 57.43 6.47 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.934 -0.765 . . . . 1.42 108.934 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -157.14 150.34 23.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.984 . . . . 1.97 110.525 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.11 149.72 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.997 -0.742 . . . . 0.65 108.997 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -107.59 121.05 43.88 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.362 -0.836 . . . . 0.97 109.155 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.4 t -103.41 123.2 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.242 -0.911 . . . . 0.67 109.736 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.61 62.19 4.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.45 111.035 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.87 139.85 14.1 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.276 1.984 . . . . 0.82 111.182 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 233' ' ' ASN . 18.1 m -73.3 162.19 29.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.219 -0.925 . . . . 1.62 110.236 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 6.7 p30 -54.33 -53.82 48.71 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.405 -0.809 . . . . 2.6 110.151 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 18.0 pt-20 -51.9 -30.62 24.91 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.34 -0.85 . . . . 3.06 109.796 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.68 -32.49 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.099 -1.001 . . . . 1.14 108.538 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.4 mt -73.68 -57.38 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.416 -0.803 . . . . 1.04 109.176 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 1.0 OUTLIER -55.83 -37.37 68.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.523 -0.736 . . . . 2.54 110.433 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.6 tttp -65.35 -39.68 92.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.021 -1.049 . . . . 2.6 109.429 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.456 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 80.3 mtp -80.42 -34.74 35.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 1.23 110.01 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -50.41 -51.35 47.14 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.96 -1.088 . . . . 2.67 110.095 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.84 -59.24 2.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 1.66 111.594 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 22.3 t -67.43 -50.56 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.026 -1.046 . . . . 2.2 111.593 -178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.456 ' CB ' ' O ' ' A' ' 239' ' ' MET . 6.3 tp60 -55.57 -39.19 70.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.848 -1.158 . . . . 3.0 109.565 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.54 -26.33 67.84 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 120.907 -1.121 . . . . 1.76 108.741 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -69.85 -20.86 63.4 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.289 -0.882 . . . . 2.78 108.717 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.05 -50.53 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 2.06 109.034 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.68 -27.74 68.08 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.298 -0.876 . . . . 2.4 108.967 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 14.5 t -77.3 -34.38 55.51 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.345 -0.847 . . . . 2.87 109.512 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.105 -0.997 . . . . 3.41 109.308 179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.346 -0.613 . . . . 3.66 109.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.2 104.46 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.136 -0.978 . . . . 1.12 110.102 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -100.4 103.99 15.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.392 -0.817 . . . . 1.45 109.326 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.519 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -104.98 -165.78 24.08 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.134 -1.586 . . . . 0.92 109.134 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.9 mt -97.57 -10.01 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.267 -1.137 . . . . 1.05 108.707 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' O ' ' O ' ' A' ' 5' ' ' ILE . 33.0 tp 53.0 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.27 -0.641 . . . . 0.88 109.27 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.68 -47.46 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.722 -1.236 . . . . 0.78 108.997 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.68 150.01 41.94 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.359 -0.838 . . . . 1.5 109.325 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.47 150.67 22.22 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.605 2.203 . . . . 0.86 114.474 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.709 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.34 178.71 36.43 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.51 -1.436 . . . . 0.78 109.51 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.4 mt -141.88 128.43 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.152 -1.205 . . . . 0.74 108.889 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.84 158.39 44.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.288 -0.882 . . . . 0.45 110.597 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -130.53 142.89 50.47 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.823 -1.177 . . . . 0.64 107.823 179.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 168.34 164.44 24.04 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 118.969 -1.586 . . . . 0.45 111.282 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -76.41 147.69 37.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.576 -0.955 . . . . 1.88 109.75 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -78.97 127.26 31.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.551 -0.718 . . . . 0.59 111.146 -178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.8 tp -103.79 92.24 4.34 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 107.472 -1.306 . . . . 0.64 107.472 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.9 tp -80.03 128.79 33.9 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.159 -0.963 . . . . 0.74 110.395 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 HD11 ' A' ' 158' ' ' LEU . 33.2 mt -99.68 95.57 7.04 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.772 -0.649 . . . . 0.74 109.743 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -91.99 161.9 14.6 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.293 -0.879 . . . . 1.87 109.019 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -121.78 130.99 53.82 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.467 -0.771 . . . . 2.58 110.284 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -80.42 131.28 35.57 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.16 -0.963 . . . . 2.14 108.506 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -64.48 132.3 49.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.412 -0.805 . . . . 1.93 109.491 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 132.53 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.449 -0.782 . . . . 0.68 109.026 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.7 t -109.39 121.2 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.478 -0.764 . . . . 0.84 109.829 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 76.4 mt -89.83 149.09 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.499 -0.75 . . . . 0.79 109.446 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 1.1 m-20 -94.28 120.06 33.97 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.125 -0.984 . . . . 1.37 109.261 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.14 29.56 3.47 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.306 -0.871 . . . . 2.62 109.193 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -88.59 142.3 27.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.489 -0.757 . . . . 2.35 109.453 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 30' ' ' LYS . 1.0 OUTLIER -88.17 127.57 35.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.39 -0.819 . . . . 2.35 108.966 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.1 pt -88.07 176.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.084 -1.01 . . . . 0.78 111.111 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.1 p -99.68 159.07 15.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.808 -0.812 . . . . 1.04 108.808 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.97 -7.19 0.98 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.218 -0.927 . . . . 1.05 109.652 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -84.09 -17.17 41.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.202 -0.936 . . . . 2.47 110.329 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -112.5 -4.74 14.13 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.287 -0.883 . . . . 1.46 109.494 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 51.3 t -66.03 -45.71 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.132 -0.98 . . . . 0.77 108.805 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -53.39 -38.82 63.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.366 -0.975 . . . . 1.46 108.366 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -67.26 -33.63 75.72 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.564 -0.71 . . . . 2.29 109.588 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -63.39 -41.02 98.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.02 -1.05 . . . . 1.3 109.248 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.6 t -62.11 -47.31 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.275 -0.891 . . . . 0.76 110.002 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.73 -41.43 95.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.163 -0.961 . . . . 1.5 108.603 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 -63.46 -35.71 81.34 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.1 -0.704 . . . . 2.66 109.1 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -86.53 -38.3 17.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.251 -0.905 . . . . 0.75 109.518 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.1 tp -71.83 -62.46 1.41 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.092 -1.005 . . . . 0.83 109.626 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 t -66.19 -30.09 70.49 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.206 -0.934 . . . . 0.78 108.76 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -53.12 48.45 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.382 -1.887 . . . . 0.57 108.382 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.515 HH22 ' CD ' ' A' ' 86' ' ' GLU . 8.4 ttm180 -53.17 -26.82 18.55 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.029 -1.277 . . . . 2.83 108.649 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.5 -48.59 81.07 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -0.806 . . . . 0.65 109.086 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' CG ' ' N ' ' A' ' 50' ' ' ALA . 15.4 pttp -76.9 -53.78 7.43 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.521 -0.871 . . . . 2.57 109.2 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.512 ' N ' ' CG ' ' A' ' 49' ' ' LYS . . . -50.19 -37.11 33.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.583 -1.323 . . . . 0.51 109.013 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -62.9 -34.41 77.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.743 -1.206 . . . . 1.36 107.743 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LYS . . . -72.29 -32.69 66.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.23 -0.656 . . . . 0.6 109.23 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -73.14 -59.15 2.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 1.36 108.872 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 54' ' ' LEU . 10.6 mp -57.05 -35.34 69.2 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 1.38 109.271 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.05 -42.6 99.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.046 -1.094 . . . . 1.27 108.046 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.7 m -60.94 -36.9 80.55 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.182 -1.044 . . . . 0.6 108.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -68.39 -24.48 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 108.688 -0.856 . . . . 0.53 108.688 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -68.45 -46.5 69.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.313 -0.867 . . . . 0.99 110.11 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -72.15 -27.52 62.65 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.142 -0.974 . . . . 0.59 110.026 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -72.75 -30.79 64.44 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.707 -1.22 . . . . 1.81 107.707 179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.96 -33.07 65.64 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.991 -0.744 . . . . 0.48 108.991 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.9 -29.29 29.21 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.361 -1.496 . . . . 0.58 109.361 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.43 -16.74 36.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.012 -1.287 . . . . 1.39 109.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.9 m -90.62 -46.27 8.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.071 -1.018 . . . . 0.82 110.059 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -106.65 -15.12 14.85 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.106 -0.996 . . . . 0.99 110.535 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' C ' ' N ' ' A' ' 68' ' ' GLU . . . 120.36 148.51 8.1 Favored Glycine 0 N--CA 1.504 3.232 0 N-CA-C 109.608 -1.397 . . . . 0.55 109.608 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -52.08 -10.95 0.14 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.306 -1.114 . . . . 2.59 109.94 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' N ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -64.66 -31.12 72.2 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.285 -0.885 . . . . 2.2 110.336 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.4 mmtm -92.71 -11.9 32.79 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.118 -0.989 . . . . 1.79 110.479 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -64.74 -26.81 68.53 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.985 . . . . 1.54 110.622 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.09 -32.75 74.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.006 . . . . 0.64 110.342 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.1 mt -68.37 -43.67 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.096 -1.003 . . . . 0.58 109.958 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -76.93 -26.04 53.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.62 110.045 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -63.53 -37.54 87.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.123 -0.986 . . . . 1.23 109.45 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.66 -32.65 49.82 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.198 -1.561 . . . . 0.52 109.198 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -60.71 -23.1 64.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -1.088 . . . . 1.29 110.074 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.2 mt -85.3 -39.3 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.915 -1.116 . . . . 0.55 109.198 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.5 ttt -56.41 -30.48 62.82 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 1.89 108.37 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.7 tp -72.32 -41.21 66.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.355 -0.98 . . . . 0.53 108.355 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.82 -43.92 71.03 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.955 -0.698 . . . . 0.43 109.46 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -84.59 9.11 14.56 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.109 -0.995 . . . . 1.24 109.701 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -48.2 122.03 4.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 1.31 109.905 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.64 -24.4 65.45 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.571 -0.9 . . . . 1.35 108.571 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -74.55 -48.59 25.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.238 -0.914 . . . . 2.16 108.927 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -63.08 -15.93 58.23 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.828 -1.149 . . . . 0.6 108.879 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' HH22 ' A' ' 47' ' ' ARG . 63.9 tt0 -75.91 -55.85 5.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.062 -1.024 . . . . 1.28 109.976 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -60.94 -27.4 68.2 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.192 -0.942 . . . . 1.28 110.281 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -75.55 -49.35 18.89 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.108 -0.995 . . . . 1.29 109.444 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 88.4 mt -57.94 -56.41 15.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.523 -0.917 . . . . 0.58 108.523 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.1 mt -43.82 -61.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.624 -0.673 . . . . 0.78 110.559 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -45.12 -54.06 7.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.374 -0.829 . . . . 0.86 110.102 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.1 mt -54.86 -53.68 52.24 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.393 -0.923 . . . . 0.79 109.04 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.36 -45.86 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.71 110.184 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -86.5 -32.13 20.93 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.821 -1.175 . . . . 2.05 111.562 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ALA . 48.4 t0 -81.71 -41.81 20.77 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.727 -1.233 . . . . 1.59 111.783 -176.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -105.07 18.39 22.43 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.664 -1.272 . . . . 1.89 109.542 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 45.0 43.73 7.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.316 -0.865 . . . . 1.31 110.155 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 34.6 mtt -95.07 150.68 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.427 -0.796 . . . . 1.28 108.9 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 p -76.83 149.56 36.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.488 -0.758 . . . . 0.62 109.985 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -52.31 -24.16 7.04 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.319 -0.863 . . . . 0.47 108.803 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -77.79 -48.67 16.0 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 121.853 0.835 . . . . 2.0 108.782 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.24 -53.64 18.8 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.342 0.592 . . . . 0.56 110.114 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.26 -51.09 70.74 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.293 -0.879 . . . . 0.48 109.442 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.99 -36.21 48.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.44 109.317 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -67.78 -32.79 73.62 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.303 -0.873 . . . . 1.42 110.115 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -56.62 -46.22 81.05 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.023 -1.048 . . . . 1.26 109.994 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.32 -49.22 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.905 -1.122 . . . . 0.61 108.676 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.7 mm -62.27 -22.55 29.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 108.903 -0.777 . . . . 0.64 108.903 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -74.05 -41.85 61.14 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.242 -0.911 . . . . 2.2 109.896 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 114' ' ' ALA . . . -87.0 -28.32 26.15 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.393 -1.384 . . . . 0.82 112.297 178.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.63 -47.47 75.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.509 -1.583 . . . . 1.27 109.195 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.0 -49.0 26.35 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.622 -0.674 . . . . 0.91 109.472 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 35.3 m -61.17 -36.91 81.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.232 -0.918 . . . . 1.73 109.472 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 110' ' ' GLY . . . -61.77 -45.75 92.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.45 -0.781 . . . . 1.04 110.8 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.95 -25.84 66.54 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 118.584 -1.247 . . . . 1.03 108.726 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -66.6 -18.5 65.4 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.175 -0.953 . . . . 1.95 108.948 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -82.92 -4.44 58.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.229 -0.919 . . . . 1.71 109.774 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 123' ' ' LEU . 1.8 mt -86.06 153.34 22.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.024 -1.047 . . . . 1.26 108.488 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -100.94 57.87 0.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.817 . . . . 2.83 109.517 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -147.05 125.14 12.09 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.197 -0.94 . . . . 1.58 109.778 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -64.57 -15.81 61.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.485 -0.759 . . . . 2.8 109.766 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -79.7 -58.12 3.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.133 -0.979 . . . . 1.02 109.082 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.687 HD13 HD13 ' A' ' 118' ' ' LEU . 18.4 mt -61.02 -25.59 67.01 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.187 -0.946 . . . . 1.06 109.12 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.2 tttp -70.31 -40.04 74.45 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.489 -0.93 . . . . 2.39 108.489 178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -64.89 -22.62 67.03 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.247 -0.908 . . . . 2.2 108.841 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -75.42 -25.99 57.99 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 106.62 -1.622 . . . . 2.09 106.62 177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.32 86.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.909 -1.145 . . . . 0.86 107.909 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.21 -33.41 69.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.546 -0.721 . . . . 0.9 109.272 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -69.98 -38.7 76.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.34 -0.85 . . . . 1.35 109.869 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.6 t -77.3 -42.44 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.388 -0.82 . . . . 0.58 109.58 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -59.83 -37.82 80.31 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.697 -1.252 . . . . 3.22 108.211 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 54.9 t0 -60.56 -34.05 73.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 1.32 109.875 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.2 mt -68.37 -26.87 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.137 -0.977 . . . . 0.5 109.687 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -78.31 -42.75 14.28 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.793 -1.323 . . . . 0.44 109.793 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -50.37 -51.38 46.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.272 -1.134 . . . . 2.71 109.803 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' CG ' HH11 ' A' ' 136' ' ' ARG . 0.4 OUTLIER -63.55 -33.21 75.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.921 -1.112 . . . . 2.2 108.77 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.439 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.1 tt -62.57 -47.59 83.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.989 -0.745 . . . . 1.13 108.989 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 12.6 mt -61.35 -49.59 76.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.54 109.075 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.8 mtt180 -52.06 -23.0 4.61 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.268 -0.895 . . . . 2.32 110.434 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 136' ' ' ARG . 85.0 m-20 -83.28 -51.63 7.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.097 -1.002 . . . . 1.26 109.194 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -53.7 -41.88 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.083 -1.011 . . . . 0.62 109.282 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 83.8 mt -84.5 2.92 38.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.421 -0.8 . . . . 0.67 109.053 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 53.48 29.36 38.97 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.1 -2.0 . . . . 0.68 108.1 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 tp -70.72 154.65 41.64 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.555 -0.968 . . . . 0.77 109.689 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -68.99 148.52 50.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.412 -0.805 . . . . 2.4 109.914 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.7 mt -106.54 153.3 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.643 -0.873 . . . . 0.87 108.643 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.777 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -79.84 105.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.215 -0.928 . . . . 1.32 109.13 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -95.33 90.68 5.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.883 . . . . 1.54 109.265 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.59 -12.96 60.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.147 -0.971 . . . . 0.77 108.928 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.2 t -80.18 5.7 13.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 1.57 109.851 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -106.5 23.18 14.63 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.327 -0.858 . . . . 0.82 110.43 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.6 mt -71.32 154.61 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.114 -0.991 . . . . 0.82 109.704 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -136.44 -11.56 1.86 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.5 -0.75 . . . . 2.11 109.261 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 136.37 54.58 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.774 -0.824 . . . . 1.41 108.774 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.16 125.56 25.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.279 -0.888 . . . . 1.3 109.331 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.3 m -147.89 169.74 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.328 -0.858 . . . . 0.57 109.196 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.539 HG22 ' N ' ' A' ' 158' ' ' LEU . 77.5 mt -90.19 164.7 2.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.969 -1.123 . . . . 0.43 107.969 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.539 ' N ' HG22 ' A' ' 157' ' ' ILE . 15.3 tp -110.72 121.52 45.54 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.614 0.721 . . . . 0.56 109.824 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.7 t -125.75 128.52 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 N-CA-C 109.325 -0.62 . . . . 0.54 109.325 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.12 147.94 11.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.62 109.56 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -59.06 -33.88 71.29 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.802 -1.186 . . . . 0.8 107.939 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -172.3 153.84 3.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.546 -0.721 . . . . 2.34 109.785 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.5 mt -128.49 131.8 48.34 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.229 -0.919 . . . . 0.65 110.116 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.4 p -92.15 150.55 40.55 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.462 -0.774 . . . . 0.74 109.17 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 169' ' ' ALA . 65.2 Cg_exo -34.61 -34.03 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.681 2.254 . . . . 0.6 113.326 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 169' ' ' ALA . 56.4 m -58.8 -71.2 0.12 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.958 -1.089 . . . . 0.63 109.069 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -47.46 -37.73 12.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.464 -0.773 . . . . 1.25 110.115 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 4.4 p -76.44 -23.88 53.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.5 109.146 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -80.76 -21.47 41.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.446 -0.783 . . . . 0.51 109.661 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -109.51 -11.89 14.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 1.17 109.603 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.8 tp -56.17 143.47 33.16 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.77 -1.196 . . . . 0.61 107.77 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.521 ' O ' HG23 ' A' ' 176' ' ' VAL . 4.6 m120 -99.55 105.68 17.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.074 -1.016 . . . . 2.12 110.275 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 173' ' ' LEU . 2.8 mm? -79.7 39.01 0.4 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.438 -0.949 . . . . 1.34 108.438 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -112.06 -25.55 9.3 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.533 -0.729 . . . . 1.97 109.56 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -132.29 0.73 3.76 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.49 -0.756 . . . . 1.9 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 172' ' ' ASN . 74.3 t -78.31 152.84 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.656 -0.868 . . . . 0.48 108.656 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.1 tt -102.96 -58.21 1.91 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.533 -0.729 . . . . 1.39 110.272 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.82 -170.74 20.86 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.627 -1.389 . . . . 0.38 109.627 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.1 OUTLIER -137.19 131.15 32.09 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.204 -1.174 . . . . 0.46 110.81 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.8 mt -131.89 129.16 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.04 -1.467 . . . . 0.59 107.04 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 203' ' ' VAL . 29.6 p -140.68 148.92 41.55 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.297 -0.877 . . . . 0.67 111.497 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -100.89 48.29 0.9 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.277 -0.638 . . . . 2.24 109.277 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.3 -141.28 0.31 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.127 -0.983 . . . . 1.11 110.447 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.25 -85.46 1.44 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.881 -1.287 . . . . 1.63 109.881 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 136.42 -38.35 1.77 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.456 -1.858 . . . . 1.47 108.456 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -45.46 -78.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.452 -1.028 . . . . 5.24 109.556 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 17.9 p -115.78 51.75 0.93 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.528 -0.732 . . . . 2.92 109.625 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.4 p -88.47 131.28 34.95 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.267 -0.895 . . . . 1.6 109.31 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -61.9 -32.85 73.27 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.288 -0.883 . . . . 0.92 109.168 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 m -57.46 -33.63 68.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 1.59 109.304 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.8 p -72.61 -28.43 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.383 -0.823 . . . . 1.42 110.143 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 92.9 mt -66.68 -35.53 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.16 -0.962 . . . . 1.41 109.63 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 56.0 mtp -70.55 -50.51 36.81 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.578 -1.267 . . . . 0.86 107.578 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.22 -29.8 65.98 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.761 -0.654 . . . . 0.59 110.553 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -48.52 11.02 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.187 -0.946 . . . . 3.06 110.641 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.7 m -70.37 -35.08 73.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.9 -1.125 . . . . 0.73 110.723 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 199' ' ' LEU . 13.3 mt -85.6 -0.91 56.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.912 -1.118 . . . . 0.67 109.398 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 53.19 1.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 1.49 110.939 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 197' ' ' LEU . 97.3 mt -64.91 170.5 4.01 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.935 -1.135 . . . . 0.64 107.935 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -88.18 139.87 4.53 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.982 1.788 . . . . 0.59 110.396 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.37 177.64 9.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.536 -1.352 . . . . 0.55 111.313 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.5 HD11 HD11 ' A' ' 220' ' ' LEU . 7.6 mt -149.17 164.37 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.22 -1.4 . . . . 0.63 107.22 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 181' ' ' THR . 3.7 m -148.64 -32.25 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 120.807 -1.183 . . . . 0.77 111.319 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -90.74 27.53 8.75 Favored Glycine 0 N--CA 1.491 2.332 0 O-C-N 121.069 -1.019 . . . . 0.87 110.778 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.432 ' HB ' HG23 ' A' ' 208' ' ' VAL . 18.4 p -53.9 -39.39 65.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.531 -1.57 . . . . 0.89 107.573 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 66.52 -35.28 0.17 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 121.086 -0.578 . . . . 0.93 112.964 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 87.9 p -122.13 -1.71 9.23 Favored 'General case' 0 N--CA 1.511 2.608 0 CA-C-N 119.385 1.592 . . . . 1.6 113.194 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 5.3 t -59.53 -42.81 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 119.964 -1.71 . . . . 0.75 110.303 -179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 11.2 p -65.37 -15.66 62.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.543 -1.348 . . . . 0.84 110.129 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.2 m -106.47 10.14 31.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.4 -0.812 . . . . 1.61 109.119 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 18.0 mm100 -136.25 -3.13 2.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.506 -0.746 . . . . 2.3 110.041 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.89 154.34 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.318 -0.864 . . . . 0.76 110.419 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -126.52 173.99 8.99 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 106.75 -1.574 . . . . 2.01 106.75 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 214' ' ' ASN . 10.2 p-10 -72.03 143.85 48.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.788 -1.195 . . . . 2.19 110.422 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 80.46 -11.36 1.15 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.867 -0.521 . . . . 2.4 110.998 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 216' ' ' ASP . 0.9 OUTLIER -57.05 144.98 32.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.792 -1.193 . . . . 1.99 108.565 179.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -85.21 124.84 32.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.822 -1.174 . . . . 1.3 109.07 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 95.2 mt -121.6 164.93 16.47 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.196 0.998 . . . . 0.53 111.238 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mt -143.97 106.84 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 106.406 -1.701 . . . . 0.6 106.406 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 202' ' ' ILE . 24.2 tp -87.32 131.15 34.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.57 109.046 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 223' ' ' VAL . 46.3 t0 -101.06 -32.48 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.521 -0.737 . . . . 2.22 109.645 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.85 24.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.834 -0.541 . . . . 0.75 111.023 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 221' ' ' ASP . 17.4 t -112.59 -40.0 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 N-CA-C 107.298 -1.371 . . . . 0.92 107.298 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -113.4 17.72 18.26 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.833 -1.173 . . . . 2.36 107.833 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.568 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.3 OUTLIER 57.37 58.95 3.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.679 . . . . 1.42 109.248 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -155.75 143.16 19.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 1.97 110.306 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.5 t -113.2 139.31 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.598 -0.89 . . . . 0.65 108.598 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -108.84 129.6 55.4 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.14 -0.975 . . . . 0.97 110.025 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.7 t -103.81 117.83 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 0.67 109.984 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.45 ' N ' ' CD ' ' A' ' 231' ' ' PRO . 50.0 t-20 54.01 52.04 8.95 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 1.45 110.453 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 230' ' ' ASN . 19.1 Cg_endo -62.91 167.58 11.89 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.04 1.827 . . . . 0.82 111.233 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.414 ' C ' ' N ' ' A' ' 234' ' ' GLU . 77.3 p -75.27 142.78 43.27 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.133 -0.98 . . . . 1.62 109.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -55.85 -12.33 1.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.079 -1.013 . . . . 2.6 108.939 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 232' ' ' THR . 55.6 tt0 -78.95 -38.34 37.36 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.536 -0.727 . . . . 3.06 109.799 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.97 -45.2 43.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.259 -1.015 . . . . 1.14 108.259 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 44.1 mt -52.99 -54.82 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.41 -0.807 . . . . 1.04 109.741 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.34 -42.31 73.64 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.043 -1.036 . . . . 2.54 110.15 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -66.04 -40.52 91.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 2.6 109.936 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 17.2 mtm -79.65 -33.64 41.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 1.23 110.0 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -55.4 -34.52 64.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.934 -1.104 . . . . 2.67 108.999 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -74.4 -56.97 4.26 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.325 -0.859 . . . . 1.66 109.65 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.91 -57.93 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.977 . . . . 2.2 110.008 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.471 ' O ' ' NE2' ' A' ' 243' ' ' GLN . 5.6 tp60 -50.0 -59.36 3.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.911 . . . . 3.0 109.881 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -63.23 -24.32 67.82 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.475 -0.765 . . . . 1.76 110.999 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -64.73 -23.71 67.33 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.59 -1.263 . . . . 2.78 107.59 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.84 -52.98 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.81 -0.811 . . . . 2.06 108.81 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.83 -31.97 63.17 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.099 -1.074 . . . . 2.4 108.099 178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 4.0 p -79.38 -22.83 43.83 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.716 -0.615 . . . . 2.87 109.58 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.857 . . . . 3.41 108.992 -179.452 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 mmt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.509 -0.552 . . . . 3.66 109.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.23 92.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.255 -0.903 . . . . 1.12 109.102 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.2 m -100.5 112.56 24.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.485 -0.759 . . . . 1.45 109.355 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -102.89 -164.05 25.91 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.181 -1.967 . . . . 0.92 108.181 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.2 mt -95.86 -3.4 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.079 -1.248 . . . . 1.05 109.618 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 7.8 tp 55.86 100.07 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.222 -0.924 . . . . 0.88 108.731 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.71 -53.62 5.51 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.008 -1.058 . . . . 0.78 108.42 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.33 149.04 36.56 Favored Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.818 . . . . 1.5 109.048 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.28 149.02 39.68 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 123.069 2.513 . . . . 0.86 114.086 -178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.62 122.67 0.79 Allowed Glycine 0 N--CA 1.501 2.97 0 C-N-CA 119.933 -1.127 . . . . 0.78 110.69 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 HD12 HE21 ' A' ' 243' ' ' GLN . 83.8 mt -91.33 123.38 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.866 -1.373 . . . . 0.74 109.725 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.66 148.13 45.47 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.365 -0.835 . . . . 0.45 110.25 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.5 OUTLIER -115.08 144.41 43.68 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.157 -1.053 . . . . 0.64 108.157 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.0 165.46 34.97 Favored Glycine 0 N--CA 1.501 3.011 0 C-N-CA 117.457 -2.306 . . . . 0.45 112.731 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -80.78 144.25 32.26 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.798 -0.824 . . . . 1.88 109.96 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.76 125.36 28.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.284 -0.885 . . . . 0.59 111.132 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 tp -111.29 91.54 3.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 107.421 -1.326 . . . . 0.64 107.421 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.679 ' H ' ' ND2' ' A' ' 214' ' ' ASN . 10.6 tp -81.7 131.55 35.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.813 -1.179 . . . . 0.74 109.306 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 24.6 mt -94.18 81.05 4.04 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.447 0.641 . . . . 0.74 111.371 -177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -96.75 134.84 39.51 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.558 -1.275 . . . . 1.87 107.558 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' CD ' ' N ' ' A' ' 21' ' ' GLU . 1.9 pm0 -129.33 156.71 43.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.187 -0.945 . . . . 2.58 109.213 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -79.04 137.99 37.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 2.14 109.277 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' CG ' ' N ' ' A' ' 24' ' ' ILE . 24.7 tt0 -65.33 160.81 20.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.59 -0.694 . . . . 1.93 109.604 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 75.2 mt -89.22 133.91 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.584 -0.895 . . . . 0.68 108.584 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -107.61 124.17 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.474 -0.767 . . . . 0.84 110.39 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.15 146.23 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 0.79 108.871 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.35 126.63 35.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.16 -0.963 . . . . 1.37 109.915 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -94.46 19.51 9.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.353 -0.842 . . . . 2.62 108.99 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -87.07 136.16 33.02 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.319 -0.863 . . . . 2.35 110.391 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -85.11 130.24 34.65 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.408 -1.33 . . . . 2.35 107.408 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.542 HD13 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -81.2 170.93 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.827 -1.17 . . . . 0.78 110.154 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.7 p -104.88 158.75 16.32 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.215 -0.661 . . . . 1.04 109.215 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.07 -21.32 8.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.124 -0.985 . . . . 1.05 109.11 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -81.34 -8.93 59.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.513 -0.742 . . . . 2.47 109.151 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -113.15 -5.53 13.69 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.914 -0.773 . . . . 1.46 108.914 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -69.26 -49.8 57.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.271 -0.893 . . . . 0.77 109.009 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.34 -37.3 77.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.164 -0.96 . . . . 1.46 109.819 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -69.12 -34.85 75.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.248 -0.907 . . . . 2.29 110.303 -179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.542 ' HG3' HD13 ' A' ' 31' ' ' ILE . 52.4 mm-40 -65.96 -35.25 80.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.047 -1.033 . . . . 1.3 109.469 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.7 t -62.29 -46.17 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.337 -0.852 . . . . 0.76 109.757 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -66.69 -39.74 88.24 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.988 -1.07 . . . . 1.5 108.98 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -62.78 -34.3 76.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.789 -0.819 . . . . 2.66 108.789 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -85.52 -54.22 4.7 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.563 -0.903 . . . . 0.75 108.563 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.0 -59.43 4.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.288 -1.004 . . . . 0.83 108.288 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.648 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 6.0 t -64.62 -30.77 71.8 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.999 -1.112 . . . . 0.78 107.999 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -54.69 -54.98 29.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 107.741 -2.143 . . . . 0.57 107.741 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 -47.14 -32.24 4.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.571 -0.958 . . . . 2.83 108.471 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.79 -34.73 73.4 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.477 -0.934 . . . . 0.65 108.477 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' GLY . 33.5 ttmt -82.01 -63.05 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 109.096 -0.705 . . . . 2.57 109.096 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.59 -38.55 55.04 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.161 -0.962 . . . . 0.51 110.024 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 t -64.23 -37.38 87.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.36 108.469 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.57 61.13 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.856 -0.528 . . . . 0.6 109.637 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -75.54 -61.69 1.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.87 . . . . 1.36 109.636 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.65 -43.94 69.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.165 -0.959 . . . . 1.38 108.865 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.91 -49.45 59.58 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.532 -0.73 . . . . 1.27 109.363 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.0 m -62.74 -40.47 97.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.138 -0.976 . . . . 0.6 109.685 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -72.11 -23.65 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -0.838 . . . . 0.53 109.107 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -63.22 -48.52 77.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.562 -0.712 . . . . 0.99 109.943 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -71.06 -23.01 62.05 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.397 -0.814 . . . . 0.59 110.419 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -69.17 -38.93 78.96 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.676 -1.209 . . . . 1.81 108.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.27 -32.95 74.74 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.283 -1.006 . . . . 0.48 108.283 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.92 -29.08 39.48 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.431 -1.366 . . . . 0.58 109.809 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -86.64 -15.66 39.01 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.258 . . . . 1.39 109.477 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.0 m -94.0 -47.58 6.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.097 -1.002 . . . . 0.82 110.227 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -107.03 -21.37 13.02 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.169 -0.957 . . . . 0.99 110.148 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 121.01 150.77 8.45 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.816 -1.314 . . . . 0.55 109.816 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -49.48 -7.3 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.536 -0.979 . . . . 2.59 110.65 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' GLY . 55.5 mt-10 -64.92 -38.18 90.13 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.055 -1.028 . . . . 2.2 110.613 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -91.21 -10.05 43.07 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.047 -1.033 . . . . 1.79 110.508 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -64.48 -24.58 67.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.825 -1.172 . . . . 1.54 110.445 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.56 -29.23 69.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.103 -0.998 . . . . 0.64 110.274 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.2 mt -72.89 -41.08 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.123 -0.986 . . . . 0.58 110.029 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -77.31 -27.65 52.98 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.941 -1.099 . . . . 0.62 109.744 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -62.49 -39.0 92.05 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.191 -0.943 . . . . 1.23 108.898 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.38 -31.7 63.14 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.108 -1.597 . . . . 0.52 109.108 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -61.86 -22.41 65.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -1.096 . . . . 1.29 109.929 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 61.5 mt -85.89 -37.66 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.703 -1.248 . . . . 0.55 109.13 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -57.39 -26.38 60.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 1.89 108.831 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.0 tp -80.01 -38.37 32.19 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.783 -0.821 . . . . 0.53 108.783 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.1 tp -69.21 -43.12 74.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.523 -0.735 . . . . 0.43 110.003 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -85.99 8.02 22.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.15 -0.969 . . . . 1.24 110.911 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -51.25 124.84 12.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.831 -1.168 . . . . 1.31 109.343 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.7 -22.16 66.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.38 -0.825 . . . . 1.35 108.814 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.34 -54.12 6.55 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.455 -0.778 . . . . 2.16 109.641 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 64.1 mt -60.37 -14.22 17.53 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.187 -1.005 . . . . 0.6 108.614 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -80.09 -46.79 15.87 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.482 -0.761 . . . . 1.28 109.725 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -62.91 -33.32 75.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.159 -0.963 . . . . 1.28 109.902 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.44 -47.23 64.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 1.29 109.282 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.26 -59.09 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.394 -0.817 . . . . 0.58 109.061 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.1 mt -44.1 -59.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.594 -0.691 . . . . 0.78 110.892 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.46 -59.77 2.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.15 -0.969 . . . . 0.86 110.542 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.1 mt -46.33 -55.61 7.03 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.402 -0.811 . . . . 0.79 110.185 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 94.0 mt -50.07 -41.69 18.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.048 -1.032 . . . . 0.71 109.811 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -85.94 -36.34 19.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.009 -1.057 . . . . 2.05 111.421 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -81.1 -44.54 17.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.92 -1.113 . . . . 1.59 111.858 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.58 14.43 31.22 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.72 -1.238 . . . . 1.89 109.773 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.423 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 1.8 m80 46.3 48.58 13.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.183 -0.948 . . . . 1.31 109.357 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtp -100.18 155.6 17.66 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.422 -0.799 . . . . 1.28 109.239 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 18.6 p -77.54 141.36 39.63 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.255 -0.903 . . . . 0.62 109.507 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.98 -25.77 2.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.955 . . . . 0.47 108.836 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.84 -47.15 22.21 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.035 -0.728 . . . . 2.0 109.035 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.96 -49.8 48.18 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.66 -0.65 . . . . 0.56 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.03 90.11 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.346 -0.846 . . . . 0.48 110.021 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.73 -33.98 70.83 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.038 -1.039 . . . . 0.44 110.122 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -71.37 -24.64 62.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.891 -1.13 . . . . 1.42 109.876 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -70.38 -53.12 17.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.064 -1.022 . . . . 1.26 110.069 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.81 -47.21 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 120.968 -1.082 . . . . 0.61 108.871 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.9 mm -63.27 -19.11 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.403 -0.81 . . . . 0.64 109.035 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.45 -38.01 83.84 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.364 -0.835 . . . . 2.2 109.813 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -87.03 -20.45 53.17 Favored Glycine 0 N--CA 1.497 2.754 0 C-N-CA 119.484 -1.341 . . . . 0.82 112.618 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -70.81 -48.94 51.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.415 -1.638 . . . . 1.27 109.165 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -47.64 40.86 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.613 -0.679 . . . . 0.91 109.463 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 69.6 m -58.18 -45.81 86.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.281 -0.887 . . . . 1.73 109.837 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.69 -37.08 85.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 1.04 110.505 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 53.9 mt -68.05 -29.64 68.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 1.03 109.45 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -67.7 -14.6 63.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.787 -1.195 . . . . 1.95 109.222 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.82 -6.92 59.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.324 -0.86 . . . . 1.71 109.112 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 mt -86.93 146.9 25.99 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.367 -0.975 . . . . 1.26 108.367 179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -100.95 61.5 0.96 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 2.83 108.979 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -152.87 115.55 4.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.057 -1.027 . . . . 1.58 110.059 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -56.7 -9.98 0.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.578 -0.701 . . . . 2.8 109.489 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -80.04 -62.31 1.72 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.402 -0.811 . . . . 1.02 109.988 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 54.0 mt -70.0 -26.49 64.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -0.991 . . . . 1.06 110.119 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -68.21 -45.47 73.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.978 . . . . 2.39 108.837 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -63.25 -22.17 66.7 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.193 -0.942 . . . . 2.2 108.609 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -72.53 -26.7 61.85 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.58 -1.637 . . . . 2.09 106.58 178.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.46 85.14 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.155 -1.054 . . . . 0.86 108.155 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.69 -38.72 90.04 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.247 -1.02 . . . . 0.9 108.247 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -69.92 -28.82 65.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.463 -0.773 . . . . 1.35 109.039 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -78.19 -50.53 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 0.58 108.753 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -55.58 -37.54 68.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.219 -1.03 . . . . 3.22 108.219 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.493 ' OD1' ' NH2' ' A' ' 136' ' ' ARG . 18.3 t70 -59.71 -38.27 81.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.559 -0.713 . . . . 1.32 109.606 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.1 mt -68.53 -26.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.5 108.775 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -83.76 -49.64 4.75 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.523 -1.431 . . . . 0.44 109.523 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -54.34 -44.71 72.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -1.142 . . . . 2.71 109.111 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.525 HH11 ' HG2' ' A' ' 136' ' ' ARG . 7.8 mtt-85 -65.04 -54.4 30.77 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.39 -0.967 . . . . 2.2 108.39 179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 35.8 tp -45.32 -36.55 4.19 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.13 109.646 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -67.41 -59.77 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 0.54 109.934 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -52.88 -16.28 0.98 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 2.32 109.64 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -84.88 -40.73 16.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.308 -0.87 . . . . 1.26 109.616 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.9 mt -64.58 -36.03 76.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.009 -1.057 . . . . 0.62 108.948 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.5 mt -92.45 -1.71 56.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.67 108.895 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.52 34.83 60.49 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.893 -1.683 . . . . 0.68 108.893 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -58.45 166.43 1.75 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.34 -1.094 . . . . 0.77 109.266 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.9 tptp -67.45 142.89 56.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 2.4 109.481 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -108.3 131.95 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 109.127 -0.694 . . . . 0.87 109.127 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.717 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.0 mp -74.85 110.58 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 1.32 108.687 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -97.07 93.2 6.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.457 -0.777 . . . . 1.54 110.136 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 151' ' ' ALA . 40.0 mt -79.61 -22.82 43.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.345 -0.847 . . . . 0.77 109.271 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.1 p -81.18 29.1 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 1.57 108.888 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -139.13 32.54 2.14 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.745 -0.835 . . . . 0.82 108.745 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.12 152.19 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.517 -0.74 . . . . 0.82 109.422 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -121.24 -20.16 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.149 -1.056 . . . . 2.11 108.149 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -123.27 133.1 54.21 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.231 -0.655 . . . . 1.41 109.231 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.64 129.89 41.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 1.3 108.935 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.7 m -148.93 177.05 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.205 -0.935 . . . . 0.57 109.447 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.0 mt -88.89 150.51 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 108.415 -0.957 . . . . 0.43 108.415 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.6 tp -104.69 118.31 36.26 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.012 -0.736 . . . . 0.56 109.012 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.85 128.36 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.076 -0.713 . . . . 0.54 109.076 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.17 146.89 12.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.62 109.982 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -58.9 -36.6 74.95 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.56 -1.338 . . . . 0.8 107.888 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -173.78 155.29 2.61 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.554 -0.906 . . . . 2.34 108.554 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 144.94 48.58 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.423 -0.798 . . . . 0.65 109.521 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.8 p -92.48 148.25 35.99 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.283 -0.885 . . . . 0.74 109.372 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -35.5 -48.72 0.93 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.585 2.19 . . . . 0.6 112.641 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 54.3 m -48.35 -65.01 0.64 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.203 -0.935 . . . . 0.63 109.57 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -49.81 -42.71 47.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.945 . . . . 1.25 109.403 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 11.2 p -67.27 -22.68 65.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.336 -0.852 . . . . 0.5 109.506 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.71 -20.75 28.87 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.249 -0.907 . . . . 0.51 110.905 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -111.44 -11.04 14.15 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.147 -0.971 . . . . 1.17 109.466 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 176' ' ' VAL . 58.0 tp -60.16 145.9 45.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.61 109.117 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.0 m-20 -95.91 148.71 22.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.026 -1.046 . . . . 2.12 108.479 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -91.54 -39.96 11.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.34 110.498 -178.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -82.45 -12.84 57.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.041 -1.037 . . . . 1.97 111.944 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -96.84 -12.66 23.27 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.611 -1.305 . . . . 1.9 108.33 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.1 t -98.38 147.57 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 108.366 -0.975 . . . . 0.48 108.366 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.422 ' CD2' ' O ' ' A' ' 13' ' ' PHE . 11.8 tp -99.19 -16.3 18.62 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.111 -0.993 . . . . 1.39 109.649 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.578 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.98 177.68 41.02 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.245 -1.542 . . . . 0.38 109.245 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.02 124.9 34.01 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.591 -0.946 . . . . 0.46 109.251 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.86 113.45 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 106.968 -1.493 . . . . 0.59 106.968 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 203' ' ' VAL . 72.3 p -141.36 150.28 42.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.479 -0.763 . . . . 0.67 111.235 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 206' ' ' GLY . 16.8 p30 -91.42 46.38 1.3 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.104 -0.997 . . . . 2.24 109.69 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -92.37 -150.89 0.27 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.99 -1.069 . . . . 1.11 110.709 -178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.02 -106.53 1.39 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 110.544 -1.022 . . . . 1.63 110.544 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.61 -56.97 0.4 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.319 -1.512 . . . . 1.47 109.319 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -47.9 109.98 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.391 -1.064 . . . . 5.24 109.55 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p 45.95 34.13 1.86 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 2.92 109.475 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 6.5 p -83.72 132.06 34.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 1.6 109.449 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -42.64 -61.72 1.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.92 110.361 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 54.7 p -43.75 -44.24 6.53 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.59 110.068 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.0 t -66.74 -33.58 75.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 1.42 110.097 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.4 mm -56.67 -37.42 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.017 -1.052 . . . . 1.41 110.053 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.5 mtm -70.59 -49.41 48.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.021 -1.103 . . . . 0.86 108.021 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.13 -36.16 72.55 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.099 -0.501 . . . . 0.59 110.146 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -80.46 -44.8 18.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.134 -0.979 . . . . 3.06 110.7 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.1 m -69.89 -35.38 74.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.841 -1.162 . . . . 0.73 110.531 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 199' ' ' LEU . 12.2 mt -88.1 1.46 54.26 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.97 -1.081 . . . . 0.67 109.683 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 59.38 -2.06 0.13 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.348 -0.845 . . . . 1.49 111.57 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.413 ' H ' ' C ' ' A' ' 197' ' ' LEU . 49.2 mt -63.7 168.21 6.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.457 -1.402 . . . . 0.64 108.949 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -90.5 146.63 4.14 Favored 'Trans proline' 0 N--CA 1.487 1.119 0 C-N-CA 122.393 2.062 . . . . 0.59 110.862 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.19 -179.2 5.49 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 118.207 -1.397 . . . . 0.55 111.378 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 53.2 mt -149.27 156.92 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.587 -1.634 . . . . 0.63 106.587 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.458 ' O ' ' O ' ' A' ' 181' ' ' THR . 6.3 m -136.93 -34.69 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.926 -1.109 . . . . 0.77 110.549 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -81.74 39.38 2.55 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 110.107 -1.197 . . . . 0.87 110.107 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.4 p -67.17 -17.47 64.85 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.13 -1.217 . . . . 0.89 108.893 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 182' ' ' ASP . . . 60.77 -98.68 0.16 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 120.262 -0.97 . . . . 0.93 111.081 178.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 37.0 p -117.7 46.14 1.8 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.127 -1.219 . . . . 1.6 112.238 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 50.9 t -76.33 -27.99 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.486 -1.302 . . . . 0.75 107.486 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.6 p -66.83 -9.95 42.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.821 . . . . 0.84 109.079 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 36.0 m -104.12 7.65 36.3 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.199 -1.037 . . . . 1.61 108.199 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -129.57 -8.04 4.62 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.95 -0.759 . . . . 2.3 108.95 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 33.8 t -122.49 154.08 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.671 -0.643 . . . . 0.76 109.521 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -129.84 -178.46 4.72 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 105.566 -2.012 . . . . 2.01 105.566 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 18' ' ' LEU . 9.1 m120 -76.42 150.68 36.72 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.609 -1.307 . . . . 2.19 110.355 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.6 t0 80.07 -25.19 0.18 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.942 -0.474 . . . . 2.4 111.212 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -59.02 121.66 11.81 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.533 -1.355 . . . . 1.99 107.903 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -86.81 126.63 34.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.836 -1.165 . . . . 1.3 109.893 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.9 mt -114.14 -173.04 2.21 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.196 -0.911 . . . . 0.53 108.621 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 7.4 mt -144.62 115.76 2.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.478 -0.934 . . . . 0.6 108.478 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.75 124.67 33.26 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.508 -1.293 . . . . 0.57 107.508 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -93.91 -34.86 12.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.05 -1.031 . . . . 2.22 108.839 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 40.11 30.38 0.07 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.748 -0.595 . . . . 0.75 110.698 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 t -122.67 -62.08 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 106.661 -1.607 . . . . 0.92 106.661 178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -94.93 15.82 17.69 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.909 -1.145 . . . . 2.36 107.909 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.434 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.4 OUTLIER 59.41 65.02 1.23 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.837 -0.539 . . . . 1.42 109.859 -179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -156.12 138.75 15.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.267 -0.895 . . . . 1.97 110.549 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 60.1 t -112.11 128.55 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.783 -0.821 . . . . 0.65 108.783 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -100.23 132.32 45.66 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.222 -0.924 . . . . 0.97 109.337 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 89.5 t -107.02 124.07 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.591 -0.693 . . . . 0.67 110.324 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 46.42 61.67 12.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.271 -0.893 . . . . 1.45 110.484 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.2 162.02 28.81 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.82 111.781 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.1 p -74.95 176.64 6.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 1.62 109.565 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.08 -19.46 58.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 2.6 109.838 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -71.6 -34.38 69.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.055 -1.028 . . . . 3.06 109.829 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 97.7 t -77.81 -35.77 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.153 -0.967 . . . . 1.14 108.991 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -60.69 -51.16 76.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.456 -0.777 . . . . 1.04 109.371 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -56.52 -42.35 78.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.308 -0.87 . . . . 2.54 111.0 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -63.83 -38.17 90.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.22 -0.925 . . . . 2.6 110.462 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 76.0 mtp -78.8 -33.52 46.14 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.118 -0.989 . . . . 1.23 109.778 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.87 -32.89 69.88 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.213 -0.929 . . . . 2.67 109.868 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.4 -52.95 8.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.961 . . . . 1.66 110.73 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.5 t -60.38 -56.78 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.001 -1.062 . . . . 2.2 110.404 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.484 HE21 HD12 ' A' ' 11' ' ' ILE . 1.7 tp-100 -50.46 -57.48 7.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.271 -0.893 . . . . 3.0 110.135 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -63.93 -23.2 67.25 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.439 -0.788 . . . . 1.76 110.942 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -65.34 -25.78 67.74 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.304 -1.369 . . . . 2.78 107.304 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 46.4 t -70.32 -47.3 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 107.967 -1.123 . . . . 2.06 107.967 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -25.98 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.259 -1.015 . . . . 2.4 108.259 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 6.8 t -75.17 -22.73 57.85 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.873 -0.788 . . . . 2.87 108.873 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 32.9 tp10 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.465 -0.772 . . . . 3.41 109.155 179.768 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 mtt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.428 -0.582 . . . . 3.66 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 70.8 mt -91.48 107.38 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.181 -0.95 . . . . 1.12 109.433 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.8 m -97.96 109.11 21.92 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.45 110.12 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.07 -166.93 27.98 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 108.428 -1.869 . . . . 0.92 108.428 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 5' ' ' ILE . 66.4 mt -93.52 -10.63 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.959 -1.318 . . . . 1.05 108.785 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tp 61.33 107.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.488 -0.758 . . . . 0.88 109.644 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.28 -50.08 6.34 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.878 -1.156 . . . . 0.78 107.878 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.18 154.26 38.89 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.753 . . . . 1.5 109.084 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -82.88 153.07 14.78 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.759 2.306 . . . . 0.86 113.873 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.684 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.74 147.76 4.69 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 110.07 -1.212 . . . . 0.78 110.07 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -111.67 129.95 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 O-C-N 121.115 -1.226 . . . . 0.74 109.443 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.7 159.84 41.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.22 -0.925 . . . . 0.45 109.987 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.594 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -130.72 137.73 49.66 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.289 -1.004 . . . . 0.64 108.289 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 164.08 33.0 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.761 -1.685 . . . . 0.45 110.982 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -78.36 147.2 34.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.474 -1.016 . . . . 1.88 109.763 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -75.48 121.91 23.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.492 -0.755 . . . . 0.59 111.091 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.0 tp -103.05 93.52 5.06 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.351 -1.351 . . . . 0.64 107.351 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 18' ' ' LEU . 13.6 tp -82.32 124.62 30.14 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 122.231 1.015 . . . . 0.74 110.829 -177.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 63.5 mt -95.2 98.66 10.79 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.563 0.696 . . . . 0.74 109.35 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -93.32 161.28 14.46 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.479 -0.763 . . . . 1.87 109.774 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.455 ' OE2' ' NH2' ' A' ' 139' ' ' ARG . 7.3 tm-20 -122.21 127.16 49.65 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.68 -0.859 . . . . 2.58 108.68 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.32 133.7 37.58 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.026 -1.046 . . . . 2.14 109.219 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -66.35 130.11 42.1 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.641 -0.662 . . . . 1.93 109.416 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.5 mt -90.62 143.25 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.369 -0.832 . . . . 0.68 109.253 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.2 t -108.64 119.24 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.508 -0.745 . . . . 0.84 109.399 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 80.6 mt -89.17 139.97 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.244 -0.91 . . . . 0.79 109.597 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -92.33 124.98 36.79 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.874 . . . . 1.37 109.852 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.3 OUTLIER -99.14 25.13 7.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.248 -0.907 . . . . 2.62 109.26 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm -85.05 146.33 27.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.188 -0.945 . . . . 2.35 110.179 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -88.39 133.97 33.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.323 -0.861 . . . . 2.35 109.032 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.414 HD13 ' HG3' ' A' ' 39' ' ' GLU . 10.3 pt -86.71 171.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.118 -0.989 . . . . 0.78 110.52 -179.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.415 ' H ' HE21 ' A' ' 35' ' ' GLN . 47.1 p -110.15 160.68 16.27 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.015 -0.735 . . . . 1.04 109.015 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.14 -20.34 6.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.049 -1.032 . . . . 1.05 109.46 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -82.31 -8.96 59.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 2.47 109.01 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.415 HE21 ' H ' ' A' ' 32' ' ' SER . 8.7 mt-30 -113.28 -12.69 13.03 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.754 -0.832 . . . . 1.46 108.754 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.13 -48.24 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.158 -0.964 . . . . 0.77 109.016 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.4 -38.28 74.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.377 -0.827 . . . . 1.46 109.664 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -69.48 -38.45 77.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 2.29 110.563 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' HD13 ' A' ' 31' ' ' ILE . 48.1 mm-40 -64.94 -39.97 94.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.012 -1.055 . . . . 1.3 109.915 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.1 -47.69 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.76 110.15 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -66.4 -42.34 87.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.003 . . . . 1.5 108.643 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -64.51 -28.67 69.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.347 -0.982 . . . . 2.66 108.347 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -86.86 -61.2 1.78 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.532 -0.73 . . . . 0.75 109.224 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 tp -52.34 -55.82 19.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.25 -0.906 . . . . 0.83 109.287 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.614 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.2 t -65.34 -33.58 76.3 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.026 -1.101 . . . . 0.78 108.026 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 49' ' ' LYS . . . -56.58 -54.42 36.37 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 107.601 -2.2 . . . . 0.57 107.601 178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.9 ttp180 -48.07 -30.35 4.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.413 -1.051 . . . . 2.83 108.737 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -61.75 -32.38 72.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.996 -1.113 . . . . 0.65 107.996 179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 46' ' ' GLY . 34.6 ttmt -79.4 -61.16 2.09 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.85 -0.796 . . . . 2.57 108.85 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -53.13 -34.03 54.98 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.084 -1.01 . . . . 0.51 109.069 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.4 m -62.96 -34.83 78.32 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.812 -1.181 . . . . 1.36 107.812 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.99 -29.72 63.26 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.244 -0.65 . . . . 0.6 109.244 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -68.57 -64.27 0.9 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 1.36 109.303 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' LYS . 20.1 mt -53.4 -50.77 64.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.354 -0.841 . . . . 1.38 109.217 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -45.41 -55.78 5.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.27 109.449 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.6 m -59.06 -35.72 73.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.285 -0.884 . . . . 0.6 109.323 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.9 mt -76.55 -33.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.141 -0.975 . . . . 0.53 109.055 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' LEU . 12.4 ttpt -52.96 -53.22 52.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.494 -0.754 . . . . 0.99 110.269 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -69.84 -31.1 68.78 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.126 -0.984 . . . . 0.59 109.924 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -70.96 -19.1 62.6 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.793 -1.192 . . . . 1.81 108.297 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.05 -34.39 26.22 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.925 -0.768 . . . . 0.48 108.925 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.24 -28.25 31.13 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.83 -1.308 . . . . 0.58 109.83 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -86.58 -14.97 41.31 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.985 -1.303 . . . . 1.39 109.359 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.9 m -94.79 -45.94 7.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.82 110.615 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -106.11 -20.69 13.33 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.061 -1.025 . . . . 0.99 110.218 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 120.9 151.13 8.54 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 109.358 -1.497 . . . . 0.55 109.358 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -52.01 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.347 -1.09 . . . . 2.59 110.929 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 66' ' ' GLY . 37.8 tt0 -66.28 -40.35 90.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.99 -1.069 . . . . 2.2 110.101 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt -91.16 -7.42 51.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.128 -0.982 . . . . 1.79 110.941 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.78 -26.7 67.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.657 -1.277 . . . . 1.54 110.66 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.32 68.77 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.001 -1.062 . . . . 0.64 110.233 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.5 mt -73.16 -38.68 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.023 -1.048 . . . . 0.58 110.007 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -76.63 -25.7 54.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 0.62 109.538 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -66.72 -40.4 88.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.1 -1.0 . . . . 1.23 109.22 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.34 -36.92 37.86 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.546 -1.422 . . . . 0.52 109.546 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -59.65 -21.36 60.4 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.205 -1.174 . . . . 1.29 109.124 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 76.9 mt -86.02 -42.55 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.01 -1.107 . . . . 0.55 108.01 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttm -59.6 -37.32 78.26 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.125 -1.065 . . . . 1.89 108.125 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.02 -43.35 95.86 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.009 -1.108 . . . . 0.53 108.009 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.9 tp -66.57 -42.34 87.18 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.357 -0.979 . . . . 0.43 108.357 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.73 8.43 19.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.546 -0.721 . . . . 1.24 109.961 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -51.08 123.37 9.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.979 -1.076 . . . . 1.31 109.6 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -67.09 -23.05 65.81 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.275 -0.891 . . . . 1.35 108.705 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -76.38 -49.29 17.17 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.49 -0.756 . . . . 2.16 109.424 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 75.1 mt -65.03 -17.25 64.28 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.072 -1.017 . . . . 0.6 109.772 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -79.01 -44.94 21.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -0.947 . . . . 1.28 109.644 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -63.61 -30.87 71.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.361 -0.837 . . . . 1.28 109.487 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.26 -46.43 50.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.232 -0.918 . . . . 1.29 108.945 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.54 -53.87 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.669 -0.863 . . . . 0.58 108.669 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.8 mt -49.66 -66.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.594 -0.691 . . . . 0.78 110.195 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -47.07 -41.91 17.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.191 -0.943 . . . . 0.86 110.111 -179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.9 mt -60.01 -56.44 21.59 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.108 -1.037 . . . . 0.79 108.669 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 99.3 mt -50.55 -46.66 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.205 -0.935 . . . . 0.71 110.624 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -85.07 -33.13 22.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.994 -1.066 . . . . 2.05 111.649 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 91' ' ' ALA . 27.1 t70 -83.42 -43.58 15.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.59 -1.319 . . . . 1.59 111.643 -177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -104.18 16.98 25.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.738 -1.226 . . . . 1.89 109.945 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.6 m80 45.46 48.87 10.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.272 -0.892 . . . . 1.31 109.845 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.2 mtt -101.63 149.33 24.23 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.922 -0.77 . . . . 1.28 108.922 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 64.1 p -76.67 149.95 36.41 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.359 -0.838 . . . . 0.62 109.816 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -54.83 -31.24 59.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.47 109.521 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -44.78 53.53 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.475 -0.935 . . . . 2.0 108.475 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.74 -53.03 14.74 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.702 -0.624 . . . . 0.56 110.191 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 0.48 109.644 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.1 -31.08 60.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.44 109.707 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 109' ' ' GLU . 28.5 t60 -72.42 -51.09 21.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.931 . . . . 1.42 110.111 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -49.79 -62.92 1.29 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 1.26 110.497 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 49.1 t -51.73 -54.55 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.102 -0.999 . . . . 0.61 109.883 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.538 HG21 ' HA3' ' A' ' 134' ' ' GLY . 40.3 mm -64.72 -29.11 46.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.381 -0.825 . . . . 0.64 109.636 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 105' ' ' HIS . 37.0 tt0 -72.75 -23.23 60.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.2 109.727 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.11 -26.29 34.53 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.267 -1.444 . . . . 0.82 111.761 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -69.16 -46.45 67.54 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.675 -1.485 . . . . 1.27 108.759 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.6 -47.96 65.38 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.36 -0.838 . . . . 0.91 109.174 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 39.7 p -61.67 -37.4 83.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.416 -0.803 . . . . 1.73 109.819 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.56 99.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.106 -0.996 . . . . 1.04 109.832 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.81 -25.68 65.7 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.859 -1.163 . . . . 1.03 107.859 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -64.29 -17.3 63.5 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.509 -0.744 . . . . 1.95 109.456 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -82.04 -9.51 59.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.271 -0.893 . . . . 1.71 109.461 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.99 148.83 24.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.91 . . . . 1.26 108.72 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.97 60.79 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 2.83 109.089 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -146.39 123.39 11.39 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 1.58 109.497 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -65.04 -10.98 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 2.8 109.576 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -79.0 -64.45 1.18 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.301 -0.874 . . . . 1.02 109.487 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.4 mt -69.08 -29.49 67.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 1.06 109.626 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 127' ' ' ALA . 80.2 tttt -66.37 -52.69 44.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.99 -1.069 . . . . 2.39 108.86 179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -56.13 -21.94 25.49 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.181 -0.949 . . . . 2.2 108.605 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -72.31 -26.84 62.1 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.608 -1.626 . . . . 2.09 106.608 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -59.74 -43.05 94.42 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.631 -0.877 . . . . 0.86 108.631 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.23 -36.85 84.11 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.7 -0.8 . . . . 0.9 108.872 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.62 -32.24 70.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.443 -0.786 . . . . 1.35 109.216 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.6 t -76.87 -42.79 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.175 -0.953 . . . . 0.58 108.469 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.418 ' HG3' HH11 ' A' ' 131' ' ' ARG . 23.3 ttm-85 -58.19 -37.1 74.12 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.161 -0.962 . . . . 3.22 108.44 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -61.0 -35.72 77.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.598 -0.689 . . . . 1.32 109.9 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.6 mt -67.54 -27.46 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.962 -1.086 . . . . 0.5 109.236 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.538 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -80.1 -41.57 11.94 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.152 -1.579 . . . . 0.44 109.152 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -56.35 -48.27 77.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.519 -0.989 . . . . 2.71 109.752 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 36.9 mtt-85 -61.4 -48.38 81.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 2.2 108.737 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -52.41 -49.1 65.17 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.562 -0.711 . . . . 1.13 109.107 179.735 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.5 mt -52.51 -61.39 2.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.125 -0.984 . . . . 0.54 109.893 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.455 ' NH2' ' OE2' ' A' ' 21' ' ' GLU . 30.1 mtt-85 -48.08 -18.84 0.22 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 2.32 110.981 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.7 m120 -85.16 -45.98 11.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.851 -1.156 . . . . 1.26 109.84 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -64.99 -36.12 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.092 -1.005 . . . . 0.62 109.739 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 47.3 mt -86.52 -0.9 57.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.943 . . . . 0.67 109.203 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 56.92 24.76 51.15 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.396 -1.882 . . . . 0.68 108.396 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.1 tp -63.16 165.23 7.48 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -1.01 . . . . 0.77 109.132 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -66.68 142.66 57.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.163 -0.961 . . . . 2.4 109.486 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 146' ' ' ILE . 25.7 mt -104.46 135.0 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.414 -0.804 . . . . 0.87 109.032 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.672 ' N ' HD12 ' A' ' 147' ' ' ILE . 3.5 mp -77.13 110.3 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.22 -0.925 . . . . 1.32 109.374 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -98.77 93.65 6.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 1.54 109.609 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.0 mt -79.59 -18.52 51.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.171 -0.955 . . . . 0.77 109.581 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -79.35 3.64 17.65 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.046 -1.034 . . . . 1.57 109.136 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -107.05 15.74 24.94 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.464 -0.773 . . . . 0.82 109.671 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.61 156.26 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.82 109.57 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -154.27 14.08 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -0.936 . . . . 2.11 109.824 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -120.07 123.27 42.99 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.52 -0.738 . . . . 1.41 109.118 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.18 112.82 1.85 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.299 -0.876 . . . . 1.3 109.159 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -150.64 175.35 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 0.57 109.439 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 4.6 mt -90.88 156.98 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 107.933 -1.136 . . . . 0.43 107.933 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 13.9 tp -107.15 117.84 35.14 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.556 0.693 . . . . 0.56 109.309 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.75 133.09 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 109.038 -0.727 . . . . 0.54 109.038 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.66 152.31 13.78 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.495 -0.753 . . . . 0.62 109.588 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -59.0 -39.0 80.49 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.382 -1.449 . . . . 0.8 107.775 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 162' ' ' ASP . 3.1 p30 -173.01 144.91 1.31 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.197 -0.94 . . . . 2.34 109.394 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.5 mt -114.25 132.97 55.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.569 -0.707 . . . . 0.65 109.443 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 165' ' ' PRO . 10.8 p -92.97 152.44 41.45 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.74 108.759 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' C ' ' O ' ' A' ' 164' ' ' THR . 59.3 Cg_exo -35.36 -39.23 0.23 Allowed 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.384 2.056 . . . . 0.6 112.326 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.9 m -57.45 -64.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.63 109.016 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -48.9 -35.98 16.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 1.25 109.488 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.2 p -76.54 -23.03 53.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.5 109.711 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.69 -25.24 38.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.51 110.083 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -105.57 -10.4 16.88 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.289 -0.882 . . . . 1.17 109.663 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.6 tp -57.63 143.35 41.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.019 -1.051 . . . . 0.61 108.368 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.419 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m-20 -99.03 93.85 6.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.186 -0.946 . . . . 2.12 109.604 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 37.1 mt -75.81 40.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.407 -0.808 . . . . 1.34 109.042 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.4 mtmm -110.25 -23.29 11.31 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.708 -0.62 . . . . 1.97 109.663 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -134.52 8.99 3.66 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.368 -0.833 . . . . 1.9 110.424 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 178' ' ' GLY . 92.2 t -78.96 156.34 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.976 -1.077 . . . . 0.48 110.103 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 176' ' ' VAL . 14.4 tp -109.96 -19.67 13.01 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.556 -0.715 . . . . 1.39 110.532 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.44 -177.73 42.89 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.506 -1.331 . . . . 0.38 110.131 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -136.01 130.48 33.62 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.391 -1.064 . . . . 0.46 110.455 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.512 ' CG2' HG21 ' A' ' 205' ' ' THR . 9.2 mt -128.3 122.7 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.598 -1.26 . . . . 0.59 107.598 178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.514 ' O ' ' O ' ' A' ' 203' ' ' VAL . 33.2 p -142.06 154.02 44.64 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.099 -1.0 . . . . 0.67 111.889 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 21.0 p30 -88.35 42.73 1.08 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.986 -1.071 . . . . 2.24 111.019 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 203' ' ' VAL . . . -94.37 100.74 12.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.709 -1.244 . . . . 1.11 109.206 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.96 32.22 1.74 Allowed Glycine 0 N--CA 1.492 2.37 0 O-C-N 120.837 -1.164 . . . . 1.63 110.462 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -96.81 117.02 5.63 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.861 -1.296 . . . . 1.47 109.861 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -54.31 -30.88 52.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -1.16 . . . . 5.24 108.557 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 19.4 p -115.37 49.45 1.07 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.932 -0.766 . . . . 2.92 108.932 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.1 m -79.2 143.21 35.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.3 -0.875 . . . . 1.6 108.896 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 54.8 t60 -48.04 -52.46 20.02 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.221 -0.924 . . . . 0.92 110.171 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 3.3 m -46.26 -53.14 11.24 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 1.59 110.032 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 m -51.58 -46.35 63.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 1.42 110.029 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 34.1 mm -50.54 -36.55 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 1.41 109.983 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 63.5 mtp -72.4 -56.93 4.65 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.852 -1.166 . . . . 0.86 107.852 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.0 -28.7 39.67 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.751 -0.658 . . . . 0.59 110.294 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -82.7 -46.76 12.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 3.06 110.141 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.3 m -69.9 -35.22 74.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.887 -1.133 . . . . 0.73 110.431 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.486 ' C ' ' H ' ' A' ' 199' ' ' LEU . 21.9 mt -85.2 2.63 42.92 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.945 -1.097 . . . . 0.67 109.414 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 55.86 -0.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 1.49 111.14 178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 197' ' ' LEU . 33.7 mt -65.23 168.1 8.54 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.71 -1.244 . . . . 0.64 108.029 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -90.39 142.57 3.6 Favored 'Trans proline' 0 N--CA 1.487 1.089 0 C-N-CA 122.05 1.834 . . . . 0.59 110.786 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.17 -179.77 6.37 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.352 -1.339 . . . . 0.55 111.058 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 203' ' ' VAL . 54.7 mt -149.01 161.76 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 106.816 -1.55 . . . . 0.63 106.816 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 183' ' ' ALA . 5.5 m -143.8 -26.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.91 -1.119 . . . . 0.77 110.649 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -87.32 36.94 3.26 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 120.832 -1.168 . . . . 0.87 110.743 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.512 HG21 ' CG2' ' A' ' 180' ' ' ILE . 12.2 p -66.21 -32.89 74.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.743 -1.445 . . . . 0.89 108.551 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 78.75 -97.25 1.47 Allowed Glycine 0 N--CA 1.488 2.13 0 C-N-CA 119.871 -1.157 . . . . 0.93 111.006 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.6 t -113.61 44.49 1.59 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.989 -1.301 . . . . 1.6 112.53 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 24.3 t -78.85 -27.98 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.498 -1.376 . . . . 0.75 107.619 177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 64.1 p -68.61 -11.63 60.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.84 109.555 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.8 m -105.25 12.05 32.28 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.414 -0.804 . . . . 1.61 108.983 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -133.21 -6.42 3.01 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.419 -0.801 . . . . 2.3 109.697 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.9 t -130.31 148.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.491 -0.755 . . . . 0.76 109.87 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -111.83 -178.27 3.39 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 107.023 -1.473 . . . . 2.01 107.023 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.9 p-10 -79.76 147.82 31.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.828 -1.17 . . . . 2.19 109.391 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.5 m-20 81.22 -10.57 1.19 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.079 0.466 . . . . 2.4 110.052 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -56.66 156.8 5.93 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.094 -1.004 . . . . 1.99 108.632 178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -88.73 118.54 28.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.912 -1.118 . . . . 1.3 108.79 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 30.4 mt -118.29 156.28 29.14 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.79 0.805 . . . . 0.53 109.97 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.402 HD12 ' HG3' ' A' ' 231' ' ' PRO . 3.4 mt -142.24 109.36 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.107 -1.072 . . . . 0.6 108.107 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 39.4 tp -88.86 126.44 35.37 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.544 -0.91 . . . . 0.57 108.544 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 222' ' ' ALA . 13.1 p30 -99.87 -28.91 12.88 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.224 -0.923 . . . . 2.22 109.592 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 38.47 27.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.624 -0.673 . . . . 0.75 110.34 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 221' ' ' ASP . 11.2 t -120.78 -58.92 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 106.039 -1.837 . . . . 0.92 106.039 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -89.6 6.36 41.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.274 -1.38 . . . . 2.36 107.274 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.515 ' C ' HD22 ' A' ' 225' ' ' ASN . 0.2 OUTLIER 60.09 62.68 1.58 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.165 -0.68 . . . . 1.42 109.165 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' OD2' ' A' ' 221' ' ' ASP . 6.8 tt0 -156.71 149.58 23.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 1.97 110.48 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.8 t -115.57 129.14 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.736 -0.838 . . . . 0.65 108.736 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -101.61 134.95 43.95 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.155 -0.966 . . . . 0.97 109.712 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -108.67 122.05 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.461 -0.774 . . . . 0.67 110.322 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 45.24 64.29 7.97 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.216 -0.928 . . . . 1.45 110.408 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.6 Cg_endo -79.06 163.96 25.15 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.808 2.339 . . . . 0.82 111.688 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 21.5 p -73.84 158.21 34.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.004 . . . . 1.62 109.506 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -62.93 -24.71 67.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 2.6 109.008 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -63.4 -33.99 76.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.466 -0.771 . . . . 3.06 109.534 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.0 -42.15 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -0.914 . . . . 1.14 109.148 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 70.3 mt -58.98 -62.33 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 1.04 109.683 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 237' ' ' ASP . 48.7 t0 -52.76 -37.51 59.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 2.54 109.742 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -66.08 -41.39 90.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 2.6 109.927 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 50.9 mtp -78.63 -38.35 39.93 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.137 -0.977 . . . . 1.23 109.559 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -58.09 -25.72 61.66 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.133 -0.979 . . . . 2.67 109.565 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -77.07 -62.05 1.78 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.172 -0.955 . . . . 1.66 109.864 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 25.5 t -62.7 -51.05 76.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.095 -1.003 . . . . 2.2 109.833 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -48.42 -59.01 3.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.925 . . . . 3.0 109.854 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -63.62 -23.38 67.36 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.442 -0.786 . . . . 1.76 110.551 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -66.31 -25.03 66.65 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.832 -1.168 . . . . 2.78 107.973 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.78 -53.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.713 -0.847 . . . . 2.06 108.713 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.49 72.01 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.836 -0.802 . . . . 2.4 108.836 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.2 p -74.45 -21.45 59.59 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.47 -0.769 . . . . 2.87 109.158 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.49 -0.756 . . . . 3.41 108.998 -179.702 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.28 0.562 . . . . 3.66 109.593 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -55.08 95.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 1.12 109.18 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.9 m -94.98 118.72 32.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -0.884 . . . . 1.45 109.732 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.808 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -113.65 -158.78 13.01 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.293 -1.923 . . . . 0.92 108.293 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 50.8 mt -96.18 -9.54 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.012 -1.287 . . . . 1.05 108.188 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 28.5 tp 55.11 110.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.399 0.618 . . . . 0.88 109.715 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -88.65 -50.62 6.14 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.012 -1.055 . . . . 0.78 108.448 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 m -143.9 150.71 50.67 Favored Pre-proline 0 N--CA 1.497 1.886 0 O-C-N 121.364 -0.835 . . . . 1.5 108.996 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.06 153.43 25.02 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.651 2.234 . . . . 0.86 114.019 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.84 172.27 31.11 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.92 -1.272 . . . . 0.78 109.92 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 18.1 mt -144.33 118.96 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.26 -1.141 . . . . 0.74 109.577 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.36 144.55 34.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.249 -0.907 . . . . 0.45 110.112 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.8 m-85 -107.41 138.0 44.42 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.804 -1.184 . . . . 0.64 107.804 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.15 165.57 36.69 Favored Glycine 0 N--CA 1.498 2.767 0 C-N-CA 118.375 -1.869 . . . . 0.45 111.603 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.12 151.54 31.31 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.889 . . . . 1.88 110.665 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 214' ' ' ASN . . . -76.21 122.91 25.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.739 -0.601 . . . . 0.59 110.602 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.3 tp -106.72 92.13 3.97 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 107.659 -1.238 . . . . 0.64 107.659 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.67 124.85 31.26 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.003 -1.061 . . . . 0.74 111.283 -177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.24 92.57 7.29 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.388 -0.597 . . . . 0.74 109.388 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.2 mtpm? -90.54 159.78 16.31 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.576 -0.898 . . . . 1.87 108.576 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -131.1 127.71 38.7 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.765 -0.828 . . . . 2.58 108.765 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.17 138.25 37.79 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.375 -0.828 . . . . 2.14 109.824 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -62.26 141.73 58.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.522 -0.736 . . . . 1.93 109.153 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.3 mt -88.77 138.58 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.278 -0.888 . . . . 0.68 109.192 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -105.8 110.71 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.437 -0.79 . . . . 0.84 109.747 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' CD2' ' A' ' 105' ' ' HIS . 61.4 mt -88.23 137.88 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.303 -0.873 . . . . 0.79 109.386 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -90.95 117.12 29.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 1.37 109.116 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -93.69 23.63 4.6 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.197 -0.939 . . . . 2.62 108.811 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.0 mtmm -81.97 139.71 34.41 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.468 -0.77 . . . . 2.35 109.692 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -86.06 134.41 33.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -0.908 . . . . 2.35 108.725 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.0 pt -94.86 178.89 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.186 -0.946 . . . . 0.78 110.314 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 34' ' ' ASP . 58.4 p -104.9 153.73 21.0 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.154 -0.684 . . . . 1.04 109.154 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.13 -6.81 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 1.05 109.943 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 32' ' ' SER . 48.2 m-20 -82.99 -22.91 33.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.018 -1.051 . . . . 2.47 109.954 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.89 -10.74 15.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.212 -0.93 . . . . 1.46 109.842 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.0 t -58.73 -42.06 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.77 109.044 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -57.3 -36.08 70.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.386 -0.821 . . . . 1.46 109.143 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -68.46 -39.27 81.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 2.29 110.518 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -60.4 -36.85 79.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 1.3 109.433 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -63.92 -44.93 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.76 109.798 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -64.92 -43.29 93.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.014 . . . . 1.5 108.939 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 42' ' ' ARG . 5.0 mtt-85 -65.66 -31.31 72.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.363 -0.836 . . . . 2.66 108.884 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 89' ' ' ILE . 47.8 t80 -85.91 -54.61 4.4 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.383 -0.823 . . . . 0.75 109.472 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -56.95 -58.1 9.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.957 . . . . 0.83 109.236 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.617 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 5.4 t -65.14 -40.06 93.89 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 0.78 108.971 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.52 -58.25 10.42 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.607 -1.797 . . . . 0.57 108.607 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' NH1' ' OE1' ' A' ' 86' ' ' GLU . 33.5 ttp180 -47.42 -30.18 3.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -1.084 . . . . 2.83 109.169 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.91 -33.73 72.27 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.261 -1.014 . . . . 0.65 108.261 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -80.78 -58.49 3.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.249 -0.649 . . . . 2.57 109.249 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.29 -43.2 53.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.838 -1.164 . . . . 0.51 110.183 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.9 t -62.02 -35.7 79.33 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.845 -1.16 . . . . 1.36 108.227 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.47 64.02 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.842 -0.536 . . . . 0.6 109.619 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -68.39 -62.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.062 -1.024 . . . . 1.36 109.315 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -50.63 -45.0 57.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 1.38 108.721 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -55.81 -45.21 78.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.914 -0.773 . . . . 1.27 108.914 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 m -65.84 -45.63 81.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.147 -0.971 . . . . 0.6 109.534 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.3 mt -68.22 -30.36 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.53 109.101 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -60.04 -41.83 93.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.387 -0.821 . . . . 0.99 108.968 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -71.54 -23.61 61.8 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.203 -0.936 . . . . 0.59 109.629 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -71.47 -35.18 70.76 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.988 -1.07 . . . . 1.81 108.135 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.437 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -73.28 -24.19 60.39 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.396 -0.964 . . . . 0.48 108.396 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.25 -36.56 12.46 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.841 -1.304 . . . . 0.58 109.841 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -85.86 -17.03 36.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.268 . . . . 1.39 108.911 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -95.09 -47.74 6.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.329 -0.857 . . . . 0.82 110.058 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -106.68 -11.56 15.79 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.182 -0.949 . . . . 0.99 110.419 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 68' ' ' GLU . . . 107.99 148.49 13.93 Favored Glycine 0 N--CA 1.502 3.054 0 N-CA-C 109.936 -1.266 . . . . 0.55 109.936 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -50.25 -8.78 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -1.042 . . . . 2.59 110.158 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 48.5 mt-10 -64.57 -28.99 70.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.997 -1.064 . . . . 2.2 110.551 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -91.83 -11.88 35.27 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.944 -1.098 . . . . 1.79 110.307 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -64.88 -26.8 68.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.811 -1.181 . . . . 1.54 110.194 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.11 -37.4 85.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 0.64 110.414 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.9 mt -70.54 -39.77 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.994 -1.066 . . . . 0.58 109.494 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -76.45 -27.76 56.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.112 -0.993 . . . . 0.62 109.522 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -62.99 -36.25 82.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.969 -1.082 . . . . 1.23 109.224 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -41.41 52.8 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.249 -1.54 . . . . 0.52 109.249 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -59.7 -16.89 30.15 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.234 -1.156 . . . . 1.29 109.594 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.99 -35.67 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.027 -1.046 . . . . 0.55 108.287 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 82' ' ' ASP . 5.5 ttt -62.43 -49.74 74.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.518 -0.919 . . . . 1.89 108.518 179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.0 tp -56.43 -38.24 71.32 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.43 -0.952 . . . . 0.53 108.43 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.6 tp -70.94 -49.91 40.42 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.828 -0.749 . . . . 0.43 110.15 -178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -85.47 7.77 21.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.123 -0.985 . . . . 1.24 110.175 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 78' ' ' MET . 49.7 t0 -44.95 121.08 2.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.176 -0.952 . . . . 1.31 109.632 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.96 -26.52 68.33 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.53 -0.915 . . . . 1.35 108.53 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.77 -49.61 29.66 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.682 -0.807 . . . . 2.16 109.125 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.5 mt -66.59 -23.22 66.16 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.937 -1.102 . . . . 0.6 109.247 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' OE1' ' NH1' ' A' ' 47' ' ' ARG . 58.9 tt0 -73.63 -45.97 49.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.28 109.74 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -64.01 -32.28 73.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.256 -0.902 . . . . 1.28 109.911 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -73.6 -40.6 63.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.049 -1.032 . . . . 1.29 108.736 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 54.0 mt -60.7 -55.32 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.196 -1.038 . . . . 0.58 108.196 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 75.1 mt -47.91 -67.15 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.715 -0.615 . . . . 0.78 110.164 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -44.3 -59.73 2.25 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.386 -0.821 . . . . 0.86 110.472 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 mt -46.36 -51.5 14.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.326 -0.859 . . . . 0.79 109.794 -178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 95.0 mt -54.93 -42.67 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.981 -1.075 . . . . 0.71 110.01 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -85.47 -39.54 17.38 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.087 -1.008 . . . . 2.05 111.788 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -84.71 -31.62 23.97 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.822 -1.174 . . . . 1.59 112.166 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -107.9 15.68 24.21 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 120.745 -1.222 . . . . 1.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 97' ' ' HIS . 0.3 OUTLIER 44.37 43.44 6.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.304 -0.873 . . . . 1.31 109.893 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 32.1 mtt -97.26 143.45 28.02 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 1.28 108.749 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.4 p -75.55 152.26 37.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.191 -0.943 . . . . 0.62 109.707 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -50.49 -31.25 14.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.956 . . . . 0.47 108.989 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -74.02 -42.68 59.96 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.335 -0.987 . . . . 2.0 108.335 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.4 -57.82 4.1 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.275 0.56 . . . . 0.56 110.442 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.81 -45.9 78.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -0.878 . . . . 0.48 109.812 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.35 68.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.44 109.239 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' CD2' ' CD1' ' A' ' 26' ' ' ILE . 32.4 t60 -71.4 -39.4 71.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 1.42 109.448 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -52.04 -65.88 0.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.499 -0.75 . . . . 1.26 110.4 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 24.5 t -49.92 -50.5 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.022 -1.049 . . . . 0.61 109.846 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mm -62.99 -15.26 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.888 . . . . 0.64 109.104 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -72.81 -41.18 65.2 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.149 -0.97 . . . . 2.2 109.989 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.99 -21.38 50.26 Favored Glycine 0 N--CA 1.495 2.615 0 C-N-CA 119.611 -1.281 . . . . 0.82 112.516 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -68.38 -45.67 72.1 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.458 -1.613 . . . . 1.27 108.796 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -77.22 -47.45 20.19 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.646 -0.659 . . . . 0.91 109.585 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 36.4 m -60.67 -43.92 97.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 1.73 110.018 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.65 84.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.089 -1.007 . . . . 1.04 110.771 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 72.9 mt -66.9 -28.9 68.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.74 -1.225 . . . . 1.03 109.692 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.25 -17.56 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.021 -1.049 . . . . 1.95 109.363 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -80.94 -5.03 56.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.305 -0.872 . . . . 1.71 109.447 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 98.0 mt -83.02 152.35 25.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 1.26 109.3 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -99.69 49.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.886 -0.783 . . . . 2.83 108.886 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -146.93 121.97 10.08 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.061 -1.024 . . . . 1.58 110.087 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -64.79 -11.48 37.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.523 -0.735 . . . . 2.8 109.258 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -76.85 -65.15 0.98 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 1.02 109.248 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.8 mt -63.91 -20.96 66.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.98 -1.075 . . . . 1.06 108.901 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 127' ' ' ALA . 75.9 tttt -67.41 -51.69 48.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.813 -1.179 . . . . 2.39 108.322 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -55.56 -22.47 21.98 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.193 -1.04 . . . . 2.2 108.193 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -71.46 -27.4 63.23 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.638 -1.615 . . . . 2.09 106.638 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' A' ' 124' ' ' LYS . . . -60.49 -40.95 93.18 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.272 -1.01 . . . . 0.86 108.272 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.36 -40.07 77.69 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.457 -0.777 . . . . 0.9 109.187 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -68.83 -29.15 67.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.351 -0.843 . . . . 1.35 108.999 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.9 t -78.33 -52.53 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.307 -0.871 . . . . 0.58 108.953 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -54.64 -37.97 66.31 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.099 -1.0 . . . . 3.22 108.524 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -58.65 -37.72 76.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.404 -0.81 . . . . 1.32 109.541 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 92.4 mt -68.69 -21.67 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.16 -0.962 . . . . 0.5 109.364 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.19 -47.24 6.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.095 -1.602 . . . . 0.44 109.095 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -50.53 -45.2 56.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -1.067 . . . . 2.71 109.741 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' NH2' ' OG ' ' A' ' 166' ' ' SER . 86.9 mtt180 -64.39 -50.81 66.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.882 -1.136 . . . . 2.2 108.529 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 31.5 tp -48.71 -32.67 8.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.617 . . . . 1.13 109.455 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.6 mt -73.49 -58.19 3.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.971 -1.08 . . . . 0.54 110.081 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -48.63 -18.28 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.127 -0.983 . . . . 2.32 110.601 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.0 OUTLIER -85.25 -36.38 20.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.065 -1.022 . . . . 1.26 109.717 -179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -73.98 -38.77 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.035 . . . . 0.62 109.821 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.7 mt -88.1 -5.03 58.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.046 -1.034 . . . . 0.67 109.445 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.38 23.97 63.08 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.521 -1.832 . . . . 0.68 108.521 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.47 155.81 6.77 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.599 -0.942 . . . . 0.77 109.376 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -66.92 137.81 56.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 2.4 109.714 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.2 mt -105.27 140.91 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.87 108.981 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 147' ' ' ILE . 4.0 mp -76.84 122.13 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.092 -1.005 . . . . 1.32 109.595 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -97.13 90.66 5.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.446 -0.784 . . . . 1.54 109.873 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 151' ' ' ALA . 20.5 mt -80.94 -28.18 35.83 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.342 -0.849 . . . . 0.77 109.256 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.3 t -79.33 26.21 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.295 -0.878 . . . . 1.57 109.495 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 149' ' ' LEU . . . -140.32 31.56 1.92 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.304 -0.872 . . . . 0.82 109.639 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -72.8 146.59 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.278 -0.889 . . . . 0.82 109.578 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -123.11 -9.95 8.15 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.795 -0.817 . . . . 2.11 108.795 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -121.35 120.88 36.32 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.65 -0.871 . . . . 1.41 108.65 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -62.89 127.45 31.33 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.3 -0.875 . . . . 1.3 109.246 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.2 m -150.1 179.05 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.27 -0.894 . . . . 0.57 109.057 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 5.3 mt -89.91 147.24 5.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.444 -0.947 . . . . 0.43 108.444 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 7.0 tp -102.35 121.34 42.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.733 0.778 . . . . 0.56 109.858 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.54 132.12 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.678 -0.86 . . . . 0.54 108.678 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.6 147.17 13.69 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.504 -0.747 . . . . 0.62 109.436 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -54.74 -36.55 64.91 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.57 -1.331 . . . . 0.8 107.532 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.6 154.19 1.56 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.865 -1.161 . . . . 2.34 107.865 179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 30.3 mt -119.45 134.56 55.16 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.331 -0.855 . . . . 0.65 109.581 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.9 p -91.32 150.9 42.22 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.483 -0.761 . . . . 0.74 109.189 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 169' ' ' ALA . 59.6 Cg_exo -36.53 -53.25 1.1 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.501 2.134 . . . . 0.6 112.617 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.438 ' OG ' ' NH2' ' A' ' 136' ' ' ARG . 61.5 m -47.61 -47.9 28.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.056 -1.027 . . . . 0.63 109.327 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -66.06 -46.48 77.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 1.25 109.392 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.1 p -69.39 -21.65 63.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.5 109.735 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 165' ' ' PRO . . . -77.72 -31.57 52.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.192 -0.943 . . . . 0.51 110.487 -179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -99.9 -10.53 21.6 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.074 -1.016 . . . . 1.17 109.312 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.86 144.15 53.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.324 -0.86 . . . . 0.61 109.498 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -96.57 144.11 26.94 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.032 -1.042 . . . . 2.12 108.376 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.9 mt -88.76 -37.28 15.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.082 -1.011 . . . . 1.34 110.838 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -83.55 -14.56 51.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.771 -1.206 . . . . 1.97 111.389 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -97.2 -6.94 33.56 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.665 -1.272 . . . . 1.9 109.122 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.617 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.0 t -99.05 146.83 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.472 -0.936 . . . . 0.48 108.472 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.25 -14.69 21.22 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.146 -0.971 . . . . 1.39 109.649 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.617 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.23 174.9 37.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.908 -1.677 . . . . 0.38 108.908 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -128.84 124.18 34.68 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.353 -1.086 . . . . 0.46 109.246 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.481 HG23 HG21 ' A' ' 205' ' ' THR . 11.3 mt -125.53 120.37 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 106.741 -1.577 . . . . 0.59 106.741 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 203' ' ' VAL . 28.3 p -140.92 153.68 45.77 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 122.272 1.034 . . . . 0.67 112.957 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.422 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 15.7 m-20 -82.44 36.32 0.47 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.619 -0.719 . . . . 2.24 109.515 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -89.01 -169.14 2.41 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.838 -1.164 . . . . 1.11 110.417 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -92.6 -101.61 1.45 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.193 -1.563 . . . . 1.63 109.193 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.04 -16.73 0.15 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.181 -1.568 . . . . 1.47 109.181 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 186' ' ' ARG . 2.0 mtt-85 -68.32 91.68 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -1.107 . . . . 5.24 109.117 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 7.0 p 48.34 48.74 18.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 2.92 109.443 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.5 t -84.74 146.57 27.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -0.888 . . . . 1.6 109.373 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -53.48 -48.0 69.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.0 -1.063 . . . . 0.92 109.252 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 12.1 m -54.69 -31.62 58.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 1.59 109.518 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.5 t -73.95 -38.42 64.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 1.42 109.58 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 70.2 mt -55.99 -27.96 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.117 -0.989 . . . . 1.41 109.221 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 79.6 mtp -71.89 -61.46 1.78 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.299 -1.371 . . . . 0.86 107.299 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.91 64.81 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.499 -0.773 . . . . 0.59 110.012 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.55 -49.11 23.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 3.06 110.248 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.8 m -69.67 -34.93 74.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.996 -1.065 . . . . 0.73 110.018 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 199' ' ' LEU . 26.4 mt -90.59 -2.42 57.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.115 -0.991 . . . . 0.67 110.162 -179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 55.28 0.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.021 -1.05 . . . . 1.49 111.157 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 197' ' ' LEU . 88.5 mt -65.75 168.52 8.49 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 120.592 -1.317 . . . . 0.64 108.426 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.45 145.4 14.85 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.92 1.747 . . . . 0.59 110.71 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -162.43 172.69 15.16 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 118.367 -1.333 . . . . 0.55 111.225 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 25.9 mt -150.74 154.39 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 106.527 -1.657 . . . . 0.63 106.527 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.469 ' O ' ' O ' ' A' ' 181' ' ' THR . 2.4 m -140.79 -33.19 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 120.877 -1.139 . . . . 0.77 110.294 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -77.43 38.93 1.66 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.914 -1.274 . . . . 0.87 109.914 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.481 HG21 HG23 ' A' ' 180' ' ' ILE . 60.4 p -71.12 -2.75 16.73 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.946 -1.326 . . . . 0.89 108.975 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 56.86 -100.96 0.13 Allowed Glycine 0 N--CA 1.483 1.77 0 N-CA-C 109.891 -1.283 . . . . 0.93 109.891 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 62.0 m -124.86 45.82 2.46 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.423 -1.045 . . . . 1.6 111.612 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 6.8 t -60.3 -29.44 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.616 -1.302 . . . . 0.75 107.76 178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 77.8 p -63.67 -13.62 44.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 0.84 109.219 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.433 ' O ' ' OE1' ' A' ' 211' ' ' GLN . 7.2 t -103.53 10.34 37.12 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.393 -0.966 . . . . 1.61 108.393 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 210' ' ' SER . 15.3 mm100 -132.35 -23.96 2.09 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.358 -0.608 . . . . 2.3 109.358 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 40.4 t -117.18 149.01 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 108.724 -0.843 . . . . 0.76 108.724 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -118.62 -172.9 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.578 -1.268 . . . . 2.01 107.578 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 16' ' ' ALA . 40.2 t-20 -80.94 145.79 31.08 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.017 -1.052 . . . . 2.19 110.811 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.9 OUTLIER 80.85 -11.45 1.13 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 122.178 -0.326 . . . . 2.4 110.992 178.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.94 140.56 51.88 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.779 -1.201 . . . . 1.99 108.344 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -86.14 111.75 20.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.996 -1.065 . . . . 1.3 108.733 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 9.7 mt -107.23 171.66 7.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.228 1.013 . . . . 0.53 110.402 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 5.3 mt -141.3 112.63 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.016 -1.476 . . . . 0.6 107.016 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.3 tp -88.51 123.8 33.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.434 -0.791 . . . . 0.57 109.399 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 223' ' ' VAL . 48.6 t0 -101.06 -35.64 9.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.22 108.859 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 39.67 27.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.572 -0.705 . . . . 0.75 110.407 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 221' ' ' ASP . 8.4 t -117.68 -57.65 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 N-CA-C 106.47 -1.678 . . . . 0.92 106.47 178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -90.75 18.59 6.29 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.189 -1.411 . . . . 2.36 107.189 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.808 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 55.05 57.06 5.9 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.617 . . . . 1.42 109.333 -179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -156.87 146.31 20.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.992 -1.067 . . . . 1.97 111.046 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 13.9 t -116.84 130.07 72.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 N-CA-C 108.162 -1.051 . . . . 0.65 108.162 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -95.81 135.49 37.46 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.828 -1.17 . . . . 0.97 109.705 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.58 129.05 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.639 -0.663 . . . . 0.67 110.585 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.5 t30 43.09 72.04 1.27 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.468 -0.77 . . . . 1.45 110.766 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -87.88 149.8 7.14 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.975 2.45 . . . . 0.82 111.465 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.9 p -75.19 151.31 38.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.959 -1.088 . . . . 1.62 109.849 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -47.46 -49.08 26.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.243 -0.91 . . . . 2.6 109.752 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -50.48 -38.04 41.91 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.456 -0.777 . . . . 3.06 109.341 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.78 -28.04 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.481 -0.933 . . . . 1.14 108.481 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 68.6 mt -80.43 -53.35 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.424 -0.797 . . . . 1.04 109.212 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.03 -40.28 76.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.298 -0.876 . . . . 2.54 110.331 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -65.71 -37.56 86.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.959 -1.088 . . . . 2.6 109.563 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 243' ' ' GLN . 42.5 mtp -79.41 -34.2 41.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 1.23 109.167 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.41 ' NH1' ' HG3' ' A' ' 240' ' ' ARG . 13.8 mmm-85 -51.03 -41.73 60.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.217 -0.927 . . . . 2.67 109.648 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -75.93 -61.67 1.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.35 -0.844 . . . . 1.66 110.808 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.6 t -67.96 -49.19 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.038 -1.039 . . . . 2.2 110.942 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 239' ' ' MET . 42.3 tt0 -54.14 -44.35 71.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.822 -1.174 . . . . 3.0 110.406 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.24 -29.76 71.03 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.866 -1.146 . . . . 1.76 109.926 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -68.59 -19.81 64.48 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.95 -1.093 . . . . 2.78 108.702 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 23.1 t -76.45 -43.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.217 -0.927 . . . . 2.06 109.463 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.71 -27.76 69.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.355 -0.841 . . . . 2.4 109.301 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 34.2 t -75.66 -24.88 56.41 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.317 -0.864 . . . . 2.87 109.659 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 3.41 110.302 -179.618 . . . . . . . . 0 0 . 1 stop_ save_